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Applying Economic Evaluation to Public 
Health: Case Studies in Cost Effectiveness 
Brendan Collins  
Abstract 
For local public health teams, commissioning services that work and are cost effective is 
important. Having ways of evaluating and assessing their cost effectiveness is invaluable. 
Health economics and public health have a natural kinship as they both take a population 
approach to maximising health. The aim of this investigation is to give examples of how a 
mixed methods approach can be used. This thesis gives three case studies where public 
health commissioned services for alcohol, tobacco and drug addiction in the North West of 
England have been evaluated for their cost effectiveness using a mix of economic evaluation 
techniques combined with elements of realist evaluation and equity impact analysis. These 
mixed methods evaluation techniques involve engaging with stakeholders to develop a 
common understanding of outcomes and assumptions in reaching a common understanding 
of the causal mechanisms that make an intervention work. This thesis outlines how the 
results of these evaluations were useful in informing strategy and the commissioning 
process and how they may be used more in the future. There were some novel analyses 
including matching up crime data and putting a cost on these crimes for people in contact 
with a drugs test on arrest programme, which found that costs were lower after the drug 
intervention. The researcher found that there was not a significant change in admissions 
post-detoxification which indicates that perhaps inpatient residential detoxification has only a 
limited effect on long term health prospects. This thesis has shown that economic evaluation 
and realist evaluation methods pose some challenges but can be carried out at a local level 
as a way of looking at public health interventions through a more complex lens. 
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COM-B - theory of motivation, stands for capability, opportunity, motivation - behaviour. 
COPD - chronic obstructive pulmonary disease. 
CUA – cost utility analysis. 
CV - curriculum vitae. 
CVD - cardiovascular disease. 
CWP – Cheshire & Wirral Partnership Trust. 
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DALY – disability adjusted life year, a measure of the burden of ill health in terms of years of 
life lost and years lived in disability compared to a benchmark (often Japan life expectancy). 
DCEA - distributional cost effectiveness analysis. 
DH - Department of Health (UK) sometimes called DoH. 
DIP – Drug Interventions Programme – a programme of drug treatment and monitoring for 
people who have been arrested for ‘trigger’ offences.  
DRR – Drug Rehabilitation Requirement – a requirement for an individual who has 
committed a crime to complete drug treatment as part of a community order. A failure to 
complete treatment will mean the person returns to court.   
DTORS - Drug Treatment Outcomes Research Study, a major longitudinal outcomes study 
of drug treatment in England, published in 2009. See also NTORS. 
EBM – Evidence Based Medicine. 
EQ-5D or EQ-5D-3L– Euroqol 5 dimension (3 level) general health related quality of life 
questionnaire. 
EQ-5D-5L - Euroqol 5 dimension (5 level) general health related quality of life questionnaire. 
EU - European Union. 
FY - financial year, in the UK runs from 1st April to 31st March. 
GDP - gross domestic product. 
GP - General Practitioner, primary healthcare giver in the UK. 
HIV - human immunodeficiency virus. 
HRU - harm reduction unit. 
HSIS - health services in schools. 
IBA – intervention & brief advice (Alcohol) (also called SBI – screening and brief 
intervention). 
ICER - incremental cost effectiveness ratio, the incremental change in cost per incremental 
unit of benefit. 
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IHS - integrated household survey, a survey commissioned by ONS on lifestyle behaviours. 
IOM - integrated offender management. 
IPED - image and performance enhancing drugs i.e. steroids, etc. 
IT - information technology. 
JSNA - Joint Strategic Needs Assessment, a local authority level assessment of health and 
social care needs of the population. 
LDQ - Leeds Dependency Questionnaire. 
LJMU - Liverpool John Moores University. 
LSD - Lysergic acid diethylamide, a psychedelic drug commonly known as 'acid'. 
LSOA – lower layer super output area – a small area of geography used by the UK Office for 
National Statistics since the 2001 Census, with an average population of around 1,500 
persons.  
MARAC - Multi Agency Risk Assessment Conferences (MARAC). 
MCDA - multi criteria decision analysis. 
MDMA - 3,4-methylenedioxy-N-methylamphetamine - an illegal drug otherwise known as 
ecstasy. 
MI - myocardial infarction (heart attack). 
MSOA – middle layer super output area – a medium area of geography used by the UK 
Office for National Statistics since the 2001 Census, with an average population of around 
8,500 persons. 
NAO - National Audit Office. 
NDTMS - national drug treatment monitoring system - a database of drug treatment data. 
NHS – (UK) National Health Service. 
NICE - the National Institute for Health & Care Excellence. 
NPS - novel psychoactive substances e.g. mephedrone. 
20 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
NRT - Nicotine Replacement Therapy. 
NSMC - national social marketing centre. 
NSP - needle and syringe programmes, whereby drug users can obtain clean needles and 
syringes. 
NTA – (UK) National Treatment Agency for Substance Misuse – was subsumed into Public 
Health England in 2013. 
NTORS - National Treatment Outcome Research Study, a large scale study into drug 
treatment carried out in England and Wales between 1995 and 2000. See also DTORS 
NWPHO - North West Public Health Observatory. 
OCU - opiate or crack user - see also PDU. 
OECD - organisation for economic co-operation and development. 
OU - opiate user. 
PbR - Payment by Results. 
PDU - problematic drug user - usually means an opiate or crack cocaine user. 
PHE – Public Health England. 
PHOF – Public Health Outcomes Framework. 
PIED - performance and image enhancing drugs (same as IPED). 
PRIME - theory of motivation, stands for plans, responses, impulses, motives, evaluations. 
PROMs - patient reported outcome measures. 
QALE - quality adjusted life expectancy (see also QALY). 
QALY – quality adjusted life year, a summary measure of health and quality of life. 
QOF - quality and outcomes framework - a mechanism by which GPs are paid to measure 
information about their patients such as disease prevalence and to manage long term 
conditions. 
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QoL - quality of life. 
RCT - randomised controlled trial. 
SCNR - successfully completing and not representing, typically referring to an individual 
completing drug treatment and not representing within six months. 
SMN - substance misuse nurse. 
SROI– social return on investment. 
SWEMWBS - Short Warwick-Edinburgh Mental Wellbeing Scale. 
TB – tuberculosis. 
TIA - transient ischemic attack, often called a 'mini stroke'. 
TOPs - Treatment outcomes profiles - outcome measurements for drug and alcohol 
treatment. 
TTO – time trade-off (method of eliciting preferences). 
UK - United Kingdom. 
UKFPH - United Kingdom Faculty of Public Health. 
US - United States of America. 
VAS or EQ-5D-VAS - Euroqol 5 dimension (3 level) visual analogue scale. 
WEMWBS - Warwick-Edinburgh Mental Wellbeing Scale. 
WHELCS - Wirral Health Economic Life Cohort Smoking model. 
WHO - World Health Organisation. 
WTP - willingness to pay. 
YLD - years of life lived with disability. 
YLL - years of life lost. 
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Chapter 1. Introduction  
1.1 Why Choose This Topic? 
This topic was chosen in the belief that health economics and public health should be natural 
bedfellows. Both disciplines have a population approach and both aim to put healthcare into 
a wider context of promoting health and wellbeing. Both aim to look at programmes over a 
long time horizon rather than short term end points. Both aim to put a check on the medical 
and pharmaceutical view of health which has been seen as too narrow and mechanistic, 
ignoring individual differences, the impact of context, and looking at health itself rather than 
the welfare and change in capability people derive from it. 
Public health policy makers are keen for interventions and programmes to be based on best 
evidence. But just because a programme is evidence-based does not guarantee it will be 
cost effective. Any programme that is suboptimal has an opportunity cost; if a programme 
costs £60,000 and does not generate any benefits it is not just £60,000 wasted; the benefits 
forgone by not investing in a better programme may have been valued at much more than 
£60,000. When public health interventions are assessed they usually come out as much 
more cost effective than traditional clinical health interventions. But historically public health 
and health economics have not been used together at a local level; this may be because of a 
lack of skills or resources at a local level or lack of a perceived need for it. It could also be 
due to distrust in the public health profession around economics and a feeling that public 
health outcomes are difficult to measure using conventional methods. Public health has its 
recent history in socially progressive, community approaches and reducing health 
inequalities. Public health may see economic theory as part of the cause of health 
inequalities as economic policies have “wiped out” traditional industries and split 
communities; practitioners may see economics as part of the problem rather than part of the 
solution.  
This thesis aims to bridge some of this ideological gap between health economics and public 
health, using realist evaluation techniques to account for some of the differences in contexts 
and implementation that are present in the services evaluated in this thesis. Local data has 
been used where possible in the modelling so that any models are optimised for the local 
context. This thesis aims to elucidate and demystify a set of techniques that can be used to 
evaluate public health interventions. The interventions in this thesis are all for addictive 
behaviours; namely drug addiction, alcohol dependence, and tobacco addiction. These 
behaviours are typically characterised by cycles of relapse and recovery, and investments in 
services to help people often have cross sector effects, meaning that investments by local 
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public health teams generate benefits in other sectors of the economy; for instance, treating 
drug addicts reduces crime. These are complex interventions in complex systems which can 
be context-dependent in how they work. This means that classic positivist techniques like 
randomised controlled trials and models carried out in isolation can be limited which is where 
realist evaluation comes in. This thesis is about bringing theories together to get a set of 
robust but practical techniques for evaluation. 
The primary hypothesis is that economic evaluation represents an essential methodological 
paradigm that must be used to inform local decision making in public health. This thesis will 
utilise a series of case studies undertaken by the author to illustrate the value of utilising a 
health economic approach to determine the cost-effectiveness of public health services in 
Wirral, an area in the North West of England with a population of approximately 330,000 
people.  The analysis of the impact underlying public health service provision will not simply 
be concerned with utility maximisation (cost effectiveness) but will also analyse impact in 
terms of benefitting the community and reducing health inequalities. The data generated 
within this thesis was directly used by Wirral public health services to prioritise investment at 
a time when public health services were being evaluated as part of the recommissioning 
process. The use of a pragmatic mixed methods methodology for evaluating public health 
interventions emphasises the complexity underlying the evaluation of such services. The 
multiple objectives underlying public health provision required the evaluative structure to 
include a range of elements including economic evaluation, realist evaluation and equity 
impact assessment. The main economic evaluation method used was cost utility analysis, 
which measures outcomes in terms of cost per quality adjusted life year (QALYs) gained. 
QALYs are a summary measure of length and quality of life.  
Although significant variations exist in the manner in which public health services are 
commissioned and provided, there are crucial commonalities in approach between different 
geographical areas. Therefore the results obtained and the methodological approach utilised 
should be generalisable to many public health commissioners especially because the 
interventions being evaluated are largely driven by national policy and make up a large 
proportion of public health expenditure. 
At a time of extraordinary constraint in public health expenditure, optimising the value for 
money obtained for each pound spent is of the utmost importance for public health. This 
introductory chapter will analyse the history of public health and its link to health economics. 
In particular it will examine the common population based analysis and outcome focus that 
the two disciplines share and the theoretical basis of economic evaluation techniques and 
realist evaluation. It will emphasize the particular synergy between the two disciplines and 
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assess the unique role that health economics can play in evaluating and informing public 
health interventions.  
1.2 A Pen Portrait of Wirral - A Microcosm of the UK? 
The Metropolitan Borough of Wirral occupies the northern part of the Wirral peninsula in the 
North West of England and is the 25th largest local authority in England by population (ONS, 
2015a).  Wirral is surrounded by water on three sides and thus has a lot of sandy beaches, 
and also has lots of green space.  Wirral used to be a popular leisure destination with New 
Brighton being a summer destination for tourists. Wirral has two road tunnels and one rail 
tunnel to Liverpool. The first Mersey tunnel was built in the 1920s and was clad with lead; 
when they came to build the second Mersey tunnel in the 1960s the authorities knew that 
lead exposure was bad for workers, unfortunately they chose to clad the second tunnel with 
asbestos instead.  The main urban conurbations in Wirral are around Birkenhead and 
Wallasey. Birkenhead had a historically very active shipbuilding and dock industry since the 
1830s. The docks have fallen into decline since the 1960s and containerisation, while 
Cammell Lairds shipbuilders are still trading, albeit not employing nearly as many staff as it 
did in its heyday. The industrial areas of Wirral fell into decline in the 1970s and 1980s as 
smokestack industries saw a decline nationally. Wirral also has a long established public 
health programme and is geographically very well defined – surrounded by water on three 
sides, with one council  providing public health services, and with most hospital activity being 
concentrated in one hospital, Arrowe Park. 
Wirral is divided roughly by the M53 motorway into a more affluent and healthy West and 
South, and a more deprived and unhealthy North and East. This thesis will make reference 
to some standard geographical units used by UK Office for National Statistics (ONS). These 
are lower layer super output areas (LSOAs), which each contain around 1,500 people; and 
middle layer super output areas (MSOAs) which have a population of approximately 5,000 - 
15,000 people. At the time of this thesis, Wirral contained 42 MSOAs and 208 LSOAs. This 
thesis will also make reference to electoral wards which are another constant geography 
used for local council elections and neighbourhood planning (ONS, 2015b) 
Figure 1 shows a map of Wirral by deprivation (IMD 2010) score at LSOA level. There is a 
clear relationship between certain lifestyle risk factors for ill health and deprivation. Figure 2 
to Figure 5 illustrate the relationship between four unhealthy behaviours and deprivation in 
Wirral. Each point on these charts represents a middle layer super output area (with the 
prevalence of the behaviour (HSCIC, 2007) on the vertical axis and the spread of deprivation 
(Noble et al., 2007) on the horizontal axis. We can see that two of the lifestyle behaviours – 
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smoking, and eating five fruit and veg a day - were very closely related to deprivation. Binge 
drinking and obesity were not as closely related to deprivation.  
Figure 1. Map showing national IMD (Index of Multiple Deprivation) 2010 ranking of LSOAs (lower 
layer super output areas in Wirral, with wards overlayed. 
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Figure 2. Deprivation against smoking in Wirral. 
 
Figure 3. Deprivation against binge drinking in Wirral.  
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Figure 4. Deprivation against obesity in Wirral. 
 
 Figure 5. Deprivation against eating 5 or more fruit and veg a day in Wirral.  
 
Data Sources: Model based estimates of lifestyle behaviours from the NHS Information Centre.  
Deprivation scores are population-weighted IMD 2007 scores from DCLG. 
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This thesis employs ‘equity impact assessment’ methods to analyse the extent to which the 
uptake and outcomes relating to service provision within Wirral reflects the levels of need in 
these groups. Mainly this involves focusing on socioeconomic groups, for instance 
deprivation quintiles, but in certain cases targeting services at specific groups may be 
important. For example, people with mental health problems are more likely to be smokers 
so it is important to understand whether they are adequately served in service provision. 
Retrospective equity impact analysis is similar to equity impact assessment, where a 
prospective judgment is made as to whether a policy or piece of work will have a detrimental 
effect on certain vulnerable groups, or whether certain groups need to be given special 
attention when decisions are made. Because the drugs and alcohol data had only contained 
partial postcodes, it became necessary to apply approximate string matching algorithms 
(known as 'fuzzy' matching) to match postcodes roughly to socioeconomic groups. 
Postcodes for drug and alcohol treatment included postcode sector only, this meant they 
were in the format “CH41 5” where the full postcode may be “CH41 5AL” so included the 
outward code and the first digit of the inward code. For each partial postcode there were on 
average 72 full postcodes, some of which may be in an LSOA that was in the most deprived 
quintile, and some may not be. Postcodes were classed as being deprived if 50% or more of 
their postcodes matched up to an LSOA that was in the most deprived quintile nationally. 
Table 1. Example of partial postcode matching process. 
Partial 
postcode 
N of 
postcodes not 
in Most 
Deprived 
Quintile 
N of 
postcodes 
in Most 
Deprived 
Quintile 
Postcodes 
not matched  
% of 
postcodes 
in Most 
Deprived 
Quintile 
Grand 
Total 
Classed 
as Most 
Deprived 
Quintile 
CH41 0 44 33   0.429 77 No 
CH41 1   67 1 0.985 68 Yes 
CH41 2   96   1 96 Yes 
 
Of course many areas have got internal health inequalities and it is important to state that 
local authority boundaries can be quite arbitrary and have changed over the years; a local 
authority may contain or sometimes dissect a set of distinct towns or places. What makes 
Wirral quite special is that it has a good representation of people from across the income 
spectrum from the very poor to the very wealthy. Wirral has some of the widest local health 
inequalities of any local authority area in England, ranking 6th highest for slope index of 
inequalities in males and 7th highest for females (PHE, 2014a). Wirral has carried out some 
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local burden of disease work to enable it to understand which diseases are most responsible 
for the mortality and quality of life gap, similar to the WHO's global burden of disease study 
(Möller et al., 2012). Table 2 shows the average number of deaths and years of life lost 
(YLL) by risk factor in Wirral for 2005-07. Smoking is the biggest cause of deaths and of 
years of life lost. This analysis does not include illicit drug use as a risk factor.     
Table 2. Average annual number of deaths and years of life lost (YLL) attributable to risk factors, 
Wirral 2005-07 (data from Möller et al., 2012). 
  Deaths YLL Ratio 
  Male  Female Both Male Female Both YLL/ 
deaths 
Male/ 
Female  
Smoking  390 419 809 5009 4711 9720 12.0 0.9 
Overweight and 
obesity 
98 87 185 1387 1036 2423 13.0 1.1 
Insufficient exercise 67 79 146 752 737 1489 10.1 0.8 
Low fruit and veg  68 59 127 880 596 1476 11.6 1.2 
Alcohol 82 38 121 2265 1026 3291 27.4 2.2 
Total  705 682 1388 10293 8106 18399     
 
1.3 Structure of the Thesis 
This thesis analyses the manner in which economic evaluation techniques can be used to 
appraise public health interventions, specifically around the treatment of addictions. The aim 
of this thesis is to show how applying economic evaluation methodologies to public health 
programmes can improve commissioning and policy decisions. In terms of scientific 
philosophy, this thesis uses a post-positivist paradigm and applies health economic 
techniques as part of a mixed methods approach. Realist evaluation has a realist paradigm 
but this thesis does not completely subscribe to this, for example, as it contains quantitative 
point estimates of cost effectiveness which would not be appropriate under a realist 
paradigm. 
The first four chapters provide an introduction to this thesis, its primary focus and theoretical 
basis and how it adds to knowledge in this area. The second chapter provides a brief history 
of public health and addiction research in particular and the third chapter outlines the history 
of the discipline of health economics and its role in informing and improving decision making 
in the field of public health. The fourth chapter outlines more of the theoretical basis of the 
work and the policy implications of the results. 
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The three case studies all analyse interventions aimed at ameliorating the impact of some 
form of ‘addiction’. As such the thesis will analyse the theoretical background and practical 
approaches to addiction theories and emphasize the importance of evidence based 
evaluation in evaluating public health interventions. Chapters 5-7 will outline in detail the 
case studies for the three services that have been economically appraised and the results 
for each service.  Each chapter will comprehensively reference previous work undertaken in 
these areas and emphasize the policy implications of the results obtained where it is relevant 
to the service being reviewed. 
This thesis represents the culmination of over eight years of research undertaken by the 
author evaluating public health services in the North West of England and in London. The 
author is widely published in this field and is a member of a NICE Public Health Advisory 
Committee. The aim of the thesis is to generate and disseminate a practical, theoretical and 
methodological approach to the evaluation of addiction and more generally public health 
using the tools and methodologies of health economics. 
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Chapter 2. History of Public Health & Addiction Research 
2.1 What is Public Health? 
This chapter summarises the history of public health and addiction research in the UK. 
Perhaps the first issue to address regards terminology; what is public health? The World 
Health Organisation (WHO) define public health as "all organized measures (whether public 
or private) to prevent disease, promote health, and prolong life among the population as a 
whole" (WHO, 2013) The United Kingdom Faculty of Public Health (UKFPH, 2013) adopts a 
similar definition; "the science and art of promoting and protecting health and well-being, 
preventing ill-health and prolonging life through the organised efforts of society". There is 
little contradiction between these definitions, the main differences being that the UKFPH 
definition focuses on wellbeing and the efforts of society while the WHO mentions private 
measures, i.e. those measures taken by individuals. There is also an economist’s definition 
of public health as in providing health related ‘public goods’; meaning health goods like 
vaccinations, sanitation & clean air that benefit everyone, and that the private sector would 
not provide (Smith & Petticrew, 2010).  
If public health is a discipline for promoting health and wellbeing of populations, then public 
health interventions or programmes are those which achieve improved health and wellbeing 
for a population. However, the exact boundaries of public health are open to debate. For 
example, paying monetary benefits to someone who is out of work will usually go towards 
maintaining their level of health and wellbeing, but this would not normally be considered to 
be a public health intervention in the strict sense of the term. Public health interventions are 
normally interpreted as being health interventions undertaken at the population level, such 
as vaccinations and immunisations, or those aimed at the maintenance of population health 
and wellbeing.  For example, the widespread use of statins as a primary prevention measure 
to lower people's cholesterol and reduce their risk of cardiovascular disease is an example 
of an intervention which is clinical and individually based but which also has a significant 
impact on the health experience of the population as a whole. As a primary prevention 
measure, statins are prescribed to healthy people with a higher risk of developing 
cardiovascular disease in the future, and therefore can be perceived as being a public health 
intervention as it involves reducing risk rather than reducing symptoms (Law et al., 2004). 
Many other public health interventions are about reducing risk. For instance, not everybody 
who is obese will end up with an obesity-related disease. In fact, the evidence is that around 
a third of obese people are metabolically healthy (Wildman et al., 2008). However, 
statistically, effective population level interventions will produce a reduction in obesity related 
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diseases overall even though it may not be possible to determine which individuals have 
actually benefitted from the intervention. While clinical interventions treat individuals whose 
health has already been damaged and where adverse symptoms are already being 
experienced, public health interventions concentrate on 'upstream' population measures 
(Cookson et al., 2008). The public health interventions considered in this thesis all 
incorporate interventions (normally pharmacological) for specified individual clients; for 
example opiate users are often prescribed methadone or buprenorphine and people quitting 
smoking are often prescribed nicotine replacement therapy (NRT), varenicline  (Champix) or 
bupropion (Zyban). People with alcohol dependence are supported by pharmacological 
interventions aimed at reducing cravings and anticonvulsants and vitamins during the period 
of detoxification. Such clients will also be provided with 'psychosocial' interventions aimed at 
addressing their addictive behaviours and personalities. This multifaceted approach 
emphasises the complex nature of the health problems addressed in this thesis and 
illustrates the need for equally complex interventions provided within a complex system to 
adequately support the needs of the individual clients. 
The effective targeting of public health interventions requires an understanding of which risk 
factors and diseases impose the greatest burden on the population being served. The WHO 
have carried out a Global Burden of Disease study to estimate the  years of life lost, and 
years lived with disability, due to different risk factors. These years of life lost (YLL) and 
years lived with disability (YLD) are summarised together as disability adjusted life years 
(DALYs). 
 
 
 
Figure 6 shows the percentage of global DALYs lost due to different risk factors. The biggest 
problem in low income countries defined in this manner relates to childhood malnutrition, 
followed by unsafe water, sanitation and hygiene and unsafe sex. In comparison the greatest 
burden imposed on populations in high income countries relates to tobacco, followed by 
alcohol and weight, food and physical activity related factors. The services evaluated in this 
thesis therefore specifically address risk factors (tobacco, alcohol and illicit drugs) which 
impose the highest burden on population health in advanced countries. However there are 
several important risk factors not included in this; for instance not all pollution is included, nor 
is social isolation (Cacciopopo & Hawkley, 2003).  
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Figure 6. Global DALYs (Disability Adjusted Life Years) Lost Due to Different Risk Factors. Source: 
WHO (2009). 
 
2.2 A Recent History of Public Health in the UK 
Public health research has a long history. This section will focus on the recent history of 
public health focusing on key policy milestones and the continuing objective of reducing 
health inequalities. The British Government's policy document "Prevention and Health: 
Everybody's Business" (DHSS, 1976) followed on from a postwar movement around the 
social determinants of health. This report was seen by many commentators at the time as 
putting too much emphasis on individual behaviour being responsible for health problems, 
and being light on policy answers (Davison et al., 1992). In 1978 the WHO published the 
‘Alma Ata Declaration’ with the goal of "Health for all by the Year 2000" (Fendall, 1978) 
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which said that health should be an objective of economic development and not just a cause 
of it; this was also when the "Healthy Cities" movement began. In the UK since the 1970s 
there was the “white collar revolution” where more people were employed in office jobs 
rather than manual jobs, which meant that literacy and numeracy skills were more important,  
and that jobs were more sedentary and less physically demanding. 
The Black Report on health inequalities (Black et al., 1980) was commissioned by a 
politically left wing Labour government in 1977 but not published until 1980 when the more 
right wing Thatcher-led Conservative government had taken power, and was famously 
published on August bank holiday with only a small number of copies printed. The 
government rejected the main findings of Douglas Black's report that health inequalities were 
mainly caused by structural income inequality and were getting wider and moreover, that 
something should and could be done about it (Singh-Manoux et al., 2003). In particular the 
report recommended increased public expenditure at a time when it was being cut. In 
Thatcher's first speech as party leader she said British people should have 
"the State as servant and not as master" so it is not a surprise that her government did not 
believe in large scale interventions to reduce health inequalities. However despite this 
rejection by the government, the Black report became hugely influential and was used as a 
blueprint for the OECD in investigating health inequalities. Reading the Black Report and 
subsequent reports on health inequalities in the context of Piketty (2014), both support the 
suggestion that apart from economic shocks from the two world wars, income inequality will 
always increase as the returns for people who are born into wealth will always exceed the 
returns for those who are not. This theory could equally be applied to health inequalities as 
people with more money will have healthier lifestyles. This is the inverse care law in action. 
Richer people can also afford private healthcare, and are better educated to notice the signs 
of ill health, and possibly have a less fatalistic attitude around health and think of their health 
on a longer time horizon (Davison et al., 1992).  There are wide variations within England of 
life expectancy at birth (data from ONS, 2010-12) which varied by 8.9 years in males 
(between Hart, 82.9 years and Blackpool, 74.0 years) and by 7.1 years in females (between 
Purbeck, 86.6 years and Manchester, 79.5 years). Such variations related to deprivation are 
also evident within smaller geographical areas. This is strongly evident within Wirral which 
exhibits a large difference of 14.6 years for males and 9.1 years for females (based on Slope 
Index of Inequality data for 2012) implying that Wirral has some of the widest internal 
inequalities in the country.  
In the 1980s the HIV outbreak affected western countries as well as developing countries, 
and brought the focus of public health back on infection control. One route of transmission 
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was through injecting drug users, who are considered in this thesis. Indeed one of the 
reasons that drug treatment services were set up and deemed to be cost effective was to 
reduce the risk of a HIV outbreak moving from injecting drug users to the general population. 
There were also high rates of hepatitis B and C virus transmission in drug users in the 1980s 
(Hep C was not known about in the 1980s).  
In 1998 the “Independent Inquiry into Inequalities in Health Report” (Acheson, 1998) once 
again showed that while overall mortality was declining, health inequalities were still very 
much apparent in the UK. It made several recommendations, including free fruit and 
vegetables in schools, parenting and relationship classes and tobacco control including 
banning tobacco advertising, increased tobacco prices, and prescribing of nicotine 
replacement therapy (NRT) on the NHS. These policy measures around tobacco were key in 
informing the last 15 years of national and regional tobacco control programmes, which are 
considered partly in this thesis. Building on the Barker hypothesis, Acheson’s report argued 
that early years were crucial and thus that interventions aimed at women of childbearing 
age, young mothers and young children should be given priority.  
“Our Healthier Nation” (DH, 1999) identified early deaths and health inequalities as a priority. 
It struck a balance between the social, economic and environmental determinants of health 
and individual responsibility. This report set out two headline Public Service Agreement 
(PSA) Targets;  
 To reduce by at least 10 per cent the gap in infant mortality between routine and 
manual groups and the population as a whole by 2010, from a baseline of 1997-99. 
 To reduce by at least 10 per cent the gap in life expectancy between the fifth of local 
authority areas with the worst health and deprivation indicators (the Spearhead 
Group) and the population as a whole by 2010, from a baseline of 1995-97. 
“Choosing Health: Making healthy choices easier” (DH, 2004) included recommendations 
such as having food labels to show the level of fat, salt, and sugar in foods. It also 
recommended that health providers and local authorities needed to work in partnership to 
improve health in their communities and reduce health inequalities. Probably most 
significantly, it recommended the ban on smoking in public places which began in 2007. This 
was associated with a reduction in heart attacks (Sims et al., 2010) as well as increasing the 
numbers of people attempting to quit smoking.  
The most recent significant national public health policy document was “Fair Society, Healthy 
Lives” (Marmot, 2011), the Strategic Review of Health Inequalities in England post-2010. 
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Michael Marmot had directed the influential Whitehall study showing that lower ranking civil 
servants had poorer health outcomes than higher ranking ones, even when lifestyle risk 
factors were controlled for (Marmot et al., 1991). The 2010 review was tasked with 
identifying the health inequalities challenge facing England, finding the evidence most 
relevant to future policy and action, and advising on future objectives and measures. This 
review built on the world-wide evidence accumulated by the World Health Organisation’s 
Commission on the Social Determinants of Health which published Marmot’s report ‘Closing 
the Gap in a Generation’ (Marmot et al., 2008). Both of these reports said “social injustice 
was killing people on a grand scale”. The Marmot Review reported results from the National 
Survey of Health and Development which had ran since 1946 and showed that the NHS had 
not had as great an impact on health inequalities as might be expected; disparities in health 
by social class that were apparent in childhood persisted into adulthood. The Marmot review 
recommended some very specific interventions to reduce social and health inequalities 
which have been acted on somewhat, and influenced the government's Public Health 
Outcomes Framework (PHOF). Marmot recommended six policy objectives: 
 Give every child the best start in life  
 Enable all children, young people and adults to maximise their capabilities and have 
control over their lives  
 Create fair employment and good work for all  
 Ensure healthy standard of living for all  
 Create and develop healthy and sustainable places and communities  
 Strengthen the role and impact of ill health prevention 
2.3 Summary of Theories of Health Inequalities  
We have seen how a lot of public health research and policy has been centred on health 
inequalities, meaning inequalities in health outcomes, or health inequities, a term which 
implies a moral judgment that these inequalities are unfair (Dahlgren & Whitehead, 1991). 
There are several theories of what causes health inequalities. The main ones are as follows 
(based on p.51-62 from Bhattacharya et al., 2013); 
1. Access to care hypothesis – people with more money are more likely to have health 
insurance or access to healthcare. 
2. Efficient producer hypothesis – that disparities in health exist because people of 
lower socio-economic status often are less well educated, and are less efficient 
producers of health than people who are better educated.  
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3. Thrifty phenotype hypothesis (the Barker hypothesis) – that poorer individuals being 
deprived of nutrition in the womb activates ‘thrifty’ genes optimised for sparse 
conditions. When these individuals are then in abundant conditions they develop 
obesity, diabetes, and heart disease.  
4. Direct income hypothesis – health inequalities exist because richer people have more 
resources to invest in health, so can buy healthier food, gym membership, private 
healthcare, do not live in polluted areas or damp housing, etc. 
5. Allostatic load theory – that health inequalities are related to stress - the cumulative 
physiological toll from efforts to adapt to life experiences; this is based on the result 
found in the Whitehall studies where someone’s rank is related to health outcomes 
independent of other health behaviours, and has been found in studies with dominant 
and subordinate chimpanzees. 
6. Income inequality hypothesis – health disparities are caused by income inequality, 
which is also a source of allostatic load for poorer people. 
7. Productive time hypothesis – differences in socioeconomic status are caused by 
disparities in health. Worsening health reduces productivity which reduces the 
capacity to produce income. 
8. Fuchs hypothesis – (time discounting) differences in health and socioeconomic 
status are caused by the willingness to delay gratification. Individuals with a lower 
rate of time discounting are more willing to invest more time now in health or 
education that will produce continuing health and employment success in the future.   
Most of these theories are insufficient on their own to explain health inequalities; for instance 
in the UK people have reasonably equal access to care through the NHS, yet inequalities 
still persist. But these theories each have some evidence behind them and some place in 
explaining health inequalities and have some relevance to the study of addictions. Some of 
these theories possibly place an emphasis on individual factors and relationships between 
health and socioeconomic status that may work in a person’s lifetime but ignore the fact that 
income inequalities persist through generations and many individuals only have a limited 
chance to improve their life chances no matter how much they can delay gratification, or use 
their time efficiently. 
Wilkinson & Pickett (2010) suggested that health and social problems are not related to per 
capita incomes but rather to the level of equality exhibited in each country or US state. 
Inequality leads to people feeling like they are not truly an integral part of society if they are 
not economically included. De Botton (2008) outlines how human beings crave status, which 
is most often acquired through money and success, and that the media sell people an idea 
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of beauty and riches that is often unobtainable. This relates to the idea of James (2007) that 
capitalism is related to poor mental health in populations. These ideas that capitalism and 
the cult of individualism and consumerism are responsible for poor public health chime with 
the ideas of Piketty (2014) who called for an international wealth tax to be reinvested in 
creating a level playing field in order to improve the health experience of disadvantaged 
populations.  
Nettle (2010) proposed that people from lower socioeconomic groups are likely to be 
exposed to greater risks that are unpredictable so the optimum amount of preventative 
health behaviour is reduced in comparison to higher socioeconomic groups where health 
risks are often delayed until old age. In such circumstances less time will be devoted to 
health promoting activities when there is a higher cause of death from extrinsic causes such 
as accidents, air pollution, cold weather, and homicide. Nettle argues that early life factors 
like low intrauterine growth restriction, lack of breastfeeding, and poor diet are essentially 
extrinsic once someone reaches adulthood as these factors have already harmed individual 
life chances. Nettle does not specify whether these things affect people in their conscious or 
unconscious decision making. If it is unconscious then the most important thing is reducing 
risk factors for extrinsic mortality, whereas if it is conscious then it is important to change 
perceptions of extrinsic mortality such as fatalistic attitudes or incorrect assumptions.  
Some public health interventions like bowel cancer screening may be taken up more by 
people from more affluent groups, meaning they have the potential to increase inequalities 
(von Wagner et al., 2011). This has been called the ‘inverse prevention law’. But there is a 
school of thought that says that if interventions work, even if they are initially taken up by 
more affluent people, the hope is that they eventually get taken up more by deprived groups 
as well, and additional resource should be put into promoting them to deprived groups or 
providing advocacy, instead of disinvesting in an effective intervention just because it is not 
immediately contributing to narrowing inequalities (Lorenc et al., 2013). There is a need to 
strike an appropriate balance between efficiency- getting maximum health across a 
population – and equity – getting a fair spread of health across a population - but for 
commissioning interventions it might depend on the absolute costs as well as the relative 
costs of putting more resource into deprived areas. Some commentators have argued that 
where additional investment has been put into deprived areas it has not succeeded in 
narrowing health inequalities and something different is needed. For instance health action 
zones in England which started in 1998 did not live up to their objectives, although in part 
this may be because they were not adequately resourced (Judge & Bauld, 2006). 
39 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
2.4 History of Addiction Theories 
Addiction theory has moved in parallel with public health thinking. For problematic drug 
users, drug use is characterised by dependence and addiction, where drug taking behaviour 
becomes unconscious or compulsive and usually causes harm or is risky. In dependent or 
addicted individuals drug use is often focused on reducing the symptoms of withdrawal 
rather than getting actual pleasure. There is no one general scientific theory of addiction, 
although there are factors that are common to most theories. The main theories are broadly 
biological, psychological, or sociological. Some theories like reinforcement theory (Robinson 
& Berridge, 1993) explain drug use in humans in general, but not why some humans use 
and become addicted to drugs and others in similar circumstances do not. Theories have 
included the genetic predisposition to addiction (Kreek et al., 2005), the idea of people 
having an ‘addictive personality’ (Nakken, 1998) or being particularly sensitive to or lacking 
in certain neurotransmitters or having a metabolic imbalance that is cured by their drug use 
(West & Brown, 2013). There is also the theory that people are self-medicating for a mental 
health problem (Khantzian, 1985), people ‘modelling’ their behaviour on others (Bandura, 
1999), or people not wanting to, or having failed to be part of the typical reward structure that 
society offers (strain theories) (Agnew, 1992). There is Alexander’s (2008) theory about 
addiction being driven by ‘dislocation’ where individualism and competition take too much 
precedence over social ties and group bonding. A common theme to Wilkinson & Pickett 
(2010) and Alexander (2008) is how modern capitalist societies are structured so that people 
should move to where the work is (the famous Norman Tebbit (mis)quote of “get on your 
bike and look for work”), but this means that people lose their social ties and their traditional 
culture. This is why Alexander thinks that “dislocation”, the loss of traditional place, culture 
and family and social bonds that he associates with a free market society, is the main cause 
of addiction. Alexander talks about there being a conflict between individualism and being a 
part of a community; drugs often divide communities. Wirral as a case study may be an 
argument against the 'dislocation' theory as it was an area with relatively stable, tight-knit 
communities, albeit hit by labour market shocks (Parker et al., 1988). Kushner (2000) 
outlines personal evaluation and case studies as a useful way of understanding the tension 
between individuals and communities. A lot of recent research has focused on the 
relationship between social isolation which can be a cause and consequence of drug use, 
and the relationship between adverse childhood events and drug use. There are also 
theories that focus not on the drug taking behaviour, but on why society reacts to the 
behaviour in the way it does.  
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Nakken (1988) talks about how addiction is the progressive replacement of people by things 
where people form relationships with objects and events. This is caused by people relating 
to others as one dimensional objects; then when people “let them down”, they learn to rely 
only on objects for pleasure. Addiction generally offers a predictable mood change. 
Gambling or taking drugs “does not let you down” like people sometimes do. Parker et al. 
(1988) was a daguerreotype of heroin users in Wirral in the mid-1980s, where users spoke 
about 'friends' as the people they were friends with before they started using while the 
people users associated with once they became heroin addicts were never described as 
friends, they were always “this guy round the corner”. Nakken says that addicts mistake the 
intensity of an experience like their first experiences with alcohol, or a big win while 
gambling, with the intimacy and self-actualisation they are searching for in a genuine human 
experience. Much of what Nakken expresses is intuitively compelling, but does not thereby 
imply an accurate explanation of addiction. Nakken believes that addicts can transfer their 
addiction from one object to another object, or from one event to another event. Some 
people believe that when people have an addictive personality they are always going to be 
addicted to something, so there is a need to transfer the addiction from something harmful 
like heroin, to something less harmful like going to the gym. This is a convenient way of 
thinking of things but people can often acquire multiple addictions one after the other, and be 
addicted to multiple drugs or behaviours at the same time.  
Two influential behavioural theories from the last ten years are the PRIME theory and the 
COM-B system. These are both general models with applications that go beyond classical 
addiction theories and have been used across public health. The PRIME theory of motivation 
(West, 2007) has three central ideas; 
1: It is wants and needs at each moment that drive our behaviour. 
2: Our intentions and beliefs about what is good or bad only influence our actions if they 
create sufficiently strong wants and needs at the relevant moment. 
3: Our image of ourselves and how we feel about that, our identity, is a potentially very 
strong source of wants and needs which can be enough to overcome ones arising from 
biological drives such as hunger. 
The PRIME theory emphasises the importance of subjective identity - if someone does not 
see themselves as a drug user anymore then they will not use drugs. In drug treatment, 
people are often said to be ‘in recovery’ for the rest of their lives, which gives them an 
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identity that they share with other people, but maybe this is not desirable where people want 
to make a clean break from their past. 
A relatively new system which may be useful is the COM-B (capability, opportunity, 
motivation – behaviour) (Michie et al., 2011). The COM-B system builds on the PRIME 
model and is thinking about the interaction between capability, the physical and 
psychological ability to do something, such as the ability to inject oneself; opportunity, the 
physical and social opportunity to do something, such as being able to buy alcohol in one’s 
street, or being at a party where cocaine use is socially acceptable; and motivation, the 
reflective and automatic processes that energise behaviour, so if someone believes 
cannabis is harmless they will not be motivated against using it, or the euphoria associated 
with smoking crack cocaine will motivate someone towards using it. These three factors, 
capability, opportunity and motivation, will act to either constrain or to promote behaviour. 
Therefore any intervention to reduce harmful behaviour needs to look at reducing the 
capability, opportunity or motivation for this behaviour. Figure 7 shows the COM-B behaviour 
change wheel which lists sources of behaviour, intervention functions and policy categories.  
COM-B has been constructed from attempting to collapse down many of the existing 
behavioural theories into categories and may have a lot of potential. The COM-B framework 
could be used in realist evaluation as a set of categories for programme theories or for 
understanding mechanisms which could therefore be used as a taxonomy for interventionist 
policies. 
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Figure 7. The COM-B Behaviour Change Wheel. 
 
2.5 Criticism of Addiction Theories  
Some researchers believe that addiction is not real, that it is a social construct like property 
or the economy. Furthermore they believe that the idea of addiction suits addicts and their 
families as an excuse for their behaviour, and suits people working in the field of addiction. 
But individual scores on addiction scales like the Fagerström (1978) nicotine dependence 
scale do predict success at quitting tobacco so this suggests that addiction can be measured 
and it is a real phenomenon (Heatherton et al., 1991) although it could perhaps be argued 
that measurement of 'addiction' could in fact be measuring something else like motivation 
that does not encapsulate the most common criteria of addiction. There is evidence that 
people who are more likely to quit smoking are more likely to support policy measures 
against smokers, suggesting that they are anticipating their move from being a smoker to 
being a non-smoker, or that they want some 'tough love' interventions that will make it harder 
for them to continue their behaviour (Hammar & Carlsson, 2005). The behaviour of people 
who are addicted suggests that they try to stay away from stimuli that trigger their behaviour 
which may indicate a realisation that their behaviour is driven by unconscious triggers.  
Heyman (2010) has been influential in framing addiction as being a choice and points out 
that if addiction is seen as a mental illness then it actually has one of the highest recovery 
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rates. Heyman (2010) advocates more punitive interventions that emphasise behavioural 
economics rather than the following the medical model. He deconstructs the idea that 
because addictions are mostly self-destructive, they must be involuntary and involve some 
kind of illness. He conceptualises addiction as using ‘local bookkeeping’ rather than ‘global 
bookkeeping’, which is similar to emphasizing short term over long term gratification. Under 
Heyman’s way of thinking, using drugs over the short term always brings higher value (in 
terms of short term pleasure or local bookkeeping) but this value diminishes over time (with 
tolerance) and at the same time the value of nondrug activities diminishes over time because 
having the capacity, the social buy-in and the money to enjoy non-drug activities reduces as 
well. So as you use drugs, you may enjoy it at first, but as your use becomes your life, the 
value of other activities becomes lower because you may have lost your friends & family, 
your employment, or money to engage in leisure activities. This chimes with other research 
that has shown how levels of psychological and social capital are predictors of remission 
from dependence (Bischof et al., 2001). In other words if someone has enough people who 
care about them, and people to care about, they are more likely to conquer their addiction. 
Heyman proposes that individuals need to be taught about ‘global bookkeeping’ to lead them 
to rational lifestyles. This may be essentially about delayed gratification and self-control. We 
know that drug users struggle to delay pleasure and are impulsive. Addiction can be seen as 
an impulse control disorder. That is why addicts often share contaminated needles rather 
than wait until they have obtained clean needles. It could be argued that much of Heyman’s 
theory is not new, and that most drug treatment does involves instigating a thought process 
around thinking more long term, and thinking about pleasurable activities that do not involve 
drugs. It could also be argued that a lot of the social gains that drug users "miss out on" are 
due to the stigma, criminality, financial cost and social constructs that society puts on drug 
use, some of which (the financial cost and criminality but not all of the stigma) are cut out in 
the case of substitution programmes like methadone maintenance.  
There are also economic theories like the 'Theory of Rational Addiction' (Becker & Murphy, 
1988), which talks about individuals aiming to maximise utility between short term pleasure 
(which could be gained from drugs or other things) and long term pleasure. It is essentially 
saying that individuals with a short time horizon will maximise utility through short term 
pleasure but that in their own way of thinking this behaviour is rational, and that ‘addictive 
capital stock’ increases over time which increases the utility that people get from drugs and 
other substances. Under the theory of rational addiction, addictions to some things like 
jogging or religion can be beneficial because they increase capital stock, whereas alcohol or 
heroin addictions are harmful because they reduce capital stock. The theory of rational 
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addiction uses economic phrases like stock, capital, consumption and depreciation to 
represent psychological variables. It is true that prevalence of addictions in populations is 
affected by price and availability, and substitution occurs. But the theory of rational addiction 
does not account for some of the neurobiological evidence around drugs and tolerance, for 
example some drugs like cocaine actually become more potent to individuals over time as 
the neuroreceptors are up-regulated and an individual’s brain gets more sensitised to the 
drug effects (Nader et al., 2002), whereas other drugs like heroin or cannabis cause 
increasing tolerance over time. 
2.6 Summary of Addiction Theories 
Understanding addiction theories is useful for framing evaluations and in realist evaluation is 
useful for starting to think about the contexts, mechanisms and outcomes associated with 
treatment of addictions. This chapter has discussed the most prominent addiction theories 
and the history of addiction. To summarise, the elements of addiction that are most 
important are that addiction is about compulsive behaviour (whether or not it is neurologically 
similar to obsessive compulsive disorder or not) and treatment is about breaking the 
compulsion. Addictions are often present with other mental health problems and are often 
correlated with adverse childhood events, poverty and economic shocks, and a lack of 
community or displacement. Most economic benefits from treatment of addiction fall to the 
criminal justice system, as a result of drug & alcohol users committing fewer crimes 
(McCollister & French, 2003) and this, rather than improving individual quality of life, is 
usually the imperative behind funding treatment of addictions. However in the case of 
tobacco addiction many of the benefits fall to the healthcare system. Taking all of these 
things into account is useful for treatment. There is an argument that addiction theories that 
major on moral judgements may not be helpful for the scientific study of addiction, even if 
they work for individuals. Because many individual addicts are aware of the language of 
addiction theories, understanding the real mechanism through which individuals recover can 
be difficult, as their descriptions can be driven to an extent by the discourse in the theories 
and ideas they know about (Hanninen & Koski‐Jannes)Once addiction theories gain traction 
with academics, practitioners, drug users or the population then these theories can exercise 
a latent power.  
2.7 The Structure of Public Health in the UK 
Local specialist drug, alcohol and tobacco treatment services are provided by local authority 
public health teams in England. Understanding the public health profession is important in 
knowing the chain of command in terms of implementation and the multidisciplinary 
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approach taken. In the UK, public health practice is led by the Faculty of Public Health 
(UKFPH). Public health policy is led nationally in England by Public Health England, which 
took on these functions from the Department of Health in 2013. Local Directors of Public 
Health are responsible for leadership across the three domains of public health; health 
improvement, health protection and healthcare public health. Treatment of addictions mainly 
falls under health improvement. Since 1988, Directors of Public Health (DsPH) have 
produced annual reports detailing the state of public health in their areas. From 2001 the 
DsPH were based in NHS Primary Care Trusts, until 2013 when they moved into local 
authorities. Since 2007 each area has been required to produce a Joint Strategic Needs 
Assessment (JSNA), which is both a process and a document to assess and describe in 
detail the health and social care needs of the local population, which is meant to inform the 
health and social care commissioning process.  
In England, local public health teams moved in 2013 from being in the NHS to being in local 
authorities. Before this, most had worked together closely with local authorities. Local public 
health teams provide leadership and strategy across the local authority on health issues and 
work with the local Health & Wellbeing Boards which provide leadership across the public 
sector. They are responsible for planning and have staff on call for local public health 
emergencies (such as disease outbreaks, large fires, chemical leaks or other major 
incidents). They also commission services such as sexual health services, weight 
management, smoking cessation, drug & alcohol treatment, and often many smaller services 
to meet specific needs. Many public health departments also provide some services 
themselves although since around 2007 the commissioner-provider split has become 
greater, and public health teams are subject to a lot more regulation around how they tender 
for services. In terms of statutory functions for local authorities, as of 2014 these are; 
1. Weighing and measuring of school children (the national child measurement 
programme or NCMP). 
2. Make arrangements to provide health checks for eligible people – the regulations 
also specify what information needs to be recorded. 
3. Make arrangements for open access sexual health services. 
4. Make arrangements for the provision of a public health advice service which should 
be agreed between the local authorities and clinical commissioning groups (CCGs). 
This means public health teams providing advice to CCGs around health needs 
assessment, demand and capacity planning, and on commissioning.  
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5. Provide advice health protection arrangements against threats to the health of the 
local population, including infectious disease, environmental hazards and extreme 
weather events.  
(Heath, 2014) 
Compared to other parts of the NHS and other local authority services, there is a lot of 
variation in what is spent, provided and commissioned in terms of local provision in public 
health. For example, some areas spend in excess of £1million per annum on weight 
management services, while some areas have only very small-scale services which cater 
only for people who are eligible for bariatric surgery. Or in terms of what is provided, some 
public health teams take lead responsibility for individual funding requests (IFRs) for people 
requesting treatments that are not routinely provided through the NHS, while in some areas 
this is done by a committee of local clinicians. Table 3 shows the spend per head (based on 
total population) on public health categories for Wirral, its statistical neighbours, and England 
for 2013/14. This data is from PHE (2015). Wirral spends more per head on Public Health 
than England or its statistical neighbours (£72 per head for Wirral vs. £59 for stat neighbours 
and £47 for England). Most of this extra spend was on drug and alcohol treatment which 
Wirral spends much more on than England or stat neighbours.   
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Table 3. Spend per head (£) on Public Health categories, Wirral, England and statistical 
neighbours, 2013/14 FY. 
 Category of spend Wirral England Stat 
neighbours 
Difference 
Wirral vs. 
England 
Difference 
Wirral vs. 
stat 
neighbours 
Sexually Transmitted 
Infection Testing and 
Treatment 
6.3 7.0 5.2 -0.7 1.2 
Contraception 2.2 3.1 3.7 -1.0 -1.6 
Sexual Health Advice 
prevention and promotion 
2.2 1.8 1.2 0.4 1.0 
Health checks 0.8 1.0 0.9 -0.3 -0.2 
Health protection 0.2 0.6 0.9 -0.4 -0.8 
National Child Measurement 
Programme 
0.1 0.4 0.2 -0.2 -0.1 
Public Health Advice to 
CCGs 
0.0 1.0 1.2 -1.0 -1.2 
Obesity - adults 2.5 1.1 1.8 1.4 0.7 
Obesity - children 0.7 0.5 0.5 0.2 0.2 
Physical Activity  - adults 0.1 0.9 1.0 -0.8 -0.9 
Physical Activity  - children  0.0 0.4 0.2 -0.4 -0.2 
Drugs adults  21.8 9.8 12.8 12.0 9.0 
Alcohol -adults  9.0 3.5 4.9 5.6 4.1 
Substance misuse -youth 1.3 1.3 1.0 -0.1 0.2 
Stop smoking services 4.8 2.3 2.9 2.5 1.9 
Tobacco control  0.0 0.3 0.1 -0.3 -0.1 
Children 5–19 Public Health 7.6 4.5 5.7 3.1 1.9 
Miscellaneous Public Health 12.2 7.2 8.1 5.0 4.2 
Total 71.9 46.6 52.4 25.3 19.4 
 
Public health made up on average 2.2% of local authority budgets (£2.7billion) in 2013/14. 
Public health funding allocations are based mainly on the size of the population and an 
area’s under-75 years standardised mortality ratio. The Government have said that the ring 
fenced grant should be spent on activities to; 
 Improve significantly the health and wellbeing of local populations. 
 Carry out health protection functions delegated from the Secretary of State. 
 Reduce health inequalities across the life course, including within hard to reach 
groups.  
 Ensure the provision of population healthcare advice (Heath, 2014) 
Since the public health budget transferred over to local authorities in 2013, there have been 
concerns expressed about the possibility of public health funding (which was ring-fenced and 
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protected for three years) being used to plug the gap in other local authority services, 
particularly as a lot of services like parks, leisure, environmental health could be broadly 
labelled as ‘public health’.  
Table 4 shows spend on public health categories in 2012/13 for England. It is clear that 
drugs and alcohol make up a large proportion of spend (around 31%). Smoking and tobacco 
control make up around 5.8% of spend.  
Table 4. Local Authority General Fund Revenue Accounts 2012/13 for Public Health (£ 
thousand). From PHE (2015). 
 Area of spend Net current 
expenditure 
(2012-13)  
% of total 
(2012/13) 
Sexual health services - Sexually transmitted infection 
testing and treatment  
366,912 13.6 
Sexual health - Contraception  155,592 5.8 
Sexual health - Advice, prevention and promotion  114,109 4.2 
NHS health check programme  86,219 3.2 
Local authority role in health protection  40,757 1.5 
National child measurement programme  22,500 0.8 
Public health advice  64,539 2.4 
Obesity -Adults  68,183 2.5 
Obesity- Children  28,461 1.1 
Physical activity - Adults  31,334 1.2 
Physical activity - Children  10,953 0.4 
Substance misuse –drug misuse  568,767 21.1 
- Alcohol misuse  204,080 7.6 
- Drugs and alcohol – youth services  54,958 2.0 
Smoking and tobacco – smoking cessation and interventions  136,290 5.0 
- Wider tobacco control  22,084 0.8 
Children 5-19 public health programmes  230,808 8.6 
Miscellaneous public health services  492,679 18.3 
Total public health  2,699,221 100.0 
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Chapter 3. History and Application of Health Economics 
3.1 The Background to Health Economics 
While public health could be described as a 'happy science', economics has been described 
as 'the dismal science' (Marglin, 2008). Health economics as a discipline is still young, with 
Arrow’s (1963) paper “Uncertainty and the welfare economics of medical care” credited with 
being the genesis, with health economics as a discipline really taking off in the 1970s. In the 
US, health economics was particularly prominent in health policy when national Medicare 
coverage was extended to include people with disabilities, including those with chronic 
kidney failure who required dialysis or transplant, and led to a quoted cost-effectiveness 
threshold of 50,000 US dollars per life year saved (Neumann et al., 2014). Health economics 
regards health as an economic good and healthcare as a market where unregulated demand 
will always outstrip supply. Healthcare is therefore scarce. Health economics believes that 
people derive utility from health. In general economic terms, utility is mainly measured in 
terms of the results of choices; is it assumed that if people choose something more often 
they get more utility from it. So if people choose to buy boats over cars then this is because 
they get more utility from boats; boats are more desirable. However the evidence is that 
people do not make rational choices; choices are framed in a certain context and changing 
the choice architecture changes the decision outcomes (Thaler & Sunstein, 2008). So for 
instance more people are likely to accept a surgical procedure if they are told it has a 90% 
survival rate, than if they are told it has a 10% mortality rate (Kahneman, 2011).  
Health economics is based on Pareto’s welfare economics theories. It is also owes a lot to 
John Rawls’ theories of social justice (Dolan, 1998). In welfare economics, if a market is set 
up well, it should be able to achieve close to a Pareto optimal allocation of resources, a state 
where one person cannot be made better off without making someone else worse off, which 
will be guided by ‘the invisible hand’ (Garber & Phelps, 1997). In terms of economics, utility 
maximising consumers and profit maximising firms interacting in a perfect competitive 
environment should achieve optimum utility. In practice there are several optima that can be 
achieved. This idea of Pareto efficiency is quite impractical in reality and has been criticised 
by commentators such as Sen who points out that a state can be perfectly optimal but still be 
“perfectly disgusting” by any standards (Kanbur, 2003). For instance a state where there are 
wide inequalities in quality of life but where any increase in the quality of life of those at the 
bottom cannot happen without it being at the expense of the people at the top. We have 
discussed earlier how the results from Wilkinson & Pickett (2010) demonstrate that inequality 
affects people across the distribution, not just those at the bottom. So a healthcare market 
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could in theory be perfectly efficient, but not be seen as being fair. In fact, healthcare 
markets are far from efficient and exist in a state of market failure (Nicolls et al., 2004). 
There are a set of issues that lead to market failure in the healthcare market, which means it 
does not tend towards maximal efficiency or a Pareto optimal allocation (Pauly, 1986). 
These issues are;  
 Information asymmetry – doctors generally know a lot more than their patients about 
healthcare issues so they are not savvy consumers. 
 Agent relationship – people often access services through a third party agent like a 
doctor. 
 Adverse selection – people in good health are less likely to purchase health 
insurance (this may be less of an issue in countries like the UK that have universal 
healthcare). 
 Moral hazard – people who have healthcare coverage or insurance may not take 
steps to keep themselves healthy. 
 Use of healthcare is unpredictable. 
 Risk of supplier-induced demand. 
 Lack of competition in some sectors - e.g. emergency department visits; individuals 
who have injured themselves seldom think about which is the best value emergency 
department, they will just go for the one which is geographically closest. 
 High transaction costs. 
 Externalities – e.g. second hand smoke negatively affects other peoples’ health, or 
immunisation and sanitation benefits others’ health. 
Many of these causes of market failure were mentioned in Arrow (1963) and have been 
highlighted in other studies such as the RAND health insurance experiment (Manning et al., 
1987). Some of these have limited relevance to public health services and to treatment of 
addictions, but some have strong relevance and will be referred to as we go on. 
3.2 Allocative and Technical Efficiency 
Health economics is often concerned with allocative efficiency - allocating resources 
efficiently between programmes, and technical efficiency - using resources in the best way 
within programmes. This is also known as horizontal priority setting – choosing between 
spend on different categories and vertical priority setting – choosing how to spend money 
within a category. However it can be argued that the difference between allocative and 
technical efficiency is an arbitrary one which depends on how you decide to slice up the 
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resources and how you categorise spending programmes. So for instance an allocative 
efficiency question could be how to allocate money to coronary heart disease as a disease 
area compared with cancer, but you could also have smoking cessation as an area which 
impacts on both CHD and cancer. You could also say that allocating resource for preventing 
cancer cases and deaths compared to preventing CHD cases and deaths is a question of 
allocative efficiency, but you could also go a level lower and say that allocating resource 
between bowel cancer and breast cancer treatment is also a question of allocative efficiency, 
but if the overall outcome is reducing cancer as a whole then maybe looking at resource 
allocation for different cancers is a question of technical efficiency.  
3.3 Egalitarianism vs. Utilitarianism 
There has been a debate over whether health economics should adopt an egalitarian 
approach or a utilitarian approach. An egalitarian approach is aiming for equal opportunity 
for individuals to enjoy health whereas a utilitarian approach is aiming to maximise health 
across a population. An egalitarian approach could include reducing health inequalities and 
possibly a ‘fair innings’ approach to health, where spending is directed at helping everyone 
to live to a certain age (Olsen, 1997). Consider for example whether the difference between 
living to 90 and living to 100 is the same as the difference between living to 50 and living to 
60. This approach is controversial. 
There is the question of whether people as a whole value collective utility or really put more 
of a premium on their individual or family’s utility. People do altruistic things that improve 
other people's utilities at the expense of their own (or at least at the expense of their own 
time). The economic theories behind this are kinsmanship (helping close friends and 
relatives) and reciprocity (helping others in the hope of promoting cooperation). Does this 
mean that people are utility maximisers across a population? Some people like Mother 
Teresa of Calcutta literally devoted their lives to helping others. In “The Selfish Gene” 
Dawkins (1976) talks about altruistic behaviour in animals including humans and how it 
relates to genes preserving themselves, sometimes at the expense of their current hosts. It 
would be interesting to try to measure if this instinct to aim for maximum utility across a 
population has changed now that societies in general seem to be becoming more 
individualistic. It might be that the cult of individualism, consumerism and advertising has led 
to individual human volitions and the power of suggestion becoming more powerful than 
genes in driving natural selection. Phenomena like addiction could be considered as a 
symptom of power struggles between genes and their hosts. Maybe our genes mean that 
our brains are hard wired to focus on the pleasure and contentment from sex, food, taking 
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care of children and evading predators but this same brain circuitry is shortcut by addictive 
substances (Bernheim & Rangel, 2002). 
3.4 Welfarism and Extra-Welfarism 
NICE’s Guide to the Methods of Technology Appraisal (2013) defines a reference case 
assumption that all equal-sized health improvements “should receive the same weight 
regardless of any other characteristics of the people receiving the health benefit” – this is a 
utilitarian approach, treating QALYs equally rather than treating people equally – although 
NICE make some exceptions, for instance they allow a higher cost effectiveness threshold 
for interventions that extend life, which are often cancer drugs (Linley & Hughes, 2013). The 
utilitarian approach is linked more to an extra-welfarist perspective, where an equal value is 
put on health across the population, as opposed to in a welfarist perspective where the 
individual value of health would be measured. With the EQ-5D which is the standard tool 
used to calculate QALYs, a population time trade-off (TTO) method is recommended to 
reflect the preferences of local taxpayers and potential receivers of healthcare rather than 
people who have already got specific diseases, so this is taking an extra-welfarist 
perspective (Dolan et al., 1996). The time trade-off method involves a sample of the 
population being given health scenarios and asked how much time they would trade off in a 
worse health state for a shorter amount of time in a better health state (usually perfect 
health). So if someone is given a scenario of severe anxiety and depression and moderate 
pain and discomfort they may say that they would trade 10 years in this state for 3 years of 
perfect health; this health state would have a utility value of 3/10 or 0.3. Alternative methods 
to time trade-off are standard gamble and discrete choice experiments. Standard gamble is 
where people ‘gamble’ on a chance of a better health state against a chance of a worse 
health state (usually death). Standard gamble appeals more to economists as it better 
represents the uncertainty inherent in real world decisions, but it can be difficult in reality 
because people are usually very risk averse in hypothetical situations (Bleichrodt, 2002). 
Discrete choice experiments involve scoring a set of scenarios so that they can be ranked 
when individual elements of the scenarios are changed, so it could be determined whether 
someone would rather lose a little finger than lose a big toe, etc. 
This thesis addresses in chapter 7 the issue of welfarism and extra-welfarism in the 
valuation of health outcomes. In essence extra-welfarism applies a population average value 
of health while welfarism aims to reflect each person's individual value of health. But the 
question is do drug, alcohol or tobacco users value health less than other people in the 
population, and value health less than other things like short term happiness, or being 
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social? Maybe heavy drinkers or smokers in part become heavy drinkers or smokers 
because they value the short term social aspect or group mentality from smoking or drinking 
more than they value the longer term negative health aspects. The time dimension is crucial 
given that although while potentially offering a short term boost to social acceptance within 
peer groups alcohol and drug abuse often leads over the longer term to relationship 
breakdown and social isolation (Perty et al., 1998). But it may be rather that the addiction 
has crowded out the value of their health, and that health is just one of many things that are 
dominated by the addiction which may include child rearing, self-improvement, and work. 
This is also brings in a productivity argument - do people value health because it allows 
them to be productive and have money and energy to enjoy themselves and work and take 
care of their families? In which case you can say that the utility derived from health is 
correlated closely to the potential economic productivity derived from health. And thus for 
people with severe drug or alcohol problems, they are less likely now or in the future to be 
'productive' members of society by ordinary perspectives (i.e. work, have a family etc.), so 
does society value their health-related utility less, as well as them valuing their own utility 
less? This is a controversial argument, and is similar to the controversy when organisations 
like NICE (although in reality the Department of Health) were seen to be debating whether 
healthcare rationing should favour younger people, taking into account 'wider societal 
benefits' (Hope & Martin, 2014). It may be more like the ecological argument from Nettle 
(2010) that people who become 'addicts' do so because it makes less sense for them to 
worry about the consequences of addiction when they are already exposed to many extrinsic 
health risk factors from before birth. We have seen in the results of cohort studies that 
people exposed to early life risk factors have poor health throughout their lives (Kuh & 
Shlomo, 2004). 
3.5 Health Economic Approaches and Methodologies  
3.5.1 Main Methods 
Table 5 shows the main health economic evaluation methods that are used today. Cost 
benefit analysis is often seen as the gold standard as it allows the value of a programme to 
be compared with other non-health programmes, so we can compare the cost benefit of a 
cardiovascular risk reduction programme with a road improvement programme, with an 
education programme. Many senior decision makers in government would love to have this 
type of comparison to hand. Cost benefit analysis is very valuable in theory but very difficult 
in practice. This is because it is difficult to establish the willingness to pay or the shadow cost 
for healthcare, particularly in the UK where most healthcare is free at the point of contact. 
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Within healthcare, cost utility analysis or cost per QALY is often seen as the gold standard 
as it allows comparison between health interventions on a common currency so we can 
compare the cost utility of an oral health improvement programme with a stop smoking 
service, with hip replacement surgery. Once again this is more difficult in practice than in 
theory, and the main tools used to calculate QALYs often have some deficiencies, so for 
example the EQ-5D which is the gold standard tool recommended by NICE, is a multi-
attribute scale but is not good at measuring the impact of sensory impairments like blindness 
or deafness, and is also not good at measuring quality of life in illnesses like chronic lung 
disease (COPD) that have a pattern of exacerbations and recovery. The EQ-5D is used in 
PROMs (patient reported outcome measures) to measure the quality of life gains that 
individuals get from surgical procedures in the English NHS, alongside condition-specific 
measures. 
NICE are often said to have a cost per QALY threshold, whereby they will recommend 
treatments where the incremental cost effectiveness ratio (or cost per incremental QALY) is 
less than £20,000, and between £20,000 and £30,000 where there is a high level of certainty 
about the cost effectiveness (Appleby et al., 2007). For some end of life treatments they may 
go up £50,000 per QALY. NICE have said that ‘a QALY is a tool not a rule’ and there are 
examples of where they have recommended treatments where the cost per QALY is greater 
than the threshold, including Pemetrexed [Alimta] for the treatment of malignant pleural 
mesothelioma. Mesothelioma was a disease caused by asbestos exposure which was most 
prevalent in older manual workers from occupations such as shipbuilding, railway 
engineering and asbestos product manufacture. Pemetrexed was assessed as having a 
cost/QALY of c. £60,000 which is above the NICE threshold of £30,000 per QALY gained. 
Because mesothelioma affected relatively small numbers and affected workers who were 
mainly from deprived populations NICE approved it but some areas challenged this 
judgment, so Birmingham East and North Primary Care Trust (PCT) submitted an appeal 
against this decision arguing that the fact the disease came from occupational exposure 
should be irrelevant to the decision (Rawlins et al., 2010). 
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Table 5. Main types of health economic analysis methods. 
Economic analysis 
method 
Cost measure  Benefit measure  
Cost benefit analysis 
(CBA)  
Money  Money  
Cost effectiveness 
analysis (CEA)  
Money  Natural units (i.e. life years gained, 
change in blood pressure etc.)  
Cost utility analysis (CUA)  Money  QALYs (Quality Adjusted Life 
Years)  
Cost minimisation analysis 
(CMA)  
Money  Benefits are equivalent  
Cost comparison analysis  Money  N/A – this method merely 
compares costs 
Cost consequence 
analysis 
Money Lists consequences separately but 
does not weight them or turn into a 
summary measure 
 
3.5.2 Social Return on Investment (SROI) 
Social return on investment (SROI) is a related concept to cost benefit that often adopts a 
wider perspective in terms of measuring the value of a programme to different stakeholders 
(Cupitt, 2009). SROI is about understanding which outcomes a programme has delivered for 
stakeholders and putting a value on this, often with financial proxies. The main downside of 
SROI as a methodology being that any SROI ratios (which are similar to cost-benefit ratios) 
are seen as being specific to the programme in question and not comparable to one another, 
although can be compared over time within a programme. So if the SROI ratio for a smoking 
cessation programme is £6 for every £1 spent, one cannot say it is better to invest in this 
than in a weight management programme where the ratio is £2 for every £1 spent. There is 
perhaps a danger here of always producing “a Dodo bird verdict” where “all have won, and 
all shall have prizes”. But if the same methods are used then the ratio could be compared 
over time, so if in 2015 the ratio is £6.10 for every £1 spent, service managers could look at 
which areas of a programme deliver the most social value and aim to maximise this so that 
in 2016 they aim to get £7.50 for every £1 spent. SROI has been used increasingly in the UK 
since the Public Services (Social Value) Act (HM Government, 2012a) which stated that 
commissioners and procurers should consider social value when commissioning services, 
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which in practice means that local public sector commissioners no longer need to go for the 
cheapest bidder, and can consider additional social value. So if a commissioner is choosing 
between a national company that will bring their own staff and a charity that will employ local 
people who have had previous alcohol problems and been long-term unemployed it can 
consider the additional value rather than just going with the cheapest option. SROI has not 
been used in this thesis but it may have some promise for looking at public health 
interventions and has been used to evaluate some addiction services. SROI is not overly 
prescriptive but uses some useful techniques in stakeholder engagement and in using 
revealed preference techniques to put a financial value on individual outcomes. The focus on 
individual stakeholder value, and in measuring value continuously rather than as a one off 
exercise, are two of the strengths of SROI (Millar & Hall, 2013). 
3.5.3 Multi-Criteria Decision Analysis (MCDA) 
MCDA is a process for making decisions using a set of criteria. A criterion is a standard 
against which something can be judged. In MCDA a programme or service can be judged on 
a set of criteria (for instance outcomes achieved, reach, customer feedback) which are then 
most often weighted to give a total score for the relative desirability of each service. Services 
can then be ranked by their total score to give an indication of the relative preference for 
each service. Like nearly all real world decision processes, MCDA involves an element of 
subjectivity. MCDA is based on the principle that a low score on one criterion can be 
compensated for by a high score on another criterion. Anything that is not compensatable in 
this way should not be a criterion, so anything that is a necessary element should instead be 
a first stage filter (Lootsma, 2013). We might use a process similar to MCDA when we make 
decisions in our own lives, so for instance if we are buying a house we may weigh up the 
things we want against each other; a smaller bathroom may be compensated for by a bigger 
garden. 
Multi criteria decision analysis is an iterative process; it often involves going back to look at 
the criteria and weightings and adjusting them; this is a natural part of the process. It will 
also often highlight where there is a lack of information on how certain services meet certain 
criteria, which can then be collected or estimated and fed back into the process. MDCA is 
also sometimes called multi criteria analysis (MCA) or multi criteria decision making 
(MCDM). The Department of Communities and Local Government (DCLG) produced a 
manual in 2009 (Dodgson et al., 2009). In the public health sphere, the HELP (Health 
England Leading Priorities) Tool used an MCDA methodology to rank potential public health 
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interventions. MCDA has not been used in this thesis but have used it in other applications 
such as in a prioritisation process looking across all local government services.  
3.5.4 Economic Modelling 
Many health economic evaluation studies involve some degree of modelling. Models are a 
simplification of the real world and involve abstraction, selection and assumptions. Modelling 
generally has three main purposes; 
1. To combine data from different sources, and in many cases, to create hypothetical 
populations or scenarios. 
2. To estimate long term outcomes (including costs) based on short term (surrogate) 
outcomes. 
3. To account for uncertainty or bias in the data sources. 
This thesis will use some of the most common types of models in health economics, namely 
decision tree and Markov (chain) modelling (Briggs & Schulpher, 1998). 
Decision trees are used to compare strategies and calculate their net present value by 
‘rolling back’ or pruning the tree. This can then be used to determine the optimum strategy. 
Figure 8 shows an example reconstructed from a book; Morris, Devlin & Parkin (2007). This 
is a decision tree with 2 initial scenarios - surgery or drug treatment. The outcome in this 
model is QALYs (quality adjusted life years). 
The decision nodes (squares) represent decision points controlled by the decision maker 
(which could be a clinician, the patient or someone else). In this case there are two 
alternative strategies at the beginning, drug treatment or surgery. And in the drug treatment 
arm there is an additional decision node where drug treatment has not cured the patient the 
first time, where a patient can either have counselling or further drug treatment. Decision 
nodes need to be mutually exclusive, so in this case a patient cannot have drug and surgery, 
if this was the case then this would require a third branch, labelled ‘Drug and Surgery’. 
The chance or probability nodes (circles) represent points where an outcome is subject to 
some uncertainty that is not controlled by the decision maker, so after surgery there is a 5% 
(0.05) chance of the patient dying, and a 95% chance of the patient surviving. Chance nodes 
can have more than two outcomes, but they must be collectively exhaustive, i.e. all possible 
outcomes are accounted for, so if 10% of clients had unknown outcome, it would be labelled 
as such. The sum of probabilities at any chance node must always equal one. The chance 
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nodes will also approximate to the proportion of patients ending up with each outcome, if a 
large simulation cohort is run through the model. 
The terminal node represents the final outcome associated with a path through the decision 
tree, so as an example if a patient has surgery, survives, and is cured they will have a quality 
adjusted life expectancy of 15 QALYs. If a patient has drug treatment, is not cured, and then 
opts for counselling then they will experience 1.5 QALYs. 
The expected value of a decision is calculated by ‘pruning’, ‘roll back’ or ‘fold back’ up the 
tree, so for the drug treatment arm, the expected value for someone having drug treatment 
and if not cured, the second course of drug treatment, would be the sum of the probabilities 
multiplied by the outcomes at each decision node. 
Figure 8. Example of a decision tree for a clinical pathway.  
 
Markov models involve a hypothetical population moving through a set of cycles. Each cycle 
represents a period of time like 6 months or a year, where at the end of each cycle they have 
Example of a decision tree Types of node
Decision node
Chance node
Terminal node
0.05
Die 0 QALYs EV= Expected Value (in this case the average number of QALYs)
Surgery
EV= 11.495 0.8
Cured 15 QALYs
0.95 EV= 12.1
Survive
0.2 0.5 QALYs
Not cured
0.7
Cured
13 QALYs
Counselling
1.5 QALYs
Drug
EV= 10.75
0.5
0.3 Cured
Not cured 10 QALYs
Drug 2
EV= 5.5
1 QALY
0.5
Not cured
these represent decision points controlled by the 
decision maker.
(probability node) these represent chance 
occurences that are not controlled by the decision 
these represent the final outcome associated with a 
particular pathway through the decision tree.
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a probability of moving between a set of mutually exclusive and collectively exhaustive 
Markov states. Markov models are particularly useful in modelling chronic diseases where 
there is a pattern of exacerbations or different stages where often a decision tree model 
would potentially end up with a large number of branches that would be difficult to check for 
errors. Figure 9 shows a simple Markov model with three states, and the transition 
probability in each cycle. Markov models typically start off with the whole population in one 
state. During each cycle for the ‘well’ state there is a 0.04 probability of moving to the 
‘unwell’ state and a 0.01 probability of moving to the ‘dead’ state (the remaining 0.95 
probability is for remaining in the ‘well’ state). In this case the ‘dead’ state would be called an 
absorbing state which means that people do not move back out of it once they are in it.  
Figure 9. Example of a simple Markov model, showing transition probabilities. 
 
In general Markov models are stochastic and have no memory, thus the probability of the 
next state is independent of the time spent in previous states, which can cause a logical 
problem. However there are adapted versions of Markov models that have tunnel states and 
other augmentations to better reflect reality. So for example a Markov model with a six 
month cycle may have a state of lung cancer and a probability of moving into a state of 
complete remission. If by definition someone cannot be in complete remission until they 
have not had any signs of cancer for five years then it would not make sense for someone to 
move to this state after six months, even though there may be an average probability of this 
happening over a longer period of time. So having a tunnel state whereby someone would 
0.050.01
0.04
0.12
UnwellWell
Dead
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have to be in a lung cancer state for at least ten Markov cycles (5 years) before they could 
have a chance of moving into a state of complete remission would make the model more 
logical. But the need to make these augmentations depends on what question the model is 
answering, if the summed outcomes at the end are a good representation of reality then this 
may be enough even if the individual transitions do not make logical sense.  
In terms of software, this work has used TreeAge, which is a piece of software dedicated to 
decision analysis and often used in economic evaluations (Menn & Holle, 2009). This thesis 
also used Microsoft Excel, which is a very widely used spreadsheet application, which when 
programmed using Visual Basic for Applications (VBA), can be used to model scenarios 
from data distributions to carry out sensitivity analyses or to simulate populations by drawing 
a large number of simulations from data distributions.  
There are other methods which are used often in health economics. One method not used in 
this thesis is discrete event simulation (DES). This involves modelling at individual level and 
has greater possibilities than Markov or decision tree modeling, so it is particularly useful for 
creating virtual populations with sets of characteristics and multiple morbidities that would be 
difficult to represent in a Markov model, as the number of Markov states required will 
increase exponentially. However DES modelling is also very data hungry and can be difficult 
to interpret. The smoking cessation case study has used a cohort simulation model which is 
more similar to a Markov model than DES. 
There is a checklist known as the ‘Drummond checklist’ which was produced for economic 
evaluation studies which is useful for assessing modeling studies (Box 1). Economic 
modeling should include sensitivity analysis, where the parameters in the model are varied 
to see how sensitive the model is to changes in these parameters. When assessing new 
technologies, NICE suggest that probabilistic sensitivity analysis (PSA) should be used. This 
is where model parameters are given a probability density function and a set of scenarios 
are drawn, so for example 10,000 scenarios may be drawn with parameters set to 
distributions, and likely cost effectiveness ratios calculated based on these scenarios. The 
distributions should be drawn from empirical studies or based on expert opinion. Any 
modelling studies should also justify the time horizon used, and the discount rate used for 
costs and benefits that occur in the future. Ideally a life time horizon should be used but it 
depends on the decision question. Often in economic evaluations costs and benefits that are 
not directly relevant to the disease area are excluded, so for instance with competing causes 
of death and intervention may prevent someone from dying from a smoking-related disease 
but they then have a chance of dying from dementia ten years later.  
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Box 1. Drummond checklist (Drummond & Jefferson 1996) 
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3.6 Applying Health Economics to Public Health Interventions 
Public health and health economics have one crucial thing in common; they both use a 
population approach rather than an individual approach. Measuring the cost effectiveness of 
public health interventions has some particular issues compared to measuring the cost 
effectiveness of more clinical interventions, which are:   
• Willingness to pay is often low; it is hard to get market prices for costs and benefits 
when people are not used to paying for interventions (Hirth et al., 2000) 
• Public health interventions often work via the mechanism of behaviour change which 
takes time, so often the behaviour is used as a proxy for the health outcomes, e.g. in 
smoking cessation when someone stops smoking this puts them on a pathway of 
eventually having a reduced risk of smoking-related diseases (Hardeman et al., 
2002). 
• Public health programmes are often complex, holistic interventions with multiple 
effects and can have competitive or synergistic effects with each other, and are often 
present within complex systems (Rychetnik et al., 2002). 
• Multi sector effects – i.e. Teenage pregnancy interventions, drug treatment – benefits 
do not all fall to health system so are harder to measure – known as the cross sector 
flow problem. It can be difficult – but, it could be argued, not impossible- to measure 
these distant effects within current economic evaluation methods (Brazier & 
Tsuchiya, 2015). 
• Effects of interventions are often measured at an individual level (although often 
aggregated and/or averaged out) while public health interventions may increase 
community cohesion or resilience which is not easily measured at an individual level. 
Also often reduce risk at a population level e.g. vaccinations (Diez-Rouz, 2000). 
• Public health interventions often evolve or are applied differently across populations, 
so can be hard to evaluate or compare like with like (lack of fidelity). This is where 
programme theory and realist evaluation are useful (Rychetnik et al., 2002). 
• Public health interventions often have a longer payback time than clinical 
interventions, for example creating a new green space, vaccinations etc. Because 
economic evaluations use discounting this can skew the effectiveness. This is why it 
is often recommended to use a range of discount rates in any sensitivity analysis, 
which is what has been done in this thesis for smoking. 
• In general cost effectiveness analyses are meant to compare to the next best 
alternative but with public health it is not always known what an appropriate 
comparator is, and in practice analyses often use a 'do nothing' alternative.  
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• Public health interventions often target health inequalities, which can be at the 
expense of efficiency. So in terms of Marmot’s principle of ‘proportionate 
universalism’ (Marmot, 2011) there is the question of how health economics should 
account for interventions with a differential impact on health inequalities, with some 
methods like distributional cost effectiveness analysis (DCEA) (Asaria et al., 2014) or 
a continuous social welfare function (Adler, 2012) being posited to essentially 
account for a more welfarist, egalitarian approach rather than the current extra-
welfarist, utilitarian approaches. DCEA has promise; but one argument against it is 
that having a utilitarian ‘QALY maximising’ perspective should in general favour 
health inequalities anyway, as more deprived people lose more QALYs through ill 
health (Mooney, 1989). QALYs have not been explicitly weighted for deprivation in 
this thesis, rather it has considered the impact on inequalities as an additional 
outcome in the analysis through a health equity impact assessment. To apply 
proportionate universalism or indeed any of these approaches, a researcher would 
need to understand how health outcomes vary across socioeconomic groups, which 
is why it is important to monitor health inequalities. 
3.7 NICE and Public Health 
NICE (the National Institute for Health and Care Excellence) is an Executive Non-
Departmental Public Body (ENDPB) of the Department of Health in the UK who apply health 
economic techniques to the appraisal of public health interventions. Since 2005 NICE have 
provided advice to local public health teams and to national policy makers on public health 
interventions. NICE was formed in 1999 by the Labour government and their main role was 
initially around clinical interventions, to provide advice to the NHS in what healthcare 
interventions should be provided, based on getting the best value for money and reducing 
the 'postcode lottery' where certain treatments were available in one area of the country but 
not in others. In 2005 NICE acquired this role in producing public health guidance in addition 
to clinical guidance from the Health Development Agency, producing their first public health 
guidance on smoking in 2006. The idea was to use evidence-based medicine techniques in 
public health guidance, therefore making guidance more robust and well respected. As of 
November 2011, they had produced 35 pieces of guidance on public health programmes or 
interventions. NICE’s first edition of ‘Methods for development of NICE public health 
guidance’ was published in 2006 (NICE, 2006). A second edition followed in 2009 and a third 
in 2013. NICE now has one manual which has unified processes and covers all of the 
guidance they produce, including public health as well as clinical guidelines, social care, and 
medicines guidelines. NICE have taken on producing advice for local authorities and 
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producing social care advice. In November 2011 NICE was asked to develop briefings for 
local government to raise awareness of evidence-based public health interventions that 
Local Authorities could employ as they take responsibility for public health. 
The economic methods that NICE utilise employ a mixture of cost perspectives, recognising 
that public health interventions have multi-sector effects (beyond health and social care). So 
for instance, an intervention to reduce unwanted teenage pregnancies can impact a number 
of systems, such as health, the benefits system and the education system. In measuring the 
benefit an intervention has for individuals, NICE has historically used cost per QALY (quality 
adjusted life year) gained (cost utility) as the gold standard (NICE, 2006). QALYs are based 
on a population level evaluation of the relative desirability of different health states. These 
health states are a simplified description of reality. In October 2011, NICE published a 
consultation document on changes to the methods and processes they use for public health 
guidance development. In recognition of the limitations around cost utility and what it 
measures, NICE are moving toward recommending that cost consequence analysis (where 
costs and consequences are listed separately without being rolled up into a summary 
measure like cost utility) also be routinely included, as well as cost benefit analysis (where 
the costs to the system, and a contingent valuation of benefits are both measured in terms of 
money). Cost consequence analysis is being recommended to capture how an intervention 
impacts on non-health benefits like participation, community cohesion, empowerment, crime 
and economic inclusion. Using cost benefit metrics like 'net present value' has already been 
adopted in some public health guidance, for instance NICE’s guidance on preventing 
unintentional injuries on the road used established cost effectiveness methods for transport 
(NICE, 2010a). NICE have also changed their emphasis so that the guidance process does 
not differentiate between smaller public health interventions and larger public health 
programmes. 
Cost benefit analysis is something that has been little used in assessing the value of public 
health interventions but is a method that if used successfully could have a lot of potential 
especially in environments such as in England where public health funding has moved from 
mostly being held in the National Health Service (NHS) to being in local government and 
other agencies like Public Health England (PHE). Because of these changes, being able to 
compare the value of public health interventions with programmes in other sectors using a 
common currency will become more important. Getting robust benchmarking data would be 
very useful for this as well. 
Some of the guidance NICE has produced around public health has been controversial, for 
instance in January 2010 when they recommended bringing in minimum alcohol pricing for 
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England to reduced alcohol related diseases (NICE, 2010b), which led to some politicians 
saying that NICE had gone beyond their remit. However minimum alcohol pricing has 
subsequently been considered more seriously by politicians and the Scottish government 
are attempting to bring it in. In general it seems that NICE are felt to have overstepped the 
mark when they venture into the realm of policy rather than interventions and programmes 
(Gornall, 2014).  
3.8 Case Studies of Public Health Cost Effectiveness 
There has not been a huge number of cost effectiveness studies carried out of public health 
interventions. A rapid review of public health evaluations found that only 27% provided cost-
effectiveness evidence (Matrix evidence, 2008). Several modelling studies have been 
commissioned by NICE to estimate the cost effectiveness of public health programmes and 
have combined outcomes and costs from different studies (Owen et al., 2012). 
21 out of 26 NICE public health publications between 2006 and 2010 used cost-utility 
analysis (cost per QALY). These included interventions for smoking cessation, promoting 
physical activity, preventing STIs and unwanted conceptions in young people, reducing 
substance misuse in young people, promoting healthy eating, supporting people at risk of 
dying prematurely, promoting social and emotional wellbeing in primary and secondary 
schools, promoting mental wellbeing in older people, management of long term sickness and 
incapacity, wellbeing at work, alcohol use disorders, and CVD prevention. In a review of 
NICE Public Health Guidance, 200 cost-effectiveness estimates were analysed. Of these, 
15% were cost saving (i.e. the intervention was more effective and cheaper than 
comparator), 85% were cost-effective at a threshold of £20,000 per QALY and 89% at the 
higher threshold of £30,000. 5.5% were above £30,000 and 5.5% of the interventions were 
dominated (i.e. the intervention was more costly and less effective than comparator). Most 
interventions had a very low cost per QALY, indicating they are highly cost-effective. Many 
interventions (particularly around smoking cessation) produced a net cost saving for the 
NHS. This study also acknowledges limitations in economic modelling of public health 
interventions such as lack of comparator, not considering synergy between interventions 
offered together, and not considering diminishing returns. NICE use economic modelling as 
part of their programme of work, but they do not explicitly recommend that local areas should 
use health economic techniques themselves. From working on a NICE Public Health 
Advisory Committee the researcher has seen first-hand that sometimes there are difficulties 
in generating evidence around the cost effectiveness of public health interventions, and 
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hopefully the techniques in this thesis will work towards demystifying economic evaluation a 
little.  
Some notable cost effectiveness models looking at public health interventions include the 
HELP (Health England Leading Priorities) Tool, which ranked several public health 
interventions against a set of criteria (Matrix evidence, 2008). This used a multi-criteria 
decision analysis (MCDA) type approach to ranking interventions. The 5 criteria they used 
were; 
a. Cost-effectiveness: Cost per Quality Adjusted Life Year (QALY) gained, including 
healthcare costs avoided. 
b. The proportion of the population eligible for the intervention (reach). 
c. The distribution of benefits: The ratio of the proportion of the most disadvantaged 20% of 
the population eligible for the intervention to the proportion of the population as a whole 
eligible for the intervention. 
d. Affordability: The budget required to fund the intervention if all eligible people received the 
intervention. 
e. Certainty: Confidence in the evaluation of the intervention, based on an assessment of the 
quality of the method and data used in the evaluation.  
As will be demonstrated this is quite similar to the methods used to appraise the case 
studies in this thesis. Table 6 shows the rankings of the interventions. The top four are 
increasing alcohol and tobacco taxes, and having mass media campaigns around tobacco 
and obesity. Then the next three are brief interventions in GP surgeries. Many of these 
interventions have been commissioned in some form in England (Heath, 2014). 
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Table 6. Ranking of public health interventions from Health England Leading Prioritisation 
(HELP) Tool, 2009. 
 
Tools have been developed for commissioners to estimate the return on investment for 
different public health interventions such as the NSMC Tools (Lister & Merritt, 2013) which 
looked at tobacco control, alcohol brief intervention, breastfeeding, weight management and 
bowel cancer screening. There is also the NICE Tobacco Control Return on Investment tool 
(Meads, 2014).  
The Australian ACE (Assessing Cost Effectiveness) Prevention Study was a large scale 
review of the cost effectiveness of public health interventions. (Vos et al., 2010) This used 
cost per DALY saved as a primary outcome, but also had some second stage filters which 
were; 
 Capacity of the intervention to reduce inequity; 
 Acceptability to stakeholders; 
68 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 Feasibility of implementation; and 
 Strength of the evidence base. 
 Sustainability; 
 Potential for other consequences (side effects). 
 Cultural security;  
 Community health gain. 
This study was essentially combining aspects of cost utility analysis (with cost per DALY 
saved) and MCDA (with the second stage filters). The study found that a large impact on 
population health (i.e. >100,000 DALYs prevented per intervention) could be achieved by: 
• Taxation of tobacco, alcohol and unhealthy foods; 
• Mandatory limit on salt in 3 food items (bread, cereals and margarine); 
• Improving the efficiency of blood pressure- and cholesterol-lowering drugs  using 
cost-effective generic drugs (or potentially a low-cost polypill that combines three 
blood-pressure-lowering drugs and one cholesterol-lowering drug) 
• Gastric banding for severe obesity; and 
• Intensive SunSmart campaign. 
The results of this study probably apply to the UK and are similar to interventions used or 
considered in the UK, with the possible exception of a SunSmart campaign; skin cancer 
ranks much higher as a cause of death in Australia than in England.  
A report by the Equality Trust (2014), a group which was formed in the wake of "The Spirit 
Level" (Wilkinson & Pickett, 2010) used quite a simple methodology to put a cost on the 
healthy life expectancy (HLE) gap. This is similar to the researcher’s work on putting a cost 
on the quality adjusted life expectancy gap (Collins, 2013a). The idea for this piece of work 
was that given that QALYs are the main outcome for health investment decisions, should 
there be there a potential for QALYs to be used more at a population level to determine the 
number of QALYs experienced in the population. This study combined survey data with life 
expectancy with data to calculate quality adjusted life expectancy (QALE). The theory behind 
this was that although quality adjusted life years are used in national decision making around 
investing in healthcare and public health, they are not a standard measure in assessing 
population health, despite potentially being more sensitive than life expectancy, or healthy 
life expectancy. QALE has the potential to be more sensitive because it is based on answers 
to a health related quality of life questionnaire which has more distinct health state 
possibilities; in this case the EQ-5D has 243 different health states and a range of 
corresponding utility scores from -0.59 (worst possible health) to +1.00 (best possible 
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health). This piece of work found that the most deprived areas of Wirral have a gap of 1,838 
QALYs per year compared with the whole of Wirral. If this is valued at £30,000 per QALY, 
this equates to £55million per year. This lost potential for quality and quantity of life could be 
considered as a premium that society pays for allowing such social inequities that manifest 
themselves in health behaviours and outcomes, even from before birth.  
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Chapter 4. Theoretical Basis of Work 
4.1 Objectives of Work 
Primarily the objective of this work was to test the cost effectiveness of the services in 
question. This thesis has outlined the theoretical basis of health economics and cost 
effectiveness. On a second level it was testing an integration of methodologies, in working 
towards a way of accounting for the complexity of public health interventions within 
economic evaluations. This was using mixed qualitative and quantitative methods to test the 
theory of what worked, and at the same time to adjust the theory based on the contextual 
qualitative testimony. On a third level it was trying to work towards a pragmatic set of 
techniques that could be replicated by other researchers or evaluators in other areas. And 
on a fourth level it was thinking about the role of evaluation in informing future 
commissioning decisions, and informing future policy, at a higher level of decision making 
within Government. Evaluations are a way of informing the decision making process but are 
still often distinct from this process; the evaluation rarely makes the decision. Evaluations 
happen all the time, some are published in journals, while it could be argued that some only 
happen in a split second in someone’s head when they make a decision. The case studies in 
this thesis are evaluations that have been written down. If these evaluations were not carried 
out, decisions would still need to be made and it may be that the same decisions would have 
been made, or it may be that the recommendations from these evaluations have not been 
particularly influential in the decision process anyway.  
4.2 What do we mean by 'Evaluation'?  
WHO (1998) define evaluation as “the systematic examination and assessment of the 
features of an initiative and its effects, in order to produce information that can be used by 
those who have an interest in its improvement or effectiveness.” This is different from audit 
which uses routine data, usually measures against defined standards, and never involves 
disturbance to patients or clients beyond normal clinical management. Evaluation is different 
from research which usually measures against a hypothesis, often has randomisation, is 
often testing out a novel intervention, and is most often for an academic standard. Evaluation 
is nearly always done retrospectively, though some analysts call prospective or theoretical 
models evaluation as well. Evaluation appeals because it seems to be most relevant to the 
on-going commissioning decision making process which is approached in terms of working 
pragmatically backwards from the decision that needs to be made, determining the 
questions that need to be answered, and then getting the information needed to answer 
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these questions. One of the key questions for any evaluation is how many outcomes to 
measure. Sometimes it makes more sense to use fewer measures even if they are only 
crude proxies for success. There are lots of taxonomies for evaluation. Because this work is 
mostly concerned with evaluating public health projects, some are less relevant than others.  
Evaluation is often described as summative - measuring whether outcomes were achieved, 
or formative - looking at the process of how a policy, programme or intervention was 
implemented. Often evaluations include both elements. Evaluation, like research, mainly 
uses three sets of methods; qualitative (collecting narrative accounts), quantitative 
(collecting data), and mixed methods (using both narratives and data). Generally, qualitative 
methods are used in inductive research, while quantitative methods are used in deductive 
research. Inductive research is about generating theories from observations, and deductive 
research is about testing theories with observations. Qualitative methods may include 
grounded theory, semi- or unstructured interviews, or focus groups. Quantitative methods 
include comparing before and after data using t tests, using regression, factor and cluster 
analysis to disaggregate the relationships between variables, and many other methods.  
There are examples of cases where mixed methods can be useful. In a qualitative study, 
having some quantitative information can be useful as context, so in a study about lung 
cancers caused by radon some context about how many people are affected by radon may 
add some background before having a ‘deep dive’ into generating qualitative themes about 
why people do something about radon in their homes. Or alternatively, adding some 
qualitative observations can be useful for adding some explanation to quantitative data that 
may not immediately be apparent in the data analysis. Mixed methods research allows 
researchers to be pragmatic about how they use information, so looking inside an 
organisation a researcher may get access to some data and may be able to have some 
focus groups or interviews to generate qualitative research. It may be that this information is 
piecemeal and combining it in the best way to form a coherent narrative involves a mixed 
methods approach. 
For public health and health promotion there has been a debate; with some commentators 
arguing that an increased use of evidence based medicine type methods like RCTs is 
required to get a stronger evidence base (Glasgow et al., 2003), while others have stated 
that these methods put too much emphasis on individual-level outcomes for what are often 
complex, community level programmes and thus that a broader set of methods, including 
process evaluation, should be used (Speller et al., 1997). Commentators have suggested 
that too often, macro-level interventions such as condom distribution may be evaluated using 
micro-level outcomes such as individual risk of HIV rather than macro-level outcomes like 
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the impact on the whole of society. Cluster or group-randomised trials partly get around this 
problem of accounting for synergies or competition in community level interventions (Smith & 
Petticrew, 2010). Realist evaluation is a mixed methods approach which accounts for a lot of 
the complexity inherent in public health programmes and trying to maximise both internal 
validity and external validity while working on the principle that real life programmes can only 
ever be partially understood. We will go on to explain realist evaluation in more detail in 
Section 4.5. 
The interventions in the case studies in this thesis are mainly delivered on an individual 
basis and thus may lend themselves to RCTs as long as these RCTs took proper account of 
the level of complexity inherent in the intervention and included the impact on wider societal 
outcomes such as fear of crime, or passive smoking. The main recent UK studies of drug 
treatment have not been RCTs (Godfrey et al., 2004; Davies et al, 2009), rather they have 
been before and after studies, and this is because it would not be felt to be ethical to 
withhold treatment from a problematic drug user who was motivated to attend treatment. The 
biggest recent UK study of alcohol treatment was an RCT which compared two different 
types of alcohol treatment, thus removing the potential ethical problem of withholding 
treatment from one group (UKATT Research Team, 2005). There have been several recent 
RCTs of smoking interventions, in particular of varenicline (Champix) which is still a relatively 
new drug with a higher prescription cost than other pharmacological agents for smoking 
cessation (Jorenby et al., 2006). 
Economic modelling techniques often combine data from epidemiological studies or RCTs 
but they do not always use the same threshold for quality of evidence and can include expert 
opinion as an input. A good model needs to be explicit about its limitations and there are 
several checklists that economic models can be evaluated against (Husereau et al., 2013). 
Social return on investment is another quasi-economic mixed methods approach that uses 
individual valuation methods to determine the value that stakeholders put on outcomes 
which are then quantified.  
Evaluation could be seen to be measuring whether a service has been implemented 
correctly or whether it has produced the outcomes that commissioners intended it to. There 
is an opportunity to move evaluation further by introducing some of the same economic 
modelling techniques that are used by policy makers at a national level at a local level, albeit 
mainly only using data from before and after comparisons rather than comparing against 
control groups, which may produce a higher level of rigour within the evidence based policy 
paradigm. Within the case studies in this thesis, the data and the modelling deal with the 
relationship between inputs and outcomes while the narrative mainly deals with the 
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complexity, although there are context-mechanism-outcomes tables as well which attempt to 
work towards a programme theory explaining what combinations of contexts, psychological 
mechanisms and outcomes are triggered by the programmes. So roughly speaking, this 
uses elements of cost effectiveness/cost utility analysis and equity impact analysis for the 
outcomes, and realist evaluation for accounting for the process evaluation, complexity and 
generalisability. Some researchers have argued that economic evaluations should take into 
account ‘procedural utility’; the utility derived from the process as well as the utility derived 
from outcomes (Jan, 2014). This thesis has not included this but there may be potential to do 
this in the future.  
Economic models can be time consuming to develop, particularly having the evidence to 
inform the parameters that drive the models. The intention with the economic models in this 
thesis was to create effective models that could be used for several years, so for instance 
the smoking analysis in the case study is from a model that is an extension of a model built 
two years earlier prior for which more recent data is applied. This is appropriate as the 
epidemiological evidence for health outcomes associated with addictive behaviours is 
unlikely to change in that amount of time. This is moving economic evaluation closer to SROI 
in that the analysis will be repeated over a period of time. 
4.3 Policy & Implementation 
Understanding policy and implementation, the theories of how policy is made and how to 
analyse policy is important for realist evaluation. This is because public health programmes 
exist in the context and the history of the policies that created and maintained them and they 
have long chains of implementation where changes happen.  
There are two main models of policy; rational and incremental. The rational model was 
popularised by Simon (1979) and involves defining a problem, assessing options, picking an 
optimal solution and implementation; often very much a top down process. The rational 
model may be good in theory but works less well in practice where the options and their 
consequences are often complex and not well understood. The incremental model involves 
starting with policies as they are, not with a blank sheet, always adapting, making it 
deliberate and trying to learn – still quite top down but recognising that you cannot start from 
zero. While the rational model involves trying to make the best choice, the incremental 
model involves ‘muddling through’ and valuing the policy with greatest consensus rather 
than the scientific ‘best’ policy (Lindrom and Woodhouse, 1993). Incremental policy is the 
actual experience of making policy where there is a complex array of existing investments in 
staff, professionals, estate, technologies and equipment that need to be taken into account. 
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Incremental policy recognises the fact of ‘bounded rationality’; that a decision maker’s 
rationalism exists within a context of their own knowledge, beliefs and the amount of time 
they have to make a decision (Kahneman, 2003). A decision can never be objectively 
rational because no one will ever have access to perfect information. 
Linked to rational policy making is evidence-based policy, which has its roots in evidence 
based medicine. Evidence based medicine is often based on analysing individual level data 
where it is easier to isolate the effect of an intervention, whereas in policy interventions the 
results are often at a community rather than individual level and are more complex and 
context-specific. But while medical practice is often tightly controlled outside of well-designed 
trials, there is actually more opportunity to have natural experiments in social policy 
programmes, and indeed in public health. Whether rightly or wrongly, social policy and public 
health is seen as less ‘life and death’ and there is less threat of litigation if someone does not 
get optimal treatment. Politicians are often criticised for picking and choosing what evidence 
they consider (Giles, 2006), and use of rational evidence based approaches like randomised 
trials or stepped roll out of policy measures is rare. In terms of ignoring evidence, the 
Government sacked the chair of the Advisory Council on the Misuse of Drugs, Professor 
David Nutt, over a series of disagreements over policy and the risks associated with different 
drugs (Humphreys & Piot, 2012). The UK government launched a ‘What Works’ initiative in 
March 2013 which worked towards having six evidence centres to provide high quality, 
independently assessed evidence for policy makers to use. This is using evidence-based 
policy methods. The idea behind this came partly from seeing how NICE was valued as an 
evidence centre and a source of knowledge transfer for health policy and decisions. This has 
to be seen as a positive step, although it remains to be seen how much these centres 
actually influence policy, and to what extent the centres are free from political influence.  
The UK’s model of policy is based on representative rather than participatory democracy and 
mainly a political ‘winner takes all’ system which means that politicians often have quite a 
prominent role in policy and have an executive role over the civil servants who implement 
policy (Richards, 2008). It may be that politicians set the policies and civil servants design 
the programmes to achieve them but in practice politicians will have a lot of input into large 
programmes as well. 
Just as realist evaluation says that programmes are theories brought to life, likewise it can 
be said that many programmes are policies brought to life. Understanding how policies work 
involves understanding behaviour and how organisations relate to each other. Also because 
most cost effectiveness analyses involve an assessment of the cost of a behaviour, to 
society, or to the health system, this is useful in informing the potential savings that can 
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result from successful policy, so for instance if it is estimated that the net cost to society of 
binge drinking is £1billion then a policy intervention to reduce or eradicate binge drinking has 
the potential to produce this cost saving (although you would need to consider deadweight, 
money reallocated and many other knock-on effects). Policies are often based on political 
ideologies that have been filtered through a lens of pragmatism; taking into account factors 
like feasibility, the availability of plant and workforce, public opinion, economics and timing 
(including the electoral cycle). If an intervention works then it might trump the ideology, so for 
example because harm reduction in drug users works, it trumps the Conservative ideology of 
not wanting to condone any drug using behaviour, and becomes ‘bottom up’ policy making 
(Ashton & Seymour, 2010). A policy may be a political desire, such as an increase in the 
proportion if the population who are self-employed, which can be achieved through a mixture 
of authorisations, instruments and programmes. So the desire is for fewer people to use 
drugs and for drug addicts to be in treatment which can be achieved by making more drugs 
illegal (a piece of legislation which is an instrument), giving police increased powers to 
search the homes of suspected drug dealers (an authorisation), and having drug treatment 
(a programme) within which there is opiate substitution (an intervention). There may also be 
large scale capital projects (which could also be facilitated by legislation or could be called 
programmes) such as building a large prison or rehabilitation unit.  
Figure 10. How policy and evaluation interact as part of the decision making process. 
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Another policy implication in this thesis is in the policy around evaluation. The UK Treasury's 
Magenta Book (2011) gives a set of techniques for policy evaluation but is not overly 
prescriptive; it does not explicitly identify 'brands' of evaluation. The Magenta book locates 
evaluation in the ROAMEF cycle which is similar to an ideal, rational model of policy, rather 
than a more practical, incremental form of policy. 
The Magenta Book splits policy evaluation into three broad categories;  
 Process evaluation – answering the question, how was the policy delivered? – This 
ties in with implementation research. 
 Impact evaluation – answering the question, what difference did the policy make? 
 Economic evaluation – answering the question, did the benefits justify the costs? 
These are similar to some of the methods used to evaluate interventions, which is not a 
surprise given that some ‘policies’ are essentially ‘interventions’. 
Figure 11. The ROAMEF Cycle. 
 
From HM Treasury (2011). 
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Economic evaluation techniques are seldom used in public health practice and are often the 
realm only of organisations like NICE or involve bringing in outside consultancy expertise. 
Tools that like the NSMC’s ‘Behaviour Change Value for Money Tools’ (Lister & Merritt, 
2013) and Public Health England’s ‘Weight Management Economic Assessment Tool’ 
(Dinsdale et al., 2014) have helped to bridge the gap between academics and economists 
on one side, and practitioners and commissioners on the other side. NICE have also 
produced costing tools around some of their public health guidance, and have produced a 
Tobacco Control Return on Investment tool (Pohkrel et al., 2014). These types of tools can 
be used more by commissioners, for example if they are deciding to commission a Payment 
by Results (PbR) rather than a block contract service.  
We have discussed differences in how policy is formulated, whether rational or incremental, 
but related to this are differences in how policy is applied. This is implementation. The 
literature around implementation really became influential in the 1970s as commentators 
such as Pressman & Wildavsky (1973) became dissatisfied with how public services were 
delivered and how many policy initiatives were not effective. Hogwood and Gunn (1984) set 
out ten preconditions for ‘perfect implementation’ which have become very influential over 
the years. These come from the assumption that the rational, top down approach to 
implementation is the correct one. They also seem to work best for policies that involve one 
organisation and do not require external negotiation, whereas many public health policies 
involve an acceptance of negotiation with external parties, and strong dependency 
relationships. 
1. External constraints - “The circumstances external to the implementing agency do not 
impose crippling constraints” 
2. Adequate time and resources - “That adequate time and sufficient resources are made 
available to the programme” 
3. Required combination of resources - “That the required combination of resources is 
actually available” 
4. Policy based on valid theory - “That the policy to be implemented is based upon a valid 
theory of cause and effect” 
5. Clear cause and effect relationship - “That the relationship between cause and effect is 
direct and that there are few if any, intervening links” 
6. Minimal dependency relationships - “That dependency relationships are minimal” 
7. Agreement of objectives - “That there is understanding of, and agreement on, objectives” 
8. Sequencing of events - “That tasks are fully specified in correct sequence” 
9. Communication and coordination - “That there is perfect communication and co-
ordination” 
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10. Total compliance - “That those in authority can demand and obtain perfect compliance” 
(Hogwood & Gunn, 1984 p. 199-206) 
Buse and colleagues (2005) state three different approaches of how policies are 
implemented; top down, bottom up, and principal-agent. Top down means that policy 
objectives often come from a senior level (‘command and control’, and often based on 
rational evidence), from civil servants and politicians and are then sent down for practitioners 
to decide out the detail while attempting to be faithful to the vision of the policy makers. In 
the top down approach, once the policy is decided, implementation is not about changing the 
objective but about incentivising and maintaining the activities needed down the chain of 
command, which may involve an amount of ‘satisficing’ or an incremental approach. There is 
an implementation ‘gap’ which is the difference between policy maker expectations and the 
actual outcomes (Marsh and Rhodes, 1992). There are always gaps in policies where 
individuals are able to have a degree of autonomy. With public health policy, it can be 
argued that practitioners have a lot of discretion compared to surgeons or market inspectors. 
This means that there is more opportunity for them to bend the rules or be more innovative 
with how they apply policy. Bottom up approaches to implementation mean that policy 
objectives are decided with practitioners, and are subject to more differences in 
interpretation, but there is the question of whether these ‘street level bureaucrats’ making 
changes in implementation are then unaccountable in the political process. The principal-
agent approach means that there is a clear relationship between principals (who set out 
policies) and agents (who implement policies) where agents are given an amount of freedom 
depending on the complexity and context of the policy being enacted. Hill (1997) suggests 
that in many cases policy tensions are left to be resolved in the implementation stage 
because it is better to make decisions first and figure out the practicalities later, or because 
implementers are better equipped to make key decisions that may involve complex 
negotiations and require a stronger knowledge of the facts than policy makers have. Over 
the past ten years there has been an expanding literature around implementation in public 
health and how public health programmes need to be implemented differently in different 
contexts. Public health interventions are more context dependent than clinical health 
interventions because they involve catering for populations with different cultural, social, 
economic and religious experiences. This may mean a greater opportunity for bottom up 
approaches where people have specific skills or can innovate in communities. 
It could be argued that one role of local public sector commissioners and managers, as well 
as specifying how a service should be delivered, recruiting and managing staff, managing 
finances and monitoring and evaluation, is deciding how a service should be implemented. 
Most public sector commissioners are commissioning services that are variations on a 
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theme, many of which are guided by national policy and guidance documents. So the job of 
managers is to decide, within the time, resource and political constraints they have, how a 
service should be implemented locally. This may involve a focus on certain elements of a 
service that are judged to be most successful or cost effective. There can be a distinction 
made between implementation differences that are decided at a service level, and those 
small changes in emphasis that individual workers make to strike up a rapport or to tailor 
their approach for clients who are motivated by different things, so for example a drugs case 
worker may use different approaches with drug users who are from a more deprived 
background, than with more educated drug users who might have a stable, well-paying job 
or for drug users with different levels of education or different interests. But these individual 
changes in emphasis should also inform the overall approach to implementation.  
The challenge of local managers is to implement programmes without losing the crucial 
elements that make a programme work at the same time as adapting programmes to local 
contexts. Hogwood & Gunn (1984) call losing the crucial elements ‘non-implementation’ 
while making local changes that adapt programmes but are not successful is ‘unsuccessful 
implementation’. The challenge of evaluators or researchers is to try to tease out where an 
intervention does not work because the theory behind it is inherently faulty, or where an 
intervention does not work because it has not been implemented with enough attention to 
being faithful to the original theory (Rychetnik et al., 2002). There is also possibly more of a 
challenge for policy makers and guidance bodies like NICE to be clear in setting out what 
are the crucial elements of a service and which elements are amenable to local 
interpretation. 
We will move on to explain how realist evaluation is one technique for understanding how 
services are implemented. By understanding the context in which services are delivered, and 
the mechanisms through which a service delivers outcomes, realist evaluation can describe 
how a service has been, and how it should be implemented. Sometimes implementation 
means that not only the elements of a service change but also the objectives. Process 
evaluation and theories of change are other methods that can be used for this type of 
evaluation. The case studies in this thesis will make reference to how services have been 
implemented to take account of the local social, political and financial contexts. 
4.4 The Evaluation Problem – Dealing with Complexity - Realist Evaluation 
Economic evaluation nearly always takes a normative rather than positivist perspective and 
the analysis in this thesis is no exception. As is the case with much cost effectiveness 
analysis in healthcare, this thesis aims to answer the question, is service X a good use of 
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resources; it does not aim to answer whether service X is the best use of resources, or 
whether it is a good idea in the first place. Someone with a politically libertarian point of view 
may think that these services should not be provided in the first place. There is also a 
difference between a service being cost effective and a service being maximally efficient. 
This thesis compares services against the NICE cost per QALY threshold which is used in 
health and social care decision making in England and Wales, which is typically an ICER 
(incremental cost effectiveness ratio) of £20,000 - £30,000 per QALY gained (Rawlins et al., 
2010). The services considered in this thesis are for treatment of addictions, some of which 
involve substitution therapies such as methadone for opiate addiction and NRT for tobacco 
dependence, and it could be argued that without these services more people may die, but 
also more people may become dependence-free on their own, or through self-help or 
independent sector groups that are not directly funded by the state, such as Alcoholics 
Anonymous (AA), so it is an important question to try to establish whether these services are 
efficient as well as effective.  
Methods like ‘theories of change’, logic modelling or driver diagrams may be useful in 
accounting for complexity and seeking to explain relationships between services (Ogilvie et 
al., 2011). These methods are used more in strategic and management grey literature than 
in academic literature. Logic models have been recommended by many research funders, 
for instance by the US Centre for Disease Control as part of a family of techniques for 
programme evaluation in public health (Koplan et al., 1999). Logic models describe the 
components of a programme as well as the sequence of events and resources needed to 
bring about a change. Logic models can be used to foster a shared understanding of 
services and outcomes so that partners can focus their energy efficiently. Logic models can 
be a way of combining qualitative and quantitative data in a mixed methods approach to 
understanding the impact of public health interventions (Baxter et al., 2010). ‘Theories of 
change’ is a different technique to logic modelling in that it emphasises the importance of 
context more and can be less linear (Blamey & Mackenzie, 2007). ‘Theories of change’ can 
be used to describe steps to achieve an outcome, whereas logic models are most often used 
to describe an actual programme or intervention. A well thought out logic model may look 
quite similar to a ‘theories of change’ model (Funnell & Rogers, 2011). 
Economics as a discipline is trying to answer ‘why’ questions; understanding why things 
happen. But a criticism of economic modelling and cost effectiveness as methods of 
evaluation is that they ignore context. To take account of this in these case studies, local 
data has been used wherever possible to parameterise the economic modelling. As part of 
the set of techniques used to evaluate services, this thesis includes elements from realist 
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evaluation. This is mainly based on Pawson (2013) and has its roots in Bhakshar's critical 
realism which builds on the epistemology of scientific realism. Bhakshar (1979) talks about 
the realm of the observable (sometimes called the empirical), the actual and the real. The 
observable is what can be observed through the senses, while the actual may be hidden in 
an immediate sense but a researcher can get to it. The real is where the epistemology of 
scientific realism differs from positivism and subjectivism; the real may not be observable or 
actual but it may comprise the latent power structures or contexts that determine the actual. 
The real is the underlying explanatory factors that cause changes in outcomes in the realm 
of the actual and is the area that critical realism is most interested in describing. Some 
commentators have said that critical realism should not consider only what the causes are of 
phenomena, but also lead to what the situation should be, so they are moving towards a 
moral or ethical judgment (Cruickshank, 2003). 
Ray Pawson is one the main theorists in the field of realist evaluation and is responsible for 
the set of techniques that are combined with economic evaluation techniques in this thesis. 
Ray Pawson and Nick Tilley's realist evaluation methods have their roots in looking at 
criminal justice interventions but have been applied to public health. Pawson (2013) states 
that researchers need to forget about tribalism in evaluation. Historically there has been a 
split between people who believe in positivist, summative, mainly quantitative, experimental 
evaluation and formative and process evaluation that was more phenomenological and 
qualitative. Pawson argues that any robust evaluation needs to utilise people with a variety 
of expertise and have a mixed methods approach. Realist methods aim to account for the 
complexity inherent in social programmes that may explain why some programmes may 
show promise in pilots but do not work when they are rolled out (Pawson, 2002). Realist 
methods recognise that reality is emergent, it does not stand still. 
Realist evaluation is part of the family of theory-driven evaluation methods. People in theory-
driven evaluation may slightly pejoratively call alternative methods 'black box' evaluation 
methods (e.g. Chen & Rossi, 1983), implying that in these studies evaluators only care about 
the inputs and outcomes not about how something works. However in reality most medical 
and public health evaluations include at least some cursory explanation of the mechanism. 
This phenomenon of the lack of explanations of mechanisms may be partly due to the 
structure and brevity required for papers in medical journals. In realist evaluation, 
programmes are said to be theories embodied. Programmes are lot of things to different 
people; so to an economist a programme might be a list of costs and benefits, to a smoker it 
might be a way for them to try to stop smoking, or to a practitioner they are a rewarding job 
and a salary. Realist evaluation should articulate the programme methods; it should aim to 
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understand what worked for people. The programme mechanism captures the idea that 
people make programmes work; if a programme does not work it may be because the 
programme theory is not being applied correctly or because it does not work in a given 
context. The mechanism in realist evaluation is described as being a change in the 
reasoning or the resources available to somebody, and cannot always be observed. Realist 
evaluation is useful for describing things like power or status that may be latent and cannot 
always be observed directly. Realist evaluation believes that programmes are unique but 
programme theories are rarely unique and are often transferable and crop up over and over 
again. Pawson (2013) argues that referring to programmes as treatments disembodies them 
and forgets about the context. Perhaps this is just getting lost in a debate about terminology 
and nomenclature. 
In ‘Personalising Evaluation’ Kushner (2000) talks about the importance of taking into 
account the personal perspective, as focusing too much on the programme loses the context 
and loses the fact that the programme might actually be quite a small part of someone’s life. 
So for example, somebody who has decided to quit smoking may use NHS smoking 
cessation services but they might have lots of other things going on their lives (like family 
pressures, work, illness) which could have a greater effect on whether or not they 
successfully quit. Personalised evaluation is about being sensible and proportionate about 
the programme’s contribution to the outcome. It is not about over-generalising from a small 
number of pen portraits or case studies; rather it is seeing things through a different lens.  
Pawson (2013) questioned the validity of the traditional randomised controlled trial (RCT) 
way of evaluating  changes in healthcare programmes, which he called the OXO paradigm: 
observe a system (O), introduce a change (X), in some participants but not others, then 
observe again (O). Instead realist evaluation is looking at a CMO paradigm – context, 
mechanism, and outcome. This has some similarities with methods such as ‘theories of 
change’, impact modelling, or driver diagrams (Funnell & Rogers, 2011). Realist evaluation 
criticises other methods like logic models for assuming a linear relationship or linear chain of 
events between inputs and outcomes when the real relationships are more complex and 
recursive. Realist evaluators argue that it is about a change from merely making judgments 
on the success of a service - ‘a thumbs up or thumbs down’ to making explanations – 
understanding why does a service work for some people but not others. This includes 
whether there is uptake for a service in the first place. Realist evaluation argues that in RCTs 
it is not necessary to understand how a programme worked while they are interested in 
multiple outcomes or patterned outcomes. Realist evaluation aims to answer the question, 
“What works for whom, in what circumstances, in what respects, and over what duration?”, 
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or in more recent years, “What works, how, why, for whom, to what extent and in what 
circumstances, in what respect and over what duration?” (Wong et al., 2013). Realist 
evaluations most often use comparative (usually quantitative) evidence to understand the 
impact of context, and use qualitative evidence to explain the complexity and the 
mechanism. Pawson claims that empiricists struggle most with the parts of realist evaluation 
that are most qualitative, for example, emergence (below). Pawson believes that social 
systems are ordered but can be infinitely complex, but that theory driven inquiry is needed to 
start to make sense of complex systems, even if it only ever generates partial knowledge at 
best. There seems to be analogues between CMO configurations in realist evaluation and 
axial coding in Straussian grounded theory (a method of analysing qualitative data) which 
talks about context, action/ interactional strategies and consequences of those strategies 
(Strauss & Corbin, 1998). 
One key term in realist evaluation is complexity. Instead of concentrating on how 
generalizable a programme is, realist evaluation is about embracing complexity and trying to 
explain it as much as possible. The main elements of complexity are summarised with the 
acronym “VICTORE” which stands for; 
[Parts of this are cited verbatim from Pawson (2013)] 
 Volitions: The “choice architecture” of a program including how program subjects 
might respond to a program or intervention; it can take time to change people’s 
minds, to move them from being an outsider to being an insider in terms of the 
programme. 
 Implementation: The implementation chains of an intervention/program which “are 
prone to inconsistency and interpretation, blockages, delays, and unintended 
consequences” (p.36); often involve very long chains for example from the 
Department of Health to the person at the front line. People in the chain are trying to 
improve as they go along. Implementation maps may look at flows of resources and 
chains of responsibility as well as the ‘theories of change’ behind every stage, 
strategy and tactic. 
 Contexts: The context of an intervention refers to the circumstance in which it plays 
out. Contexts vary from the micro to the macro. Pawson outlines a “four I’s” 
framework: Individuals (characteristic and capacities of stakeholders in the program); 
Interpersonal relations; Institutional settings; and Infrastructure (which refers to the 
wider social, economic, and cultural setting of a program/intervention); 
 Time: Map the history of the family of programmes of which the intervention under 
study is a member. Temporal mapping may include the experiences and success 
84 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
and failure of similar interventions. There is often a ‘showcasing effect’ where new 
interventions work because they have impetus, people are excited about them; 10 
years later they have become “part of the furniture”.  
 Outcomes: Map the approaches for monitoring and ways stakeholders might 
interpret the outcomes; and whether behavior may change as a result of extra 
monitoring as well as through the primary intervention. 
 Rivalry: The pre-existing policy landscape in which the program is embedded – this 
primarily refers to “other, contiguous programs and policies may share or oppose the 
ambitions of the intervention under study and actions of stakeholders and subjects 
under study”. Policy is made up of programmes, so it is difficult to measure a single 
“unwashed” action of a programme; some programmes are rivals. 
 Emergence: Potential emergent effects, long-term adaptations, societal change, and 
unintended consequences associated with the programme/intervention. Programmes 
change the conditions that make them work, e.g. CCTV was first used in terms of 
town centre disruption. Later on young people started having mock fights in front of 
cameras. CCTV started off as the programme; now it is the context. Consider how 
the programme will maintain a balance between recruitment, retention and exit. 
It is acknowledged that it is hard to account for all of this but researchers can only keep 
trying, keep going deeper in to trying to understand the real mechanisms and adding more 
levels of detail and caveats. It is suggested that any piece of evaluation should start with an 
initial mapping of these elements of complexity. There is also realist review and realist 
synthesis, which realist evaluation should include in terms of accounting for the history, 
context and previous evaluation literature (Pawson et al., 2005). 
There is a debate in evaluation about whether the evaluator should sit outside programme or 
sit inside to improve it. Practitioners are good at delivering theories about whom a service 
would work for. Instead of trying really hard to minimise bias (such as by using double or 
triple blind analysis and not involving practitioners in evaluation), realist evaluation aims to 
include the wisdom of practitioners in the study, and make any prior potential biases explicit.  
Commentators such as Ben Goldacre have called for more trials in the social sciences 
(Haynes et al., 2012), but the level of complexity and the impossibility of generating a well 
matched comparator for social interventions has been used as a reason (or maybe an 
excuse) to not do randomised controlled trials (RCTs). However often in the absence of 
these kind of trials, nothing concrete has been used instead and evaluations have had little 
justification for the choice of methods used and have had a strong confirmation bias. In the 
UK the Government has established a network of ‘What Works’ evidence centres to bridge 
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the gap between evidence and policy. There have been some examples of realist RCTs as 
well (e.g. Waterlander et al., 2013), but there is a debate over whether RCTs and realism 
can work together. 
The MRC's guidance for evaluating complex interventions (see Craig et al., 2008) 
recommends assessing the fidelity of programmes and using methods like stepped wedge 
randomisation where withholding programmes is difficult to justify. Pawson says that 
randomisation has become a fetish. Moreover he says that using language like ‘fidelity’ and 
‘confounds’ is missing the point of how programme implementation evolves. He states that 
this language regards this evolution as something unwanted, a negative, something to be 
controlled for in trial design rather than a natural and positive part of the process that needs 
to be accounted for in the evaluation. 
There has been calls to use realist RCTs for complex public health interventions (Bonell et 
al., 2012) but this has been rejected by some of the main proponents of realist evaluation, 
mainly because they say the ontological and epistemological philosophies behind realist 
evaluation are incompatible with the positivist ontological assumptions behind RCTs 
(Marchal et al., 2013). RCTs typically assume relationships between independent and 
dependent variables are stable and exist in equilibrium, while realism states that although 
there can be some explanation, causal mechanisms for complex social outcomes cannot be 
described in this way as being stable or having this external validity. This difference in 
philosophy would of course also be the case with economic modelling although economic 
modelling does not make all of the same assumptions as RCTs. 
A paper by Shiell and colleagues (2008) emphasised the need to differentiate between 
complex interventions and interventions which were implemented in complex systems. So 
for example a hospital is a complex system where an intervention to reduce A&E 
attendances may have implications somewhere else in the system. Many public health 
interventions are complex, as they work at a population level, where we are working with 
'free range' not 'battery hens'. There are often several components to an intervention, as well 
as several outcomes, and externalities. This level of complexity is especially true in addiction 
treatments as they often combine pharmacological with psychosocial interventions; it may be 
known that combining in this way is more successful than using one technique on its own, 
but the mechanism of the interaction between the two is not always well understood. So for 
instance for smoking cessation, the evidence is that dual NRT or Champix combined with 
counselling is the most successful intervention (West & Owen, 2012), or for heroin addiction, 
combining opiate substitution with psychosocial interventions is regarded as the most 
successful intervention.  
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There have been calls to use realist methods more in economics. In "Economics and 
Reality" (2006) Tony Lawson outlines how the field of economics needs to update its 
methods to deal with real world problems, and think about economic problems in terms of 
their mechanisms in the tradition of critical realism. Lawson believes that economics as a 
discipline is over-reliant on modelling techniques that neglect the influence of context and do 
not account for complexity. When models fail to predict accurate results, economists still do 
not always realise that it may be because they have failed to take contextual factors into 
account. 
4.5 The Realist Evaluation Process 
In this thesis, the realist evaluation methods involved include talking to stakeholders in the 
form of service users, service providers, managers and commissioners. This was carried out 
using semi structured interviews that were synthesised by the researcher into the text and 
into the CMO tables. The questions used are shown in Appendix 2. The interviews asked 
similar questions around drug, alcohol and smoking specialist treatment although most of the 
interviews were with drug treatment staff. Realist evaluation also involves trawling existing 
evidence and policy documents for mechanisms and making comparisons within the service 
data to see who the service works best for. This process is summarised in Figure 12.  
Figure 12. Realist Evaluation Process. 
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4.6 Summary – Introductory Chapters 
Chapter 1 introduced the geographical location for the case studies and emphasised why the 
history and health inequalities existing within Wirral make it an ideal place to undertake the 
analyses presented in the remainder of this thesis. Chapter 2 summarised the history of 
public health and addiction and Chapter 3 and 4 introduced health economics, the main 
theories of evaluation and emphasised how evaluation is crucial in underpinning evidence-
based policymaking. These chapters have introduced the main techniques used to evaluate 
public health programmes, namely, economic evaluation, realist evaluation and health equity 
impact assessment. The next three chapters provide the case studies which form the 
empirical heart of this thesis as they illustrate the practical application of the mixed methods 
approach applied to public health evaluation in this thesis. The methods employed evolved 
as the research developed and met with a mixed degree of success which will be examined 
in each case study. Each case study took a slightly different approach based on the 
availability of data and the number of semi structured interviews that could be carried out to 
produce qualitative evidence on the service. 
The primary aim was to assess the cost effectiveness of each of the interventions analysed 
with the main outcome measure utilised being the cost per Quality Adjusted Life Year or the 
Incremental Cost Effectiveness Ratio. In the case of the realist evaluation the primary aim 
was to enhance our understanding of the CMO (context-mechanism-outcome) configuration. 
In particular an enhanced understanding of the mechanisms of action would imply that 
services could be improved to get these mechanisms firing more often, and in more people. 
These mechanisms are drawn from policy documents, strategic commissioning plans and 
from talking to commissioners, providers and service users. Qualitative information was 
about services was gleaned using semi structured interviews. An example of the questions 
used for the semi structured interviews is in Appendix 2. Semi Structured Interview 
Questions. Some of the questions were mainly asked to try to relax the interviewee or get 
them to open up rather than to directly inform the research.  
The health equity dimension is also important as assessed through equity impact 
assessments where the primary aim is to assess the extent to which a service meets needs 
across the spectrum of health and social groups and in particular on the main areas 
identified in the Marmot report (2011). 
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Figure 13. Main methods used in this thesis. 
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Table 7 shows the data available for each service considered in the case studies in the 
subsequent chapters. Costs and QALYs were estimated for all services while hospital 
admissions were measured for alcohol residential detoxification, and crime was measured 
for the Drugs Intervention Programme. Social care and personal costs were not included as 
outcomes in any of the case studies as this data was not available or was difficult to 
estimate. 
Table 7. Summary of time period and outcomes included in case studies. 
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Stop smoking services 5 2013/14 FY D D E E     
Specialist alcohol treatment 6 2011/12 FY D D SR
/E 
E     
Alcohol residential rehabilitation  6 2010/11 & 
2011/12 FY 
D D SR
/E 
E   D 
Drug treatment - opiate & crack users - 
CWP 
7 2012/13 FY D D SR
/E 
E E   
Drug treatment - cannabis & stimulant 
users - ARCH 
7 2011/12 & 
2012/13 FY 
D D SR
/E 
E     
Drug Intervention Programme - criminal 
justice intervention 
7 April - 
September 
2013 
D D SR
/E 
E D   
D=direct real data, E= estimated, SR=self report. 
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Chapter 5. Economic Evaluation of Smoking Services 
5.1 Smoking - Burden of Disease 
Tobacco is the greatest preventable cause of illness and early death in the world, and in the 
UK. Chronic lung diseases (COPD) which are mainly caused by smoking cost an estimated 
2.1 trillion US dollars a year globally. Tobacco is a highly addictive substance, which 
individuals find hard to give up even when they have suffered personal health losses. For 
example 60% of people smoke again post-myocardial infarction, 50% smoke again even 
when they have had their larynx removed following cancer (Bobak, 2009).  In addition 
despite the evidence concerning the potential health loss to their baby, as much as 80% of 
women fail to stop smoking during their pregnancy. The addictive nature of tobacco is 
emphasised by the fact that most smokers regret taking up smoking and want to quit (Bobak, 
2009).   
In the UK, although only approximately 20% of people smoke smoking is still the major 
contributory factor in 100,000 deaths per year meaning that smoking kills more people than 
obesity and alcohol combined. Treating smoking-related diseases cost the NHS £5.2billion 
per year in 2005/06 (Allender, 2009) and the wider economy £2.5 billion in sick leave and 
lost productivity. The Policy Exchange (Nash & Featherstone, 2010) estimated the total cost 
imposed on UK society by smoking to be £13.74 billion. This included £2.7bn cost of 
smoking related illness, the loss in productivity from smoking breaks (£2.9bn) and increased 
absenteeism (£2.5bn),the cost of cleaning up cigarette butts (£342 million),  fires (£507m) 
and the loss of economic output resulted from the death of active smokers (£4.1bn) and 
passive smokers (£713m).  
The tobacco industry point to the £10billion per year in taxes contributed by smokers and 
emphasize that this represents 2% of total government revenue (ASH, 2014). However such 
an argument ignores the health loss suffered by individual smokers and the fact that taxation 
would rise from other sectors if expenditure currently devoted to smoking was diverted to 
other taxable goods and services that would benefit both the individual and the economy to 
a greater degree.  
Tobacco contains many chemicals but the most important in terms of public health and 
addiction is nicotine, although it is the other chemicals and the carbon monoxide produced 
which mainly cause health problems. Nicotine is an alkaloid stimulant which is absorbed 
from tobacco smoke through the large surface area of the lungs and leads to dopamine 
release in the nucleus accumbens in the brain, similar to cocaine (Pontieri et al., 1996). In 
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terms of conditioning, this dopamine release reinforces the behaviour through triggering the 
brains reward pathways. And as with cocaine, prolonged exposure to nicotine reduces the 
amount of dopamine released in response to other pleasurable activities like sex or eating 
food (Henningfield & Benowitz, 2004). Dopamine is related to ‘seeking’ or ‘wanting’ which is 
seen with drugs like cocaine as opposed to ‘liking’ which is seen with opiate drugs like 
heroin. 
Smoking remains the biggest cause of health inequalities in the UK (DH, 2011) and therefore 
efforts to reduce health inequalities must focus on smoking as a priority. Smoking causes 
health inequalities in several ways; the ill health from smoking reduces an individual’s 
lifespan and capacity to work; and also smoking is expensive - individuals on income support 
may spend 15% of their disposable income on tobacco even if they or their families have to 
go without more essential items (Acheson, 1998). Reducing the gap between rich and poor 
in smoking prevalence would therefore significantly contribute towards reducing the gap 
between rich and poor in premature death rates. This is particularly important as unhealthy 
lifestyle behaviours (smoking, excessive alcohol use, poor diet, and low levels of physical 
activity) tend to combine to impose a significant health loss in the most deprived populations 
(Buck & Frosini, 2012). In response public health policies and interventions must become 
more holistic and integrated to successfully reduce health inequalities resulting from 
unhealthy life choices. 
The most recent key national policy document is ' Healthy Lives, Healthy People, a Tobacco 
Control Plan for England (DH, 2011)' which followed 'A Smokefree Future: a Tobacco 
Control Strategy for England' (HM Government, 2010a) and 'Smoking Kills' (HM 
Government, 1998). In addition there are several pieces of NICE Guidance which make 
recommendations around tobacco, including around preventing tobacco use in young 
people, brief interventions, workplace intervention, and harm reduction. The National Centre 
for Smoking Cessation and Training (NCSCT) was established in 2009 to improve the 
delivery, management and commissioning of smoking cessation support services in 
England. The Public Health Outcomes Framework published in 2012 set three target 
domains measuring success in reducing smoking prevalence in 15 year olds, adults, and 
pregnant women.  
 2.3 Smoking status at time of delivery per 100 maternities (National target is to 
reduce from a 2010 baseline of 14% to 11% or less by 2015, most recent for Wirral 
was around 12%, although Wirral has data quality issues) 
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 2.9 Prevalence of smoking among 15 year olds (National target is to reduce from a 
2010 baseline of 15% to 12% or less by 2015 – not currently measured at LA level 
but most recent national prevalence is 8% regular smokers) 
 2.14 Prevalence of smoking among persons aged 18 years and over (National target 
is to reduce from a 2010 baseline of 21.2% to 18.5% or less by 2015, currently for 
Wirral prevalence is 18.4% so Wirral was on course to exceed this target, although 
prevalence estimates do fluctuate). 
(Data from PHE, 2014a) 
Smoking prevalence 
There are currently two main sources for smoking prevalence data. The integrated 
household survey (IHS) is commissioned nationally by ONS and measures smoking 
prevalence for all adults and for routine and manual groups in Wirral. There have also been 
locally commissioned smoking surveys which include an estimate of overall smoking 
prevalence as well as looking specifically at the most deprived areas of Wirral.  
Based on the IHS (2014), smoking prevalence in Wirral has dropped substantially in the last 
4 years data and was 18.4% in 2013 (Figure 14). However this is an estimate and is subject 
to a degree of uncertainty. Smoking in routine and manual groups is higher than the general 
population at around 24-30% (Figure 15). 
Figure 14. Smoking Prevalence from Integrated Household Survey, 2010-2013. Shown with 
95% confidence intervals. 
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Figure 15. Routine & Manual Groups – Smoking Prevalence, 2011-2013. Shown with 95% 
confidence intervals. 
 
Wirral has periodically commissioned local prevalence surveys (e.g. Praxis, 2012). Before 
the public health outcomes framework was brought in 2012, there was little accurate 
smoking prevalence data available at local authority level. The local surveys have been 
useful in focusing on the most deprived areas, providing data about tobacco products used 
and their frequency, quit attempts and abstinence, access to counterfeit or duty free 
cigarettes, smoking in the car and the home, and cannabis usage. Prevalence in this survey 
for 2012 was 31.4% of the population surveyed, however because the survey is focused in 
the most deprived areas this is not indicative of the whole Wirral population (Praxis, 2012). 
This survey found that smoking prevalence had fallen since 2009 significantly in women but 
not in men. This chimes with the fact that more women have quit with stop smoking services 
than men (see Table 8). Overall the survey found that around 60% of quitters use stop 
smoking services, while around 40% do it using their own willpower and resources.  
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Table 8. Results from Wirral local smoking prevalence survey, 2009-2012. Smoking 
prevalence in most deprived areas of Wirral (from Praxis, 2012). 
Classification  
[Sample size, 
2012] 
2009  2010  2011  2012  +/- 
Variation 
2009 – 2012  
95% 
C.I.  
Statistically 
significant 
change? 
Overall Smoking 
Prevalence  
34.7%  34.5%  33.2%  31.4%  - 3.3%  +/- 
1.55  
Yes  
Male [1381]  35.1%  35.5%  35.3%  36.2%  +1.1%  +/- 
2.53  
No   
Female [1998]  34.5%  33.8%  31.7%  28.9%  -5.6%  +/- 
1.99  
Yes 
 
The local survey found that smoking prevalence was highest in routine and manual groups 
(33%) than other groups (26%) and was higher in White British groups (32%) than Black and 
Minority ethnic groups (18%). The survey also found that smoking had fallen most 
significantly in 20-24 year olds and 35-49 year olds (Table 9). The fact that smoking has 
fallen in younger age groups is positive as it indicates that fewer young people are taking up 
smoking.  
Table 9. Smoking prevalence by age, Wirral most deprived areas, 2009-2012 from local prevalence 
survey (from Praxis, 2012). 
Age group   
[sample size]  
2009  2010  2011  2012  +/- Variation 
2009 – 2012  
95% 
C.I.  
Result  
16 – 19 [95]  38.3%  30.3%  35.8%  31.6%  - 6.7%  +/- 9.35  Not Significant  
20 – 24 [213]  38.9%  36.9%  31.4%  31.0%  - 7.9%  +/- 6.21  Significant  
25 – 34 [556]  43.2%  38.7%  40.5%  38.5%  - 4.7%  +/- 4.04  Not Significant  
35 – 49 [878]  42.2%  41.0%  40.4%  37.2%  - 5.0%  +/- 3.20  Significant  
50 – 59 [555]  37.1%  40.1%  34.5%  35.5%  - 1.6%  +/- 3.98  Not Significant  
60+ [1129]  24.2%  25.5%  24.4%  21.8%  -2.4%  +/- 2.41  Not Significant  
 
Smoking prevalence has also been collected by the fire brigade as part of local fire safety 
checks. The prevalence as measured on these checks is lower than other smoking 
prevalence but there may be a question about whether they represent a random sample of 
the population, thinking about which groups are most likely to get fire safety checks, so are 
they more likely to own their own homes or be more safety conscious and risk averse and 
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therefore less likely to smoke etc. The most recent adult smoking prevalence based on this 
was 16% for Wirral (Figure 16). 
Figure 16. Smoking prevalence from Fire Safety Checks.  
 
Source: Merseyside Fire & Rescue Service, 2014. 
 
Cannabis 
There is a subgroup of smokers, mainly aged 16-24, who also smoke cannabis, with the 
dependency on nicotine and cannabis having a combined effect where it is more difficult for 
clients to quit smoking or quit cannabis (Bélanger et al., 2011). Evidence suggests that this 
group are more likely to have psychosocial problems (Degenhart et al., 2010). Results from 
the Wirral wellbeing survey, carried out in 2009, showed that people who had smoked 
cannabis in the last 30 days (nearly all of whom were also smokers) had a significantly lower 
EQ-5D health-related quality of life score than the general population (0.68 vs. 0.78), but it is 
not clear which way the causation lies, i.e. people who have a poor quality of life may be 
more likely to use cannabis, or people who use cannabis may have a poorer quality of life. 
Regardless it shows there is a need for the health status of this group of people to be 
improved. The current smoking database does not record cannabis use but the next 
smoking prevalence survey for Wirral will include a question on cannabis.  
Figure 17 shows average EQ-5D scores by age group and cannabis category. 
Figure 17. Average EQ-5D Index Score, by age group and cannabis use category; never used, used 
in last 30 days, or used but not in the last 30 days. There were no individuals who said they had used 
in last 30 days in the 16-17 and 65+ age group. 
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Source: Raw data from Wirral wellbeing survey, 2009. 
Electronic cigarettes 
Widespread use of e-cigarettes has brought a new challenge to the smoking policy 
landscape. Electronic cigarette use seems to have plateaued at around 16% of smokers 
nationally (Beard et al., 2014). The World Health Organisation (WHO) has come out against 
them, but a lot of UK smoking policy experts believe they have potential to be a less harmful 
alternative to smoking. This is not an incompatible position as the WHO represents the 
whole world and regulation of e-cigarettes may mean that they are safe in the UK but less 
safe in poorer countries with less regulation. Electronic cigarette manufacturers have 
positioned themselves as providing a harm reduction product (Grana et al., 2014). The 
NCSCT [National Centre for Smoking Cessation Training] have said that stop smoking 
services can provide behavioural support to clients who are using electronic cigarettes and 
can include these clients in their national data returns (McRobbie, 2014). Stop smoking 
services do not currently get measured on whether they move non-smokers from e 
cigarettes to being nicotine-free. From 2016 e-cigarette products will be regulated by the 
MHRA (Medicines and Healthcare Products Regulatory Agency) so will be subject to more 
strict regulation. This increased regulation may hand more of the market to big tobacco 
companies because e-cigarettes are still made from tobacco. If e-cigarettes prove to be a 
safer form of nicotine then it may be that in future tobacco could be banned completely as 
people have the option to use e cigarettes if they wish to use a nicotine product.  
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Smoking in pregnancy is related closely to deprivation, and being single, or having a partner 
who also smokes (Wakefield et al., 1996). Smoking while pregnant increases the risk of 
ectopic pregnancy, spontaneous abortion, placenta previa, abruptio placenta, preterm 
premature rupture of membranes, although decreases risk of preeclampsia and gestational 
hypertension. It also increases the risk for the infant of low birthweight, infant mortality, 
infections, asthma, and sudden infant death syndrome (SIDS) (Rogers, 2009). Making the 
financial case to the NHS and maternity hospitals is important as smoking is the biggest 
cause of intrauterine growth restriction, and is the biggest casual factor for women needing 
additional ultrasound and Doppler scans. Smoking runs in families so when parents quit it 
helps to break the cycle. Champix and Zyban are not licensed for use during pregnancy, but 
some NRT products can be used (80 out of 90 pregnant clients for Wirral were recorded as 
using NRT). Interventions for smoking in pregnancy need to focus on partners if they smoke 
as well. A Cochrane review (Lumley et al., 2009) found that the evidence around incentives 
for smoking cessation was mixed. Financial incentives have been found to be successful in 
some trials in helping pregnant women to quit smoking. 
A paper by the Public Health Research Consortium (PHRC) published (Godfrey et al., 2010) 
put the NHS costs of maternal increased complication risk as a result of smoking at £8-
64million, and infant increased illness risk as £12-23.5million. This paper estimated that 
spending between £13.60 - £37.00 per pregnant smoker would yield positive cost savings for 
the NHS. However this is not particularly useful as real costs of smoking cessation are a lot 
higher than this. Based on NICE’s model, accounting for early mortality, the child of a 
quitting mother is likely to experience 23.56 discounted QALYs, compared to 23.54 for the 
child of a non-quitting mother. This difference is purely accounted for by the total number of 
life years lost due to premature death. Also the child of a smoking mother is estimated to 
cost around £371 more on average in health costs than the child of a quitting mother. The 
NICE model estimated that an expectant mother quitting would produce on average £371 in 
cost savings and 0.02 incremental QALYs gained. That means that to be considered cost 
effective (at a cost per QALY of less than £30,000) any intervention would need to cost less 
than £971 per quitting mother, not taking into account any additional weighting for 
deprivation. The service in Wirral costs around £1,100 per pregnant smoker who quits at 12 
weeks, which may be cost effective once deprivation is taken into account, as pregnant 
smokers are more likely to be from deprived backgrounds.  
Wirral’s smoking at time of delivery (SATOD) data has not been published nationally for 
2013/14 because the number of maternities has been under-reported, probably due to 
homebirths, 1 to 1 midwives, or births in hospitals outside of Wirral being missing from the 
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datasets. But based on the data collected for 2013/14 the proportion of mothers smoking at 
time of delivery was 13.7% while for quarters 1-3 of 2014/15 the proportion was 11.7%. 
There is a national target to reduce smoking in pregnancy to 11% or less by 2015. Services 
in Wirral have seen an increase in the number of pregnant women quitting smoking over the 
last three years. 
Figure 18. Trend in women smoking at time of delivery (%), Wirral, 2010/11 – 2014/15. 
 
* 2013/14 data was not published nationally due to data quality issues.  
 
5.2 Smoking - Available Interventions  
Many people do succeed in quitting smoking on their own. NHS Stop Smoking services, 
which rolled out nationally in 2000, were developed to help those smokers who need more 
support to quit. NHS Stop Smoking Services generally attract smokers with a higher level of 
dependency and who therefore require higher levels of support if they are to successfully 
quit (Kotz et al., 2009). Public health-commissioned services aim to support 3-5% of the 
smoking population per year in their aim to quit (Jarvis et al., 2002). Services which are more 
intense typically offer the greatest chance of success but reach smaller numbers of smokers 
(Fidler, et al., 2011). Current estimates of 12 month success rates vary from 1% for brief 
interventions to 31% when pharmacological therapy (Champix) is combined with specialist 
group behavioural support (West & Owen, 2012). 
The stop smoking services give out nicotine replacement therapy (NRT) but do not prescribe 
other pharmacological agents, Champix and Zyban, which currently need to be prescribed 
by a General Practitioner or Nurse Prescriber so fall under the Wirral CCG budget. Zyban is 
an antidepressant type drug which relieves the withdrawal symptoms from quitting smoking. 
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Zyban has fallen out of use since Champix came onto the market in 2006 as Champix is 
more effective on average. Champix is a drug which partially blocks the nicotine receptor in 
the brain, reducing the effects of nicotine withdrawal while also blocking some of the 
pleasurable effects of smoking. Champix is effective but often has side effects, most 
commonly nausea and sleep disorders (Moore et al., 2011). There is a drug, Cytisine, which 
is similar in action to Champix, possibly with fewer side effects, which if it was licensed, 
could be a very cheap alternative to Champix and make cost less of an issue (Leaviss et al., 
2014). 
Figure 19 shows the interventions included in the smoking cessation programme for Wirral. 
This was produced by the service manager for Wirral. Most interventions are around 
smoking cessation, although there are interventions around tobacco control (stopping sales 
of illegal and illicit tobacco, or sales to under 18s), ASSIST (which stands for A Stop 
Smoking in Schools in Trial, a peer-led intervention aimed at changing social norms amongst 
year 8 adolescents to reduce young people taking up smoking), smokefree homes (an 
intervention to reduce smoking in the home, particularly for individuals with families). There 
are other broad interventions like the Health Action Areas (HAAs) and Health Service in 
Schools (HSIS) that include smoking cessation.  
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Figure 19. Interventions in smoking cessation programme for Wirral. 
 
5.3 Background to Case Study 
Smoking & tobacco control activity makes up a large proportion of the public health budget 
both in Wirral and throughout the NHS thus emphasising the importance of optimising both 
the clinical and economic efficiency with which resources devoted to this area are utilised. In 
2013/14 Wirral Council spent around £1.57million on smoking & tobacco control which was 
around 6% of the total public health spend, and a spend per head of £4.80 per head of 
population. Wirral’s total public health spend per head was significantly higher than England.  
Through the use of valid and reliable methods of economic and realist evaluation, smoking 
cessation programmes can be more effectively targeted with services that are proven to be 
more cost effective being expanded using resources that can be diverted from services that 
are less cost effective. It is also essential to evaluate innovative approaches to service 
provision. For example Wirral has piloted a Payment by Results (PbR) smoking service, 
whereby Wirral paid for each client who was proven to have quit at 4 and 12 weeks. This 
Payment by Results approach means that providers are only paid for 'success' although 
providers have to be prevented from ‘cherry picking’ clients and avoiding those highly 
addicted smokers who are arguably in greatest need. 
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5.4 Cost Effectiveness of Smoking Services - Case Study  
5.4.1 Aim 
The aim of this study is to determine whether services in Wirral are a cost effective use of 
resources and to understand the local contexts that determine whether or not the service is 
successful. Smoking interventions are a complex intervention (in that they most often include 
psychosocial or behavioural support as well as pharmacological interventions) in a complex 
system (as people have a range of social, environmental and economic influences and 
triggers that determine whether they smoke). 
5.4.2 Literature review 
There have been many economic modelling studies around smoking cessation (e.g. Song et 
al., 2002, Woolacot et al., 2002, Godfrey et al., 2010, Godfrey et al., 2011). These have all 
found that smoking cessation services are cost effective and often are cost saving over time. 
This includes interventions for pregnant women (Lumley et al., 2009), having computer or 
other electronic aids to increase smoking cessation (Chen et al., 2012), or anti-tobacco 
education in schools (Tengs et al., 2001). 
A review of realist evaluations found one published study around adding a nutritional 
intervention to smoking cessation (Mackenzie et al., 2009) but this majored on the nutritional 
element. There was one protocol for a realist evaluation of smoking services, by Douglas 
and colleagues (2010) who were planning to look at smoking cessation services for pregnant 
women and young people in North East Scotland. The CMO table has been constructed by 
the author from looking at policy documents around smoking, as well as the data collected 
by smoking services, and through talking to service providers and commissioners. The CMO 
configuration was included in the evaluation to encourage commissioners and providers to 
think particularly about the mechanisms that work to get people to successfully quit smoking 
so that they can think about services changes that get these mechanisms firing more often. 
This list does not claim to be exhaustive, and can only claim to be middle range theory. 
Some commentators have suggested that the context needs to be shifted so that treatment 
and substitution is a routine part of the environment around smoking, so for instance Nash 
and Featherstone (2010) suggest that all retailers should have NRT available next to 
tobacco products (although most now have electronic cigarettes at least). 
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5.4.3 Data sources 
From a local perspective accurate information regarding the prevalence of smoking in Wirral 
has been difficult to obtain, however, since 2009 several surveys have been conducted 
looking at different aspects of smoking in Wirral. The main sources of prevalence data 
regarding smoking behaviour in Wirral are; 
 Local prevalence survey and panel survey – these have been carried out over the 
last four years, focussing on the most deprived areas, with around 3,500 
respondents. These have shown a fall in smoking prevalence in the most deprived 
areas (Praxis, 2012). 
 Local wellbeing survey – last carried out in 2009, this included questions on smoking 
and also about cannabis use. This survey also included questions on general health 
and wellbeing (including EQ-5D and WEMWBS) which can be measured against 
smoking status (Deacon et al., 2010). 
 The Integrated Household Survey (IHS) –. This has been carried out nationally since 
April 2009 and measures smoking prevalence for adults aged 16 and over. The IHS 
is the largest social survey produced by ONS with over 420,000 respondents 
nationally - the biggest pool of UK social data after the census. All IHS statistics 
are designated as experimental at the moment, which means they are new official 
statistics that are still being evaluated (ONS, 2014). 
 Smoking at delivery data - has been collected by the NHS Information Centre, 
quarterly since 2002 (e.g. HSCIC, 2015a) 
 Quality and Outcomes Framework (QOF) Data – General Practitioners get paid 
through QOF for having a record of smoking status for patients aged 15 and over, 
and for having offered advice and support to quit smoking. This was previously only 
collected for certain long term conditions, like CHD and diabetes (HSCIC, 2015b) 
 Synthetic Estimates – synthetic estimates of smoking prevalence were based on a 
model applying demographic and social characteristics such as income, ethnicity, 
age structure of a local area to Health Survey for England data for 2006-08, to 
generate expected smoking prevalence. These were last produced in 2010. These 
went down to MSOA level (Middle-layer super output area, a statistical area with a 
population of c.7,500) so were useful for estimating smoking at a small area level. 
Based on this, Wirral had a total smoking prevalence of 21.5%, which varied at 
MSOA level between 7.6% and 44.4%. This is shown in Figure 20. As is the case at 
a higher geographical level, smoking is highly correlated with deprivation in Wirral 
(HSCIC, 2007). 
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Figure 20. Smoking prevalence by MSOA (Middle Layer Super Output Area) in Wirral, based on 
Health Survey for England synthetic estimates from 2006-08 data. 
 
Source: APHO (Association of Public Health Observatories) 2012. 
 
Since 2011, all smoking cessation activities in Wirral have been recorded in a single 
database ('Quit with Us') which includes: 
1. Demographic data about people using services like date of birth, age, gender and 
postcode, ethnicity, deprivation group, socio-economic classification, employment 
status and type of employment. 
2. Quit method – i.e. Zyban, Champix, NRT or combinations. It is not clear how reliably 
or consistently this is recorded. The evidence is that combination NRT is more 
effective than one NRT method but this is not consistently recorded. 
3. Medical conditions - the most common medical conditions recorded are respiratory 
problems, mental health issues, high blood pressure, and heart problems. 
4. Referral date and quit attempt date. 
5. Carbon monoxide (CO) reading for some clients. 
6. Whether someone has quit successfully at four weeks and whether it has been 
validated with CO reading. 
7. Whether someone has quit at 12 weeks (recorded for some clients); whether 
someone has quit at 26 or 52 weeks (not generally recorded). 
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8. Type of intervention delivered - Closed Groups; Drop In; Family/Couples; One To 
One; Open Groups; Telephone Support. 
9. Type of intervention setting, typically Stop Smoking Service, Pharmacy, Primary Care 
or Other; where other is split mainly between HAAs, Quit Stop, Solutions for Health, 
external provider, third sector, health service in schools. 
10. Fagerström Nicotine Dependence test data is recorded for around 50% of clients. 
11. Number of cigarettes smoked per day is recorded for around 40% of clients – the 
average is 18.3 cigarettes per day. 14% of clients were recorded as smoking 30 or 
more cigarettes per day. 
12. Years smoked and number of pack years is recorded for at least 16% of clients – the 
database has lots of zeros which could be zero years smoked or could be not 
recorded. The average number of years smoked excluding zeros is 17.85 years. 
13. Whether or not someone smokes at home, in the car, or lives with children (recorded 
for around 50% of clients). 
Full data definitions are available in Appendix 4. Smoking Treatment Data Definitions. The 
treatment database does not include costing data for each service. The costing data was 
applied at a higher level, using the total spend on smoking cessation in Wirral which supplied 
by finance department.  
5.4.4 Methods 
The data were analysed using Microsoft Excel and SPSS. Quit rates and demographic data 
were analysed using regression and t tests where appropriate.  
To inform the economic analysis the Wirral Health Economic Life Cohort Smoking 
(WHELCS) model was constructed based on the outcomes for each service over a period of 
one year extrapolated over a 20 years period on the assumption that 8% of four week 
quitters become lifetime quitters (this assumption was rigorously tested in a sensitivity 
analysis). This model was constructed de novo by the author in 2012. The epidemiological 
input data was not refreshed since 2012 as there was no more relevant data available.  
The analysis was based on data for 1,726 smokers who quit with service support in Wirral in 
2013/14. A background quit rate of 0.5% was assumed based on data used for a similar 
smoking cessation modelling study (Parrott et al., 2006a) and costs for staff, overheads and 
drugs were derived from service line reporting. The outcomes measured were number of 
people engaging with services, number of quitters, prevalence of diseases, Quality Adjusted 
Life Years, costs, and life years gained. 
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Long term outcomes were modelled using an individual cohort model, where the baseline 
model looked at prevalence, QALYs lost and healthcare costs from smoking-related 
diseases. These diseases were lung cancer, COPD (chronic obstructive pulmonary 
disease), CHD (coronary heart disease), MI (myocardial infarction or heart attack), and 
stroke. The baseline model was adjusted by applying the age and gender of each smoking 
quitter for 2013/14 and switching individuals from being smokers to be ex-smokers, and 
ageing them through 20 years, applying the age-specific mortality rates for non-smokers and 
measuring the discounted cost savings and QALY gains when compared to the baseline 
model. The rest of the model was kept constant over the 20 years, i.e. no assumptions were 
made about demographic change or background smoking prevalence changing. This cross 
sectional approach was chosen to isolate the effect of the intervention. 20 years was chosen 
because with discounting and background mortality the difference in the net effect between 
groups became very small after 20 years. The model did not take into account indirect 
effects such as reduced morbidity and mortality through reduced passive smoking.   
Disease costs (Table 11) are from the NICE (2007) model. They were inflated to 2011 prices 
using the Hospital & Community Health Services (HCHS) inflation index (PSSRU, 2011). 
The costs are only for disease prevalence, not for acute events, or for deaths. They are 
health costs and do not include social care and other consequential costs. 
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Table 10. Smoking model parameters drawn from evidence. 
Populations Single year of age (SYOA) population estimates for males and females for Wirral, ONS 2010. 
The Census data for 2011 showed that the population of Wirral had been underestimated by 
around 3%; however refreshed SYOA population estimates were not available at the time of 
constructing this model. 
Mortality Average of mortality by single year of age for Wirral, 2007-2011 (5 years pooled) from ONS. 
Five years data was used to smooth out random fluctuations which may occur, particularly in 
age groups where deaths are rare. 
Smoking 
prevalence 
Smoking prevalence by age (16+) was taken from the Wirral smoking prevalence survey 
September 2011. This data is for the most deprived areas of Wirral where smoking 
prevalence is higher than the whole of Wirral. The proportions of men and women in three 
groups (current smoker, ex-smoker and never smoked) was adjusted by a factor from the IHS 
(Integrated Household Survey) smoking prevalence data, October 2010-September 2011, 
until the total smoking prevalence for males and females matched to the nearest 1%. 
Disease 
prevalence 
This was from NICE model (2007) which had disease prevalence by single year of age for 
smokers, ex-smokers and never smoked. The COPD prevalence came out slightly lower than 
the measured prevalence which may be partly because COPD definition was extended in 
2011 to include more people as having mild COPD. The NICE model is from 2007. 
The prevalence of lung cancer was based on Peto R, Darby S, Deo H, Silcocks P, Whitley E, 
Doll R. Smoking, Smoking Cessation, and Lung Cancer in the UK Since 1950: Combination of 
National Statistics with Two Case-Control Studies. British Medical Journal. 2000; 321 323-
329. 
The prevalence of the other diseases was based on Department of Health and Human 
Services, National Center for Chronic Disease Prevention and Health Promotion, Office on 
Smoking and Health, Washington DC. 
The Health Consequences of Smoking: A Report by the Surgeon General. 2004. 
Utility scores This came from a NICE model for disease groups, and Wirral wellbeing survey for smokers 
and non-smokers - additive utility has been used which may overestimate the lost utility due to 
smoking, as most surviving older smokers will have more than one disease due to smoking 
(Feeny et al., 2002). The utility scores are shown in the table in the next section. Life years 
gained were given a utility score of 0.7 which was the average utility score for people aged 55 
and over in Wirral, based on the 2009 wellbeing survey. 
Risk of 
death 
This was from the seminal study by Doll (1994). It is assumed that under the age of 35, the 
relative risk ratio of deaths of smokers/non-smokers/ex-smokers is 1:1:1.  
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Table 11. Smoking cost and utility estimates used. 
Comorbidity / 
Health State Utility 
Cost per year 
2006 
Cost per year 
2011 Data source 
Lung cancer 0.58 £5,501 £6,077.97 NICE model 
CHD 0.8 £1,063 £1,174.49 NICE model 
MI 0.8 £2,175 £2,403.12 NICE model 
COPD 0.73 £926 £1,023.12 NICE model 
Stroke 0.48 £2,061 £2,277.17 NICE model 
Current smoker 0.75     NICE model 
Former smoker 0.78     NICE model 
     
Current smoker 0.75013169 
  
NW wellbeing 
survey data for 
Wirral 
Former smoker 0.78597945 
  
NW wellbeing 
survey data for 
Wirral 
Non smoker 0.80193229 
  
NW wellbeing 
survey data for 
Wirral 
 
Changes in longer term costs and benefits as a result of smoking quitters were discounted at 
3.5% per year. This is the standard discount rate recommended by the UK Treasury (HM 
Treasury, 2003). Discounting costs and benefits is standard in economic modelling to take 
into account time preference (that people prefer to receive benefits now than in the future) 
and that events in the future are subject to more uncertainty. 
A parameter sensitivity analysis (where parameters are varied to see how sensitive the 
results are to these changes) was carried out where the quit rate was varied between 6% 
and 10%. Also the discount rate was varied between 0% and 6%. A structural sensitivity 
analysis (where the model type or structure is varied) was not carried out, but the results 
were compared to the results from the NICE return on investment tool, which is a tool for 
estimating the impact of smoking cessation. 
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For the realist evaluation, the CMO table was constructed from semi structured interviews 
with service providers and commissioners and through interpreting the data.  
5.4.5 Results  
Quits by Provider 
The majority of referrals were recorded as self-referrals (83%), followed by GPs (3%) and 
midwives (3%). Overall 4 week quit rates were slightly higher for the third sector providers 
(44.1%) than for Wirral CT (41.5%). The service for pregnant women, MeTime, had a 
particularly high quit rate (57%, 71 quitters) although this is more intensive than other 
services and has a higher cost per client of around £1,100. Third sector providers had a 
higher proportion of quits that were confirmed with carbon monoxide (CO) readings (97%) 
than the main provider, Wirral Community Trust (74%). The overall CO confirmation rate was 
79%. 
Client Characteristics & Quit Methods Influence on Quit Rates 
A preliminary regression analysis found that type of referral, age group, ethnicity, CVD and 
COPD status, quit method, and specifically Champix use were all significant predictors of 
whether or not somebody quit, although the overall impact of each of these factors was 
small.  
Quit rates by type of intervention 
Telephone support had the highest quit rate which is perhaps surprising as it may be less 
intensive than other forms of support, although may attract people who are more well 
motivated to quit.  
Table 12. Quit rates by type of intervention, Wirral, 2013/14. 
Type of 
intervention 
Number of 4 
week quits 
Unsuccessful 
quit attempts 
Total 
clients 
Quit 
(%) 
Closed Groups 80 89 169 47% 
Drop In 272 294 566 48% 
Family/Couples 7 7 14 50% 
One To One 1272 1903 3175 40% 
Open Groups 39 42 81 48% 
Telephone Support 56 39 95 59% 
Grand Total 1,726 2,374 4,100 42% 
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Quit rates by quit method  
Champix [Varenicline] had a much higher success rate than any of the other major quit 
methods. Although Champix is much more expensive (the cost is quoted as £164), this 
higher quit rate would suggest that the additional investment is worth it and that it should be 
recommended to all smokers who are eligible and willing to try it. But as with any 
pharmacological agent, Champix has side effects and contraindications which may make it 
not appropriate for some people (Moor et al., 2011). The database did not accurately record 
whether people were using combination NRT or mono NRT. The evidence is that 
combination NRT has a higher quit rate, although for the small number of people in Wirral 
that were definitely using combo NRT the quit rate was actually lower than average. Zyban 
[Bupropion] is not used very often any more but had a high quit rate for those who used it. 
Table 13. Quit rates by method, Wirral, 2013/14. 
Quit Method Number 
of 4 
week 
quits 
Non- 4 
week 
quits 
Total 
clients 
Quit 
(%) 
Champix 627 419 1046 60% 
Combo NRT 12 51 63 19% 
NRT 
[unspecified] 987 1714 2701 37% 
Other 91 185 276 33% 
Zyban 9 5 14 64% 
Total 1,726 2,374 4,100 42% 
Clients by Fagerström Nicotine Dependence Test Score 
Fagerström nicotine dependence scale was measured for 50% of clients using services in 
Wirral. This assesses how dependent someone is on nicotine by asking questions about 
smoking behaviour, such as whether someone smokes within the first 5 minutes of waking, 
or whether someone continues to smoke when they are sick in bed, and how many 
cigarettes someone smokes per day.  Over the last 10 years, in addition to fewer people 
smoking overall, the level of dependence of people who continue to smoke has dropped. 
Fagerström dependence scale is useful in understanding how strong someone’s urge to 
smoke is, and can be used in formulating how much NRT to give. In terms of implementation 
theory and realist evaluation, Fagerström score is a context which contributes to which 
mechanism works best, as it measures how physiologically addicted somebody is.  
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Most clients in stop smoking services had a low level of dependence while only 2.4% had 
high dependence. The group with highest level of dependence had the highest quit rate but 
these differences were not statistically significant. 
Table 14. Proportion of clients recorded and 4 week quit rate, Wirral, 2013/14. 
Group Fagerström Group Quit Didn’t 
quit 
Total Proportion 
of those 
clients who 
had 
Fagerström 
measured 
(%) 
Quit rate 
(%) 
1 Low dependence 578 818 1396 68.0% 41% 
2 Low-mod dependence 189 251 440 21.4% 43% 
3 Moderate dependence 69 100 169 8.2% 41% 
4 High dependence 23 26 49 2.4% 47% 
  
Total with Fagerström 
measured 859 1195 2054 100.0% 42% 
 
Quit rates by age and gender 
The average age of service users was 43 years. There were 2,309 females and 1,784 males 
in the service (7 with no gender recorded). The biggest age/gender groups were females 18-
34 and 45-59. The highest quit rate was in women aged over 45 and men aged over 35 
while younger groups had lower quit rates. Estimated smoking by age group and gender was 
estimated based on data from the North West wellbeing survey (Deacon et al., 2010) and 
compared to quits in 2013/14. Estimated smoking rates were higher in younger females than 
males, and were much higher for older males than older females. It is important to state that 
there is most likely a health survivor effect in the older age group, with smokers less likely to 
survive as long as non-smokers or ex-smokers. 
The age group with most quits per smoker is females aged 60+, while the age group with 
fewest quits per smoker is males aged 60+. This indicates that maybe more needs to be 
done to get older men into smoking cessation. For younger men aged 18-34 there was a 
high rate of attempts but a lower rate of successful 4 week quits. 
  
111 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
Table 15. Estimated number of smokers, smoking prevalence and quits per 100 smokers, by age and 
gender in Wirral. Based on Quit with Us Data for 2013/14 financial year. 
Gender Age 
group 
Population  Estimated 
N 
smokers 
N quit 
attempts 
4 
week 
quits 
Attempts 
per 100 
smokers 
Quits per 
100 
smokers 
Females 18-34 31033 9731 704 263 7.2 2.7 
Females 35-44 20953 6953 476 201 6.8 2.9 
Females 45-59 35004 7681 648 298 8.4 3.9 
Females 60+ 46253 4282 404 185 9.4 4.3 
Males 18-34 29732 7322 513 171 7.0 2.3 
Males 35-44 19276 6873 379 179 5.5 2.6 
Males 45-59 32550 8624 491 230 5.7 2.7 
Males 60+ 37786 8282 318 160 3.8 1.9 
Quit attempts with no age or gender recorded have been excluded. 
Quit rates by ethnic groups 
Some ethnic groups had low numbers using the services (less than 10) so making any 
strong judgment on the quit rates in these groups may not be useful. But in general it seems 
that overall, Asian groups have similar quit rates to White British groups while ‘Other White’ 
background and ‘White Irish’ groups have low quit rates, and ‘Chinese’ and ‘any other ethnic 
group’ have particularly low quit rates.  
Quit rates by deprivation groups – Equity Impact Analysis 
This section will discuss the equity implications of the stop smoking service. For smoking 
prevalence this used smoking by deprivation quintile data for Wirral from the North West 
Wellbeing Survey, 2013. Table 16 shows that smoking is highest in the most deprived 
quintile, with a prevalence of 37%. 
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Table 16. Smoking prevalence by deprivation quintile in Wirral, 2013 Wellbeing Survey. 
  Deprivation Quintile Current 
smoker 
Ex-
smoker 
Non 
smoker 
Total 
1 Most deprived 37% 29% 34% 100% 
2 Second most deprived 21% 35% 44% 100% 
3 Third most deprived 29% 38% 33% 100% 
4 Fourth most deprived 14% 25% 61% 100% 
5 Least Deprived 6% 27% 67% 100% 
 
This prevalence was then used to calculate estimated number of smokers by LSOA (lower 
layer super output area, which is a low level geography where each area contains 
approximately 1,500 residents) in Wirral, and gave a total number of smokers of 54,684 
(21% of the population) which is in the same ballpark as other estimates which are generally 
between 18-23% of the population. For each LSOA the number of quit attempts and number 
of 4 week quits was also matched up and the ratio of quit attempts and quits per 100 
smokers was calculated. This data was aggregated up to ward level, where wards contain 
roughly 10,000 - 20,000 population.  
The results show that the most deprived wards have the highest ratio of quit attempts and 
quits per 100 smokers. The lowest ratios were for Hoylake and Meols and for Pensby and 
Thingwall. However the estimates for smoking prevalence are quite crude, so it may be that 
these wards have a lower number of smokers than these estimates suggest. These results 
may be used to see if more needs to be done to engage with smokers from Pensby & 
Thingwall. Evidence is that being from a more affluent background has a protective effect so 
that smokers from deprived areas are more likely to die from smoking related diseases than 
affluent smokers, so it maybe more important for services to focus on smokers from deprived 
areas. 
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Table 17. Estimated number of smokers, smoking prevalence and quits per 100 smokers, Wirral 
wards. Based on Quit with Us Data for 2013/14 financial year. 
Ward Estimated 
Number of 
smokers 
Estimated 
smoking 
prevalence 
Sum of 
Clients 
Sum of 
Quitters 
Quit 
attempts 
per 100 
smokers 
4 week 
quits per 
100 
smokers 
Bebington 2723 18% 137 65 5.0 2.4 
Bidston and St James 3074 34% 342 141 11.1 4.6 
Birkenhead and Tranmere 4289 34% 496 171 11.6 4.0 
Bromborough 2856 24% 201 106 7.0 3.7 
Clatterbridge 790 8% 29 14 3.7 1.8 
Claughton 3642 29% 209 80 5.7 2.2 
Eastham 1900 17% 164 88 8.6 4.6 
Greasby, Frankby and 
Irby 
1269 9% 43 21 3.4 1.7 
Heswall 908 7% 40 20 4.4 2.2 
Hoylake and Meols 1893 16% 47 18 2.5 1.0 
Leasowe and Moreton 
East 
2768 26% 267 126 9.6 4.6 
Liscard 3352 26% 262 110 7.8 3.3 
Moreton West and 
Saughall Massie 
2854 23% 148 86 5.2 3.0 
New Brighton 2899 25% 185 80 6.4 2.8 
Oxton 1971 18% 122 57 6.2 2.9 
Pensby and Thingwall 1834 20% 27 9 1.5 0.5 
Prenton 2878 23% 234 90 8.1 3.1 
Rock Ferry 3402 30% 336 121 9.9 3.6 
Seacombe 3609 30% 349 130 9.7 3.6 
Upton 2799 23% 159 53 5.7 1.9 
Wallasey 2147 17% 101 55 4.7 2.6 
West Kirby and 
Thurstaston 
827 9% 39 21 4.7 2.5 
Wirral 54684 21% 3937 1662 7.2 3.0 
Note: quit attempts and 4 week quitters that could not be matched up to LSOAs have been excluded. 
Cost Effectiveness of Services 
The baseline economic model was constructed in 2012 and tested as to whether it reflected 
the reality of health outcomes associated with smoking. The baseline model was a ‘do 
nothing’ model which aimed to describe the current state of smoking, mortality and disease 
prevalence in Wirral, onto which the impact of different types of interventions can be grafted. 
The baseline model applied mortality and morbidity age-specific risks for Wirral's current 
population of smokers, non-smokers and ex-smokers. The results are shown in Table 18. 
The national health profiles estimate 680 smoking related deaths per year in Wirral for 2009-
11; a rate of 256 per 100,000 people aged 35 and over, which is 21% higher than the 
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average for England as a whole. This is close to the number of deaths estimated in the 
model providing strong support for the validity and reliability of the model. For validating lung 
cancer prevalence Forman and colleagues (2003) identified a crude lung cancer prevalence 
of 55 people per 100,000 for England as a whole. This would equate to 170 people for Wirral 
which is much lower than the estimate generated in the model. Similarly the CHD prevalence 
estimated for Wirral in the model appears to be much higher than the GP-measured QOF 
(Quality and Outcomes Framework) data which is based on known disease prevalence. 
However,  the Association of Public Health Observatories estimate CHD prevalence in Wirral 
to be 19,177 cases so the fact that the model estimate lies between these two figures is 
reassuring, while the prevalence of stroke estimated in the model is similar to that obtained 
from the QOF data. The COPD prevalence estimated in the model is lower than the QOF-
measured prevalence (7396) and much lower than the APHO estimated prevalence 
(14,417).  This may be because NICE's COPD definition was extended in 2011 to include 
milder COPD which would have previously been diagnosed as being pre-clinical. This 
extension of COPD diagnosis to earlier stages had a function of delivering a shock to 
patients to motivate them towards quitting smoking before their COPD symptoms would get 
more severe. The data in the model is from 2004 - before the extended definition of COPD 
utilised by NICE was introduced. Overall, the results obtained in the model seem to be 
reasonably consistent with other sources of health data relating to the Wirral population.  
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Table 18. Results of the baseline model for Wirral. Source: WHELCS Model. 
Predicted totals - 
baseline model 
All 
16+ 
All 16+ All 16+ Comparator 
to 
triangulate 
data 
Ratio of 
Model to 
Comparat
or 
Source of 
comparat
or data 
  Males Femal
es 
Person
s 
      
Population 11751
0 
13262
3 
250,13
3 
    
Smokers 30259 29968 60,228 57,577 1.05 Mosaic 
Public 
Sector 
Ex-smokers 38416 42247 80,663     
Never smoked 48835 60407 109,24
2 
    
Smokers (%) 26% 23% 24% 24% 1.0 Integrated 
Household 
Survey 
Lung cancer 
prevalence 
297 135 432      
CHD prevalence 9671 7379 17,050  13,769 1.24 QOF Data 
Myocardial 
Infarction 
prevalence 
4496 1986 6,482      
COPD prevalence 2781 3622 6,403  7,396 0.87 QOF Data 
Stroke prevalence 3420 3502 6,922  7,359 0.94 QOF Data 
(Stroke & 
TIA) 
Deaths - current 
smoker 
454 457 911      
Deaths - ex smoker 834 820 1,654      
Deaths - never 
smoked 
493 726 1,219      
 
Figure 21 provides an example of the outputs that can be calculated from the model. It 
shows survival over the next 30 years for 40 year old smokers and ex-smokers. For 40 year 
male old smokers, probability of surviving to 70 is around 55%, while for female ex-smokers 
it is around 80%. Interestingly female smokers have a similar probability of surviving to age 
70 as male ex-smokers, at around 71%. This is entirely consistent with evidence from a 
Scottish cohort study, where it was found that smoking cancelled out the survival advantage 
that women have over men (Gruer et al., 2009).  
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Figure 21. Probability of surviving next 30 years for male and female smokers and ex-smokers in 
Wirral, as predicted by the model. 
 
 
 
 
 
Figure 22 and Figure 23 show the proportion of males and females predicted by the model to 
be smokers, ex-smokers and never smoked. There are some clear quantisation effects, 
where the data has been grouped into age groups rather than having data for each age. 
Male smoking rates are highest in 24 to 35 year olds whereas female smoking rates are 
highest in 35 to 50 year olds. Interestingly smoking in women is lower in 20 to 24 year olds 
than in the two age groups either side, women aged 16 or 20, or 25 to 30, which suggests 
that girls under 16 are taking up smoking more. This age structure is almost the opposite of 
what would be expected given that young women who are from more affluent backgrounds 
are less likely to smoke, and are more likely to leave Wirral in their early twenties to go away 
to university. 
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Figure 22. Male smoking behaviour by age for Wirral as predicted by baseline economic model, 
showing proportion of total population who are current smokers, ex-smokers and never smoked, Ages 
16 to 90. 
 
Figure 23. Female smoking behaviour by age for Wirral as predicted by baseline economic model, 
showing proportion of total population who are current smokers, ex-smokers and never smoked, Ages 
16 to 90. 
 
The local model considers the QALYs gained from smoking in adults through a reduction in 
risk of COPD, lung cancer and cardiovascular disease (heart disease and stroke) from 
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individuals moving from being a current smoker to being an ex-smoker, modelled over 20 
years. The model also considers gains from smoking cessation in pregnant women. The 
model assumes a central 8% long term quit rate which is based on the 5-7% known quit rate 
in Scotland with some adjustment for loss to follow up (NHS Scotland, 2012). In Wirral there 
were 335 clients in 2013/14 who had 52 week quit status recorded, of which 302 had 
relapsed and only 2 reported they had still quit, which would equate to a long term quit rate 
of less than 1%, so there is uncertainty over what the actual long term quit rate is for 
smokers in Wirral. The overall central estimate of cost per QALY for services was £18,485 
which would be considered cost effective, but lower than other studies of smoking cessation 
which have largely come out as dominant (i.e cost saving) (for example Fidler et al., 2011). 
This figure considers only the healthcare cost savings, not the productivity gains or gains in 
terms of reduced need for social care for smoking related illnesses, and reduced litter and 
fires caused by cigarette butts. 
Table 19. Results of local smoking economic model for Wirral, 2013/14 FY. 
 
Net effect over 20 years 
Outcome 
6% quit 
rate 
8% quit 
rate 
10% quit 
rate 
Total NHS disease costs saved £84,285 £112,380 £140,475 
QALYs gained through reduced smoking related 
disease 43 57 71 
Additional child QALYs through pregnant mothers 
quitting 1.72 1.72 1.72 
Additional cost savings from pregnant mothers 
quitting £31,906 £31,906 £31,906 
Total life years gained 32 42 53 
Total QALYs through life years gained (valued at 
0.7) 22 30 37 
Total QALYs gained 67 88 110 
Total NHS cost savings £116,191 £144,286 £172,381 
Total 4 week quitters 1753 1753 1753 
Cost of programme £1,778,343 £1,778,343 £1,778,343 
Net cost per QALY £24,909 £18,485 £14,591 
Cost:benefit ratio 0.82 1.08 1.33 
 
Figure 24 provides a summary of the net result of smoking quitters over 20 years. The 
biggest change in number of cases is in CHD, followed by MI. Although ex-smokers have a 
lower risk of disease than smokers, they also have a lower risk of dying which means that 
more of them live to an older age to get diseases. So in terms of total disease prevalence 
this cancels out some of the effect of people quitting smoking. This is true for the cost 
savings as well, while people quitting smoking generates considerable cost savings, some of 
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these costs are delayed or offset, so for instance people who quit smoking are more likely to 
live to an older age where they get dementia and generate costs to the health and social 
care system.  
Figure 24. Net discounted reduction in disease cases over 20 years, as a result of smoking cessation 
activities in Wirral, 2013/14.   
 
 
Cost Effectiveness - Sensitivity Analysis 
 
The net cost per QALY (the cost per QALY after NHS cost savings) is heavily impacted by 
the quit rate and discounting rate chosen for the model. In their guidance for economic 
evaluation of public health interventions, NICE have stated that any sensitivity analysis 
should vary the discount rate between 0% and 6%. In the best case scenario (with discount 
rate at 0%, long term quit rate at 10%) the cost per QALY is £3,798 while in the worst case 
scenario (discount rate 6%, long term quit rate 6%); the cost per QALY is £35,197. The 
distribution of cost per QALYs gained for different quit rates and discount rates shown in 
Figure 25. As with any public health intervention that has a long payback time the cost-
effectiveness of anti-smoking interventions is very sensitive to the effects of discounting. 
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Figure 25. Difference in cost per QALY (cost utility) for different quit rates and discount rates. 
Wirral smoking economic model. 
 
Realist Evaluation – Context-Mechanism-Outcome Table 
 
Smoking cessation programmes can be described as complex interventions in complex 
systems. They are complex because they often provide a mixture of pharmacological 
interventions such as offering NRT or Champix, and behavioural or psychosocial support, 
and these elements interact in different ways in different people. We do not always know 
what has been the crucial change in someone’s reasoning or resources that has enabled 
someone to maintain a situation where their resolve to quit is stronger than their urge to 
smoke. Smoking cessation programmes exist in a complex system because people’s 
success in giving up smoking is not driven only by physiological changes in the body; rather 
this success is driven by the policy and economic environment, the social environment, and 
people’s capabilities, opportunities and motivation to change their behaviour. This is why 
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local tobacco control programmes also include prevention and enforcement as well as social 
marketing.  
Table 20 shows the smoking context-mechanism-outcome table. The CMO table has been 
put together by looking at policy documents around smoking, as well as the data collected by 
smoking services, and through talking to service providers and commissioners. Including this 
in the evaluation was to encourage commissioners and providers to think particularly about 
the mechanisms that work to get people to successfully quit smoking so that they can think 
about services changes that get these mechanisms firing more often. This list does not claim 
to be exhaustive, and can only claim to be a ‘middle range’ theory. The CMO table acts to 
add some nuance to the assumptions behind the economic evaluation. Some commentators 
have suggested that the context needs to be shifted so that treatment and substitution are a 
more routine part of the environment around smoking, so for instance in 'Cough Up' they 
suggest that all retailers should have NRT available next to tobacco products (although most 
now have electronic cigarettes at least). 
Table 20. Smoking cessation CMO Table. SC= source of information is local service 
commissioner, SM= source of information is service manager. 
Group Contexts Mechanisms Outcomes 
Adult 
smokers 
Wirral and the North West of 
England have a history of 
smoking culture. Although it 
has declined since the 
1970s, smoking is still a 
fixture of working class 
culture (Hiscock et al., 2011) 
People come to realise 
that they value their 
health and the 
opportunities that it gives 
them more than they 
value smoking (SC) 
Some people do not 
successfully quit smoking 
but they realise that 
services are free and 
approachable for when 
they are ready to try again; 
they may also recommend 
services to others (SM) 
 
Adult 
smokers 
Smoking was originally more 
popular in men and affluent 
groups but for the last 50 
years it has become popular 
in women and in routine and 
manual groups (Kotz & 
Westm 2009). 
Many people come to 
services as the result of 
a health shock, such as 
a diagnosis of CVD or 
COPD which puts them 
in a mind-set where they 
are receptive to 
messages about 
change. Some people 
come as a result of 
being told by a health 
professional (GP) that 
they have to attend SSS.  
This presents a different 
scenario for the SSS as 
the client may still be in 
pre-contemplation stage 
for quitting (SM). 
 Some people quit 
smoking, and get better 
health as a result as well 
as financial benefits. This 
can contribute to NHS cost 
savings, as well as 
savings to other public 
agencies and increased 
economic productivity. 
People who quit then 
contribute to smoking 
becoming less of a norm 
and less socially 
acceptable to their family, 
friends and neighbours 
(SC). 
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Group Contexts Mechanisms Outcomes 
Adult 
smokers 
For many people in routine 
and manual groups, smoking 
is associated with work 
breaks, or socialising and 
drinking alcohol (McEwen et 
al., 2008). 
Many people will be 
pressured by family or 
friends to stop smoking 
or experience significant 
life changes e.g. new job 
or new baby (SC). 
Adult 
smokers 
Smokers from deprived 
areas spend 15% of their 
disposable income on 
tobacco (ASH, 2005) 
People realise that 
spending a large 
proportion of their 
disposable income on 
cigarettes does not 
make sense (SC) 
When people quit there 
will be reduced revenue 
from tobacco sales but 
many people will spend 
the same money on other 
goods so it is not lost to 
the economy altogether 
(ASH, 2015). 
Adult 
smokers 
As well as routine and 
manual workers, certain 
groups such as carers and 
people with mental health 
problems are more likely to 
smoke (ASH, 2005). 
Group sessions for 
people with similar 
experiences can 
reinforce a sense of 
identity and group 
dynamic around the 
transition to being a non-
smoker (SC) 
 
Adult 
smokers 
Smoking cessation has been 
available through the NHS 
since the 1990s and 
successive national policy 
measures have been 
brought in to make smoking 
more expensive and more 
difficult, such as increasing 
the age of buying tobacco 
from 16 to 18, and banning 
smoking in indoor public 
places (Hill et al., 2014). 
Pharmacological 
therapies (e.g. NRT) 
reduce the cravings, or 
Champix reduces 
cravings while also 
reducing the pleasure 
gained from smoking 
(Heydari et al., 2014). 
  
Chewing 
tobacco 
users 
Some stop smoking advisors 
are for specific groups e.g. 
chewing tobacco, illicit 
tobacco (SM) 
Advisors advocate giving 
up chewing tobacco 
during Ramadan where 
Muslims do not use it 
during the day so it is a 
good time to get people 
out of the habit. Advisors 
also push Muslims to 
quit smoking with quotes 
from religious leaders 
saying that quitting "will 
be an act of ibadah 
(worship) that helps to 
keep you healthier.” (SC) 
  
123 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
Group Contexts Mechanisms Outcomes 
Pregnant 
women 
Wirral has historically high 
rates of smoking in 
pregnancy compared to 
other areas. It may be the 
case that smoking messages 
need to be delivered to 
mothers earlier, before they 
even get pregnant, for them 
to be most effective (HSCIC, 
2015a; SC) 
The implementation of 
Payment by Results 
(PbR) mechanisms has 
meant that services only 
get paid when pregnant 
women successfully quit 
(SC) 
The number of pregnant 
women quitting has 
increased considerably 
over the last 3 years (local 
data). 
The service Mass media campaigns like 
Stoptober, which is 
deliberately timed so that 
smokers who have gone on 
holiday abroad in the 
summer and bought cheap 
cigarettes will have used 
them up by October (SC). 
    
The service E cigarettes have produced 
a sea change in culture. The 
number of people changing 
to e cigs has proven how 
many smokers want to have 
a healthier lifestyle. E cigs 
have split the academic and 
tobacco control community. 
Local leaders in Wirral 
recognise that e cigs have 
got a capacity to improve the 
health of many people but 
that surveillance and product 
regulation is needed (SC) 
Electronic cigarettes 
may be a stepping stone 
to some people 
becoming tobacco free, 
and can be a hook to get 
people into services. 
However it may be that 
they replace the need for 
traditional services 
(McNeil et al., 2015) 
Some people will quit 
tobacco with e cigs. There 
is a theoretical risk of 
young people taking up e 
cigarettes, and a risk that 
they might prolong 
dependence on nicotine, 
but there is not a lot of 
evidence for this at the 
moment (McNeil et al., 
2015). 
The service It can take a long time to 
make changes to stop 
smoking services; everything 
has protocols and standards, 
which are based on years of 
research and evidence. 
However this can stifle 
innovation (SM). 
   
The service There is a lot of potential in 
self-care and digital support 
which may be a lot more 
efficient and fit in with an 
asset-based agenda. Locally 
it is believed that this 
potential is untapped (SC). 
The service could make 
better use of social 
media platforms such as 
Facebook; Twitter; 
Instagram. However it 
would have to ensure 
that this was done in a 
cost effective way (SM). 
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Group Contexts Mechanisms Outcomes 
The service In the past services offered 
'Quit and Win' where 
smokers could win prizes, 
which was a financial 
incentive to quit. This is not 
currently offered. Under this 
system smoking advisors did 
not have to assess smoker's 
motivations to quit, which 
they usually have to do (SM). 
Financial incentives can 
work, with even small 
amounts of money. They 
give smokers an excuse 
to discontinue a 
behaviour that is part of 
their peer group. To 
some outsiders and non-
smokers, these schemes 
can be seen as 
rewarding unhealthy 
choices however (Giles 
et al., 2015). 
The financial incentives 
offered in Wirral were 
successful in increasing 
quit rates - there were 
some inappropriate 
referrals for people who 
were not ready to quit, but 
the overall quit rate was 
still reasonable and much 
better than without the 
intervention. There may be 
some potential for 
rewarding quitting with 
non-financial incentives 
(SC). 
The service Stop smoking services have 
been around for so long it is 
difficult to keep them fresh 
(SC).  
Trading Standards have 
a commissioned 
programme of work 
(commissioned on 
activity) that covers 
Under Age sales and 
also working with local 
retailers re: illegal and 
illicit tobacco (SC). 
Making better links with 
other services will improve 
outcomes (SC). 
The service New York has shown that 
smoking prevalence can be 
dramatically reduced to 
around 10%, possibly 
refuting the idea that 
eventually as prevalence 
decreases areas are left only 
with 'refuseniks' - hard-core 
smokers who will never quit 
(Coady et al., 2013). 
This rapid improvement 
in New York reinforces 
the belief in people in 
tobacco control 
community that quick 
change is possible, 
although ASH have said 
that disinvestment in 
tobacco measures has 
led to an increase in 
smoking prevalence in 
New York (SC) 
  
The service The service has continuously 
met its target of reaching 
around 5% of smokers. 
There is always a 
compromise between getting 
a high volume of people 
through a service and getting 
a high rate of quitters (SC). 
The service is struggling 
to reach targets as fewer 
smokers are accessing 
it; this will be due to e-
cig use, as well as there 
being fewer smokers, 
and the residual 
smokers being those 
who find it hardest to quit 
(SM) 
There are fewer people 
accessing the service than 
two years ago (SC) 
Young 
people 
Most people took up 
smoking while they were still 
children (SM). 
People may realise that 
if they would not want 
their children and 
grandchildren to smoke, 
so they should not 
smoke themselves (SC). 
  
Young 
people 
Young women often smoke 
because they think it helps 
them to control their weight 
(Doxie & Hammond, 2011). 
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Group Contexts Mechanisms Outcomes 
Young 
people 
Young people are using 
rolled tobacco more, partly 
because they believe it is 
cheaper than cigarettes and 
possibly because it is being 
marketed to young people 
more, with 'funky packaging'. 
Some people incorrectly 
believe that hand rolled 
tobacco is a healthier option 
& more fresh, organic or 
natural (Moodie et al., 2012). 
 There is a need to find 
ways to bust the myths 
around that exist around 
hand rolled tobacco (SC) 
Young 
people 
Some people (mainly young 
people) smoke tobacco with 
cannabis. There is a culture 
around thinking that 
cannabis is not harmful and 
it is becoming decriminalised 
in parts of the USA (Crick et 
al., 2013) 
    
Young 
people 
Young people are born into a 
world without tobacco 
advertising (de Andrade et 
al., 2013) 
Many young people are 
very much 
psychologically against 
the idea of smoking, but 
there is less information 
about how people feel 
about vaping e 
cigarettes (de Andrade 
et al., 2013) 
Young people are less 
likely to take up smoking 
when they have not 
encountered it (SC). 
Young 
people 
Anti-smoking programmes 
directed at children and 
young people have not been 
particularly effective so far. 
Wirral has used ASSIST 
which is a peer led 
intervention (Hollingworth et 
al., 2012). 
In the absence of any 
successful programmes, 
some young people may 
still be tempted to try 
smoking. 
Young people do not 
connect with long term 
health impacts re; 
tobacco use but they do 
connect with the 
negative practices of the 
tobacco industry e.g. 
issues such as child 
labour, deforestation, 
unethical marketing and 
media and advertising. 
This is important 
because the liquid in e 
cigarettes is still made 
from tobacco so causes 
a lot of the same global 
problems (SC). 
 
Some young people may 
still take up smoking, 
particularly in deprived 
communities (SC). 
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5.4.6 Discussion 
Smoking cessation is a complex intervention in a complex system and the ecosystem 
around smoking is changing every year. For example electronic cigarettes are now being 
marketed as a harm reduction aid. There is conflicting evidence on whether e-cigarettes will 
expose a new generation to nicotine, with a recent study finding that many teenagers had 
tried e-cigarettes (Hughes et al., 2015). The UK has led the way in terms of policy measures 
being brought in to make smoking less marketed and less socially acceptable, including 
measures brought in since 2010 by the Conservative-led coalition government who may 
have been expected to have more of a free market leaning. 
 A comprehensive cost effectiveness analysis of smoking services in Wirral was previously 
carried out by this researcher in 2012, looking at data for 2011/12 financial year (Collins, 
2012). This found that smoking services were highly cost effective, having achieved 3,379 
four week quitters. In 2014 the model was refreshed and this found that the number of 
people setting a quit date in 2012/13 was 5,403 of whom 42% quit at four weeks. The 
number of quits in 2012/13 was 2,259 compared with 3,379 the year before (so was one 
third lower). The number of quits in pregnant women had risen significantly from 21 in 
2011/12 to 69 in 2012/13 and 81 in 2013/14. In 2013/14 there were 1,729 quits which means 
that quit rates have fallen by 49% in 2 years. This is a massive change in smoking cessation 
rates and has caused commissioners and service providers to worry that the service is no 
longer successful in engaging with smokers. The quit rate as a proportion of people using 
the service has not dropped so the issue is getting people to engage with the service. The 
likely cause is a combination of a reduction in the overall pool of smokers as prevalence has 
dropped; the remaining smokers being more of a ‘hardcore’ who find it particularly difficult to 
quit, and many smokers, who may have used the service, choosing instead to use e-
cigarettes as a harm reduction measure or aid to quit.  
The results from the WHELCS model provide evidence that smoking cessation services 
should provide benefits for individuals through better quality of life and more years of life. 
The model is looking at smoking cessation in isolation, when in fact several public health 
interventions are delivered in a more integrated fashion so this model does not take into 
account the potential synergy between different interventions. The model also does not 
explicitly consider diminishing returns; i.e. that as interventions cast the net wider to get 
more clients they may get people who are less motivated to change. As stated previously the 
model does not explicitly take into account the effect of smoking cessation services on 
decreasing health inequalities, so has not added an additional weighting for health gains for 
127 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
people from deprived areas, which some public health models have done (e.g. Lister & 
Merritt, 2013). Instead a separate health equity impact assessment was carried out.  
There have been other tools which estimate the cost effectiveness of smoking cessation 
interventions including the National Social Marketing Centre’s Value for Money Tools (Lister 
& Merritt, 2013), and the NICE Return on Investment Tool for tobacco control (Pohkrel et al., 
2014). These tools are based on good evidence and are useful for commissioners. These 
tools assume a higher long term quit rate than has been assumed in our model, and as a 
result the stop smoking services would be analysed as being a lot more cost effective. 
In 2013 NICE produced guidance PH45 recommending a harm reduction approach calling 
for a reduction in smoking intensity for smokers who find it impossible to quit completely. 
This approach has the potential to get more smokers engaged with services, but also could 
be potentially less cost effective, if health benefits are watered down as a consequence of 
failure to achieve smoking cessation. There have also been several attempts to produce a 
nicotine vaccine that blocks the pleasurable effects from smoking, either for children to 
reduce uptake, or to help smokers to quit. This is still several years away and may pose 
ethical questions. 
This work is the most recent iteration of a programme of evaluation work that was carried out 
over three years. The results of these analyses have been presented to Wirral council 
leading to several of the recommendations being incorporated into commissioning 
guidelines. For example Payment by Results (PbR) services were expanded and a 
dedicated service established to support joint cannabis and tobacco users. In addition 
commissioners were reassured that their smoking cessation services has been rigorously 
evaluated and found to be cost effective even when using a very conservative set of 
assumptions. This work was useful in getting cross party agreement in the council in calling 
for generic packaging for cigarettes. A comprehensive set of recommendations were derived 
from this analysis of smoking cessation policies in Wirral. These were as follows; 
1. It is recommended that smoking services should be considered on a regional scale more 
often, for interventions to be more efficiently managed and delivered. It is difficult to 
achieve the change in social norms needed for population level behaviour change while 
working on a local footprint. 
2. NICE recommend that smoking cessation programmes should engage with at least 5% 
of smokers and achieve a 4 week quit rate of greater than 35%, both of which services in 
Wirral have consistently achieved. In most years, stop smoking services in Wirral have 
engaged with around 1 in 9 smokers in the population.  
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3. Nearly 1 in 5 adults in Wirral smoke, and smoking causes around 1 in 5 deaths. Public 
health and partners should reinforce with the population and with partners the facts - that 
smoking is still the biggest lifestyle cause of ill health and early death, and helping 
people to quit smoking is one of the most cost effective public health interventions.  
4. The most important recommendation for services is for them to really know their 
population groups and think about which mechanisms or triggers are most successful in 
reducing smoking uptake and helping smokers to quit tobacco and become nicotine free. 
5. Making systems as seamless as possible and as efficient as possible is important, so 
making it possible for healthcare workers to book a smoker’s first appointment with stop 
smoking services, having NRT available in healthcare settings, making every contact 
count, having PGDs for Champix, and using NHS Healthchecks as an opportunity to 
motivate smokers to quit.  
6. Electronic cigarettes have sent a shock to the tobacco control landscape which is still 
having an effect on people’s smoking behaviour and quit rates. As e-cig use continues at 
around 15% of smokers, decision making needs to focus on the opportunities and 
threats related to e-cigs. This could mean that e-cig venders and stop smoking services 
need to work together, but also means that services need to promote being nicotine free 
as an important outcome as well as being tobacco free. In future service outcomes 
should include whether someone has moved to e cigs or whether they are nicotine free, 
and also there could be some measurement and service planning to move e-cig only 
clients to being nicotine free.  
7. Wirral have not implemented much in the way of harm reduction yet, this is likely to be 
less cost effective than helping people to quit outright, but should be considered. 
8. Services should do more to try to monitor whether individuals have quit at 12 months. 
Most of the uncertainty around the cost effectiveness is around whether people do quit 
successfully at 12 months; most people who reach 12 months without nicotine will 
become lifetime quitters. If we can be certain that at least 5% of 4 week quitters (or 2% 
of service users) go on to become long term quitters then the service should be cost 
effective. 
9. Wirral is implementing a PGD so that pharmacists can prescribe Champix, which is more 
expensive but more effective than other quit methods, with a 4 week quit rate of 60% 
compared to 30-40% for most other quit methods. 
10. Preventing and delaying tobacco uptake in young people needs to be high priority. 
Services around preventing tobacco use in young people have not been particularly 
successful or co-ordinated in the past. Wirral Community Trust are developing 
interventions to prevent tobacco uptake as part of the 0-19s contract. These need to be 
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well planned and based on best evidence. Interventions could be developed that focus 
on looked after children and troubled families.  
11. Having interventions for men is important as smoking prevalence has fallen less in men 
than in women in the last 5 years. Making it easy for working men to access services and 
NRT is important. 
12. The quit rate for pregnant women has increased over the last few years, but the service 
is paid at a high tariff cost per quitter. Weighting the payment so that services are paid 
the full tariff when a woman has quit 2 months post pregnancy would mean that Wirral 
were potentially getting more value. 
13. Making smoking less socially acceptable is important in motivating people to quit and 
reducing uptake. Measures to do this can include enforcing the ban on smoking on 
council premises, and trying to deter people from smoking around parks and areas 
where children play. 
14. As the price of tobacco has increased, this reduces the amount of tobacco consumed by 
smokers as well as giving a financial motive to quit. Working with Trading Standards to 
reduce supply of illegal and illicit tobacco means that these price measures have their 
desired effect. 
15. The PbR (Payment by Results) Stop Smoking Service was relatively successful in 
attracting clients from target groups, so should be considered as a future service model. 
16. Future PbR services need to be able to prescribe Champix, which has the highest quit 
rate, as this may be a lost opportunity otherwise. 
17. Senior officers in Wirral should use their voice with national organisations to lobby for 
more smoking legislation to create an environment that further decreases the social 
acceptability of smoking.  
5.4.7 Conclusion 
This case study has shown how economic modelling, realist evaluation, and descriptive 
statistics highlighting equity impact can work as an integrated methodology in evaluating a 
public health commissioned service. This case study was useful to commissioners and 
providers in understanding the successes of the smoking service and making 
recommendations to make the smoking service and the wider tobacco control system work 
better.  
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Chapter 6. Economic Evaluation of Alcohol Treatment Services 
6.1 Alcohol - Burden of Disease 
The second case study focused on alcohol treatment. It is important to acknowledge that the 
moderate consumption of alcohol can provide health and social benefits to individuals. For 
example there is some evidence that drinking small amounts of red wine can have health 
benefits in decreasing LDL cholesterol but the health benefits of alcohol have been hotly 
debated (Knott et al., 2015). The social benefits include the impact of alcohol in assisting 
people to relax and acting as a social lubricant. However when taken to excess either on 
individual occasions or on a continuous basis drinking alcohol can cause significant health 
and social problems as it may lead to financial problems, family problems and is also highly 
associated with crime and violence (WHO, 2014). Because most people in the UK are 
continuously exposed to alcohol, it follows that a high number of people will go on to become 
problem drinkers or be alcohol dependent.  
Alcohol related brain damage often manifests itself in the acute phase as Wernicke-
Korsakoff’s encephalopathy, where people do not record new memories. This is why testing 
for memory problems needs to happen where people are identified as having alcohol 
problems and a long drinking history. Rehabilitation for people with alcohol related brain 
damage is currently funded outside of the public health alcohol budget and is a lot more 
expensive than general rehabilitation for alcohol problems. Alcohol causes liver damage 
which is why liver function tests should be carried out in individuals who are identified as 
having a long drinking history (Williams et al., 2014). Giving people their liver function results 
can form part of a brief intervention in terms of demonstrating the impact of an individual’s 
drinking on their physiological markers. Wirral has a high rate of mortality from digestive 
diseases and liver diseases which are associated with alcohol, and it is a cause of the life 
expectancy gap between Wirral and England. 
Alcohol use has fluctuated, and is lower now than it was at the start of the 20th century 
(Plant & Plant, 2006). However, the average amount of alcohol per year drunk in England & 
Wales has increased from 5 litres per year in the 1950s to over 11 litres per year in 2007 
(Smith & Foxcroft, 2009). The alcohol market in the UK is subject to fewer restrictions than 
the tobacco industry as alcohol is still advertised and is heavily marketed.  
Societal harm in the UK from alcohol is estimated to include one million incidents of violent 
crime, over 100,000 cases of domestic abuse, and hundreds of deaths from drink driving. 
Alcohol causes acute health problems through intoxication, violence and injury and long-
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term health problems through liver and brain damage as well as other diseases. There were 
8,461 alcohol related deaths in the UK in 2013, which was 1.7% of deaths (ONS, 2015c). In 
2011, a sexual health needs assessment of young women in Wirral (aged 20 – 34 years) 
reported that alcohol was a factor in their failure to use condoms, putting them at risk of 
sexually transmitted infections and unplanned pregnancy.  
It is also important to acknowledge that excessive alcohol consumption would appear to be 
socially acceptable and even applauded in many societal groups (Measham, 2006). This 
implies that many individuals who consume 'excessive' quantities of alcohol on a regular 
basis never become known to alcohol services. Alcohol Concern (2010) estimated that to 
provide alcohol treatment services to even 15% of dependent drinkers would require at least 
doubling the current national expenditure on alcohol treatment. 
Measuring alcohol consumption is complicated by the fact that people consciously or 
unconsciously underestimate the actual amount of alcohol that they consume (Goddard, 
2001). Dependent drinkers are classified based on their level of addiction to alcohol, with 
dependency being characterized by craving, a preoccupation with alcohol, and continued 
drinking despite harmful consequences. Binge drinking is defined as females drinking six or 
more units in one session or males drinking eight or more units in one session (Drinkaware, 
2009). Increasing risk is analogous to the World Health Organisation (WHO) definition of 
hazardous drinking, while higher risk is analogous to their definition of harmful drinking (see 
Table 21). 
Table 21. Units per week for increasing risk and higher risk drinking. 
Units per week  Increasing risk  Higher risk  
Men  21-50  50+  
Women  14-35  35+  
 
Wirral has a higher proportion of dependent drinkers and increasing risk drinkers than 
national, but a slightly lower proportion of higher risk drinkers (see Table 22). The risk 
estimates are based on local modelled drinking behaviour data from the General Lifestyle 
Survey while the dependent drinker estimates are based on individual’s answers to the 
AUDIT and SADQ (Severity of Alcohol Dependence Questionnaire) in the Psychiatric 
Morbidity Survey Wirral had a lower proportion of abstainers than England as a whole. 
Qualitative evidence obtained in an ethnic minority needs assessment identified significant 
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alcohol misuse on Wirral amongst the Irish and Polish communities, with links to social 
isolation, poverty and mental health (Highton, 2014). 
There is some ‘prevention paradox’ in alcohol as ‘A large number of people at a small risk 
may give rise to more cases of disease than the small number who are at a high risk’ 
(Rossow & Romelsjö, 2006). Although dependent drinkers have a higher risk of injury, lower 
risk drinkers make up a larger proportion of the population, and hence a greater number of 
alcohol-related injuries come from lower risk drinkers. There is also some evidence for an 
‘alcohol harm paradox’ where people from affluent groups drink more alcohol overall than 
people from more deprived groups, yet suffer less alcohol-related harm, with protective 
factors like diet and income playing a mediating role (Smith & Foster, 2014). 
Table 22. Estimated proportion of adult population who are dependent, higher risk, and increasing 
risk). drinkers in Wirral, North West of England, and England, 2009. The first 4 columns add up to 
100%, while dependent and binge drinkers fall within increasing and higher risk drinkers. 
 % of total population aged 16+ in each alcohol risk category 
  Abstain Lower Increasing Higher Dependent1 Binge2 
North West 15.4% 62.2% 16.8% 5.6% 4.3% 23.3% 
England 16.5% 61.1% 16.7% 5.6% 3.8% 20.1% 
Wirral 13.7% 63.7% 17.1% 5.4% 4.5% 20.8% 
Wirral 
(numbers) 
35,846 166,178 44,544 14,195 11,760 54,238 
Source: NWPHO, modelled estimated based on general lifestyle survey 2009.  
http://www.lape.org.uk/downloads/alcoholestimates2011.pdf 
1  Data for 2008. 
2 Data for 2007-08 
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Figure 26. Estimated proportion of adult population who are dependent, higher risk, and 
increasing risk drinkers and abstainers in Wirral. Shown as if Wirral were 100 people. 
 
172 people per 100,000 of the working population in Wirral were claiming incapacity benefits 
with a main medical reason of ‘alcoholism’, significantly higher than the North West (153 per 
100,000) and England (93 per 100,000) (NOMIS, 2015). In 2009 a report identified an 
increase in drinking amongst women, middle- and older-age groups and an increase in 
alcohol consumption amongst very young adolescents (Smith & Foxcroft, 2009). However 
the most recent general lifestyle survey data has shown overall alcohol consumption falling 
in the population (see Figure 27). 
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Figure 27. Trend in proportion of men and women drinking alcohol, and drinking on more 
than 5 days in the last week, Great Britain. 
 
Source: General Lifestyle Survey - Office for National Statistics, 2012. 
 
The North West wellbeing survey (2009) included questions on alcohol consumption and 
found that 11% of people within Wirral were identified as being hazardous or harmful 
drinkers. Figure 28 and Figure 29 provide the comparative quality of life data collected for 
each alcohol group. Perhaps the most surprising result was that in general non-drinkers had 
lower EQ-5D scores than harmful drinkers however this may be because they are older or 
have given up alcohol because of ill health or previous alcohol dependency. The average 
mental wellbeing (SWEMWBS) scores were not hugely different between groups; female 
hazardous drinkers had the lowest wellbeing scores at 25.75 out of 35. 
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Figure 28. General Health Related Quality of Life (EQ-5D Index) scores from wellbeing 
survey 2009 by drinking category. 
 
Figure 29. Subjective Wellbeing (SWEMWBS) scores from wellbeing survey 2009 by 
drinking category. 
 
 
Nationally, deaths that were directly attributable to drugs and alcohol had fallen in men but 
increased in women from 2009 to 2011. For the five year time period 2007-2011 there were 
314 deaths in Wirral from alcohol specific causes, an average of 63 per year (Beynon et al., 
2013).  Of these 67.5% were male and 32.5% were female with an average age at death of 
53.and 88% of these alcohol related deaths being caused by liver disease. The Wirral ward 
areas with the highest numbers of deaths were those with the highest levels of social 
deprivation and alcohol-specific deaths correlated quite closely with deprivation, with an r2 
value of 0.783 (Figure 30). 
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Figure 30. Number of alcohol specific deaths vs. average IMD 2010 deprivation score for Wirral 
wards. Based on data from Beynon et al., 2013 matched with data from McClennan et al., 2011. 
 
A report by the National Confidential Enquiry into Patient Outcome and Death (NCEPOD, 
2013) found that many people who died from alcoholic liver disease were known to health 
agencies and opportunities had been missed to refer them to alcohol specialist services as 
three quarters had experienced a hospital admission in the 5 years before their death. In 
response the report recommended greater use of alcohol screening for all patients, including 
outpatients and A&E as well as those admitted to hospital. Alcohol as a risk factor was 
estimated to cause 121 deaths per year, and 3,291 years of life lost within Wirral (Möller et 
al., 2012). Within Wirral alcohol was estimated to be the fifth biggest cause of death, but the 
second biggest lifestyle-related cause of years of life lost, after smoking. This difference in 
effect is because alcohol causes more deaths at a younger age than other lifestyle risk 
factors. Alcohol was estimated to cause more than twice as many deaths in men than  
women.  
Data from Wirral’s Joint Strategic Needs Assessment (Highton, 2014) shows that 11% of 
crimes in Wirral were alcohol-related with a steep social gradient in crime rates between 
Birkenhead which had 160 alcohol-related crimes per 1000 population, to Clatterbridge 
which had 16 per 1000 population. The volume of alcohol-related violence decreased by 
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14.9% between 2008 and 2012 (from 687 to 608), however, the volume of alcohol-related 
domestic violence in Wirral increased by 14.9% over the same period (from 255 to 293 
offences). Alcohol-related sexual crime increased by 290% (10 - 39 offences).  
Alcohol-related hospital admissions are seen as a headline indicator is because they include 
admissions from across the population, from younger people who have drank too much and 
most often fallen over been involved in a fight, to people who been involved in traffic 
accidents, to older drinkers who have liver disease or alcohol related dementia from years of 
drinking. In this way alcohol admissions are seen as a useful barometer of how an area is 
progressing in tackling alcohol problems. In the last six years in Wirral, 1% of patients were 
responsible for 10% of alcohol related admissions, while 10% were responsible for 36% of 
alcohol related admissions with some patients having over 40 alcohol related admissions in 
a year. A multi-agency frequent attendees group tries to link frequent attendees into 
community services thus reducing their need to attend A&E. 
Alcohol related admissions are calculated using an alcohol attributable fraction (AAF), which 
is the proportion of a disease code that is estimated to be caused by alcohol (Jones et al., 
2008). This fraction varies by age and gender. So for ‘Mental and behavioural disorders due 
to use of alcohol’ the AAF is 1, that is the disease is completely caused by alcohol, whereas 
for males with hypertensive disease the average AAF is 0.27, so 27% of the disease is 
estimated to be related to alcohol intake whereas the rest is due to other causes, for 
example, genetic factors, smoking, and cholesterol. Therefore for every 100 admissions for 
hypertensive disease, 27 will be attributed to alcohol. For haemorrhagic stroke around 24% 
of admissions in males, but only 11% of admissions in females are recorded as being due to 
alcohol.  
 
Figure 31 shows the trend for the top 10 causes of alcohol-related admissions in Wirral. 
Cardiac arrhythmias (AAF=0.28) and hypertensive diseases (AAF=0.19) have increased 
between 2006 and 2012, while admissions for mental & behavioural disorders due to alcohol 
(AAF=1) have stayed quite flat over the time period. So the message from this is that while 
admissions that are directly attributable to alcohol have not increased, admissions from 
common health problems that are partly attributable to alcohol have increased, and this may 
be partly due to the population in Wirral getting older on average. During 2010/11, nearly a 
quarter of all re-admissions to Arrowe Park Hospital in Wirral were attributable to alcohol. 
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Figure 31. Trend in alcohol related admissions in Wirral, sum of alcohol attributable fractions (AAFs), 
2006/07 to 2011/12 financial year. 
Source: SUS Hospital Admissions Data. 
6.2 Alcohol – Available Interventions  
Wirral’s alcohol programmes were designed to cover the needs presented by the whole 
population, from giving advice to people about safe drinking limits, to helping people who are 
alcohol dependent and may also have severe mental health, criminal justice, social and drug 
problems. The main categories of alcohol services provided in Wirral were; 
 Marketing & Prevention - often focussed on young people, these aim to prevent 
young people from drinking before they are 18, and from drinking to excess. 
Sometimes people who are arrested for relatively minor alcohol related offences such 
as urinating in the street are given a chance to attend an education session rather 
than accept a caution. There are local marketing campaigns such as ‘Drink Aware’ 
that aim to highlight the risks of drinking alcohol. 
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 Screening and brief intervention – known as identification and brief advice (IBA) - this 
is a population level intervention which identifies people who drink more than the 
recommended units in one session or per week and giving them brief advice to try to 
make them drink at a safer level. Individuals are categorised using the AUDIT 
(Alcohol Use Disorders Identification Tool) – developed by the World Health 
Organisation to screen patients in primary care settings for hazardous or harmful 
drinking (Allen et al., 2001). The AUDIT has a high level of sensitivity and specificity 
and can accurately predict future alcohol related-harm, including illness, 
hospitalization and social problems (Roche & Freeman, 2004). Brief advice usually 
includes as a minimum a discussion around the adverse impacts of drinking, the 
supply of a worksheet, and possibly the development of a drinking agreement. A brief 
intervention takes between 5 and 15 minutes, however some literature considers 
brief interventions to be made up of more than one session with the client. This is 
typically aimed at reducing alcohol problems in people who are not dependent but it 
may be that dependent drinkers are identified through this too. 
 Services aimed at young people – including alcohol treatment, and services provided 
as part of health services in schools.  
 Specialist alcohol interventions – this includes specialist alcohol treatment which 
uses a range of psychosocial interventions and motivational techniques. These are 
often structured psychosocial interventions where individuals have regular meetings 
with their caseworkers and work towards a set of goals which usually include safe 
drinking or abstinence from alcohol. 
 Residential and community detoxification – this involves withdrawing an individual 
from alcohol and monitoring their health status, and often involves pharmacological 
interventions to reduce physiological withdrawal symptoms and reduce the risk of fits 
or tremors. There is also residential rehabilitation (rehab) where people spend a 
period of time, usually with other people who are recovering, to maintain their 
recovery from alcohol dependence in an environment where they are taken away 
from their environmental triggers which cause them to drink. 
 Criminal justice interventions – this involves people who have been arrested with 
alcohol being a factor in their arrest. In 2010/11 services engaged with 991 people as 
part of the alcohol intervention project (AIP), delivering a total of 1,962 sessions. In 
this project people arrested for alcohol-related crimes are given brief interventions in 
the cell or referred into alcohol treatment. These clients were 85% male; 25% of 
clients had committed an alcohol related violent offence, 44% a criminal damage or 
alcohol related disorder offence, and 31% some other type of alcohol related offence.  
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 Aftercare & Recovery – these are services for people who no longer drink alcohol 
hazardously to try to keep individuals on the path of recovery, by providing training to 
increase their skills, and employment opportunities as well as kinship and social 
activities to keep them occupied.  
Based on analysis by the author of data from PHE (2014b), in 2012/13 Wirral had 1,340 
people in contact with structured alcohol treatment, a crude rate of 5.13 per 1000 population, 
which was the 10th highest out of 152 areas in England (the highest was Blackpool with a 
rate of 7.75 per 1000). The average rate for England was 2.5 people per 1000 population. In 
comparison with other parts of Merseyside, Wirral had a higher rate than Knowsley (ranked 
12th), Halton (ranked 13th), Liverpool (ranked 16th), Sefton (ranked 24th), and St. Helens 
(ranked 53rd). This high rate indicates that Wirral has a high level of need for alcohol 
treatment and when compared with other areas, Wirral is being relatively successful in 
engaging with people and getting them into treatment. The rate for Wirral has fallen slightly 
over the last few years, partly because the estimated Wirral population which is the 
denominator for the rate has been adjusted upwards from around 305,000 to around 
320,000 in light of the results of the 2011 census. Figure 32 shows the relationship between 
different categories of alcohol expenditure. Shared care features as part of the services 
provided by CWP (which is accounted for under specialist alcohol treatment). There is also a 
frequent attendees intervention, which comes from existing budgets. This is a monthly care 
planning meeting where people from the hospital, alcohol services, housing and other 
relevant partners discuss clients who have been frequent attendees in hospital. There are 
other groups such as Alcoholics Anonymous which are voluntary groups that do not receive 
funding but play a part in helping people in recovery and stopping them from relapsing into 
alcohol problems. 
141 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
Figure 32. Spend on different elements of alcohol programme, shown with relationships between 
services.
 
Based on the UK Department of Health's alcohol needs assessment, 10% of dependent 
drinkers accessing treatment is considered a low level of access, while 15% is considered a 
medium level and 20% a high level of access (DH, 2005). Assuming that everyone in 
treatment is a dependent drinker, then in 2012/13 Wirral had an access level of 11.3%. The 
target number in treatment for Wirral of 1,777 equates to 15.1%. Using these criteria, to have 
a high level of access Wirral would need to have 2,352 people in treatment. It is important to 
note that there is a lot of uncertainty around the actual number of dependent drinkers in 
Wirral, so for instance the estimates for higher risk drinkers in Wirral (of which dependent 
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drinkers are a subset) have a 95% confidence interval of being between 2.3% and 20.5%, or 
between 1 in 40 of the population and 1 in 5 of the population. This would mean that the 
numbers in treatment needed to represent a high level of access could be anywhere 
between around 1,000 and 10,000 people. Looking at the ratio of high risk drinkers to people 
in treatment, the average for England is around 5.0% of high risk drinkers being in treatment, 
whereas for Wirral the figure is 9.6%, so this indicates that Wirral is performing quite well in 
getting people into treatment. 
Table 23. Numbers of people in alcohol treatment needed to achieve low, medium and high levels of 
access in Wirral. 
 
Number % of dependent 
drinkers 
Estimated number of dependent drinkers (2008) 11,760 100 
Number needed for low level of access 1,176 10 
Number needed for medium level of access 1,764 15 
Number needed for high level of access 2,352 20 
      
Target Numbers in treatment (2012/13) 1,777 15.1 
Actual Numbers in treatment (2012/13) 1,334 11.3 
 
Because many clients have concomitant drug and alcohol problems, it can be difficult to 
disaggregate some of the expenditure by client group particularly because many clients also 
have mental health problems (17% of opioid users in Wirral were also hazardous drinkers). 
The estimated total spent on alcohol interventions for Wirral in 2011/12 was around 
£3.3million. Wirral ranked 31st highest out of 151 PCT areas for spend on substance misuse 
in 2011/12. 
The services considered in this case study are the main specialist alcohol treatment service, 
and the residential detoxification services, these were chosen because together they make 
up the bulk of the alcohol spend in Wirral at around £2m per annum, and because they had 
the most rich client-level data.  
6.3 Background to Case Study 
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Throughout Europe, it has been estimated that the social costs of alcohol are between 1% 
and 3% of GDP (Klingemann & Gmel, 2001). Within the UK it has been estimated 
(Leontaridi, 2003)  that alcohol misuse costs the health service £1.7 billion per year ( 2001 
prices), while the costs associated with alcohol-related crime and anti-social behaviour were 
estimated at £7.3 billion, workplace costs of alcohol misuse were estimated at £6.4 billion 
per year through loss in productivity. Deaths from alcohol-related causes doubled in the 15 
years between 1992 and 2006 largely caused by an increase is deaths from alcoholic liver 
disease, which rose by 36% between 2001 and 2008. This increase in liver disease imposes 
significant costs on the health service with liver transplants costing between £60,000 and 
£80,000 per patient (van der Hilst et al., 2008). 
An update to the 2003 report (DH, 2008) estimated that the cost of alcohol harm to the NHS 
in England had risen to £2.7 billion in 2006/07 prices. The Government’s alcohol strategy 
(2012) estimated the total societal cost of alcohol (health, social problems, criminal justice 
and lost productivity costs) at £21billion, which without weighting the cost for deprivation 
would equated to a cost of £127million when applied to the population of Wirral (see Figure 
33).   
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Figure 33. Diagram showing costs and benefits associated with alcohol (taken from Leontaridi, 2003). 
 
 
The European Alcohol Strategy (adopted in 2006) outlined how alcohol was a cause of 7.4% 
of ill health and death in the EU, and particularly a cause of death in younger people, with 
alcohol also being implicated in one in four traffic accidents in the EU.  
In 2009 the World Health Organisation (WHO) produced Guidance on Action to Reduce 
Alcohol-Related Harm which had objectives around monitoring and disseminating evidence 
around alcohol harm and around partnership working. WHO (2009) estimate that alcohol 
misuse causes a greater number of disability adjusted life years (DALYs) lost globally than 
tobacco (see Figure 6), although these are skewed more towards middle- than high-income 
countries like the UK. 
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The Government’s alcohol strategy  (HM Government, 2012b) included policy measures 
such as considering a minimum unit price for alcohol in England and Wales, as well as 
increasing alcohol duty at 2% above retail inflation and changing the duty charged on ciders 
and beers to reflect their strengths. It encouraged greater use of brief interventions, 
specialised treatment for people dependent on alcohol, the use of alcohol liaison nurses 
within A&E and the inclusion of alcohol consumption as part of NHS health checks. The 
strategy provided greater powers for local areas to regulate the number of licensed premises 
in an area.  
Alcohol is big area of spend for Wirral and for public health teams in general, therefore is it 
important to determine whether services are cost effective. This case study did not cover all 
alcohol services provided within Wirral but concentrated on evaluating the cost effectiveness 
of alcohol identification and brief advice (IBA), alcohol treatment, including shared care, and 
residential detoxification. The aims and outcomes of the different services will vary unlike in 
smoking where services largely had a similar objective - a reduction in smoking behaviour. 
The analyses for alcohol services aimed to measure the impact of excessive drinking on the 
quality of life experienced by 'problem' drinkers. By evaluating quality of life using the EQ-5D  
outcome measure the outcome analysis could be framed in a cost-utility framework allowing 
calculations to be made of the cost per QALY (quality adjusted life year) derived for each 
service. All of the interventions analysed were essentially compared to a 'do nothing' 
alternative in which drinking behaviour was assumed to continue unaltered. A previous, 
mainly qualitative, evaluation (ciResearch, 2010) recommended that Wirral alcohol service 
reviewed their strategies for engaging with clients to maximise attendance. The research 
highlighted the existence of tensions within Wirral between medical and social approaches to 
therapy. This research also called for a greater degree of clarity around pathways of care. It 
was acknowledged that there existed a lot of choice with regard to patient pathways but that 
this heterogeneity of service provision meant that it could be hard for clients to navigate their 
way through the system. Services were generally well coordinated and successes in 
targeting services to 'hard to reach' clients such as homeless and street drinkers and people 
in criminal justice settings. However services needed to be better joined up, particularly 
between criminal justice settings and treatment. 
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6.4 Case Study 
6.4.1 Aim 
The aim of this case study was determine whether alcohol treatment interventions were 
successful in improving the health and wellbeing of individuals in treatment. In addition, the 
aim was to demonstrate how these economic modelling techniques and realist evaluation 
methodologies could be used to create a narrative that described the effectiveness of the 
interventions and the complex system in which they were embedded.  
6.4.2 Literature review 
A lot of evidence of what works for alcohol comes from US studies which are not always 
generalizable to UK settings, because the US has a different drinking culture, and because 
the most common models of alcohol treatment in the US are around achieving complete 
abstinence from alcohol whereas in the UK this is not always seen as the most important 
element of alcohol treatment. 
Despite alcohol interventions requiring a large proportion of public sector spending, there are 
comparatively few economic studies looking at the cost effectiveness of alcohol 
interventions. One reason for this lack of economic evidence may be that alcohol costs and 
outcomes fall across many different sectors, which greatly enhances the complexity of any 
analysis undertaken. Much information is self-reported and therefore may not be reliable as 
individuals may be unwilling to admit to any excesses in their drinking behaviour. Ideally a 
study would be able to match data from many different sources to accurately establish the 
client’s journey and any costs incurred across several sectors.  
Matrix and Health England’s 2008 research study (Matrix evidence & Bazian, 2008) around 
prioritisation for public health interventions examined various preventative health 
interventions, including alcohol brief interventions. They estimated, with strong certainty, the 
cost per QALY gained for alcohol brief intervention as being £4,507. They also estimated 
that in the longer term these interventions would be cost effective, and would potentially 
reduce health inequalities as problem drinking was 1.78 times more prevalent among routine 
and manual groups than the population as a whole. This cost per QALY ratio would be 
considered to be cost effective when compared to the NICE threshold of £20,000-£30,000 
per QALY gained. Matrix estimated that the total cost of rolling out this intervention nationally 
would be between £100million and £1billion, which is roughly between 0.1% and 1% of the 
total health budget for England. 
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An economic model estimated that a strategy of opportunistic screening and brief 
intervention would be cost saving to the NHS in the long term, with the optimum strategy 
being opportunistic screening i.e. screening at next GP consultation, followed by a five 
minute brief intervention carried out by the GP (Jackson et al., 2010). Increasing the number 
of people screened might only be of value if resources were available to provide more high 
intensity interventions, where screening indicates this to be necessary. The IBA data for 
Wirral indicated that only 0.2% of people screened are referred on to more intensive alcohol 
services. A tool created by the Department of Health’s National Support Team for health 
inequalities used data on mortality rates in heavy drinkers to estimate the impact of brief 
intervention on mortality rates (Cuijpers et al., 2004). For brief interventions the number 
needed to treat (NNT) to prevent one death was 402. So for Wirral, carrying out 5,596 brief 
interventions was estimated to prevent 14 deaths. 
A series of Value for Money Tools have been developed by the National Social Marketing 
Centre (NSMC) with a health economist, Professor Graham Lister, and data from NICE 
(Lister & Merritt, 2013). These allow local agencies to model the impact of public health 
interventions, including alcohol identification and brief advice.   
Table 24  shows the results from the NSMC Value for Money tool when applied to Wirral. 
The population gain from 19,332 brief interventions is estimated to be 90.5 QALYs based on 
the average QALY gained from an opportunistic 5 minute GP brief intervention which is 
estimated to produce a 0.5% change in individuals from heavy to moderate drinking after 
one year. The cost per QALY before is £3,644 which is similar to the estimate in Matrix’ 
study of £4,507 per QALY gained and similar to previous work carried out for Wirral which 
estimated a cost per QALY of £3,609 (not published). Overall the intervention is estimated to 
be cost saving to the NHS, with an investment of £329,743 producing a long term discounted 
net cost saving of £506,937 to the NHS.  
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Table 24. Results from NSMC Value for Money Tool, based on Wirral activity for 2011/12 
financial year and a 0.5% shift from heavy to moderate drinking. 
    Results  Health  Impact 
QALY 
Public Sector 
Services Cost 
Savings 
Net Cost to 
Public sector                
Net cost Per Health 
Gain        £/QALY 
Outcomes 90.49   £329,743 £3,644 
(between £3,280 
and £4,009) 
Cost Savings to NHS  
from Health Gain 
  £836,680 -£506,937 (i.e. 
Cost saving) 
Cost saving 
Cost savings to     Police 
and Other Criminal 
Justice Services 
  £216,754 -£810,978 (i.e. 
Cost saving) 
Cost saving 
Cost savings to    Social 
Care  
 £87,287 
Hospital Admissions 
averted (over the long 
term) 
112.73 
(between 
101.46 -
124.01) 
   
Total Deaths Averted 2.29 (between 
2.06 and 2.52) 
   
Total Years of Life 
Added 
26.10 (between 
23.5 and 28.7) 
   
 
One of the biggest UK economic studies of alcohol treatment was the UKATT trial (UKATT 
Research Team, 2005) which compared Motivational Enhancement Therapy (MET) with 
what was then a new technique, Social Behaviour and Network Therapy, (SBNT) in terms of 
their relative cost effectiveness. The study showed that SBNT was more cost-saving and 
less effective than MET but these differences were not statistically significant. NICE estimate 
that relapse rates for people in alcohol treatment are around 82-90% which is very high. In 
general the economic costs used in economic evaluations of alcohol services are lower than 
those in cost of illness studies, as an economic evaluation will assess alcohol-related crime 
in individuals in treatment while a cost of illness study will look at the proportion of crime that 
is alcohol-related. This is important from a policy perspective as it may imply that economic 
evaluations provide an underestimate of societal cost effectiveness (van Gils et al., 2010). A 
report (NTA, 2006) found that for every £1 spent on treatment, £5 is saved elsewhere 
(Heather et al., 2006). The Department of Health’s Guidance for Commissioners (2009) said 
that commissioning interventions for dependent drinkers in the average PCT (population 
350,000) – for every £583,464 invested, there would be a saving of £1,808,737 in return on 
the investment. This 3:1 ratio would equate to a saving of £6.8million from Wirral’s 
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investment of £2.2million. It also stated that for every additional £1m invested in alcohol 
interventions, 1,200 alcohol-related hospital admissions could be avoided. This report stated 
that interventions based on cognitive behavioural approaches have the best chance of 
success. 
6.4.3 Data sources 
Data was received from Wirral specialist alcohol treatment service and from the residential 
detoxification centre at Birchwood. This was provided in the form of Excel spreadsheets 
which had a line listing where each line represented one client who had used the service. 
For Birchwood residential detox data was provided for 673 admissions for 562 unique clients 
admitted in 2010/11 and 2011/12 financial years. For specialist alcohol treatment services, 
the data covered 1,234 clients referred in 2011/12 financial year. The data definitions are 
outlined in Appendix 5. Drug & Alcohol Treatment Data Definitions.  
The models were also populated with some data from the evidence where the data from the 
services was not sufficient to estimate outcome or probability parameters, or to estimate long 
term outcomes from short term surrogate outcomes.  
6.4.5 Methods 
Alcohol Treatment Services – Economic Modelling Methods 
 
The economic model was constructed by the author. For the main alcohol treatment 
services, an economic model was constructed to assess the clinical and cost effectiveness 
of services within Wirral in comparison to a 'watchful waiting' (i.e. no treatment) comparator. 
This model evaluated health outcomes over a one year period and was primarily based on 
data derived from the service. The input parameters for the decision tree model developed 
are shown in Table 25. Quality of life scores derived from the TOPs (Marsden et al., 2008) 
were used as a proxy for utility so for instance if the average score was 14 out of 20 then this 
would correspond to a utility score of 0.7. This has limitations in validity but has a strength in 
that it is based on actual data from individuals in the service. The model structure is shown 
in Figure 34. 
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Table 25. Model parameters for one year alcohol treatment model. 
Parameter Value Standard 
deviation 
for PSA 
Probability 
distribution 
for PSA 
Source 
Utility (dependent 
drinker) 
0.498 0.265 Beta Baseline TOPs quality of 
life (QoL) score from 
service data 
Utility (occasional 
drinker) 
0.701 0.224 Beta Follow up TOPs QoL 
score  from service data 
Utility (alcohol free) 0.786 0.195 Beta Follow up TOPs QoL 
score  from service data 
Cost of no treatment not included    
Cost of treatment £1,123 £229 Gamma Wirral finance data 
Spontaneous recovery 
rate 
0.2 not included not included Walters (2000) 
Recovery rate treatment 
(moving to occasional 
drinker) 
0.374 not included not included  
Recovery rate treatment 
(moving to alcohol free) 
0.238 not included not included  
Mortality rate (no 
treatment) 
0.05 not included not included Barbosa (2010) 
Mortality rate (treatment) 0.015 not included not included Service data 
Time horizon 1 year not 
applicable 
not applicable   
Discount rate None as only 
1 year time 
horizon 
not 
applicable 
not applicable   
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Figure 34. Structure of alcohol treatment decision tree model. # = the remainder of the 
probabilities on each branch. 
 
 
Alcohol Residential Detoxification - Economic Modelling Methods 
The economic model was constructed by the author. The Birchwood residential 
detoxification data was used to create a Markov chain model to estimate the cost 
effectiveness of residential detoxification at Birchwood compared with standard non-
residential care. The main input parameters of this model are provided in Table 26.  
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Table 26. Parameters for economic model for alcohol residential detoxification. 
Parameter Value 
Standard 
deviation 
for PSA 
Probability 
distribution 
for PSA 
Notes 
Successful treatment 0.89 0.02 normal Based on Birchwood service data 
Relapse rate 5 years 0.85 
not 
included 
not included Based on NICE Guidance CG115 
Relapse rate 1 years 0.379 0.06 normal 
Based on 5 year rate from CG115 
(SD based on SD for succcessful 
treatment)  
Spontaneous recovery rate 
or recovery rate in other 
alcohol services 
0.58 0.08 normal 
Based on treatment complete in 
alcohol services for Wirral 
QALY Utility score 
(dependent drinker) 
0.6349 0.299 normal 
Based on harmful drinker from 
UKATT trial (UKATT Research 
Team, 2005) 
QALY Utility score (safe 
drinker) 
0.8 0.26 normal 
Based on normal EQ-5D UK utility 
age 50-60 
Upfront cost of residential 
detoxification 
£946 £95 gamma Based on Wirral finance data 
Additional healthcare cost 
per year (dependent drinker) 
£1,800 £180 gamma 
Based on NICE Guidance CG115, 
assumed to include readmission 
to residential detoxification  
Mortality rate (dependent 
drinker) 
0.09 
+(0.01 
per 
year) 
not 
included 
not included Based on Barbosa (2010) 
Mortality rate (ex-dependent 
drinker) 
0.0215 
+(0.01 
per 
year) 
not 
included 
not included Based on Barbosa (2010) 
Discount Rate 
3.5% 
Per 
annum 
not 
included 
not included 
This is the UK standard discount 
rate from the Treasury green 
book. 
Time horizon 
50 
years 
not 
applicable 
not 
applicable 
This was a time horizon by the 
end of which almost all of the 
cohort in the model will have died. 
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Figure 35. Structure of Markov economic model for alcohol residential detoxification. # = 1 
minus sum of other probabilities.  
 
The Markov model for residential detoxification assumed that a person exists in one of a set 
of mutually exclusive states - dependent drinker, safe drinker, and death. Each person has a 
probability of moving from one state to another for every year over the 50 year time horizon 
of the model-in effect a lifetime analysis as after this period nearly all clients would be dead. 
All people in the model started off as dependent drinkers, then in each cycle they would 
either remain as dependent drinkers, move to being ‘safe drinkers’, (this includes people 
who are abstinent), or would die. Costs and outcomes which occurred in the future were 
discounted at 3.5% per annum. Going through residential detoxification is assumed to 
reduce an individual’s chance of spending the following year as a dependent drinker, but the 
high relapse rate would mean that people would have a high chance of moving between 
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groups. This makes intuitive sense as we know from the evidence that people with alcohol 
problems often go through several cycles of relapse and recovery.  
6.4.6 Results  
Specialist Alcohol Treatment Services – Economic Model Results 
 
Specialist alcohol treatment services in Wirral included pharmacological interventions, 
motivational interventions, cognitive behavioural therapy and psychosocial interventions. The 
data provided covered referrals from April 2011 to January 2013 and included 1890 unique 
clients, and 2304 referrals in total. Self-referrals had a slightly higher completion rate which 
may indicate that these individuals are better motivated to change on average than 
individuals that have been referred by other parties. Overall men made up around two thirds 
of clients and the biggest age group was between 40 and 50 (Figure 36). Compared to 
national treatment data, Wirral has a greater proportion of clients aged 60 and over, and a 
lower proportion of clients aged under 25. 
Figure 36. Proportion of specialist alcohol treatment clients by age and gender, 2011/12 FY. 
 
Programme completion rates were similar for males and females. In terms of age, 20-24 
year olds had the lowest completion rates, while there seemed to be two distinct groups, with 
completion rates around 56-58% for 25-50 year olds then 64-67% for 50-70 year olds. 
Overall alcohol completion rates were similar to national rates (57% for 2011/12).  
Table 27. Proportion of specialist alcohol treatment clients completing the treatment programme by 
age and gender, 2011/12 FY. 
Age group Female Male Total 
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
14.0%
16.0%
18.0%
20.0%
18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
% of  
all clients 
Age Group 
Male Female
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18-19 100% 33% 60% 
20-24 27% 38% 32% 
25-29 46% 58% 56% 
30-34 56% 54% 54% 
35-39 59% 56% 57% 
40-44 58% 58% 58% 
45-49 58% 55% 56% 
50-54 72% 64% 67% 
55-59 53% 68% 64% 
60-64 63% 70% 67% 
65-69 60% 69% 66% 
70-74 75% 47% 52% 
75+ 64% 43% 50% 
Total 59% 58% 58% 
 
The majority of clients with AUDIT scores were identified as being either dependent (77% of 
clients) or higher risk drinkers (4%). The proportion of clients in each severity category did 
not differ significantly by age or gender. Clients did not have full postcodes so could not be 
accurately matched to deprivation groups. However based on the partial postcodes it is 
estimated that just over half of clients were from the 20% most deprived areas nationally 
(which contain 32% of the Wirral population). This indicates that people in the more deprived 
areas are more likely to be in alcohol treatment (Figure 37). 
Figure 37. Proportion of specialist alcohol treatment clients by deprivation category, 2011/12. 
 
Employment status was recorded for 17.3% of clients. Of these, the majority were 
unemployed. There were 46 clients who were recorded as being in employment.  
Table 28 shows the number of clients by type of intervention and proportion that had 
completed treatment as of January 2013. The most common treatment modality was other 
structured intervention followed by psychosocial interventions and brief interventions. 16.2% 
of clients (200 clients) were recorded as being under shared care. Most clients (83%) had 
one treatment modality, although 6.7% of clients had 2 or more modalities recorded. 
18% 
15% 
67% 
least deprived
most deprived
partly deprived
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Table 28. Number of clients by type of intervention & setting with proportion having treatment 
completed as of January 2013, 2011/12 FY. Specialist alcohol treatment clients 
Intervention Number of clients % of referrals Treatment completed % Average 
N 
contacts 
per 
client 
Average 
days in 
treatment 
Brief intervention 238 19.3% 55.9% 2.7 24 
Prescribing 13 1.1% 30.8% 32.4 174 
Other structured 887 71.9% 65.5% 8.3 94 
Pharmacological intervention 5 0.4% 20.0% 17.2 300 
Psychosocial intervention 51 4.1% 19.6% 26.0 335 
Recovery support 3 0.2% 0.0% 28.7   
All interventions 1,109 89.9% 58.3% 7.5 73 
      Shared Care 200 16.2% 50.5% 10.0 91 
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Clients with dual diagnosis (meaning a concurrent mental health problem as well as alcohol 
dependence) were, perhaps surprisingly, slightly more likely to complete treatment than 
those without; 64.5% of dual diagnosis clients from 2011/12 completed treatment. Clients 
with concurrent other drug problems were much less likely to complete treatment however, 
with only 20.0% of clients completing treatment. So from a realist evaluation point of view, 
having concurrent drugs problems is a context that makes people less likely to successfully 
complete alcohol treatment.  
Treatment Outcome Profiles (TOPs) are outcome tools that were developed by the NTA 
(National Treatment Agency) in England (Marsden et al., 2008). These are typically collected 
for drug users in treatment, but are collected for people in alcohol treatment too. There has 
previously been a UK target around 85% people in drug treatment having TOPs completed, 
but no equivalent target for alcohol. In alcohol treatment there is not a current consensus 
around which outcome measures are most important. For clients with before and after TOPs, 
there was a statistically significant improvement in all of the outcome measures; drinking  
days reduced by 64%, daily units reduced by 74%, self-assessed physical health increased 
by 38%, psychological health by 51%, and quality of life increased by 52%. Unfortunately 
there does not seem to be a current gold standard for converting TOPs to a summary utility 
score like that derived from the EQ-5D which is the current gold standard questionnaire for 
calculating QALYs. Because before and after TOPs was only recorded for around a quarter 
of clients, it is not clear whether these are representative of the rest of clients or may just 
represent the success stories, with other clients having dropped out or not benefitted as 
much from treatment. Most importantly, because TOPs is self-reported there is a lot of 
uncertainty around reliability, as clients may be trying to meet the expectations of service 
providers, and in the case of drug treatment clients often have other outcomes contingent on 
this, so for instance would not admit to continuing heroin use if they are receiving 
methadone. Table 29 shows changes in TOPs outcomes for specialist alcohol treatment 
clients in Wirral. For this analysis 95% trimmed averages are provided because some 
extreme values skewed the data. 
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Table 29. Specialist alcohol treatment clients. TOPs outcomes as of January 2013, 2011/12 
FY. 95% Trimmed averages. 
 Outcome  Initial Discharge Most recent  
(where most recent is 
not initial or discharge) 
Number with TOPs recorded 839 (76%) 276 (25%) 104 
Alcohol drinking days (per 28 
days) 
20.3 7.4 14.3 
Average daily units 25.0 6.4 12.9 
Estimated weekly units 126.9 11.7 45.9 
Average physical health status 10.4 14.4 11.3 
Average psychological health 
status 
9.6 14.6 11.0 
Average Quality of Life 10.0 15.1 11.9 
 
The most common treatment outcome was treatment completed – occasional user, which 
indicates that not all clients become completely abstinent from alcohol. The definitions of 
completing treatment come from the service rather from the clients so it may be that some 
clients who drop out have actually conquered their alcohol problems themselves but do not 
feel they want to have continuing contact with the service. 
Table 30. Treatment outcomes for Specialist alcohol treatment clients, 2011/12. 
Treatment Outcome N 
% of 
total 
Treatment completed - occasional user (not heroin or 
crack) 
430 37.4% 
Treatment completed - alcohol-free 283 23.2% 
Incomplete - dropped out 202 15.9% 
Incomplete - treatment commencement declined by client 135 10.0% 
Treatment Declined by Client 56 4.1% 
(blank) 48 3.7% 
Did Not Attend Any Appointment 19 1.2% 
Incomplete - Client Died 15 1.3% 
Transferred - in custody 15 1.0% 
Other 31 2.2% 
Total 1234 100.0% 
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There were 1,109 clients who were recorded as having alcohol interventions in 2011/12. The 
total spent on CWP specialist alcohol treatment services for 2011/12 was £1,245,176 which 
works out as £1,123 per client or £153 per contact. The cost per completer was £1,729. 
Many clients will use several services i.e. detoxification, aftercare etc., and it is not possible 
to match up all clients across the patient journey with current data so the total average cost 
per client will be higher than this. 
The deterministic model estimated that over a one year period people in alcohol treatment 
programmes experienced on average 0.13 QALYs more in comparison to those not in 
treatment programmes. Applying this average to the total number of patients referred to 
CWP in 2011/12 equates to an estimated additional 160.42 QALYs gained in this population. 
Given the total cost of service provision (£1,245,176) this provides an estimated cost per 
QALY of £7,761. Such a figure can be interpreted as being highly cost effective when 
compared to the quoted willingness to pay threshold used by NICE of £20,000 to £30,000 
per QALY gained (Rawlins et al., 2010). This model represents a short term approximation 
of the costs and benefits that would be likely to arise from effective multi agency 
interventions to reduce alcohol abuse. The development of the model is continuing to 
improve the data sources and to extend the time line with a view to enhancing the accuracy 
of the analysis undertaken. If the perspective of the analysis was widened to take into a 
broader perspective then the service may produce a greater return on investment through 
reduced crime, antisocial behaviour and indirect health and social care spending.  
Probabilistic Sensitivity Analysis – Alcohol Treatment 
 
A probabilistic sensitivity analysis (PSA) was carried out to see how sensitive the model 
results were to uncertainties in the input parameters. Because the model included costs of 
treatment only, the net costs were always positive. Figure 38 shows a scatterplot of 10,000 
iterations of the model where each iteration was drawn randomly from the probability density 
functions. It is clear that for most iterations, the benefits are positive, but for some the 
benefits are negative. Figure 39 shows the cost effectiveness acceptability curve (CEAC) 
which shows that alcohol treatment has a probability of 53% of being cost effective where 
willingness to pay is £10,000 per QALY gained, and a probability of 69% at £20,000 per 
QALY gained. Overall the results of the PSA indicate some uncertainty around the cost 
effectiveness of the service based on this model. In a set of 1-way sensitivity analyses 
shown in a tornado diagram, the net mean benefit based on a willingness to pay of £30,000 
per QALY was particularly sensitive to uncertainty around the utility values, and less 
sensitive to uncertainty around the cost per client (Figure 40). 
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Table 31. Results of probabilistic economic model with 95% confidence intervals. 
 One year horizon 
 Treatment  No treatment 
Total cost (CI) £1,266,368 (£817,469-£1,817,375) 
 
0 (0-0) 
Total QALYs (CI) 0.64 (0.36-89) 0.52 (0.16-0.87) 
Cost per patient (CI) £1,149 (£737-£1,639) 0 (0-0) 
Cost per completer (CI) £1,776 (£1,147-£2,549) 0(0-0) 
Cost per QALY (CI) £9,301 (£1,261-£29,774) 
 
 
 
Figure 38. Specialist alcohol treatment model, iterations of incremental cost effectiveness, 
with ellipse showing 95% prediction intervals. 
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Figure 39. Cost effectiveness acceptability curve, alcohol specialist treatment showing 
probability of alcohol treatment being cost effective vs probability of no treatment being cost 
effective at different values of willingness to pay for one QALY. 
 
Figure 40. Tornado diagram showing one way sensitivity analyses for alcohol specialist treatment. 
EV= expected value of net mean benefits. 
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Alcohol Residential Detoxification - Economic Model Results 
Birchwood residential detoxification was provided by ARCH initiatives, who offered a 
residential detoxification service for people with drug and alcohol problems, with intensive 
one-to-one advice, medical and therapeutic support, life skills sessions and alternative 
therapies. They also prescribed benzodiazepines and anticonvulsant drugs alongside 
vitamin supplements where appropriate. Evidence from the US suggests that outcomes for 
residential detoxification and community detoxification are similar (Hayashida et al., 1989). 
Outpatient withdrawal allows people to access more social support from their families or to 
potentially carry on with job or family commitments. Inpatient detoxification is more 
appropriate where someone has severe side effects of withdrawal, does not have social 
support, or has other health problems that need to be monitored. Outpatient detoxification 
can be less expensive and time consuming than inpatient detoxification (Parrott et al., 
2006b). The data was provided for 673 admissions for 562 unique clients admitted in 
2010/11 and 2011/12 financial years (see Table 32). Based on the alcohol performance 
report for 2011/12, there were 296 people from Wirral who entered Birchwood, of whom 88% 
(260) had a planned discharge. 
Table 32. Proportion of alcohol residential detoxification clients by age group and gender, 
2011/12. 
Age Group Female Male Total 
16-24 0% 1% 1% 
25-39 13% 21% 34% 
40-54 21% 28% 49% 
55-64 5% 8% 13% 
65+ 1% 1% 2% 
Total 41% 59% 100% 
 
Nearly 90% of clients completed treatment in Birchwood as alcohol free (see Table 33). 
Females had a slightly higher rate of completing treatment than males (93% in women vs. 
86% in men). The average number of days in Birchwood for all clients was 7.7 days. For 
clients who completed, the average was 8.3 days. The average age was similar for 
completers and non-completers. 
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Table 33. Alcohol Residential Detoxification - Treatment outcomes with average age and 
average number of days. 
Outcome N 
clients 
% of 
clients 
Average 
Age  
Average Number 
of Days in 
Birchwood 
Treatment Complete - Alcohol 
Free 
332 88.77% 43.4 8.33 
Dropped out 23 6.15% 44.0 2.83 
Treatment Withdrawn by provider 13 3.48% 41.0 3.23 
Treatment commencement 
declined by client 
4 1.07% 48.0 1.00 
Transferred - not in custody 2 0.53% 62.5 3.00 
 Total 374 100.00% 43.5 7.71 
 
As part of the economic evaluation, hospital admissions data was analysed to determine 
whether being admitted to Birchwood was associated with a reduction in alcohol related 
admissions after discharge from Birchwood (see Table 34). This data is for inpatient 
admissions and does not include A&E presentations or outpatient appointments. This data 
includes diagnosis codes which are regarded as having an alcohol attributable fraction and 
codes that are regarded as being alcohol specific. This hospital admissions data was 
matched up to Birchwood data using a matching algorithm and approximately 60% of clients 
were matched up to at least one hospital admission. Each client had an average of 6.5 
admissions over the five years analysed providing an estimate of an average of 1.2 
admissions per year. The total cost of hospital admissions for these clients across six years 
was estimated as being approximately £1.5million, based on the HRG tariff costs for the 
hospital admissions which are recorded in the admission tables. 
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Table 34. Alcohol related hospital admissions in Wirral for alcohol residential detoxification 
clients. 
Outcome Year of admission to alcohol 
residential detoxification 
2010/11 2011/12 
Number of clients with hospital admissions 168 209 
Total unique Birchwood clients within year 273 352 
% of clients with hospital admissions 62% 59% 
Total hospital admissions Apr 2006-Aug 2012 1127 1301 
Average admissions per client with any admissions 6.7 6.2 
Average number of admissions per year 1.24 1.15 
 
For patients admitted to Birchwood in 2010/11 and/or 2011/12 the most common alcohol-
related diagnoses for their history of hospital admissions were mental and behavioural 
disorders due to alcohol which accounted for 71% of admissions (see Table 35). 
Table 35. Alcohol related conditions for hospital admissions for alcohol residential detoxification 
clients. 
Alcohol related condition Number of 
admissions 
Mental and behavioural disorders due to use of alcohol 1445 
Ethanol poisoning 204 
Alcoholic liver disease 110 
Alcoholic gastritis 59 
Hypertensive diseases 39 
Epilepsy and Status epilepticus 32 
Assault 25 
Intentional self-harm/Event of undetermined intent 23 
Fall injuries 20 
Chronic pancreatitis (alcohol induced) 15 
Cardiac arrhythmias 14 
Acute and chronic pancreatitis 7 
Other 31 
Total  2024 
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The average number of hospital admissions for Birchwood clients appeared to tail off in the 
year after they were admitted to Birchwood, which indicates that admission to Birchwood 
may be successful in preventing future hospital admissions. However it is possible that 
clients were experiencing a time of crisis during which they were more likely to be admitted 
to hospital and have since overcome this crisis and have shown regression to the mean. 
There is a spike in the average number of hospital admissions around the time of admission 
to Birchwood which is not surprising as many clients are admitted straight to Birchwood from 
hospital. Admissions also appear to show a slight but insignificant downward trend after 
admission to Birchwood.  
A Markov chain economic model was constructed as described in the methods section of 
this chapter. The budget for Birchwood alcohol residential detoxification was £280,000 for 
2011/12. There were 296 clients of whom 260 completed successfully. The cost per client 
was £946 and the cost per completer was £1,077. The results of the economic model are 
shown in Table 36. 
Residential detoxification resulted in a modest increase in the average number of quality 
adjusted life years (QALYs) experienced (0.09 QALYs gained or around 1 month of quality 
adjusted life expectancy), and a decrease of £653 in discounted costs incurred over the next 
50 years. These results mean that residential detoxification is a dominant strategy, i.e. in the 
long term it is cheaper and more effective than the alternative. As a rough rule of thumb, if 
dependent drinkers cost an additional £1800 per year in healthcare costs, and if Birchwood 
residential detoxification costs £946 per client, then if residential detoxification can stop 
someone being a dependent drinker for six months it will pay for itself in offset healthcare 
costs. 
Probabilistic Sensitivity Analysis – Alcohol Residential Detox 
 
A probabilistic sensitivity analysis (PSA) was carried out to see how sensitive the model 
results were to uncertainties in the input parameters. Because relapse and mortality rates 
were high, and quality of life for dependent drinkers was low, the total number of discounted 
QALYs experienced was low despite the model being a lifetime Markov model. In the base 
case scenario, residential detox was less costly and more effective than treatment as usual 
without residential detox, so was the dominant option (Table 38). However both scenarios 
tended towards the same maximum QALY expectancy, and as willingness to pay for one 
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QALY increased, the no residential detox option becomes slightly more likely to be cost 
effective but is still dominated by the residential detox option (Figure 42). Overall the PSA 
suggested that the detoxification treatment may only present marginal benefits when 
compared to other treatment. 
Table 36. Results of probabilistic economic model with 95% confidence intervals. 
  Life time horizon  
  Treatment  No treatment 
Total cost (CI) 
£829,231 (£710,498-
£955,507) 
£850,978 (£728,581-
£981,148) 
Total QALYs (CI) 0.801 (0.173 -1.420) 0.780 (0.124 - 1.420) 
Cost per patient 
(CI) 
£2,801 (£2,400 - £3,228) £2,875 (£2,461 - £3,315) 
Cost per 
completer (CI) 
£3,189 (2,733 - £3,675) £3,273 (£2,802-£3,774) 
Cost per QALY 
(CI) 
£8,744 (-£9,812 to £27,548) 
£9,469 (-£9,766 to 
£28,991) 
ICER Dominant Dominated 
167 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
Figure 41. Alcohol residential detoxification, iterations of incremental cost effectiveness, with 
ellipse showing 95% prediction intervals. 
 
Figure 42. Cost effectiveness acceptability curve for alcohol residential detoxification 
showing probability of alcohol detoxification being cost effective vs no detoxification being 
cost effective at different values of willingness to pay for one QALY. 
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Figure 43. Alcohol residential detox. Tornado diagram showing one way sensitivity analyses. 
EV= expected value of net mean benefits. 
 
Alcohol Services – Realist Evaluation 
One table was produced for all services in terms of alcohol context-mechanism-outcome 
configurations. In a search for previous realist evaluations of alcohol services, one PhD 
thesis with several presentations was found (Doi, 2012) which was a realist evaluation of 
midwives providing alcohol screening and brief interventions to pregnant women. This found 
that the impact of the intervention was limited by midwives’ levels of confidence in asking 
questions about alcohol, competing clinical priorities, low numbers of women eligible for a 
brief intervention, and women providing socially desirable responses (i.e. saying that they 
did not drink alcohol when in fact they did). Hunter and colleagues (2012) used realist 
synthesis methods (a form of qualitative systematic review) to synthesize data from a 
sample of drug and alcohol related programmes in Australia to determine the barriers and 
facilitators in implementing these programmes. 
Holmes & colleagues (2014) outlined a 'Transparent Reporting of Alcohol Intervention 
ContExts' (TRAICE) checklist for reporting the policy contexts of alcohol interventions. This 
says that any research around alcohol policy interventions should report (i) baseline alcohol 
consumption, norms and harm rates; (ii) baseline affordability and availability; (iii) social, 
microeconomic and demographic contexts; (iv) macroeconomic context; (v) market context; 
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and (vi) wider policy, political and media context. This is a useful way of thinking about 
alcohol interventions where context is important, for example a lot of the evidence for alcohol 
interventions comes from the US which has a different drinking culture than the UK, and the 
price of alcohol varies a lot between countries; Scandinavian countries typically have very 
high alcohol duties (Anderson et al., 2009). 
The alcohol CMO configurations are shown in Table 37. These were worked through from 
talking to service providers, commissioners and some service users as well as looking 
through evidence and policy documents. 
Table 37. Alcohol Context-Mechanism-Outcome Table. SC= source of information is local service 
commissioner, SM= source of information is service managers. 
Group Context Mechanisms Outcome 
General 
Population 
Drinking excess alcohol is 
a mainstay of British 
culture, and working class 
culture in particular. Many 
people in the general 
population drink too much 
and are at increased risk 
(Williams et al., 2014). 
Alcohol screening and brief 
intervention makes people realise 
that they may be harming their 
health by drinking too much 
(Dhital et al., 2015) 
A proportion of people 
move from hazardous to 
safe levels of drinking. 
There is an increase in 
knowledge about safe 
levels of alcohol 
consumption, particularly in 
Wirral where there has 
been in excess of 50,000 
screenings carried out in 
the last ten years (Dhital et 
al., 2015) 
General 
Population 
Alcohol has got cheaper in 
supermarkets and off 
licenses while getting more 
expensive in bars and 
clubs (Gill et al., 2015). 
People on low incomes who want 
to drink alcohol cannot always 
afford to drink regularly outside of 
the home (SC). 
More people are drinking at 
home. This leads to an 
increase in the risk of 
domestic violence in some 
cases (SM). 
Dependent 
Drinkers 
Alcohol dependence 
affects around 4-8% of the 
population. It is one of the 
most common substance 
use disorders because 
most people in the 
population are exposed to 
alcohol and it is easy for 
harmful drinking to go 
undetected. A proportion of 
young hazardous drinkers 
become dependent 
drinkers in middle age, with 
adverse life events, 
relationship breakdown, 
and unemployment being 
risk factors (Shield et al., 
2014). 
Pharmacological treatments like 
Librium reduce the short term 
symptoms of withdrawal. 
Psychosocial interventions allow 
people to explore and confront the 
causes of their alcohol use. CBT-
based interventions help people to 
change their behaviour and 
understand what their triggers are. 
Shared care with GPs gives 
general practitioners easy access 
to services and detoxification. 
Residential detoxification allows 
people to dry out under controlled 
conditions (Shield et al., 2014). 
Some dependent drinkers 
move into controlled 
drinking or being abstinent. 
Some will not complete 
treatment or will relapse. 
Alcohol is a fixture of culture 
and is more omnipresent 
than other drugs so can be 
harder to give up.  
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Young people The culture around alcohol 
in young people is 
changing. There are more 
interventions around pubs 
and off sales to reduce 
alcohol sales to young 
people. 
Because youth unemployment is 
high, young people are more 
competitive in terms of 
performance in schools, university 
and the jobs market. This has 
made drinking excess alcohol less 
of a priority for them. Also 
because of the proliferation of 
smart phones, young people are 
scared of having their drunken 
behaviour shared on social media 
and being ‘cybershamed’. 
Young people are drinking 
less alcohol. Getting drunk 
is becoming less of a rite of 
passage for young people.  
Young women Young women in their 20s 
are more likely to not be in 
relationships, and are often 
outperforming young men 
in the jobs market so they 
are likely to have more 
money and more freedom. 
Women in their 20s are going out 
socialising more. 
Women in their 20s are 
drinking greater amounts of 
alcohol and are suffering 
increasing amounts of liver 
damage. 
 
6.4.7 Discussion 
The modelling suggested that, even using quite a narrow set of outcomes, the specialist 
alcohol treatment services are likely to be cost effective. For identification and brief advice 
(IBA), the estimated lifetime cost per QALY (quality adjusted life year) gained was £3,644. 
For specialist alcohol services provided by CWP, 1 year cost per QALY gained was £7,761 
and clients showed a significant improvement in all outcomes collected, such as fewer 
drinking days, and better physical & psychological health. For Birchwood residential 
detoxification, a lifetime model estimated that services produced a net increase in QALYs at 
a reduced cost, meaning the service was more effective and cheaper than a ‘do nothing’ 
alternative. This work had strengths in that it used local, individual level data which gave it a 
good deal of internal validity. A weakness of this work was that it used before and after 
rather than control group comparison, and that it did not consider all of the wider social value 
associated with people moving from being a dependent drinker to be in recovery. However 
the before and after analysis found a pattern of positive change on several variables, which 
is more evidence for the change being real.   
This evaluation found that the conversion rate from screening to brief intervention, and to 
referral into services is lower than would be expected given the estimated prevalence of 
alcohol problems in the population and recommended that services should increase the 
number of men screened. The evaluation recommended that treatment services should 
collect more long term follow-up data to know how people fare in the long term after being 
discharged from alcohol treatment. It also recommended that services needed to engage 
more with young people, as the evidence suggests there are a lot of people in their 20s who 
are problem drinkers but numbers in treatment are low in comparison. The evaluation noted 
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that services only seem to cater for dependent drinkers and recommended that some kind of 
intermediate service may be needed for hazardous drinkers for whom a brief intervention is 
not enough. 
Out of the results from this piece of work, the result that was most powerful was the finding 
that going through residential detoxification did not seem to reduce subsequent hospital 
admissions. The evaluation did put several caveats around this finding, such as that the data 
matching process used was not ideal; and that with some clients it may be that, as they have 
conquered their alcohol problems, other health problems have come to the surface, so they 
are still likely to have hospital admissions. However if the continued hospital activity was due 
to underlying health problems, you would expect more outpatient appointments and elective 
(planned) admissions rather than a continuing pattern of mainly emergency, alcohol-related 
admissions. There may also be issues with how hospital admissions are coded; coding is not 
an exact science and people’s past hospital admission codes are often appended onto their 
subsequent admission diagnosis codes, so if someone has previously been admitted for liver 
disease and is subsequently admitted for skin cancer, the primary code may be skin cancer 
but there may still be a secondary code of liver disease which would result in the admission 
coding as alcohol-related. Overall, there is debate for whether people should go from 
detoxification into aftercare or into treatment services. This evaluation recommended that in 
future some comparison could be made between residential and community detoxification.  
6.4.8 Conclusion 
This analysis in general supported the cost effectiveness of alcohol services provided in 
Wirral. This work had direct policy relevance as it was used to influence the development of 
new contracts for alcohol services, which were put out to tender around six months after this 
programme of work was completed. Because the analysis indicated that residential 
detoxification may not prevent hospital admissions, this prompted more investigation and 
more data collection. It highlighted the importance of clarity concerning service objectives as 
residential detoxification may be a lifesaving safety net for the small proportion of highly 
dependent drinkers who end up there. This analysis was universally perceived as being a 
valuable contribution to policymaking as it established the parameters around which 
contracts were established and helped to determine which outcomes were considered most 
important in the future.  
This analysis reinforced the importance of alcohol as a lifestyle risk factor in Wirral, having a 
high cost to the local economy in terms of health, crime and lost productivity. The local 
authority has since taken a greater interest in using its licensing powers and is piloting a 
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‘Reducing the Strength’ intervention where off licenses are asked to voluntarily stop selling 
high strength lager and cider which is typically consumed by dependent street drinkers and 
young people.  
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Chapter 7. Economic Evaluation of Drug Treatment Services 
This third set of case studies provided the opportunity to apply a mixed methods approach to 
evaluation using a combination of mutually supportive qualitative and quantitative techniques 
to comprehensively assess a complex intervention in a complex system. This chapter has 
tried to integrate the data analysis with the qualitative results obtained though undertaking 
detailed semi structured interviews with commissioners, providers, and current and ex- 
service users. As with tobacco and alcohol, the main outcome for this analysis was cost per 
QALY (quality adjusted life year), known as cost utility analysis (CUA). Modelling the cost 
effectiveness of interventions for addictive behaviours is complicated by the fact that service 
users experience cycles of relapse and recovery. It is also difficult to model the productivity 
gains as many people experience chaotic lifestyles that perhaps are not suited to paid 
employment (Smith & Riach, 2014). The analysis therefore largely concentrates on the 
extent to which service provision contributes towards an improved quality of life, reduced risk 
of dying and reduced resource use in terms of health, social care and the criminal justice 
system. 
A great deal of national evidence has been produced concerning the cost effectiveness and 
economic impact of drug treatment. So the focus of this analysis largely concentrated on 
how drug treatment worked at a local level in Wirral. To what extent did such local services 
perform similarly to the evidence, outperformed the evidence, or performed less well than 
the evidence would predict. 
7.1 Drugs - Burden of Disease 
Problematic drug use is estimated to affect 0.8% of the adult population in England, or 1 in 
125 people. About a third of the UK population admit to taking drugs at some stage in their 
lives (Home Office, 2013), most commonly cannabis, but few people go on to develop 
problems. Between 2011 and 2012, an estimated 8.9% of adults in the UK used an illegal 
drug which increases to 19.3% for young people aged between 16 and 24. There are an 
estimated 299,000 heroin and crack cocaine users in England, and in prisons 40% of people 
have used heroin at some point in their lives. It is estimated that 1.2 million adults are 
significantly affected by a family member’s illegal drug use. Drug use often follows a 
sequence, where people generally move from beer or wine, to cigarettes and/or spirits, to 
cannabis, and then to other illegal drugs (Kandel, 1975). For the majority of casual users 
little harm is done however some people become addicted leading to the potential for being 
criminalised, feeling ostracised or isolated from family or society, financial hardship, physical 
and mental ill health, prison, and potentially a very early death from overdose or the serious 
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adverse health effects resulting from long term drug abuse. The drugs trade also damages 
communities in the countries where drugs are made, such as heroin in Afghanistan, cocaine 
in Peru, and sassafras oil for ecstasy in Burma and Cambodia as well as communities in 
areas where illegal drug use is endemic (Mannava et al., 2013). Problematic drug use is 
more common in countries with greater income inequality, and is more common in deprived 
communities within countries (Wilkinson & Pickett, 2009). Conflict theory (Currie, 1993) 
hypothesises that heroin and crack use are concentrated in urban areas, where lack of 
economic opportunities leads to community feelings of powerlessness and alienation and a 
breakdown of communities and families.  
Many drug users are second or third generation drug users; one person working in drug 
treatment in Wirral talked about people "whose mum bought you a bag of smack for your 
16th birthday". For problematic drug users, their drug use is characterised by dependence 
and addiction, where drug taking behaviour becomes unconscious or compulsive and 
usually causes harm or is risky. In Wirral and other deprived areas in the north of England, 
drug use became a big problem in the early 1980s with a boom in brown heroin use 
following the onset of high unemployment. In Wirral some people started using heroin who 
had previously been injecting Diconal, a drug which had been prescribed by many Wirral 
GPs in the late 1970s (Parker et al., 1998). Many people had also been using and injecting 
amphetamine. Drug use is mainly spread by micro diffusion which is person to person 
contact. Drug users will often want to reinforce their own behaviour, so involving other 
acquaintances in their behaviour makes them feel like what they are doing is more socially 
acceptable. Drug users can often get into debt with their dealers and have to work for them 
to pay back their debt, becoming their dealer’s “foot soldiers”. In Wirral it was estimated that 
the number of new heroin users peaked in 1985 at about 1,400 while the total number of 
users peaked in 1988 at around 4,000 users (Parker et al., 1998, see Figure 44). It is not 
clear to what extent the prevalence of heroin use is driven by the cost and availability of the 
drug, the social acceptability of it, the ratio of pleasurable effects to side effects, and the 
quality of social ties & employment and the amount of social capital in the population.  
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Figure 44. Model of the initial Wirral heroin outbreak, showing numbers of new users and total users, 
1979-1992. 
 
From Home Office (1998) New Heroin Outbreaks Amongst Young People in England and Wales (Parker et al., 
1998). 
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In 1983, crime rates in Merseyside were increasing rapidly and it was estimated that around 
1 in 10 young people were using heroin (Parker et al., 1988). Burglary in Wirral increased 
from 2,824 in 1979 to 10,238 in 1986 and 50% of people arrested for burglary were opiate 
users. The UK heroin market was centred on Merseyside with a small number of individuals 
and families controlling the business; this also brought an increase in gun crime which was 
damaging to the economy and to people's perceptions of community safety (Bennett & 
Holloway, 2004). In Wirral there was a burglary epidemic caused by heroin addicts, some of 
whom had previous criminal ‘deviant careers’, while some were driven by ‘economic 
necessity’ (Parker & Newcombe, 1987). Merseyside was also where the public health 
response began; Liverpool had the first needle exchange in 1986 and methadone 
prescribing programmes were introduced across Merseyside in the late 1980s (Ashton & 
Seymour, 2010). This approach is now used around the world so this is an example of 
‘bottom up’ policy making. Harm reduction interventions are still a source of debate, such as 
whether it is a good idea to give drug users naloxone (an opiate antagonist) to counteract 
the effects of opiate overdose and save lives, or whether it will encourage more risky 
behaviour which would counteract the benefits. A study in the US suggested that naloxone 
did not promote more risky behaviour but did save lives (Maxwell et al., 2006). Another 
intervention is to have supervised heroin injections for the 5-10% of opiate users who cannot 
stop injecting heroin, however this can be costly compared to oral methadone and may also 
be politically unpalatable (Byford et al., 2013). Most addicted clients in Wirral were on long 
term oral methadone, although Wirral also prescribed heroin for a very small number of long 
term users. 
Crack cocaine took off in the US in the late 1970s and was first noticed by UK drug 
treatment services in 1989. Use of crack increased as evidenced by a 74% increase in UK 
seizures of crack cocaine between 2000 and 2006. With crack cocaine there is no 
substitution therapy and nearly all crack users smoke it so do not need needle exchange 
services. Crack use is also associated with acquisitive crime, drug dealing, begging and 
prostitution as people become more dependent and need to make money quickly, as some 
users spend as much as £400 a day on crack. In Wirral most crack users are also opiate 
users; often using heroin to deal with the comedowns from crack highs which are particularly 
unpleasant.   
Drug use often leads to dependence and an early death for many users. But the main 
reason so much investment was put into drug treatment services was not to improve the 
lives of drug users. It was to reduce crime, and to reduce the risk of infectious disease 
outbreaks that may spill over into the non-drug using population. One of the successes of 
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the harm reduction approach in areas like Wirral was that because of needle & syringe 
exchange services they avoided the type of large scale HIV outbreak that was seen in other 
areas like Edinburgh in the 1980s (Robertson et al., 1986), and is seen in places like Russia 
now (Eaton et al., 1998). 
There is a lack of local data about levels of drug use for individuals who are not in services 
as questions about drug use are often not included in local adult lifestyle surveys due to 
ethical considerations and issues around reliability of responses. Figure 45 and Figure 46 
provide estimates of drug use in Wirral based on data from the Crime Survey for England 
and Wales (Home Office, 2013) applied to the Wirral population. There are obvious 
limitations with this method but it may be useful for a ‘ballpark’ figure. The most widely used 
drugs are cannabis, nitrous oxide [laughing gas or ‘balloons’] and powder cocaine.  
Figure 45. Estimated number of people using selected drugs in Wirral.  
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Figure 46. Estimated numbers using any drugs in Wirral  
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Figure 47. Estimated number of opiate & crack users, and injectors, Wirral 2010/11. From Hay et al., 
2010. 
 
Figure 48. Estimated prevalence rate of opiate & crack users, and injectors, Wirral, North West & 
England, 2010/11. From Hay et al., 2010. 
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In Wirral, the number of people in drug treatment has fallen slightly since 2007, while the 
number of successful completions has increased. For Wirral, 41 (1.7%) clients in 2012/13 
accessed residential rehabilitation facilities which is slightly lower than the national average 
of 2.1%. It may well be that because good alternatives are provided in the community, clients 
are less likely to require residential care. 
Table 38. Numbers of people in drug treatment and completions, Wirral, 2005/06 to 2012/13. 
Data from historic performance reports for Wirral.  
Variable / Year > 2005 
/06 
2006 
/07 
2007 
/08 
2008 
/09 
2009 
/10 
2010 
/11 
2011 
/12 
2012 
/13 
Successful Completions 66 133 245 249 319 374 380 404 
Treatment complete drug free (opiates) 
[measured since 2011/12] 
      288 150 
Numbers in Effective Treatment 2399 2526 2640 2578 2448 2377 2355 2242 
Numbers In Treatment 2497 2667 2753 2714 2530 2461 2468 2363 
Waiting Times < 3 Weeks 247 443 600 716 666 639 749 683 
Percent of Waits < 3 Weeks 81 90 93 98 97 99 99 99 
 
In terms of time in treatment, Wirral has a comparatively high proportion of clients who have 
been in treatment for more than 6 years and for less than 1 year when compared with a 
cluster of similar areas. Approximately 50% of clients have a drug taking career of over 21 
years. This data highlights the barriers to getting people to stop their drug use completely, as 
many have been using drugs for their entire adult life. The picture for Wirral is of an older 
treatment population who have been in treatment for a long time and have a long drug taking 
career. These individuals find it hard to leave treatment but when they do leave, are likely to 
maintain their recovery. 
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Figure 49. Proportion of drug population in treatment by years in treatment, Wirral vs. 
cluster, 2010/11 to 2012/13. From NTA (2013). 
 
Figure 50. Proportion of drug population by length of drug taking career, Wirral vs. cluster, 
2010/11 to 2012/13. From NTA (2013). 
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Figure 51. Treatment naïve clients by length of stay, Wirral vs. cluster, 2010/11 to 2012/13. 
From NTA (2013). 
 
Figure 52. Completion rate by time in drug treatment, Wirral vs. cluster, 2010/11 to 2012/13. 
From NTA (2013). 
 
In terms of complexity of drug problems, Wirral is below the national average  for most 
complexity indicators, which indicates a high number of people who are relatively stable in 
their drug behaviour. 
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Figure 53. Prevalence of complexity indicators for individuals in drug treatment, Wirral vs. 
national 2012/13. From NTA (2013). 
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The spread of blood borne viruses is a risk in the drug using population, as viruses can be 
spread through sharing needles and also drug users are more likely to work as commercial 
sex workers or to engage in risky sexual behaviour. Blood borne viruses can also potentially 
be spread by sharing crack smoking equipment or by snorting cocaine with the same bank 
note or key as someone else. The blood borne viruses that drug users are most at risk from 
are HIV, hepatitis B and hepatitis C. Hepatitis B is much more infectious than hepatitis C but 
hep C has no vaccine available. Hepatitis C was not really known about until 1989 with a test 
developed in 1990. Hep C is around 10 times more infectious than HIV, so it is a lot more 
prevalent than HIV in the drug using population. 
Hepatitis C infection in the general population is estimated to be 0.67% (Harris et al., 2011). 
According to estimates from the Health Protection Agency (HPA), Wirral has a prevalence of 
46% of injecting drug users having hepatitis C so around 70 times greater than the general 
population (HPA, 2012). However there is a lot of uncertainty around this estimate, with 95% 
credible intervals of anywhere between 20% and 70% prevalence. This estimate means that 
Wirral was categorised as being a medium prevalence area for hepatitis C virus in injecting 
drug users (medium is where prevalence is between 40% and 60%, low is where prevalence 
is less than 40% and high is where prevalence is above 60%). This indicates that most long 
term injectors are likely to have hep C antibodies but that most new injectors most likely do 
not have hep C. Local testing data suggests that prevalence of hepatitis C in drug users who 
have been tested was likely to be around 31%, compared with 64% across the North West. 
Hepatitis B prevalence was around 1.5% compared with 29% across the North West. Spread 
of HIV through injecting drug use was estimated to be low in Wirral, with around 3% of 138 
people living with HIV in Wirral having contracted the virus through sharing needles. The fact 
that Wirral has lower prevalence of blood borne viruses than their neighbours can be seen 
as indications of the success of the harm reduction model, which involves educating drug 
users, and providing needle and syringe exchanges and other drug treatment interventions. 
In some places like Edinburgh and Dundee, HIV rates in IDUs were much higher (Davies et 
al., 1999). 
Nationally the prevalence of hepatitis B in people surveyed who inject drugs fell from around 
60% in the early 1990s to around 45% in 2013, and hepatitis C from around 42% to around 
16% in 2013 (PHE, 2013). HIV rates in drug users have fluctuated between 1 and 1.5% 
(though are around 4 times higher in London) but are much lower than most other European 
countries (Latkin et al., 2001). Nationally there were two spikes of increased HIV 
transmission, one in the mid 1980s when heroin and HIV first took off and little was known 
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about HIV, and one in around 2005 which was probably associated with the crack cocaine 
outbreak (Harris et al., 2011) 
Drug policy in the UK is led by the Home Office. Drug treatment strategy was previously led 
and monitored nationally by the NTA (National Treatment Agency for Substance Misuse) 
which was formed in 2001, which from 2013 was moved to Public Health England. From 
2013, local drug and alcohol services now fall under Local Authority Public Health teams. 
The UK Government’s drug strategy was published in 2010 (HM Government, 2010b) and 
focuses on recovery rather than harm reduction. The government have stated that recovery 
is based on three principles; wellbeing, citizenship and freedom from dependence. For 
heroin users, having long term treatment with methadone or other substitution drugs is now 
out of favour, and getting clients to be in a position where they abstain completely is now the 
desired outcome. This means that clients who have been prescribed methadone for several 
years and have been stable are facing renewed attempts to get them totally drug free. The 
government have developed funding models that incentivise the best outcomes for both 
individuals in treatment and wider society by using a Payment by Results (PbR) approach 
with the risk that by focussing entirely on outcomes that providers are paid for this can have 
an effect of 'crowding out' other important outcomes or added value of services. A recent 
international review of pay for performance suggested that paying for processes rather than 
outcomes could hold more promise (Hull & Ritter, 2014). 
Because Wirral has one of the oldest drug using populations, it is one of the first areas 
where people in long term drug treatment are starting to die in great numbers from chronic 
diseases. Wirral was a pioneer in harm reduction and getting heroin addicts to stabilise their 
lives, and reduce their levels of crime and risky behaviour (Ashton & Seymour, 2010). 
Although services would always want clients to ultimately recover and become abstinent, it 
may be difficult for clients who have been stable (some interviewees used the word ‘parked’) 
on methadone for over 10 years. Some staff from services in Wirral who were interviewed for 
this evaluation said that recovery was not always possible with some clients whose drug use 
had become entrenched, and that for these clients some small victories like moving them 
from injecting to smoking heroin should be recognised. Certain experts have pushed more 
for abstinence-based recovery rather than offering people harm reduction or maintenance 
(Gyngell, 2011) whilst others have argued that drugs should be decriminalised or regulated 
(Transform Drug Policy Foundation, 2009) as this would bring in tax revenue and reduce the 
risks associated with drugs  being contaminated with adulterants. In Portugal drug use has 
been largely decriminalised and the most dangerous drug use has fallen. Conversely making 
drugs illegal may actually increase their attraction as in the case of ketamine where the 
186 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
numbers of people using the drug increased after it was made illegal in 2006. In August 
2013 the Chief Medical Officer for England said that drugs are a medical problem that 
society is choosing to treat as a criminal justice issue (Press Association, 2013). Drug policy 
is a very controversial area of policy and in 2009 the UK Government sacked Professor 
David Nutt who was the chair of their own Advisory Council on the Misuse of Drugs (ACMD) 
after a string of disagreements on the relative risks of cannabis, ecstasy and other drugs. 
Wirral ranked 143rd out of 149 local authorities for premature mortality from liver disease 
(data for 2009-11) and a rate of alcohol-related deaths that is 80% higher than the national 
average (PHE, 2014a). A report looking at drug related deaths (Beynon et al., 2013) found 
that nationally, deaths that were directly attributable to drugs and alcohol had fallen in men 
but increased in women from 2009 to 2011. In Cheshire and Merseyside the number of older 
drug users (defined as aged 40 and over) in drug treatment has increased from 750 in 1998 
to 6,500 in 2010/2011 so there are a lot more older clients than there used to be and 
therefore a lot more clients who have a higher risk of death (NTA, 2013). 
There were 95 people recorded in the NDTMS system as being in contact with a Wirral-
based service and confirmed dead over the 8 years between 2003/04 and 2011/12; 75 men 
and 20 women. Most had been in contact with treatment for over 5 years. The median age of 
death was 44.25 so quite a lot lower than normal life expectancy of 77 for males and 80.8 for 
females in Wirral. This is higher than the average age for drug related deaths of 28 years in 
1992 and 35 years in 2000 which indicated a lot more people were dying of drug overdoses 
rather than longer term damage in these years. 81 of the deaths from 2003-2012 were non-
drug related, though 13 were from alcohol-related liver damage and 14 were from cancer 
and 15 from respiratory disease, many of which were likely related to smoking. This 
highlights that drug users have a competing set of causes of death, so while the drug use 
may be brought under control, alcohol and smoking are still common causes of early deaths, 
and having a body that is already damaged by years of drug abuse makes individuals more 
vulnerable to other diseases. Long term opiate substitution use has been linked with heart 
problems, particularly the drug LAAM (Levacetylmethadol) which was withdrawn from the 
market in 2001 (Wieneke et al., 2009). Oral methadone typically contains a lot of sugar so 
people on high doses are at risk of diabetes, but this is complicated by the fact that people 
who are opiate addicts generally prefer sweet tasting food as it activates similar reward 
mechanisms in the brain (Colantuoni et al., 2002). Because people who are ill are most often 
transferred to the care of the Harm Reduction Unit, services who were interviewed reported 
that people in Wirral are probably more likely than people in other parts of the country to be 
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classed as in treatment when they die. The Harm Reduction Unit provides palliative (end of 
life) care to very sick clients and encourages continued engagement with services. 
Table 39. Deaths recorded for current or former drug treatment clients in Wirral, 2003/04 – 
2011/12. Data from Beynon et al. (2013). 
Cause of death  Number  %  
Certain infectious and parasitic 
diseases  
8  9.9  
Neoplasm  14  17.3  
Diseases of the circulatory system  12  14.8  
Diseases of the respiratory system  15  18.5  
Diseases of the digestive system  18  22.2  
Other  4  4.8  
Codes for special purposes  2  2.5  
External causes of morbidity and 
mortality  
8  9.9  
 
Local Data on Drugs and Crime 
The majority of available data on drugs and crime was short term performance type data 
rather than longer term strategic intelligence. Crime has fallen in Wirral since the crime wave 
in the 1980s that was directly associated with the heroin outbreak, with crime peaking in 
1996 and in 2003/04 (Figure 54). In the mid-1980s, it was reported that around 50% of 
people arrested for burglary in Wirral were opiate users (Parker et al., 1988). The volume of 
acquisitive crime, particularly burglaries, is caused by an interaction between the number of 
people with criminal careers, individual need to commit crime (such as to fund drug use or to 
pay off debts) and the ease at which objects can be acquired and subsequently sold on. The 
number of craved items that can be easily stolen and sold on has increased in recent years 
with many people having laptops, portable music players, vehicle satellite navigation 
systems ("sat navs") and tablet computers, but at the same time the resale value of other 
items like DVD players and televisions has decreased (Yapp, 2010). 
Deposited syringes, street dealing, crack houses, aggressive begging, and public drug use 
are examples of antisocial behaviour associated with drug use. Although alcohol is related to 
violent crime (Toomey et al., 2012), the relationship between drugs and violent crime is less 
established. The theory of the pharmacological effects of drug use causing violence is widely 
disputed, but violence around disputes between drug dealers or violence to accompany 
crime such as robberies is more common (Nutt et al., 2010). In Wirral the police believe 
there is evidence for a link between cocaine use and violence in the night time economy; 
however it is difficult to unpick because there are common causal factors for cocaine use 
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and violence and much of the observed affect may be because cocaine use allows people to 
drink a lot more alcohol. Gun crime is rare in Wirral, with 13 in 2011/12 and 4 in 2012/13, 
and knife crime is lower in Wirral than in other parts of the country with 52 incidents in the 
year from September 2012 to August 2013, which was 31% lower than the year before 
(ONS, 2015d). 
Before 1988, very few cases of possession of controlled drugs were recorded in crime 
figures so there was a big increase in drug-related crime post 1988. There have been other 
changes to crime recording over the last 20 years which may affect the figures. The age of 
criminal responsibility was reduced from 14 to 10 in 1998. Cannabis has been reclassified 
from class B to class C and back to class B again which has had an impact on enforcement. 
There was previously a National Indicator around drug-related crime (NI38: To achieve a 
reduction in the rate of Class A drug related offending over the 12 month period (18 years 
and over)) which might have changed policing priorities when it was removed. 
Figure 54. Annual trend in all crimes per 1000 people, Wirral. Annual data for 1979-1998. 
Financial year data for 199/2000 to 2012/13. No data for 2005-06 or 2006/07. From Home 
Office (2015). 
 
Drug offences in Wirral have fluctuated with drug trafficking offences falling between 2003 
and 2007 to around 110 per year, then reaching a higher average of around 225 per year 
since 2008. Since a sharp increase in 2005, drug possession offences have numbered 
around 1300 per year. Other parts of the country did not see a similar increase between 
2004 and 2005 and it was reportedly due to a change in policing emphasis around drug-
related offending in Wirral. In terms of acquisitive crime, domestic burglary has fallen more 
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downward trend, falling by around two thirds from 354 between in 2002/03 to 111 in 2012/13 
while theft from the person has fallen by around three quarters from 407 in 2003/04 to 95 in 
2012/13 (Home Office, 2015). These big improvements in rates of acquisitive crime could be 
partly attributed to the response to the drug epidemic (Ashton & Seymour, 2010). 
Figure 55. Trend in theft and drug offences, Wirral, 2002/03 – 2012/13. Police recorded 
crime data. Data from Home Office (2015). 
 
Criminal behaviour is recorded with drug treatment clients as an outcome in the Treatment 
Outcome Profiles (TOPs) although it is unclear how reliable this is as it is self-reported. In 
general ARCH dealt with drug clients who were actively committing crime. For example if a 
client being seen by the CWP Drug Service was arrested once, they would be kept under 
CWP but if they were arrested twice, they would be transferred to ARCH services, at least 
until they are felt to be less of a risk for criminal behaviour. ARCH services use the 
Integrated Offender Management (IOM) framework which is known in Wirral as Compass.  
This approach encompasses; 
 Prolific and Other Priority Offenders (PPO) – these are repeat offenders who are 
typically committing a high volume of crime in their communities. 
 Multi Agency Public Protection Arrangements (MAPPA) – these are typically sexual, 
violent or other dangerous offenders who have been released from prison.  
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 Multi Agency Risk Assessment Conferences (MARAC) – these are regular local 
meetings where information about high risk domestic abuse victims (those at risk of 
murder or serious harm) is shared between local agencies. 
 Drug Interventions Programme (DIP) – these are people who have been arrested 
and tested positive for drugs on arrest, many of whom are given a drug rehabilitation 
requirement (DRR) where they will enter drug treatment for six months. 
 Deter Young Offender (DYO) – this is scheme for young offenders who have been 
assessed as posing the highest risk of causing serious harm to others and having a 
high probability of re-offending  
CWP services also work within these frameworks and attend the MARACs. There are also 
probation interventions and 'Through the Gate' which is a mentor-led intervention for people 
who have served short prison sentences. In Wirral there is more of a focus on challenging 
drug users on their offences, and having a partnership response, focusing on the individuals, 
the families and the community rather than just the individual.  
7.2 Drug Treatment – Available Interventions  
Most guidelines and guidance documents for drug treatment do not provide rigid protocols; 
rather they recommend broad treatment modalities. This means that local providers have an 
opportunity to tailor treatments to local populations, but this provides a risk that local 
interpretation might miss out the crucial elements of a theory that make a treatment work. 
The main guidance document used by drug treatment providers in England is the NTA’s 
Models of Care for Treatment of Adult Drug Misusers: Update 2006 (DH/NTA, 2006). This 
recommended that drug services should have integrated care pathways and should consider 
including;  
 Harm reduction interventions  
 Community prescribing interventions (GP prescribing and specialist prescribing)  
 Structured day programmes 
 Structured psychosocial interventions 
 Other structured treatment 
 Inpatient drug treatment 
 Residential rehabilitation 
 Aftercare 
There is also ‘Drug Misuse and Dependence: UK Guidelines on Clinical Management’ which 
was published by the Department of Health in 2007 (DH, 2007). 
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‘Commissioning for Recovery’ (NTA, 2010) reinforced the shift in focus of drug treatment to 
recovery, and reintegrating drug users into society, for example through working more 
closely with housing providers and employers. This document has a set of checklists for drug 
commissioners to check that they are meeting the NTA’s competencies in commissioning 
services and using the best evidence and intelligence. 
NICE recommend that drug treatment includes brief advice, and for opioid users include 
maintenance with methadone and buprenorphine (in general the evidence suggests that 
methadone works better than buprenorphine for keeping people in treatment). For drug 
users NICE recommend considering formal psychosocial interventions such as behavioural 
couples therapy (where couples have a ‘recovery contract’ where they assist in individuals 
becoming drug-free), cognitive behavioural therapy (where dysfunctional emotions, 
maladaptive behaviours and cognitive processes are targeted to achieve specific goals), 
psychodynamic therapy (which has its roots in Freudian psychoanalysis and focuses on 
unconscious thoughts, and people’s negative expectations of the response they get from 
others), and contingency management (where clients are given stepped rewards for positive 
behaviours like reducing drug use or getting tested for blood borne viruses) (Connock et al., 
2007). 
The average cost per person in effective treatment in Wirral was £2,171 in 2012/13 which 
compares favourably with other areas (from local data). This does not include all spend on 
drugs as there was some additional money which came from Wirral Council. In the last nine 
years the highest number of people in treatment was in 2005/06.  
Table 40. Funding and numbers in effective treatment, Wirral, 2004/05 to 2012/13. 
  2004/05 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 
Adult Pooled Treatment 
Budget (£) 
1,704,000 
2,273,903 
+ 
565,912- 
DIP 
3,010,591 
+ 
614,860- 
DIP 
3,356,491 
+ 533,240 
- DIP 
3,503,490 
+ 
533,240- 
DIP 
3,978,411 
+ 
533,240- 
DIP 
4,427,558 
+ 533,240 
DIP 
4,285,799 
+ 
506,578- 
DIP 
4,366,217 
+ 
491,721- 
DIP 
Local funding (£) 
0 
85,000- 
ROB 
52,000- 
SSCF 
132,000- 
PSG 
60,000- 
ROB 
61,526- 
SSCF 
132,923- 
PSG 
138,795- 
PSG 
105,000- 
PSG 
127,747- 
PSG 
 
0 
 
0 0 
Total funding (£) 1,704,000 6,033,630 3,879,900 4,028,526 4,141,730 4,639,398 4,960,798 4,792,377 4,857,938 
Number of adults in effective  
treatment 
2950 3145 2559 2676 2602 2448 2400 2355 2237 
Total treatment funding per 
adult in effective treatment 
(£) 
577 1,918 1,516 1,505 1,591 1,895 2,066 2,034 2,171 
DIP= Drug Interventions Programme. ROB = Restrictions on Bail. SSCF = Safer & Stronger Communities 
Funding. PSG = Partnership Support Grant 
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Wirral commissioned specialist drug treatment services from CWP, needle & syringe 
exchange from CWP, and Daycare, Aftercare and criminal justice services from ARCH. 
There are also engagement services from Phoenix, residential rehabilitation from Phoenix 
House, housing projects with Forum Housing, women’s project coordination, and Hep C 
nurse specialist and substance misuse liaison nurse from WUTH. There are some residential 
recovery services that are commissioned or spot purchased. There is Intuitive Recovery 
which is a recovery programme which changes clients’ perceptions of themselves as addicts 
and teaches them that they have a choice. Wirral also commission community drugs 
engagement services from the Social Partnership, 1 to 1 community rehabilitation from the 
Independence Initiative, the intensive day recovery SHARP programme from Action on 
Addiction, and SPIDER which is an abstinence-based self-help rehabilitation programme. 
There are also back to work and mentoring services from The Social Partnership and Wirral 
Council for Voluntary Services.   
Wirral commission alcohol prevention, assessment and education work which is delivered in 
schools by Response. There is also peer education delivered by young volunteers 
commissioned through Connexions. Young people aged 17-21 are trained to deliver these 
educational and prevention messages to young people aged around 14. Because the age 
gap between the two groups is not that big, these peer-delivered messages are felt to have 
more relevance and are structured in a way to appeal more to young people than messages 
delivered by a teacher or other older adult. 
There was also a school drugs adviser, who worked both proactively and reactively in 
schools, and there was a drugs policy document which was given to schools. In the four year 
gap since the last school drugs adviser post, schools had dealt with drug-related incidents 
either through Response or through the police, or have developed processes and policies 
themselves within the ethos of the school. The Department for Education (2012) and the 
Association for Chief Police Officers (ACPO) have produced drug advice for schools. There 
are other services delivered in the voluntary sector like Fellowship services (Narcotics 
Anonymous and others). Clients and people working in services believed that Fellowship has 
a role to play but is not for everyone. The spend breakdown is shown in Table 41. The 
figures do not include all management or evaluation costs, or police crime and disorder 
spend, or national spend by agencies like the NTA or Public Health England. 
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Table 41. Breakdown of Wirral drugs budget, 2012/13 financial year. 
Category Total 
Structured Community Based Drug Treatment 
Interventions 
£3,765,377 
Residential drug treatment £548,569 
Harm reduction £411,549 
Commissioning £393,881 
DIP / Drugs and crime £303,902 
Open access interventions £299,599 
Drug information & advice £161,679 
Back to work and mentoring £140,640 
User involvement £58,106 
Training £38,030 
Dispensing costs £1,068,000 
Prescription costs £591,047 
Total £7,780,380 
Source: Wirral council finance. 
People in drug treatment services are often prescribed substitute opiates; mainly methadone 
and buprenorphine [subutex or known to clients as ‘subbies’]. Methadone (methadone 
maintenance treatment) is prescribed in liquid form and is initially supervised, where the 
client will come to the service or to a pharmacy once a day and take their dose of 
methadone in front of a worker. Both methadone and buprenorphine have the capacity to be 
abused by being injected, and both have the capacity to be sold or passed on to other 
people. Services in Wirral did not generally prescribe Suboxone, which is a mixture of 
buprenorphine and naloxone which has less abuse potential as it does not produce a high 
when injected (although can still be insufflated [snorted] to produce a high). The Harm 
Reduction Unit in Wirral has started giving some users prophylactic naloxone, which can be 
used to reverse the effects of an opiate overdose. They encourage people in the case of 
overdose to administer naloxone, call 999 and stay with the person until they are handed 
over to paramedics. Anecdotally two people have been revived from overdose so far, 
although it not possible to be sure what would have happened without naloxone. Wirral also 
prescribes morphine and diamorphine [heroin] in some cases where clients had been 
transferred from other services and were stable on these drugs. Other drugs such as 
antidepressants, antipsychotics, anticonvulsants, ADHD drugs, and benzodiazepines (which 
are anti-anxiety or sleeping tablets) were also prescribed for people in drug treatment. The 
amount of sugar in methadone is a risk for dental problems, and methadone also causes dry 
mouth which can lead to plaque formation, so oral health monitoring is important.   The drug 
dispensing costs were high at £1,068,000 for the year because of a high number of clients 
who require supervised consumption, i.e. they have to drink their methadone dose while the 
pharmacist is watching to ensure it is not diverted. Table 42 shows the number of items and 
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spend on schedule 2 drugs like morphine and methadone, and schedule 3 drugs like 
buprenorphine for Wirral. 
Table 42. Number and cost of items prescribed by community drugs teams and shared care, 
Wirral 2012/13 FY (Data from Wirral Clinical Commissioning Group Medicines Management 
Team, 2013).  
BNF Name  Number 
of Items  
Actual Cost  
Schedule 2 controlled drug 39,505 £465,018 
Schedule 2 controlled drug – 
Injections 
1,462 £58,428 
Schedule 3 controlled drug 3,226 £65,994 
 Total 42,731 £531,012 
 
CWP Services 
At the time of writing this, Cheshire & Wirral Partnership NHS Foundation Trust (CWP) was 
the main provider of drug and alcohol treatment services for Wirral. Previously alcohol and 
drug treatment was separate, however now CWP reported that they had integrated teams. 
This change mainly involved ‘skilling up’ alcohol workers to also deal with drug clients 
through training and shadowing. CWP provide outreach and engagement, harm reduction, 
syringe exchange, detoxification, structured drug treatment and services targeted at 
vulnerable people, commercial sex workers, pregnant women, people with severe mental 
health problems, people with personality disorders, younger clients, and prescription drug 
users. They also have a hepatitis B nurse and staff who work with homeless and hostel 
dwellers. They work to support people who are at risk of being made to leave hostels due to 
their challenging behaviour. In 2013 a separate evaluation of the homelessness nurse was 
carried out which found that this service was cost effective (Collins, 2013b). CWP have a 
member of staff who deals with service veterans who may have picked up drug habits when 
stationed abroad or have drug use that is associated with post-traumatic stress disorder 
(PTSD). They have engagement workers who go into the community to find clients who have 
withdrawn from engaging with services. CWP also subcontract aftercare services from the 
Olive Branch. An evaluation of the first 12 months of the Olive Branch was completed in 
January 2014 which said that 46 people had completed the programme as of November 
2013 and 21 were drug free. Clients said the programme was beneficial in providing 
intensive support, increasing their awareness of recovery and opportunities and exposing 
them to people who had recovered from drug addiction. Clients reported that the things they 
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appreciated about the service were that the coaches were approachable, believed in them 
and texted them every day (Karpusheff & Honor, 2014). 
The total spend on drug services provided by CWP was £3,073,005 in 2012/13. CWP 
reported that any revenue they saved had to go into efficiencies as part of their 4-5% cost 
improvement programme (CIP). This had meant stripping non pay costs, reducing travel 
costs, and downgrading and losing posts. 
CWP have a team who are involved in safeguarding, women and domestic violence which 
deal with families who may have safeguarding issues around care of children when they are 
using drugs and alcohol, and safe storage of drugs. When interviewed for this evaluation, 
staff reported that domestic violence was increasing in drug and alcohol users as more 
couples and families drink at home "until they get fed up with each other". The service do 
home visits and work with social services. They also do outreach work with commercial sex 
workers on the streets and in parlours. This involves providing advocacy, condoms, and 
advice on safety, including the national 'Ugly Mug' scheme which shares information about 
violent and abusive customers. Commercial sex workers will often use drugs to make their 
work more bearable, or will be working to pay for drugs, often crack cocaine. They reported 
that there were 'quarterly girls' who work to pay their bills every three months. They reported 
that Wirral's street sex working scene is smaller than it used to be, but is still there. This 
team are the main service in Wirral for helping commercial sex workers. The safeguarding 
team have links with the Family Safety Unit and go to the MARAC (Multi Agency Risk 
Assessment Conferences) to talk about domestic violence cases. They often deal with cases 
of co-dependence, where people are in relationships which are mainly founded on sharing 
drugs and do not want to be together otherwise. 
The harm reduction unit provide palliative care services and see clients with some of the 
most severe health problems. They have non-medical prescribers who can prescribe for 
some illnesses. They reported that they operate like a walk-in centre and see some of the 
most vulnerable people who often do not access other services. HRU staff gave an example 
of self harmers who would come into the unit to get their wounds cleaned up. They give out 
food vouchers and homeless packs for people who are sleeping on the streets. The harm 
reduction service also provide community alcohol detoxification for clients who would not be 
appropriate for residential detoxification in Birchwood. Services said that being co-located at 
the St Catherine's site with dental, heart, X ray and other services was beneficial. Services 
said that having direct referral pathways for pregnancy, sexual health, stoma, TB, pain 
management and other health issues meant that they could be part of seamless care 
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provision. Heavy opiate use often stops menstruation which means that pregnancies can go 
unnoticed for several months which can be very risky to the unborn child. 
CWP services said that some of the main benefits of their work were keeping people from 
having unnecessary healthcare activity (GP consultations, A&E presentations and hospital 
admissions) and maintaining drug users in the community. Services said they had a very 
good relationship with GPs and with pharmacists, who were their "eyes and ears on the 
ground". Smoking is common in drug users and is a big cause of death. All staff have level 1 
and some have level 2 smoking cessation training and provide smoking advice. They 
recommend Champix as a stop smoking aid to clients as working in the same way as 
Subutex (it is a partial agonist so partially stimulates the nicotine receptor while blocking it). 
Needle & Syringe Exchange 
Wirral had one central needle exchange service based at the Harm Reduction Unit at St. 
Catherine’s and also had needle exchange services based in 14 pharmacies. Nationally 
around 8% of pharmacies provide needle and syringe exchange services. The Harm 
Reduction Unit allowed needle and syringe users to choose from a broad range of needles, 
whereas the pharmacies had a more narrow selection. The HRU carried out injecting 
assessments and would warn clients about the legalities and follow up on any public health 
alerts around steroids. Pharmacies believed that they mainly saw heroin clients, but data 
showed that some of the syringes they provided are greater than 1ml which would indicate 
they are more likely to be being used by steroid users. Data on needle & syringe programme 
(NSP) clients is available from the Inter Agency Drug Misuse Database (IAD) which is 
reported on regularly by the Centre for Public Health at LJMU. The HRU was provided by 
CWP and had a separate entrance to the rest of the drug service so that people on 
methadone who were also injecting heroin would not be deterred from accessing the needle 
exchange through the fear that they may encounter their key worker in the corridor and it 
would be clear that the client is still injecting. 
There is good evidence that needle exchange programmes are effective and cost effective in 
preventing HIV transmission in injecting drug users, especially when there is also good 
coverage of drug treatment services present (Degenhart et al., 2010). In an economic model 
commissioned by NICE in 2008, increasing coverage of needle & syringe programmes such 
as through vending machines, and recruiting people who use needle and syringe exchanges 
into opiate substitution therapy, and recruiting injecting drug users into hepatitis C treatment 
were found to be broadly cost effective with incremental costs per QALY of less than 
£20,000 (Vickerman et al., 2008). 
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Nationally needle sharing had decreased but around 1 in 7 injectors still reported sharing 
needles. Wirral had a lower prevalence rate of blood borne viruses like hepatitis B & C than 
similar local authorities, which was one indication that needle syringe programmes have 
been successful in preventing viral transmission.  
There were principally two groups who use needle exchanges in Wirral; these were heroin 
users who were mainly aged over 40 and had been using services for a long time, and 
steroid users who were mainly younger, almost all male, and may not have be known to drug 
treatment services. In the North West, numbers of performance and image-enhancing drug 
users (PIEDs) accessing needle and syringe exchange services have increased steadily 
since 1991 (Figure 56) (Evans-Brown et al., 2012). Staff from the HRU said that young men 
would previously start on oral steroids so the average age of injectors used to be around 25, 
but now young men aged around 17 were going straight into injecting steroids. These users 
are at a greater risk of blood borne diseases than was previously thought - it was previously 
believed that they were much lower risk than injecting opiate users, but because many of 
these clients have high numbers of sexual partners and low condom use they are at risk 
from this as well as needle sharing (Hope et al., 2013).  Steroid use is high in young gay 
men as well, who usually have higher rates of HIV than heterosexual men. One drug service 
member of staff highlighted a potential risk of older heroin addicts who may have BBVs 
"hitting the gyms" and sharing injecting paraphernalia with other users. There have been 
reports of injecting rooms in gyms in Wirral, and that steroid injectors think that as long as 
they use their own needle they cannot catch BBVs, not realising the risk from sharing a 
syringe. The service talked about one case of a man in his 20s who had developed some 
breast tissue from steroid use, and was identified through the service as having breast 
cancer, which had been prevalent in the women in his family. This person may have died if 
he had not been engaging with the harm reduction unit. In their draft updated guidance on 
needle and syringe exchange programmes, NICE have recommended that NSPs should 
offer outreach or detached services in gyms for PIEDs (NICE, 2013a). The HRU reported 
they wanted to do more outreach work in gyms. 
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Figure 56. ‘All’ & ‘new’ clients attending agency based NSPs in Cheshire & Merseyside 
(1991-2011). AS = Anabolic Steroid 
 
Source: This chart is from Evans-Brown et al., 2012. 
Based on data for Q3 2012/13, 97% of new clients presenting to needle exchanges were 
male, and 57% were aged below 30. In Quarter 3 2012/13, 33,061 syringes in total were 
provided (21,189 in the HRU and 11,872 in pharmacies). Clients can give false details so the 
database may not always pick up new clients accurately. There has been some cross-
matching done to compare between the needle & syringe programme clients and the 
NDTMS and around 10-20% of NSP clients are cross-matched with drug service data (most 
steroid users were not in drug treatment). There have been 14 new clients over the 12 
months who use melanotan, which is an illegal synthetic hormone injected as a skin tanning 
agent.  
ARCH Services 
Unless otherwise references, this information is based on semi structured interviews with 
managers and staff. ARCH started providing services in 1985 when Wirral Council moved 
investment from what had previously been Merseyside Drugs Council and invested in setting 
up ARCH as a separate service in Wirral, initially with six counsellors. ARCH provided drop 
in services, structured counselling, training, family support and aftercare services as well as 
the criminal justice and drug testing services and residential detoxification at Birchwood. 
They also provided a stimulant service, a family service, young adult service and outreach 
and home visits to family service clients.  In 2012/13 spend on drug services provided by 
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ARCH was £1,414,958 for Wirral (Wirral finance data), although many of these services are 
for people with primary alcohol as well as drug problems. With the loss of a Wirral Council 
grant, and with the end of lottery funding, ARCH had their income reduced by around 
£325,000 from March 2013 and closed their Aftercare building, meaning that Aftercare was 
geographically located next to the other treatment services. Service staff interviewed for the 
evaluation said that this possibly a risk as people who are further down the road to recovery 
are mixing with people who are still using drugs, but can also be seen as a positive as it 
means that services can work together more closely and people in recovery can act as role 
models to people who are earlier in their journey. The entrance to the aftercare and alcohol 
services is located through a café which was set up to remove feelings of stigma or 
trepidation for people going into the building.  
ARCH provided social interventions that help people who are recovering from addiction to do 
something productive with their time; crack and opiate users are often shunned by society so 
helping them to become more confident, interact and increase their self-esteem is important 
in helping them to become drug free. Keeping people busy, helping people to deal with 
cravings and reinforcing positive behaviour is a part of this. Helping clients to reintegrate into 
the real world and find hobbies and interests is useful in staving off boredom. For some 
clients who had moved away from their home situation so that they could stay drug-free, 
making new friends was important. Staff in ARCH reported that with a reduced amount of 
resource, they were now less able to provide some activities such as drama, arts and crafts, 
and outdoor sports which were useful in getting clients to mix with people, find new hobbies 
and keep busy. People in the general population do not generally access these kind of 
enjoyable activities for free though, so there is a debate about what should be provided as 
part of drug treatment. ARCH worked with housing trusts to try to help clients improve their 
housing situation. ARCH also helped clients to write CVs for job applications and to learn IT 
skills. With continued lack of job opportunities, and changes to social benefits such as 
people getting benefits monthly instead of weekly, and the changes to the spare room 
subsidy [known as the bedroom tax] there had been a reported increase in clients who are 
getting more desperate, such as stealing to buy food. ARCH also reported that with changes 
in social care funding they were having to do more social care type work, and that it could be 
difficult to get clients to be assessed by social care as being vulnerable adults. They gave an 
example of a man who had a place in a hostel but instead slept in a bush every night 
because he was being bullied by other residents and had mental health and self-harm 
issues, yet they could not get him assessed as a vulnerable adult. ARCH’s family services 
support up to 50 families, and work closely with social care and the Intensive Family 
Intervention Project (IFIP) and go to joint case conferences. They work intensively with 
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families in the home on improving the drug and alcohol aspect of their lives. They reported 
how it can be very emotive work as they have to report any signs of neglect and sometimes 
children are removed. Staff from ARCH reported that they would prefer to see more referrals 
for families before children are removed.  
Clients using ARCH over 2 years were parents to an estimated 2,900 children which 
indicates that clients need extra support for things like childcare which ARCH support 
through their family service. This also indicates that drug treatment can be cost effective in 
helping parents to beat their addictions and be able to keep children who may otherwise end 
up in care. Wirral has high rates of looked after children, which may partly be a legacy of 
decades of social and drug problems. Staff said that they use techniques such as the NTA’s 
ITEP (the International Treatment Effectiveness Project) which is a set of techniques for 
structured psychosocial interventions centred on mapping out where clients want to see 
improvements in their lives. Services also use motivational interviewing techniques.  
Staff from ARCH said that with more resource they could provide better cover when people 
are on sick and maternity leave; they raised the importance of this cover for tracking crime in 
drug users who were in some cases prolific and persistent offenders (PPOs) or dangerous 
criminals. They said that there was no funding to send clients who had complex needs for 
residential rehabilitation ; they said that clients who were well motivated and had attended 
meetings were higher priority for rehabilitation but for some chaotic clients being sent away 
for rehabilitation in another area could be a lifesaver. More resources could allow clients to 
access Aftercare for longer than 6 months (it was reported that some clients get anxious 
about leaving Aftercare after 6 months although they can then go on to the Spider service 
which has activities to prevent relapse); they could market their services better so that more 
people accessed them, particularly people with problems with stimulants that may be 
anxious about accessing services. Staff interviewed from Prison Throughcare said there 
were issues around housing for people coming out of prison; people who were stable but on 
methadone were often not eligible for housing because they had to be abstinent from all 
opiates, but going back to hostels where drug use was rife meant they could quickly relapse 
back into using street drugs. Since the economic downturn and benefits changes there were 
a lot of people with housing needs so housing associations could 'cherry pick' from a larger 
pool of potential tenants which means they are less likely to provide housing to people with 
drug problems. Some staff questioned the value of giving drug using offenders very short 
prison sentences which meant that they lost their place in a hostel, would be put on 
methadone but wouldn’t have any other intervention and then would come out of prison and 
have no fixed abode. As was the case with CWP, ARCH staff indicated that there were 
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issues with hostels turning clients away when they didn’t meet their criteria or had caused 
problems before, and clients having to spend a long time living on the streets. 
The Drug Interventions Programme (DIP) 
The Drug Interventions Programme (DIP) is a part of the Government’s strategy for tackling 
drugs. It began in 2003/04 as a programme to develop and integrate measures for directing 
adult drug-misusing offenders out of crime and into treatment. In this programme people who 
have committed ‘trigger’ offences such as drug-related crime such as possession or drug 
dealing, or crimes that are often related to drug addiction such as fraud or acquisitive crime 
are saliva tested in the custody suite for the presence of cocaine or opiate drugs and are 
then referred into drug treatment services. Since public health moved to local authorities the 
DIP has become optional but most areas are opting to retain it.  
An individual will be tested on arrest where they fulfil all of the following conditions: are aged 
18 or over; are in police custody; and were arrested for a trigger offence or for an offence 
where a police officer of Inspector rank or above suspects specified Class A drug use was a 
causal or contributory factor. Testing on Arrest enables the police to identify adults misusing 
specified Class A drugs earlier in their contact with the criminal justice system, so that they 
may be steered into treatment and away from crime as soon as possible. It has also 
increased the volume of drug misusing arrestees identified – providing an opportunity to 
screen more people at some stage of their detention - and will ensure that those who misuse 
drugs but are not charged with an offence are nevertheless helped to engage in treatment 
and other programmes of help. 
 
7.3 Background to Case Study 
In England and Wales, around 99% of the population think that taking heroin occasionally is 
not acceptable, compared to 92% for cocaine and ecstasy, 66% for cannabis and 15% for 
getting drunk on alcohol (Home Office, 2013). Unsurprisingly people who have used drugs in 
the last year are more likely to rate drug use as being more acceptable or as being safe than 
people who have not used those drugs. Most people do not see drugs in the categories of 
harm, class A, B, C, that are used by the Home Office so for instance although cocaine and 
heroin are class A most people think that heroin is a much worse drug. 
Interestingly people on higher incomes are more likely to think that taking ecstasy, cocaine 
or cannabis is safer compared with people on lower incomes (Home Office, 2013). Possibly 
this is because affluent people are more insulated from seeing the effects of drug use in their 
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communities, or because their actual experience of drug use in their peer group has been 
largely insulated from negative effects of people spiralling into addiction or having financial 
problems caused by drug use. This is due to the protective effect of employment, social 
networks and education.  
Thinking about subgroups and subcultures is useful in terms of targeting harm reduction 
messages. A lot of drug use is related to music and other subcultures. There is a subculture 
of mainly older people known as ‘psychonauts’ who try out new drugs and usually report on 
their experiences. Subcultural theory and social learning theory predicts that people who are 
in subcultures are primed to the drugs used by their peer group, even before trying them 
(Golub et al., 2005). Of course even within many subgroups the majority of people do not 
use drugs.  
Figure 57. Attitudes towards acceptability of getting drunk and taking drugs, England and 
Wales, 2012-13. Data for 16-24 & 25-59 age groups. 
 
 
There were several drug-related indicators in the Public Health Outcomes Framework 2013-
2016 (PHE, 2014a). Some of those metrics which are particularly relevant to drug treatment 
are: 
PHOF 2.15 Successful completion of drug treatment [this is separated into opiate and non-
opiate users] 
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PHOF 2.18 Alcohol-related admissions to hospital  
PHOF 2.2 Take up of the NHS Health Check programme by those eligible (which will include 
screening for alcohol misuse from 2013). 
2.23: Self-reported wellbeing  
PHOF 4.3 Age-standardised rate of mortality from causes considered preventable per 
100,000 population – includes drug & alcohol related deaths 
PHOF 4.6 Mortality from liver disease 
PHOF 4.8 Mortality from communicable diseases  
There is also ‘PHOF 2.16 Proportion of people assessed for substance dependence issues 
when entering prison who then required structured treatment and have not already received 
it in the community’.  
The future of the illegal drugs market 
In the past five years, novel psychoactive substances (NPSs) and 'legal highs' have become 
much more popular with young people. Novel psychoactive substances are often purchased 
online from cyber-entrepreneurs (Measham et al., 2010).  
There is evidence that young people mistakenly think that the moniker ‘legal high’ indicates 
that these drugs are safer than illegal drugs. Illicit drug manufacturers have been tweaking 
the chemical structure of illegal NPSs when the drug becomes illegal to make a new drug 
that is not illegal. This has led to whole classes of drug being made illegal for instance 
cathinones like mephedrone, or piperazines like BZP (Morris, 2010).  
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Figure 58. Predictive factors for initial novel psychoactive substance use. Produced by the 
author.  
 
 
With most drugs there is a substitution effect, where people move onto cheaper drugs if the 
price of their chosen drug increases or if availability drops. When mephedrone was legal and 
therefore very cheap and easy to get hold of, it was used by MDMA/ecstasy users as a 
substitute because the average amount of MDMA in ecstasy tablets had dropped very low, 
and similarly with cocaine typical street purity was very low (King & Kicman, 2011). However 
now that mephedrone is illegal and the price has gone up, these users have gone back to 
their original drug of choice. There is evidence for a similar substitution effect with crystal 
meth, crack and cocaine, where people would only use crystal meth if the price or availability 
of crack or cocaine became a serious issue (Sumnall et al., 2004). There is an unintended 
consequence of enforcement that reducing availability of drugs like heroin or cocaine might 
increase prices and move people onto cheaper but more harmful drugs, or that drugs may 
be cut with more harmful additives.  
Drug services managers said that there was a danger that as the older generation of heroin 
addicts are less visible, the deterrent potential is reduced (which they called the ‘scarecrow 
effect’). Service managers said that at the moment young people have an idea of the typical 
heroin addict or pejoratively labelled ‘smackhead’ as being gaunt with pale skin and bad 
teeth, and injecting themselves every day. Even though this stereotype promotes 
stigmatisation of recovering addicts and is not always accurate, it serves a social purpose in 
putting young people off trying heroin for the first time. If and when this association wears off 
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over time, it may be that there is a renewed danger of young people trying heroin and the 
potential for a new heroin outbreak. While opiates and crack are going out of fashion or seen 
as not socially acceptable with most young people, England has the highest prevalence of 
NPS use in Europe, continued high cocaine use, and there is always a threat that 
methamphetamine [‘crystal meth’] which is prevalent in US cities could one day take off in 
the UK just as the heroin and crack era in the UK was several years after those in the US. 
So far recorded use of methamphetamine has been mainly restricted to gay men who often 
inject rather than smoke it, and because it is currently a niche drug in the UK, prices are 
actually higher than for other drugs whereas in the US it is cheaper than other drugs 
(Neptune, 2015). National numbers of people in drug treatment for methamphetamine are 
small but have increased steadily from 22 in 2005/06 to 208 in 2012/13 (PHE, 2014b). There 
is also a threat from people getting addicted to prescription drugs either diverted or bought 
illicitly over the internet, such as painkillers like Tramadol, which has been implicated in an 
increasing number of deaths, 220 in 2013, 154 in 2011 compared with 83 in 2008 (ACMD, 
2013). Tramadol prescriptions have increased every year since it came on the market in 
1994, reaching 7.5 million prescriptions in 2012. In Wirral the main prescription drug used by 
people in drug treatment is codeine, although there were 8 clients in 2012/13 with Tramadol 
as their primary drug. Because prescription drugs are legal, clients are less likely to come 
into treatment through the DIP (Drug Interventions Programme, where people arrested are 
tested for drugs), although opiates like Tramadol and codeine would show up on an opiate 
screen. Prescription drugs kill more people in the US than illegal drugs (Paulozzi, 2012). 
Because most prescription drugs can be bought quite easily off the internet (although 
sometimes they are counterfeit or passed-off drugs which makes this even more 
dangerous), it means that more needs to be done to identify people who are dependent or 
addicted to drugs prescribed to them by a doctor, as stopping the prescription will not always 
stop someone accessing the drugs (NTA, 2011). 
There was also an increase in young people using performance enhancing drugs and 
anabolic steroids for training and body building (ACMD, 2011). People from the Harm 
Reduction Service in Wirral reported that steroid use was a ticking time bomb in Wirral which 
was associated with blood borne viruses (some had been found to have hepatitis C), 
sexually transmitted infections (most were young men who would have several sexual 
partners and some would describe themselves as heterosexual but would have sex with 
other men in the peak of their cycle), male breast formation (gynecomastia) and infertility, 
liver disease and cardiovascular disease. These men were often cocaine users as well and 
were often getting most of their information from the web; they were prone to depression and 
could be using a cocktail of other drugs like insulin or Herceptin. 
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Nationally there is also an increase in young people and students using nootropic ‘brain 
enhancer’ type drugs like Ritalin, a stimulant drug aimed at adults and children with ADHD, 
and Modanifil, a wakefulness- and concentration-promoting drug aimed at people with 
narcolepsy and other sleep disorders (Singh et al., 2014). High rates of youth unemployment 
and graduate unemployment means that many young people will try anything they can that 
might give them a slim advantage over their peers (see Figure 53). This might mean they are 
less likely to use recreational drugs because of the risks of getting arrested or having 
impaired performance, but are more likely to use nootropic drugs because of the chance of 
being given an advantage over peers. Wirral has high rates of Ritalin prescribed to young 
people.  
In young people use of energy drinks which typically contain high amounts of legal 
stimulants like taurine, caffeine and guarana as well as sugar has increased over the last 
five years (Walker, 2015). These drinks which have a mild to moderate stimulant effect on 
the central nervous system may in theory prime young people for stimulant use, or be used 
instead of stimulants. A recent US study suggested that teenagers who drink the most 
energy drinks are more likely to use drugs, and that energy drinks promote an accelerated, 
stimulant culture (Terry-McElrath et al., 2014). The growth in young people drinking shots 
and shooters like vodka red bull or “jägerbombs” [jägermeister liquor and red bull] which mix 
the depressant effects of alcohol with the stimulant effects of energy drinks and have a 
similar effect to mixing alcohol and cocaine in allowing people to get ‘drunk and wired’ and 
therefore may be used instead of mixing cocaine or ecstasy with alcohol.  
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Figure 59. Trend in youth unemployment in Wirral, North West of England, and Great Britain, 
November 1992-November 2013 (yearly snapshot). Source: NOMIS. 
 
These newly emerging drugs will differ in the type of problems they cause for individuals and 
therefore the number of people who might end up needed some kind of drug treatment or 
intervention. Little is known about many of these drugs, their long term effects, and how they 
interact with each other and with alcohol. The drug market has become more fragmented, 
with the cross-reactions and long term effects of drugs not being well understood. This leads 
to the potential danger of previously unobserved mental and physical problems in the future 
for individuals using new drugs. Although problems related to crack and opiate use have 
declined, the level of investment that is needed to deal with other emerging drug and 
addiction problems may need to be considerably increased. 
7.4 Case Study 
7.4.1 Aim 
The aim of this case study was to determine whether three main elements of Wirral’s 
commissioned services, those from CWP, ARCH and the DIP, were cost effective in 
improving health and reducing crime.  
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7.4.2 Literature review 
Direct expenditure on drug services was £1.106 billion for the UK in 2010/11 (0.17% of 
public expenditure), while unlabelled expenditure (expenditure which is in some way related 
to drug abuse) was estimated as £6.265 billion, the majority of which related to public order 
and safety (Table 43) leading to an overall total of drug-related public expenditure amounting 
to £7.37 billion which was 1.1% of all public sector expenditure (Davies et al., 2012). The 
Home Office have estimated that each problematic drug user (PDU) costs around £50,000 
per annum (Singleton et al., 2010). Drug use was estimated to cost society £15.4 billion a 
year, of which £13.9 billion was related to crime committed by people who are dependent on 
drugs (Godfrey, 2002). 
Table 43. Estimates of unlabelled (non-drug specific) costs of drug use, UK, 2011. From 
Davies et al., 2012 p. 194. 
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Table 44. List of costs associated with drug use. 
Bearers of costs/ 
harms 
Examples of Costs: 
Users Premature Death, Loss of quality of life: mental and physical health; 
relationships; Impact on educational achievement, training 
opportunities.  Excess unemployment and loss of lifetime earnings 
Families/carers Impact on children of drug users, Transmission of infections, 
Intergenerational impact on drug use, Financial problems, 
Concern/worry for users, Caring for drug users or drug users’ 
dependents 
Other individuals 
directly affected 
Victims of drug driving; drug-related violence; drug related crime,  
Transmissions of infections from drug users 
Wider community 
effects 
Fear of Crime. Environmental aspects of drug markets – needles, 
effects of drug dealing in community. 
Industry Sickness absence and theft in the workplace 
Security expenditure to prevent drug-related crime 
Productivity losses. Impact of illicit markets on legitimate markets 
Public sector Health care expenditure and criminal justice expenditure, 
Social services, Social security benefits 
Based on Godfrey, C. The economic and social costs of Class A drug use in England and Wales, 2000 
 
In the NTA's Value for Money (VfM) Tool they estimate the national net cost per QALY 
(quality adjusted life year) gained for problematic drug users (PDUs or heroin or cocaine 
users) as £6,468 per QALY and for non-PDUs (people using stimulants, cannabis etc.) as 
£10,055 per QALY (PHE, 2013), before any cost savings are taken into account. Both of 
these cost effectiveness ratios would be considered cost effective by NICE who recommend 
that interventions should be adopted if the incremental cost effectiveness ratio (ICER) is less 
than £20,000 per QALY gained (Rawlins et al., 2010). Once the cost savings from reduced 
crime are taken into account, the interventions produce a net cost saving with a cost 
effectiveness ratio of around £5 for every £1 spent over a 4 year time horizon, and around 
£10 for every £1 spent over a 10 year time horizon (PHE, 2013). 
In 2010, the National Audit Office (NAO) published 'Tackling problem drug use' which 
estimated that every £1 spent on drug treatment produced £2.50 in savings to the taxpayer. 
Drug treatment services have seemingly become more efficient over time with average cost 
per adult in effective treatment dropping by 20% from £3,600 in 2004/05 to 2008/09 (when 
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adjusted for inflation this drop is 31%) but over this time the drug using population has 
changed as well, with fewer opiate users. 
Table 45. Spend on adult drug treatment, England, 2004/05 to 2008/09. 
 
2004/5 2005/6 2006/7 2007/8 2008/9 
Adult Pooled Treatment Budget £255m £300m £380m £383m £373m 
Local funding £226m £226m £224m £207m £208m 
Total funding £481m £526m £604m £590m £581m 
Number of adults in effective 
treatment 
134,000 
145,00
0 
164,000 183,000 195,000 
Total treatment funding per adult 
in effective treatment 
£3,600 £3,600 £3,700 £3,200 £3,000 
From National Audit Office (2010) Tackling Problem Drug Use.  
 
The Drug Treatment Outcome Research Study (DTORS, 2009) looked at outcomes for drug 
users (including PDUs and non-PDUs) and included a cost effectiveness element. It 
combined cost and activity data from the NDTMS with interview data for around 1,800 
people that was used to estimate QALYs gained and resource use (health and social care 
and cost of offences). The QALYs were calculated using the SF12 survey instrument. There 
was a lot of variation around the average QALY gains. In the DTORS, the net benefits of 
drug treatment were positive in 80% of clients. The average net benefit ratio was around 
£2.50 for every £1 spent. This is much lower than the NTORS ratio of £9.50 for every £1 
spent but was measured over a time period of 51 weeks compared to a 4 year time period in 
the NTORS, as well as there being other differences in measuring costs and benefits 
between the two studies (Godfrey et al., 2004). 
Table 46. Estimated costs and QALYs over a 51 week period, data from the DTORS 2009. 
Parameter Without 
treatment  
With treatment  Net benefit  
Cost of structured treatment - £4,914 - 
Cost of health and social 
care  
£4,543  £3,120  £1,423  
Cost of reported offences  £50,585  £39,967  £10,618  
Total  £55,127  £43,087  £12,041  
QALYs  0.63  0.68  0.05  
 
Frontier Economics (2008) found that treatment services for young people were very cost 
effective in stopping young people continuing substance abuse problems into adulthood.  
For every £1 spent on drug treatment they found a return in investment of around £2 over 2 
years and between £5 and £8 over the long term. In Wirral ARCH engages with young 
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people by having cannabis education and providing harm reduction messages for stimulant 
and NPS users. 
The NTA (now part of Public Health England) produced a Value for Money tool, working with 
Department of Health and Home Office economists, which includes estimates for the local 
cost savings that are generated by having people in drug treatment. It includes the crime and 
health benefits realised when people are in effective treatment (i.e. 12 weeks or more) or 
when people complete treatment and do not represent, a proxy for sustaining recovery. The 
most recent version of the tool was published in tool was last updated at the end of 2013 
with 2012/13 data. The tool uses the costs for structured treatment. Overall the cost/benefit 
ratio was calculated as £4.77 for every £1 spent, including benefits for people in long term 
recovery, or £3.26 in year benefits for each £1 spent, which does not include benefits for 
people in sustained recovery. However this does not represent a cashable benefit; it 
includes the value of QALYs (Quality Adjusted Life Years) gained at £60,000 per QALY 
which may be considered high when NICE's threshold for willingness to pay for a QALY in a 
public health setting is generally quoted as £20,000 per QALY. The tool includes all adult 
drug users who are in effective treatment, defined as being in treatment for 12 weeks or 
more or making a planned exit from treatment. The tool assumes that with treatment, an 
individual’s drug taking career is on average reduced from 20 years to 12 years. It assumes 
that opiate users spend 3 years in treatment on average (Figure 60). These parameters 
were based on the NTA report ‘A long-term study of the outcomes of drug users leaving 
treatment’ which looked at whether clients who left drug treatment in 2005/06 re-presented 
to treatment (measured by NDTMS) or had contact with the criminal justice system 
(measured by DIP drug test or Drug Interventions Record (DIR) in prison or the community) 
in the 4 years after they left treatment (2006-07 to 2009-10). These are quite broad 
assumptions that may not reflect the diversity in different populations; we know that many 
clients in Wirral have been prescibed methadone for 20 years or more, and were likely 
heroin users for several years before that. It may be that actually methadone extends drug 
use for many clients who may have otherwise died, or stopped using heroin on their own. In 
terms of the realist evaluation context-mechanism-outcome configurations, methadone might 
have moved from being a mechanism towards people confronting their drug use, to being 
part of the context, it is something that is omni-present, a baseline of opiate use that can be 
topped up with street drugs. 
The costs in the tool include those from premature death of drug users, the impact on 
children of drug users, drug related crime, health care expenditure, criminal justice 
expenditure and social security benefits. A report by the Advisory Council on the Misuse of 
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Drugs stated in 2003 that between 250,000-350,000 children in the UK are affected by 
parental drug use (ACMD, 2003). 
 
Figure 60. Schematic of PHE VfM drug taking career. From PHE (2013). 
 
For Wirral the total cost of harm without any drug treatment would be £30.7m in 2012/13. 
The estimated spend on drug treatment was £6m which is less than the actual total spend in 
2012 of £7.8million (PHE, 2013). The cost savings this generates are estimated as 
£19.6million per year. The tool also gives natural benefits which are based on a valuation of 
the QALYs gained from clients’ health improvement (valued at £60,000 per QALY gained) 
and crime reduction (valued at £81,000 per QALY gained). These benefits are non-cashable, 
i.e. they would not be accrued back to the public sector, but are based on society’s 
willingness to pay for an improvement in health or a reduction in crime. For Wirral the tool 
assumes 2,242 drug users in treatment for 12 weeks or more (1,856 PDUs and 386 non-
PDUs) and 403 completions (166 PDUs and 237 non-PDUs). 
Realist Evaluations Review 
A review of realist evaluations found few that were specific to drug treatment. There was a 
realist review by Hunter & colleagues (2014) around barriers and enablers for drug and 
alcohol treatment. There was a realist synthesis by Jackson & colleagues (2014) which 
looked at which contexts improved psychosocial and employment outcomes for people on 
methadone and found that being client-centred, having positive relationships and having 
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ongoing engagement were all important. There was a paper by Leone (2008) which looked 
at a test on arrest type programme in Northern Italy. A recent paper by Davey and 
colleagues (2014) was a realist evaluation of a community addiction programme for urban 
aboriginal people, which found that the psychological mechanisms through which clients 
achieved their outcomes were mainly around client needs, trust, cultural beliefs, willingness, 
self-awareness, and self-efficacy. There was a project by the Australian Injecting and Illicit 
Drug Users League (AIVL, 2011) which looked at consumer participation in drug treatment 
programmes and used a realist methodology to determine the issues around participation. 
This study found that drug treatment service users were not aware of opportunities for 
participation, and some services did not believe that service users should have the chance 
to influence decisions. There was some realist evaluation work by Kazi & Spurling (2000) 
which looked at developing social inclusion models for drug users. 
7.4.3 Data sources 
Data was provided from Wirral drugs service (provided by CWP) for 2012/13 financial year 
and from criminal justice and other drug services provided by ARCH for 2011/12 and 
2012/13 financial years. This was provided in the form of Excel spreadsheets which had a 
line listing where each line represented one client who had used the service. The analysis 
also used matched crime data from Merseyside police for criminal justice clients. Appendix 4 
describes the drug and alcohol treatment datasets and the variables contained in these 
datasets.  
The models were also populated with some data from the evidence where the data from the 
services was insufficient for estimating outcomes or probabilities for the economic modelling.  
7.4.4 Methods 
Three different service user groups were modelled; these were opiate and crack users, 
which represented mainly those who used CWP’s services; cannabis and stimulant users, 
which represented mainly ARCH clients; and the Drugs Intervention Programme, which was 
mainly concerned with criminal justice outcomes as these were clients who had been 
identified through being arrested. These models were all created by the author.  
Opiate and Crack User Model  
 
A Markov model was constructed by the author using local data about opiate and crack 
users. The model was constructed using TreeAge 2013 software.  Drug users were either in 
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one of four states; in treatment, not in treatment, in recovery, or death. A Markov model with 
6 month cycles was used, where after every 6 months clients have a probability of moving 
from each state to another state. These probabilities were derived from local and national 
data. The model was run for a 60 year time period. The model assumed a fixed cohort over 
time, so over time their quality of life would diminish and risk of death increased. The quality 
of life value was highest for people in recovery, and was lower for people in treatment and 
lower still for people who were drug users who were not in treatment. Overall the model 
included an estimate of the QALYs (quality adjusted life years) gained for treatment and the 
costs of crime committed by drug users and an estimate of treatment costs.  
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Figure 61. Structure of opiate and crack user model.  
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Table 47. List of parameters for opiate and crack user model.  
Parameter N 
Standard 
Deviation 
for PSA 
Distribution 
for PSA Units Source 
Drug taking career (in absence of 
treatment) 20 NA   years NTA VfM tool 
Drug taking career (with treatment) 12 NA   years NTA VfM tool 
Average time in treatment 4 NA   years NTA VfM tool 
Drug taking career pre-treatment 8 NA   years NTA VfM tool 
Mortality rate post treatment, per 
year 0.01000 0.00100 normal 
person per 
year NTA VfM tool 
Mortality rate in treatment 0.01500 0.00100 normal 
person per 
year assumption 
Mortality rate outside of treatment 0.03000 0.00100 normal 
person per 
year assumption 
Representation rate for drug 
treatment over 4 years 0.56000  Not inc Not inc  person NTA VfM tool 
Representation rate for drug 
treatment over 10 years 0.69000  Not inc Not inc  person NTA VfM tool 
Relapse from opiates cut off - time 
after which no more clients 
represent 10.00000  Not inc Not inc  years NTA VfM tool 
Recovery rate - PDUs 0.29000  Not inc Not inc  person NTA VfM tool 
Unsuccessful discharge rate 0.08737  Not inc Not inc  person years NTA VfM tool 
Successful discharge rate 0.07740  Not inc Not inc  person years NTA VfM tool 
Successful discharge (15% higher) 0.089008  Not inc Not inc  person years   
Utility (in treatment) 0.742 0.14 beta QoL scale 
Dijkgraaf et al. 
(2005) 
Utility (in recovery) 0.786 0.15 beta QoL scale 
Age average for 60 
yr old man 
Utility (drug user) 0.67 0.13 beta QoL scale 
QoL change data 
from TOPs 
mortality increase per 6 months 0.001  Not inc Not inc  
persons/6 
mths 
assm (equates to 
0.1% increase 
every six months) 
increase in disutility per year 0.001419  Not inc Not inc  QoL scale 
Based on national 
EQ5D data 
Recovery rate non PDUs 0.40000  Not inc Not inc    NTA VfM tool 
Crime costs (in treatment) (£) 39,967 4000 gamma £ per year DTORS 
Crime costs (not in treatment) (£) 50,585 5050 gamma £ per year DTORS 
Difference in crime costs (£) 10,145 
       
30,678 gamma 
£ per year DTORS 
Treatment costs 4,000 120 gamma £ per year Local finance data 
Recovery costs (First year only) 700 35 gamma £ per year Local finance data 
Stimulant and Cannabis User Model 
A simple model was constructed to estimate the cost per QALY (Quality Adjusted Life Year) 
for people completing stimulant and cannabis treatment through ARCH. This used quality of 
life (utility) data for regular cannabis users in Wirral from the North West Mental Wellbeing 
Survey (2009) which found that cannabis users’ quality of life score was 0.68 compared to 
0.74 in the general population. This was matched to baseline TOPs quality of life scores 
which were very similar for cannabis and cocaine users. The average increase in quality of 
life scores between commencing and leaving treatment were also very similar for cannabis 
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and cocaine, at around 27%. A low estimate of QALY gains was produced with the 
assumption that any quality of life gained peaked at six months then went back to the 
baseline average quality of life. A high estimate assumed that any quality of life change was 
maintained over one year. Of course it is possible that the service may produce a quality of 
life change for many years, particularly in people who have had severe addiction and who 
have benefitted the most from treatment.  
Table 48. Crime and employment outcomes, ARCH data for Wirral, 2011-2013. 
Description Value Source 
Baseline utility  0.68 Cannabis utility for Wirral from NWMWBS 
2009 
TOPs QoL Baseline (cannabis) 11.60 ARCH TOPs data 
TOPs QoL Treatment Exit 
(cannabis) 
14.75 ARCH TOPs data 
TOPs QoL Baseline (cocaine) 11.51 ARCH TOPs data 
TOPs QoL Treatment Exit (cocaine) 14.58 ARCH TOPs data 
Utility on completion 0.864 Estimated follow up utility based on ratio of 
TOPs QoL scores 
 
Drug Interventions Programme Model 
An economic model was constructed for the Drugs Interventions Programme (DIP) which is 
a programme where people who are arrested for trigger offences are funnelled into drug 
treatment to reduce their criminal behaviour. This model was constructed by the author using 
MS Excel with Visual Basic for Applications (VBA). This model was a client level Monte 
Carlo simulation model which was run for 10,000 hypothetical clients where each time a 
random scenario was drawn from the data distributions. Overall averages were then 
calculated from the 10,000 random walks through the model. The model had a 12 month 
time horizon. Table 49 shows a list of parameters for the model. In the absence of data 
distributions for individual costs for the DIP and for drug treatment, an estimate of around 
20% was used for the standard deviation for each, to introduce some rational variation into 
the model. In practice contact with the DIP usually results in a flat 6 months contact with 
drug services so costs may not vary by much. 
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Table 49. Parameters for Wirral DIP Cost Utility Model. 
Parameter Distribution Mean Standard 
deviation 
Cost of crime - before Skewed - bootstrapped from 
rawdata 
£2,717 £111,766 
Cost of crime - after Skewed - bootstrapped from 
raw data 
£11,626 £7,316 
Cost of DIP Normal – estimate based on 
local data 
£924 £200 
Cost of drug treatment Normal - estimated based on 
local data 
£429 £100 
QALYs gained Normal – from DTORS 0.05 0.201 
 
The cost of crime unit costs were matched with the arrest reason for each time someone 
known to the DIP had been arrested in the 12 months before and 12 months after they have 
been identified as a drug user through the DIP. This data was matched with national crime 
database data by Merseyside Police. Some people will not be prosecuted or found guilty of 
these crimes, thus it may be that the crime was not committed and the total costs were not 
incurred (the costs of arrest have definitely been incurred though). It could be that some 
adjustment could be made to reduce the average cost to account for arrests that are not for 
genuine crimes. However it is estimated that only 27% of crimes are detected [but those 
detected are likely to be the more serious crimes], so any cost of crime estimate may also 
theoretically be inflated to take into account those crimes that are not detected (Home Office, 
2012). Based on this it may be assumed that for each crime that is detected, individuals 
commit an average of three crimes that are not. Nationally, about 83% of people prosecuted 
for crimes are found guilty; however this varies by type of crime group. This present study is 
mostly concerned with the change in crime costs over time for people who have been 
identified through the DIP, so even if the estimated magnitude of costs are higher than they 
may be in reality, the ratio of costs for twelve months before and after being identified 
through the DIP should still be roughly correct.  
By far the highest unit cost per crime is for homicide at £1.8million which is an outlier, so it 
may be that a small number of homicides will skew the average costs for clients before and 
after they have been through the DIP. The analysis of average costs has been carried out 
including and excluding homicides to see how this affects the results. Table 50 shows the 
arrest reason and the costs used. 
  
219 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
Table 50. DIP Arrest reason and matched crime type and unit cost.  
Arrest Reason Crime type Unit Cost 
2012 Other Theft Theft – not vehicle  £781 
[Blank] [Mainly 'warrant'] <other arrests> £685 
Drugs Possess Class A <other arrests> £685 
Other Non-Crime <other arrests> £685 
Drunk and Disorderly <other arrests> £685 
Drugs Possess Class B <other arrests> £685 
Burglary Dwelling Burglary in a dwelling  £4,018 
Breach of the Peace <other arrests> £685 
Drugs Possess W/I Supply Class A <other arrests> £685 
Burglary Other Burglary not in a dwelling  £4,718 
S.47 Assault Other wounding  £10,024 
Criminal Damage Criminal damage 
(personal)  
£1,078 
Other Violence Against Person Common assault  £1,792 
Theft Of Vehicle Theft of vehicle  £5,088 
Other Crime <other arrests> £685 
S.39 Assault Common assault  £1,792 
Robbery Robbery – personal  £9,020 
Theft From Vehicle Theft from vehicle  £1,059 
Disorder - Other <other arrests> £685 
Traffic OPL <other arrests> £685 
S.18 Wounding Serious wounding  £26,360 
Fraud and Forgery <other arrests> £685 
Drugs Supply Class A <other arrests> £685 
Disorder - Serious <other arrests> £685 
Drugs Produce Class B <other arrests> £685 
Going Equipped for Stealing <other arrests> £685 
Drugs Possess W/I Supply Class B <other arrests> £685 
Handling Stolen Goods <other arrests> £685 
Aggravated Vehicle Taking Theft of vehicle  £5,088 
S.20 Wounding Other wounding  £10,023 
Traffic General <other arrests> £685 
Aggravated Burglary Dwelling Burglary in a dwelling  £4,018 
Sexual Offence Sexual offences  £37,831 
Burglary in a dwelling  Burglary in a dwelling  £4,018 
Drugs Other <other arrests> £685 
Violence against the person Common assault  £1,792 
Drugs Supply Class B <other arrests> £685 
Homicide Homicide  £1,816,918 
All others <other arrests> £685 
 
 
Average QALYs gained from the DTORS study (2009) were used. The QALYs were 
calculated using the Short Form 12 (SF-12) survey instrument. As will be shown, the 
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average QALYs gained per client in the DTORS was small, with a wide spread of data points 
which included many clients who were estimated to have net QALY losses in their time in 
drug treatment. The DTORS cost effectiveness study was essentially a before and after 
study as well, where baseline utility scores were extrapolated. To calculate the net present 
value (NPV) of the intervention, the QALYs were valued at a base scenario of £20,000 per 
QALY gained which is the quoted threshold for willingness to pay for a QALY used by NICE 
for assessing public health interventions. The difference in costs and the monetary valuation 
of benefits were used to estimate the cost-benefit ratio. 
Both the costs of crime and the QALY differences were estimated over a 12 month time 
horizon only so no discounting was used for the costs or outcomes. Analysis of differences 
between crime rates before and after were carried out by subgroups, these were gender; 
those testing positive for cocaine only, opiates only and both cocaine and opiates; and by 
test outcome groups (assessed, care planned, no further DIP contact). Measures of quality 
of life and psychological and physical health from the Treatment Outcomes Profiles (TOPs) 
were also analysed.  
7.4.5 Results  
Results – CWP Drug Treatment 
Because there is little actual population data on problematic drug use across different 
groups, it is difficult to carry out an equity impact assessment. The best that can be said is 
that the services seem to be open to many different groups and have a broad mixture of 
clients. There would be debate about what represents ‘need’ in a population, with some 
people believing that a level of recreational drug use in young people is not aberrant 
behaviour, although it can be dangerous in some cases; most young people naturally grow 
out of drug use by the time they reach their 30s without any intervention (Home Office, 
2013). 
We were provided with data for primary drug users in treatment during 2012/13. This 
includes clients who were discharged after 1st April 2012, and clients who were still in 
treatment as of 28th October 2013. 51% of clients were aged between 40 and 50. There 
were no clients aged less than 20 years. 71% of clients were men, 29% women. Ethnicity 
was recorded for 93% of clients; 2% of clients were non- White British. 
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Figure 62. CWP drug treatment clients by age. Wirral, 2012/13 financial year. 
 
The biggest source of referral into services was self-referral, which accounted for 58% of 
referrals. This may include people who have been signposted from other services or 
agencies. 
The data had only partial postcodes, but using a rough matching algorithm (described in 
chapter 1.2 A Pen Portrait of Wirral - A Microcosm of the UK?) , around 64% of clients lived 
in the areas of Wirral that fall into the most deprived quintile (20%) nationally in terms of 
Index of Multiple Deprivation (IMD 2010) scores. This area accounts for around 32% of the 
Wirral population, so drug treatment clients are about twice as likely to be from the most 
deprived areas. The primary drugs of abuse for CWP clients were nearly all cocaine or 
opiate drugs. In terms of primary drug, the most frequently used was heroin. The average 
age of first drug use was 22 years. 51% of users had a second drug recorded which were 
mainly crack cocaine (34%), methadone (22%), heroin (12%) and benzodiazepine drugs like 
diazepam [Valium] (12%). A small percentage (5%) of clients were recorded as injecting, 
although route of drug administration was only recorded for around 50% of clients. 
People who primarily use other drugs like stimulants or cannabis are more often seen in 
ARCH's services, although CWP provide support for some people who use prescription 
drugs. One member of staff interviewed from CWP talked about a case of an older woman 
who had become dependent on morphine (oramorph) after going through intense 
radiotherapy for cancer, where the GP did not know what to do to get her off the drug. In this 
case the drug service's expertise could be used to talk to her, deal with her fears and 
psychosocial problems and taper her dose of oramorph until she no longer needed it. In this 
case the service stated that the GP may have struggled to find enough time to deal with all 
of these issues. Staff from CWP said that they would like to be able to provide more 
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prescription drug support and that GPs would value help with people who were dependent 
on benzodiazepines in particular. 
Table 51. CWP clients by primary drug and average age first used. Wirral, 2012/13 financial 
year. 
Primary drug Number % of total Average age 
first used 
Heroin illicit 450 61.1% 22 
Methadone Mixture 101 13.7% 22 
NULL 93 12.6%  
Dihydrocodeine 21 2.9% 30 
Cocaine Freebase (crack) 12 1.6% 21 
Buprenorphine 10 1.4% 26 
Codeine unspecified 9 1.2% 27 
Tramadol Hydrochloride 8 1.1% 32 
Codeine Tablets 5 0.7% 20 
Diazepam 4 0.5% 19 
Other 23 1.9% 20 
Total 736 100.0% 22 
 
According to the data, 75% of clients had a psychosocial intervention, and 89% of clients 
had some sort of prescribing. Shared care prescribing arrangements were in place for 37% 
of clients; rather than attending the drug service these clients were able to be seen in their 
own GP practice and to pick up their prescriptions from their local pharmacist which makes 
life easier for them, especially as some of them work or take care of families so do not want 
to have to go to St Catherine's, "the hospital on the hill" where the drugs service is based, all 
of the time. GPs were paid for having their clients under Shared Care and the Shared Care 
drug workers are a central point of contact for any drug problems seen in primary care. 11% 
of clients had no intervention recorded. This could possibly be because they did not agree to 
their data being shared with the NDTMS. The recorded modalities specified by the NTA are 
very broad so do not tell us much about the specific elements of drug treatment. 
The primary drugs of abuse for CWP clients were nearly all cocaine or opiate drugs. In terms 
of primary drug, the most used was heroin. The average age of first drug use was 22 years. 
51% of users had a second drug recorded which were mainly crack cocaine (34%), 
methadone (22%), heroin (12%) and benzodiazepine drugs like diazepam [Valium] (12%). A 
small percentage of clients (5%) were recorded as injecting, although route of drug 
administration was only recorded for around 50% of clients. 
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Table 52. CWP clients by treatment modality. Wirral, 2012/13 financial year. 
Treatment modality % of total clients 
Shared care prescribing 37% 
CWP prescribing 74% 
Psychosocial intervention 75% 
Recovery support 13% 
Total with any modality recorded 89% 
 
30% of clients had a discharge outcome recorded (the rest were presumably still in 
treatment at the end of the time period). Of those with discharge outcomes, 46% were 
treatment completed-drug free, and 32% were transferred.  ‘Transfer not in custody’ means 
that either; 
1. Client was transferred to another treatment provider for ongoing community 
treatment.  
2. Client was transferred to a residential detoxification unit.  
3. The client transferred to a residential rehabilitation unit on completing a community 
detoxification. 
Table 53. CWP clients by discharge outcome, where recorded. Wirral, 2012/13 financial year. 
Discharge Outcome % of total with 
outcomes 
recorded 
Treatment completed - drug-free 46% 
Transferred - not in custody 20% 
Incomplete - dropped out 13% 
Transferred - in custody 12% 
Incomplete - Client Died 7% 
Treatment completed - occasional user (not heroin or 
crack) 
1% 
Incomplete - treatment commencement declined by 
client 
1% 
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The number of opiate and crack users moving into recovery had increased overall in the last 
five years although the number of people completing drug free had stalled over the last three 
years. The service said that they were having shared learning sessions where key workers 
who were particularly successful in getting their clients into recovery could share their ways 
of working. They were also running focus groups for clients who had been on methadone for 
over six years to see what they needed to move into recovery. Blind reductions in 
methadone were one method that could be used with client consent, or moving them onto 
buprenorphine (Subutex) was another method of moving clients towards being drug free. 
Clients showed an improvement in self-reported psychological health and quality of life over 
time but not in physical health. They did not show deterioration in physical health. 
Figure 63. CWP clients’ average self-reported physical health, psychological health, and quality of life 
from TOPs. Scores out of 20. Wirral, based on a cross section of clients from 2012/13 financial year. 
 
For clients who were discharged in the time period, the average time in treatment was 13.8 
months, and clients were seen on average twice a month, for 30 minutes each time. The 
clients with no primary drug recorded were those who were most likely to have been in 
treatment for over 5 years on average. There may be issues with how the data is updated as 
the NDTMS database has not been in operation for all the time that long term clients have 
been in the service. Some clients and other services reported that CWP had a lot of clients 
on long term methadone who were not seen very often and were followed up over the phone 
rather than face to face. Some people who had been through drug treatment said they had 
not been told about how they could go into recovery. The minimum recommended review 
schedule for people on methadone is to see their key worker face to face every three months 
and a doctor every six months. CWP said that all clients had a plan which included how 
often they wanted to be followed up, and whether they wanted to come off methadone. The 
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service reported that because some of their clients had very intensive needs, key workers 
may have to put a lot of resource into one person so if other clients did not want to be seen 
or were stable then they could not always prioritise seeing them. They gave an example of a 
man who had been in treatment for 20 years; the key worker had seen him regularly and he 
was on a stable methadone prescription, but the key worker had never been let in to see him 
at home where he lived alone with his dog. One time they went with an ex-service user who 
knew the man, and were able to access his home. They found that the accommodation was 
in an appalling state, with pigeons living in the upstairs rooms and the downstairs rooms 
being full of dog mess and rubbish. This client could not look after himself, but they could not 
get social services to define him as a vulnerable adult, so the CWP key worker took 
responsibility for finding him a place in sheltered accommodation, finding a place nearby for 
the client's dog who he did not want to be apart from, and organised a collection in the office 
to buy this client basic household items. This took the key worker the best part of a week to 
do, and would have ultimately given the client a significant improvement in his quality of life. 
The service also reported that dealing with clients with personality disorders can take up a 
lot of time, as they are often at the point of being kicked out of housing, rejected by their 
families, and where mainstream health services do not want to deal with them. 
Table 54. CWP discharged clients, average time in treatment and number of times seen. Wirral, 
2012/13 financial year. 
Primary drug N of clients 
completing 
treatment 
Average 
of 
Months 
in 
treatment 
Average N 
of times 
seen 
Average 
number of 
hours seen in 
treatment 
Average N 
appts 
/month 
Heroin illicit 145 11.4 23.2 9.7 2.0 
Methadone Mixture 26 8.3 20.0 8.9 2.4 
Not recorded 16 62.3 86.4 35.0 1.4 
Dihydrocodeine 7 3.7 15.4 9.8 4.2 
Codeine unspecified 6 5.9 20.0 11.3 3.4 
All clients 221 13.8 26.5 11.3 1.9 
 
Cost Effectiveness Results – Crack & Opiate User Model 
 
The majority of clients in CWP services were crack and/or opiate users. Results were 
modelled for 713 clients, of whom 221 completed treatment.  
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The average life expectancy with treatment was 3 years greater (or 2.61 QALYs) than 
without treatment and crime costs were around £150,000 lower over an individual's lifetime. 
So the treatment scenario dominates the no treatment scenario; it is more effective and less 
costly.  The average life expectancy was quite low overall at around 15.5 years; this is 
because the model has taken into account the age of the OCU population in Wirral who are 
generally in their 40s or 50s and have a high risk of health problems related to years of drug, 
alcohol and tobacco use. 
Table 55. Results from cost effectiveness model for opiate and crack users in Wirral, based on a 
lifetime model including treatment and criminal justice costs. 
  Treatment  No treatment 
Total cost (CI) 
 £10,929,649 
(7,628,388-
£14,230,910)  
 £95,177,051 
(£69,015,994-
£121,338,108)  
Total QALYs (CI) 
738 (730-
744) 
733 (726-739) 
Cost per patient (CI) 
£15,328 
(£10,699-
£19,959) 
£133,488 
(£96,797-
£170,178) 
Cost per completer (CI) 
£49,453 
(£34,517 - 
£64,393) 
N/A 
Cost per QALY (CI) 
£14,807 
(£10,251 - 
£19,483) 
£129,768 
(£93,385 - 
£167,105) 
ICER (Incremental Cost 
Effectiveness Ratio)  Dominant  Dominated 
 
Probabilistic Sensitivity Analysis – Crack & Opiate User Model 
 
A probabilistic sensitivity analysis (PSA) was carried out to see how sensitive the model 
results were to parameter estimates that are subject to a degree of uncertainty. The results 
of the probabilistic sensitivity analysis are shown in Figure 64. The iterations are mainly in a 
region that would be considered to be cost effective at a willingness to pay threshold of 
£20,000 per QALY (to the right of the dashed line). In the cost effectiveness acceptability 
curve, shown in  
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Figure 65, the intervention has a 73% probability of being cost effective at a willingness to 
pay of £20,000 per QALY and a 78% chance of being cost effective at a willingness to pay of 
£30,000 per QALY. A set of one way sensitivity analyses showed that the net present value 
of interventions was most sensitive to the costs of treatment and the cost of crime 
associated with drug use (Figure 66). 
Figure 64. Opiate and crack user model; iterations of incremental cost effectiveness, with 
ellipse showing 95% prediction intervals. 
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Figure 65. Cost effectiveness acceptability curve, opiate and crack user model, showing probability of 
drug treatment being cost effective vs probability not cost effective at different values of willingness to 
pay for one QALY. 
 
Figure 66. Opiate and crack user model. Tornado diagram showing one way sensitivity 
analyses. EV= expected value of net mean benefits. 
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Results – ARCH Drug Treatment Services 
ARCH typically saw clients with less severe drug dependence issues or provided aftercare to 
people in recovery. Clients were 73% male, 27% female. As with the other drug treatment 
service, it is difficult to carry out much equity impact assessment as it is difficult to determine 
the level of need in the population. Most local needs assessment around drugs is based on 
numbers of people in treatment rather than working from the ground up, although this may 
be very difficult to do. With aftercare services, the data indicated that a majority of people 
who exited the main drug treatment services provided by CWP did go onto something else, 
whether it was formal aftercare or whether it was narcotics anonymous which is provided 
voluntarily. 
Excluding those who had alcohol as their main drug, clients were 79% male, 21% female. 
There is evidence that female problematic drug users have greater needs than males so 
tailoring interventions is important; for example one in three women in prison have suffered 
sexual abuse compared with just under one in 10 men (Corston, 2007). Services said that 
women who had been heroin addicts talked about heroin culture as being “a man’s world” 
and that when they went into recovery they learned to be a woman again. Ethnicity was 
recorded for all clients; 98% were White, while 1.4% were Asian/Asian British, Black/Black 
British or Mixed, while 0.5% were not stated. Using a rough matching algorithm (as the 
postcodes only included the first 5 characters), around 61% of clients were from the most 
deprived parts of Wirral, which fall into the most deprived quintile nationally in terms of Index 
of Multiple Deprivation (IMD 2010) scores. These areas make up 32% of the Wirral 
population, so the most deprived areas have an odds ratio for being in drug treatment of 3.3 
compared to the whole of Wirral. In terms of sexuality, 1.7% of clients were recorded as 
homosexual (gay or lesbian) while 1.0% were bisexual, 87.5% heterosexual and 9.8% 
sexuality not given or not recorded. 
Overall there were 1,972 unique clients for Wirral in this time period of which 639 had 
alcohol as their primary drug and 1,333 had another drug. There were around 150 clients 
who were in the service for more than one different primary drug in the two years, mainly 
combinations of alcohol, heroin and methadone. Most drug groups had many more males in 
treatment than females. Cannabis had the highest ratio of males to females, while crack and 
amphetamine were the closest to having equivalent numbers of males and females in 
treatment. Most people (61%) lived in the most deprived areas, with crack users being 
particularly likely to be in the most deprived areas (74% estimated to live in the most 
deprived quintile). Compared with the CWP treatment services which were almost all primary 
opiate and cocaine users (although many steroid users use the needle and syringe 
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exchanges), there is a lot more diversity in terms of the drugs used by ARCH’s clients. This 
is because they provide a cannabis and stimulant service and because they have clients 
who are identified through the criminal justice system. 
Table 56. ARCH clients by source of referral. Wirral, 2011/12 financial year. 
First Primary Drug Group N clients Females Males Ratio 
M:F 
% of 
total 
clients 
Estimated % 
living  in most 
deprived 
quintile 
Alcohol  639 238 401 1.68 32% 59% 
Heroin  376 79 297 3.76 19% 66% 
Cannabis  363 47 316 6.72 18% 64% 
Cocaine (excluding Crack)  319 57 262 4.60 16% 54% 
Amphetamines (excluding 
Ecstasy)  
78 34 44 1.29 4% 63% 
Crack  68 32 36 1.13 3% 74% 
Methadone  56 15 41 2.73 3% 63% 
Prescription Drugs  34 11 23 2.09 2% 56% 
Other Opiates  12 5 7 nts 1% 42% 
Benzodiazepines  10 <5 6 nts 1% 50% 
Other Drugs  8 <5 5 nts 0% 50% 
Ecstasy  <5 <5 <5 nts 0% 67% 
Hallucinogens  <5 <5 <5 nts 0% 67% 
Misuse free  <5 <5 <5 nts 0% 50% 
Other Opiates  <5 <5 <5 nts 0% 100% 
Grand Total 1972 525 1447 2.76 100% 61% 
nts= numbers too small to calculate a meaningful ratio. 
In terms of additional drugs, 59% of clients had a second drug recorded (43% excluding 
alcohol as drug 2) and 28% of clients had a third drug recorded. Heroin and crack users 
were most likely to have a second and third drug recorded.  
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Table 57. Number of clients by first primary drug group with second and third drug recorded, ARCH 
data for Wirral, 2011-2013. 
Drug 1 Number of 
clients 
% with a drug 2 
(including 
alcohol) 
% with a drug 2 
(excl. alcohol) 
% with a drug 3  
(including 
alcohol) 
Alcohol  639 32% 32% 12% 
Heroin  376 85% 76% 54% 
Cannabis  363 47% 20% 13% 
Powder Cocaine  319 79% 39% 31% 
Amphetamines 
(excluding Ecstasy)  
78 68% 47% 28% 
Crack Cocaine 68 85% 69% 51% 
Methadone  56 79% 55% 39% 
Prescription Drugs  34 79% 59% 50% 
Other Opiates  12 67% 58% 50% 
Benzodiazepines  10 90% 80% 70% 
Total 1972 59% 43% 28% 
Excludes Other Drugs (continued), Ecstasy, Hallucinogens, Misuse free and Other Opiates (continued) which 
have small numbers. 
 
In terms of combinations of first and second drug groups, clients were very diverse with in 
excess of 150 combinations. Many clients reported combinations of alcohol and other drugs. 
Alcohol makes people less inhibited and more likely to seek drugs (Feil et al., 2010), which 
reinforces the need to treat any alcohol problems at the same time as other drug problems. 
Across the two years, 5% of clients were recorded as current injectors and 30% were 
previous injectors, excluding primary alcohol clients. 
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Table 58. Most common combinations of first and second drug, ARCH data for Wirral, 2011-2013. 
Drug 1 & 2 combination N of clients % of 
clients 
Alcohol only 436 22% 
Cannabis only 193 10% 
Heroin Crack  156 8% 
Cocaine (excluding Crack) Alcohol  126 6% 
Cannabis Alcohol  99 5% 
Cocaine (excluding Crack) Cannabis  83 4% 
Cocaine (excluding Crack) only 67 3% 
Heroin only 56 3% 
Heroin Methadone  52 3% 
Alcohol Cannabis  46 2% 
Heroin Alcohol  36 2% 
Cannabis Cocaine (excluding Crack)  35 2% 
Alcohol Anti-depressants  32 2% 
Alcohol Cocaine (excluding Crack)  30 2% 
Other combination 107 27% 
 
The majority of heroin users reported smoking rather than injecting heroin which is a 
success of clients in treatment being encouraged to use heroin in a less risky way (Figure 
67). Services also encourage crack smokers to smoke crack in a safe way, i.e. not through 
plastic or copper pipes which give off toxic fumes. 
Figure 67. Primary drugs by route of administration, ARCH clients, 2011/12 – 2012/13. 
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There were 1,972 unique clients in treatment over the 2 years, with the most common 
treatment modality being advice and information. There were 1,564 psychosocial 
interventions delivered. 487 clients had some sort of prescribing or pharmacological 
intervention. 
Table 59. Number of clients by treatment modality, ARCH data for Wirral, 2011-2013.  
Treatment modality Number 
 Alcohol Inpatient Treatment 347 
 Alcohol Structured Day Programme 280 
 Inpatient Treatment Detoxification 129 
 Inpatient Treatment Stabilisation 1 
 Specialist Prescribing 202 
Advice and information  1761 
Alcohol – Other Structured Treatment  8 
Alcohol - Structured psychosocial intervention  72 
Other formal psychosocial therapy  236 
Other structured intervention  13 
Pharmacological Intervention  285 
Psychosocial Intervention  579 
Psychosocial Intervention Mental Disorder  1 
Recovery Support  410 
Structured day programme  164 
Structured psychosocial intervention 676 
Total interventions delivered  5,164 
N clients with any modality 1,972 
 
In terms of housing status, 4% of clients had a recorded housing problem and 2.7% of 
clients had no fixed abode. 41% of clients with housing problems were primarily heroin users 
while the majority of the rest were primarily cannabis and cocaine users.  
Clients were fairly evenly spread across age groups from 20-49 with a few clients being 
older or younger than this. The average age of clients was 36 years including alcohol clients, 
or 32.8 years excluding alcohol clients.  The average age for men and women was similar. 
Staff from ARCH said that younger clients often felt let down by services and the police and 
sometimes the most important thing was 'planting the seed' with them, and making it easy 
for them to drop in when they were ready to make a change. ARCH has a partnership 
intervention with Forum Housing where they see mainly young people who are identified by 
a link worker. These clients may be identified through their behaviour such as having noisy 
all night parties. ARCH sees these clients in an informal non-drug setting, at Forum offices, 
in their home or in a café to break down the barriers so that the clients feel comfortable 
speaking honestly about their behaviour.  
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Figure 68. ARCH clients, Age at start of year in treatment, 2011/12 - 2012/13. 
 
In terms of individual drug groups, alcohol, crack, heroin, methadone and prescription drug 
clients were around 8-10 years older than cannabis, cocaine and amphetamine clients. In 
terms of average age of first use, there was a pattern of cannabis being very young at 14 
years, ecstasy and alcohol at 17, then cocaine and amphetamines at 20, heroin at 22, 
methadone at 25 and crack at 27. A member of staff from ARCH talked about clients who 
had used cannabis since their adolescence who were “locked in puberty and still acting like 
13 year olds”. The people who deliver the services reported that cannabis use was 
increasing as a problem in service users, who were coming through open access and 
referrals. There had been an increase in service users who had been arrested for cultivating 
cannabis for their own use, which they had chosen to do as it was more economic than 
buying off other people. The service reported some success stories for people who were low 
level cannabis users who did not realise the harms of cannabis. The service runs a monthly 
cannabis awareness session through the police which is provided as an alternative for 
receiving a caution for people who have been caught with small amounts of cannabis in their 
possession. 
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Table 60. ARCH clients by average age started using primary drug and average age at start of year in 
treatment. 
Primary drug group Number of 
clients 
Average age first 
used 
Average of age at start 
of year in treatment 
Alcohol  639 17 42 
Heroin  376 22 38 
Cannabis  363 14 27 
Cocaine (excluding 
Crack)  
319 20 28 
Amphetamines 
(excluding Ecstasy)  
78 20 33 
Crack  68 27 39 
Methadone  56 25 40 
Prescription Drugs  34 28 39 
Other Opiates  12 30 35 
Benzodiazepines  10 26 35 
Other Drugs (cont.)  8 33 39 
Ecstasy  <5 17 27 
Hallucinogens  <5 32 34 
Misuse free  <5 n/a 43 
Other Opiates (cont.)  <5 46 48 
Grand Total 1972 19 36 
 
In terms of source of referral, the biggest sources were self-referral, followed by arrest 
referral (i.e. through the Drug Intervention Programme), then hospital (mainly alcohol 
referrals to Birchwood residential detoxification), CARAT [Counselling, Assessment, Referral 
Advice, Throughcare ]/Prison, and drug services.  
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Table 61. ARCH clients by source of referral. 
 Main drug Tot
al 
% of 
Total Referral Source Alco
hol 
Other 
Drug Self  81 529 61
0 
31% 
Arrest Referral  6 250 25
6 
13% 
Hospital  219 11 23
0 
12% 
Other  113 86 19
9 
10% 
Counselling, Assessment, Referral, Advice and 
Throughcare (CARAT) /Prison  
26 117 14
3 
7% 
General Practitioner 97 30 12
7 
6% 
Drug service non-statutory  39 84 12
3 
6% 
Drug service statutory  20 90 11
0 
6% 
Probation  2 95 97 5% 
Social Services  18 22 40 2% 
Community Alcohol Team  9   9  <1% 
Outreach  1 6 7  <1% 
Criminal Justice Other  <5 <5 5  <1% 
Accident & Emergency <5 <5 <5  <1% 
Drug Rehabilitation Requirement <5 <5 <5  <1% 
Job Centre Plus  <5 <5 <5  <1% 
Drugs Interventions Programme <5 <5 <5  <1% 
Employment Service  <5 <5 <5  <1% 
Connexions  <5 <5 <5  <1% 
Syringe Exchange  <5 <5 <5  <1% 
Psychological Services  <5 <5 <5  <1% 
Total 639 1333 19
72 
 100% 
 
These outcomes are based on a cross section of clients across the two years. During this 
time a number of clients will start treatment, be followed up and will leave treatment. Most of 
the outcomes are based on TOPs (Treatment Outcomes Profiles) which are subject to bias 
as individuals may be keen to please their case worker, or may be afraid to say that they are 
continuing to use drugs. However some clients like those who are prescribed opiate 
substitution therapy or those on probation are also saliva tested for drugs every two weeks 
which acts as a check against their self-reported outcomes.  
Across all clients, average numbers of days using drugs in the last 4 weeks fell between 
treatment start, review and treatment exit (Figure 69). Use of cocaine, crack and 
amphetamine was particularly low at treatment exit. There were still 21 clients using opiates 
at treatment exit, but this would include prescribed methadone and buprenorphine. Alcohol 
and cannabis use was still prevalent at treatment exit. 
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Figure 69. Average numbers of days using drugs in the past 28 days, based on TOPs for all clients, 
ARCH, 2011/12 to 2012/13. 
 
Physical health was rated as 22% better for people at treatment exit than at treatment start, 
while psychological health was rated as 25% better and quality of life as 36% better. All of 
these differences were statistically significant (p<0.05). 
Figure 70. Average self-reported physical health, psychological health and quality of life, 
based on TOPs for all clients, ARCH, 2011/12 to 2012/13. Scores out of 20. 
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There were improvements in the proportion of clients who reported shoplifting and other 
crimes, and improvements in the number of clients who were in paid work or education at 
treatment exit. As stated previously, these self-reported measures may not always be 
reliable. 
Table 62. Crime and employment outcomes, ARCH data for Wirral, 2011-2013. 
TOPs Stage % 
reporting 
shoplifting 
% 
reporting 
selling 
drugs 
% 
reporting 
other 
theft 
% 
reporting 
assault 
% with 
paid 
work 
% in 
education 
Treatment 
Start 
4.1% 1.07% 0.71% 2.0% 12.8% 1.1% 
Review 3.3% 0.72% 0.32% 1.0% 10.1% 2.0% 
Treatment 
Exit 
0.3% 0.17% 0.00% 0.5% 17.2% 3.5% 
 
Economic Model Results – Cannabis & Stimulant Users  
A simple economic model was produced for cannabis and stimulant users based on 
evidence and data from ARCH. Overall the mid-range estimate of cost per QALY gained was 
£4,934 which would compare favourably with NICE’s threshold for willingness to pay for 
public health interventions of anything less than £20,000 per QALY gained (Rawlins et al., 
2010). This model considered the value of the individual quality of life gains alone; so once 
crime, employment, relationships, and reduction in risk of health problems like psychosis, 
lung disease or heart attack is taken into account, these interventions could be cost saving 
to the public purse. This is a very simple model and carrying out a PSA may change the 
results but even with this simple model the interventions are very likely to be cost effective 
based on the quality of life improvements alone. 
Table 63. Results of cannabis and stimulant user model 
Parameter Value Notes 
Estimated QALYs gained by completers 
(low estimate) 
0.046 QALYs based on 6 months linear change only 
Estimated QALYs gained by completers 
(high estimate) 
0.184 QALYs based on 1 year change 
Cost of intervention per completer £364 Cost of psychosocial only treatment SCNR for 
Wirral 
Cost per QALY gained (low estimate) £1,974   
Cost per QALY gained (mid estimate) £4,934   
Cost per QALY gained (high estimate) £7,895   
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Results – Drug Interventions Programme (DIP) 
The main types of offences committed by the 266 people in contact with the DIP were 
acquisitive and drugs offences. The analysis by LJMU (Cuddy et al., 2015) found that there 
was a significant reduction in offending in the 12 months post-test compared with the 12 
months pre-test (F [1,263] = 58.035, p < 0.001). There was a reduction across people who 
had tested positive for cocaine, opiates and both drugs (see Table 66). The overall volume 
of offending of Wirral residents in the sample reduced by 52% post DIP positive drug test. 
National research from 2007 suggested a 26% reduction in crime post-DIP (Skodpo et al., 
2007) so if national figures are still similar this means that the DIP in Wirral is associated 
with a greater reduction in crime than the national average. Those individuals who were care 
planned by the DIP team following their arrest showed the most substantial reduction in 
number of offences pre and post-test. However, there were no statistically significant 
differences between the three groups in the change in the numbers of offences pre to post 
test (F [2,263] = 1.931, ns) (Cuddy et al., 2015). This lack of statistical significance may be 
driven in part by the smaller sample size once the sample was split (see Table 64). 
Regression analysis was carried out to investigate predictors of future offending among 
Wirral residents who tested positive during the time period examined. The prolificacy of 
clients’ offending pre-test was a significant predictor of future offending (p < 0.001) but no 
other factors examined provided statistically significant predictors for this group. Individuals 
in the highest group for offending and with the most serious crimes showed the most 
substantial reduction in the seriousness of their offending.  
Table 64. Wirral Residents Testing Positive in the DIP – Number of Trigger Offences. Data 
for Wirral, April - September 2013. 
Groups Compared Mean Number of Offences Difference 
(pre – post) 
Significance 
 12 months 
pre test 
12 months 
post test 
  
Overall (n=266) 2.8759 1.3835 1.4924 p < 0.001 
Assessed (n=68) 2.2647 1.3088 0.9559 Ns 
Care Planned (n=141) 2.6809 0.9858 1.6951 
No further DIP Contact 
(n=57) 
4.0877 2.4561 1.6316 
Source: Table from Cuddy et al. (2015) 
 
The crime costing data included 264 out of 266 clients. The crime costs were 77% lower in 
the 12 months post DIP, or 43% lower excluding the one case of homicide (Table 65). This is 
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similar to the 52% reduction in the number of crimes. The data for costs of crime was not 
normally distributed so a non-parametric Wilcoxon signed ranks test rather than paired 
sample t test was used. The difference in costs between 12 months pre and 12 months post 
DIP was statistically significant (p<0.0001) with 209 out of 264 clients in the data having 
lower crime costs. This difference was still significant when homicide was taken out 
(p<0.0001). 
Table 65. Difference in average crime costs for Wirral DIP clients, 12 months before and 12 
months after DIP contact. Data for Wirral, April - September 2013. 
  12 months 
before 
12 months 
after 
Difference 
Average crime costs £11,626 £2,717 £8,909 
Average crime costs (excluding 
homicide) 
£4,762 £2,728 £2,034 
 
Table 66. Differences in crime volume and costs for Wirral DIP clients, 12 months before and 
12 months after DIP contact, by drug tested positive for (crimes include homicide). Data for 
Wirral, April - September 2013. 
Drug tested 
positive for 
Number of 
clients 
12 months pre test 12 months post test 
Mean N 
offences 
Mean cost of 
offences 
Mean N 
offences 
Mean cost of 
offences 
Both (Cocaine 
& Opiates) 54 3.69 £39,207 2.76  £4,246  
Cocaine 166 2.63 £4,808 1.02  £2,570  
Opiates 46 2.80 £3,348 1.09  £1,334  
Total 266 2.88 £11,538 1.38  £2,697  
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Table 67. Differences in crime costs for Wirral DIP clients, 12 months before and 12 months 
after DIP contact. Results of Wilcoxon signed ranks test (p <0.001). Data for Wirral, April - 
September 2013. 
Difference pre-post 
DIP Number 
Higher costs 42 
Same costs 13 
Lower costs 209 
 
A client level Monte Carlo simulation model was run for 10,000 simulated clients where each 
time a random scenario was drawn from the data distributions. Overall the Drug 
Interventions Programme came out as cost effective with an average net cost saving of 
£6,207, and 0.05 QALYs gained. A net benefit ratio was also calculated to compare with 
previous studies. The cost benefit ratio was £6.33 for every £1 spent, or £2.26 where 
homicide was excluded. As a comparison, in the DTORS study which included crime 
outcomes, also had a one year time horizon, but did not include the DIP, average net benefit 
ratio was around £2.50 for every £1 spent. Or in the earlier NTORS study which had a longer 
4 year time horizon, the cost benefit ratio was estimated as £9.50 for every £1 spent 
(Godfrey et al., 2004). The QALYs gained from the DTORS study were quite small and 
subject to a lot of uncertainty so they did not have a big effect on the overall cost 
effectiveness. There is no evidence for the minimally clinically important difference in QALYs 
for drug treatment, although in a cancer study it was 0.11 QALYs, which is more than the 
average difference here (Walters and Brazier, 2005).  
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Table 68. Wirral DIP Economic modelling results. Shown with 95% prediction intervals. 
Outcome Average 
2.5% 
lower 
limit 
97.5% 
higher 
limit 
Average 
with 
homicide 
taken 
out 
Cost of crime - before £10,226 £685 £37,069 £4,824 
Cost of crime - after £2,666 £0 £22,621 £2,802 
Cost of DIP £922 £532 £1,318 £923 
Cost of drug treatment £430 £236 £630 £431 
QALYs gained 0.050 -0.34 0.44 0.052 
Net costs -£6,207 -
£24,572 
£18,042 -£668 
Net Present Value (based on £20,000 per QALY) £7,234 -
£18,028 
£27,237 £1,699 
Total costs of DIP & drug treatment £1,352 £768 £1,948 £1,354 
Net social benefit (cost savings + monetary 
valuation of QALYs at £20,000 per QALY) £8,560 -£6,115 £23,248 £3,062 
Net Benefit Ratio (Benefits for every £1 spent) £6.33 -£7.96 £11.93 £2.26 
 
The cost effectiveness acceptability curve was developed to determine whether an 
intervention is likely to be cost effective at different levels of willingness to pay (WTP). This is 
particularly pertinent in drug treatment where QALYs related to crime are typically valued at 
£81,000 per QALY while QALYs related to health are typically valued at up to £30,000 per 
QALY.  
Figure 71 shows the cost effectiveness acceptability curve (CEAC) for the DIP. The curve 
with homicide taken out was almost identical to this. At £20,000 and above, the probability of 
the intervention being cost effective stays at around 60%. This is because many of the QALY 
changes in the DTORS study were negative so as the willingness to pay for a QALY gets 
higher, the uncertainty around the cost savings have less of an impact on the cost 
effectiveness and the value of the QALY has the greatest impact. In other words, at a 
willingness to pay of £20,000 per QALY and above, the value of the positive individual QALY 
changes are close to balancing out the value of the negative QALY changes so it becomes 
more of a cost comparison than a cost utility analysis. 
Figure 71. Cost Effectiveness Acceptability Curve. Wirral DIP model. 
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Drug Treatment Context-Mechanism-Outcome Table  
As with the smoking and alcohol work, the CMO table was distilled from the results of semi 
structured interviews with practitioners, commissioners and staff within the services as well 
as looking at other evidence and policy documents (Table 69). There are multiple complex 
mechanisms surrounding drug use and treatment and they are still not always understood.  
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Table 69. Drug Treatment Context-Mechanism-Outcome Table. SC= source of information is local 
service commissioner, SM= source of information is service managers, SW = source of information is 
drug service caseworker. 
Group Contexts Mechanisms Outcomes 
Heroin and 
crack users 
Wirral has a history of 
heroin addiction which 
began in the late 1970s 
when people would abuse 
an opioid, Diconal which 
was widely prescribed and 
stolen. Heroin smoking took 
off in the early 1980s which 
coincided with an economic 
downturn. Soon many 
people were injecting 
heroin and turning to crime 
to fund their addiction. 
Since then, numbers have 
been stable as people have 
been in treatment and 
heroin is seen by the 
younger generation as 
socially unacceptable. 
Smoking of crack cocaine 
took off in the early 2000s 
but is also much less 
common than other drug 
use such as powder 
cocaine use. Many people 
who use crack also use 
heroin. Since the 1980s 
substitution, mainly with 
methadone, has been 
available as well as needle 
exchange and drug 
treatment (Parker et al., 
1988) 
Methadone maintenance gives 
people a chance to confront 
their psychological and social 
problems while not having to 
immediately confront their 
addiction to opiates by going 
'cold turkey'. It can also help 
people to confront their financial 
problems. People are forced to 
confront their criminal behaviour 
and to recognise the impact they 
have had on their families and 
their communities. Psychosocial 
interventions allow people to 
explore and confront the causes 
of their drug use. Group 
sessions create a group 
dynamic which supports change 
(Connock et al., 2007). 
In Wirral, a large network of drug 
users means that drug takers 
can find a community of like-
minded people to reinforce their 
drug taking behaviour (SW). 
Merseyside’s prominence in the 
international drugs trade means 
drugs are cheaper and purer on 
Merseyside than other parts of 
the country and there are 
opportunities to work as middle 
men in the drugs business (SC) 
Some people go into 
'recovery' and become 
drug-free. Other people 
stay on methadone for a 
long time but it allows 
them to live more normal 
lives and have families, 
relationships and jobs. 
Some people leave 
treatment or relapse. 
Providing clean needles 
stops drug users from 
getting blood-borne 
viruses. Crime is 
reduced as people move 
to substitution or into 
recovery (SC). 
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Cocaine and 
stimulant 
users 
Powder cocaine use has 
become very prevalent. 
Use of stimulants like 
ecstasy and amphetamine 
('speed') is also prevalent 
although they are less 
addictive. Use of stimulant 
type novel psychiatric 
substances (NPS) in 
particular mephedrone is 
much higher than 5 years 
ago although has most 
likely peaked. Most 
stimulant users who use 
services are powder 
cocaine users but this may 
be partly as a result of how 
the service is structured 
(SM). 
Powder cocaine addicts are 
made to reassess their 
behaviour through psychosocial 
interventions. They may be 
sparked to change through 
realising that cocaine use brings 
out impulsive or violent 
behaviour, that it has become 
too much of a financial drain or 
that it is affecting their health too 
much. Many cocaine users are 
in a chemical depression (SW). 
People reduce their drug 
consumption or become 
abstinent. People 
understand what triggers 
cause them to use drugs 
(SW).  
Cannabis 
users 
Cannabis users often 
believe that cannabis is 
largely harmless. Cannabis 
is generally not a priority for 
police enforcement (SW). 
Interventions offer people who 
get apprehended by police in 
possession of cannabis 
education sessions instead of 
receiving a police caution (SM). 
These interventions often 
lead people to learn 
more about cannabis 
and the health risks 
associated with it and 
reduce their use (SM). 
The general 
population 
Many people in the general 
population have tried an 
illegal drug at some time, 
the most common being 
cannabis (Home Office, 
2013). 
People in the general population 
have differing ideas about the 
social acceptability of using 
different illegal drugs, with 
cannabis seen as acceptable by 
many and heroin seen as 
unacceptable by most (Home 
Office, 2013). 
People's drug use is 
partly driven by what is 
socially acceptable (SC). 
Image and 
performance 
enhancing 
drug (IPED) 
users 
Many young people, mainly 
young men, are using 
IPEDs, mainly steroids. 
Steroid injecting is 
increasing (ACMD, 2011). 
Services educate IPED users 
and provide needle and syringe 
exchange (SM). 
IPED users get fewer 
injection site injuries and 
infections and reduce 
their risk of getting 
infectious diseases from 
sharing injecting works 
(SM). 
Recovering 
drug users 
Many recovering opiate 
users are drifting into 
alcohol dependency. 
Opiate users are sensitive 
to mu receptor activity in 
the brain and the 
pleasurable effects of 
alcohol. They also may not 
have other activities or 
social ties that make them 
less likely to drift into 
alcoholism (Gelemter et al., 
1999). 
Services try to keep channels of 
communication open through 
aftercare programmes and 
identify people at risk of drifting 
into alcohol dependence and 
warn people in recovery that this 
is a common occurrence (SC). 
These interventions 
should increase the 
numbers of people in 
recovery who are 
supported to drink safely 
(SC). 
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Recovering 
drug users 
Some recovering drug 
users want to return to the 
labour market. 
In Wirral, structural 
unemployment means 
employers have a large pool of 
applicants, and do not need to 
keep people with drug or alcohol 
problems or take on people with 
a history.  
People in recovery may 
struggle to get jobs 
outside of the drug and 
alcohol field.  
Opiate users Opiate users sometimes 
overdose, especially when 
they come out of prison or 
have not used for a period 
of time, or if a particularly 
pure batch of heroin is in 
circulation (SW). 
Training users to administer 
Naloxone (an opioid antagonist) 
means that they can reverse the 
effects of a heroin overdose 
(McCauley et al., 2012). 
Heroin overdose deaths 
should be reduced 
(McCauley et al., 2012). 
Long term 
opiate users 
Many long term opiate 
users are afraid of coming 
off methadone and there 
are many myths around 
what happens when an 
individual tries to become 
opiate free (SM). 
Service users will do what they 
can to stay on methadone (SM). 
Clients do not move into 
recovery and become 
drug-free (SM). 
Drug 
treatment 
services 
The services have met their 
previous targets but are 
struggling now to get 
enough people into 
recovery (SC). 
The service still feels it is doing 
well given the circumstances 
that people are in (SM). 
People in the service 
may feel like the 
commissioners are not 
appreciating what they 
do or their successes 
(SM). 
Prescription 
drug users 
Prescription drug abuse is 
increasing and the internet 
has made it easier to obtain 
these drugs without a 
prescription (Holmes, 
2012). 
Drug treatment services feel 
they are only seeing 'the tip of 
the iceberg' in terms of 
prescription drug users (SM). 
Many prescription drug 
users do not get support 
from drug treatment, and 
deaths from some 
prescription drugs like 
Tramadol have 
increased greatly (SM; 
ACMD, 2013). 
 
7.4.6 Discussion 
This chapter has talked about an economic evaluation of drug treatment services in Wirral. 
The services that were modelled came out as being cost effective.  
Parts of Wirral had a heroin ‘epidemic’ in the mid-1980s, with as many as 1 in 10 young 
people using in some areas, and a crime epidemic as individuals stole to fund their habit 
(Parker et al., 1988). This epidemic was related to high levels of unemployment and young 
people feeling disenfranchised, as well as relative naivety about the risks and addictive 
nature of heroin. There are lessons to learn about how communities need to be more 
resilient to economic shocks, and how public health messages around new drugs need to be 
247 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
fed out into the community quickly. A peak in youth unemployment in 2011 does not seem to 
have led to an increase in young people trying crack or heroin as it did in the 1980s; this may 
be because the message has gotten out about the dangers of crack and heroin. Young 
people now are more likely to become daily cannabis users. 
The picture now for Wirral is of an older treatment population of mainly opiate, or polydrug 
opiate and crack users who have been in treatment for more than 5 years and have a long 
drug taking career of 20 years or more. These individuals normally stay engaged with 
treatment for a long time and many have been on a methadone prescription for a long time. 
These clients are typically scared of coming off methadone and some have resigned 
themselves to being dependent on the drug for the rest of their lives. These individuals find it 
hard to leave treatment but when they do leave, many are likely to maintain their recovery 
although around 30% come back into treatment within six months. Most people who relapse 
into drug use do so in the first few days and weeks, so supporting people through this time 
would seem to be crucial.  
There are also a group of people coming into treatment who are younger, do not use 
opiates, often come through being tested for drugs after being arrested, many of whom 
successfully complete treatment within 6 months. It has been reported that there are more 
professionals coming into services with cannabis and cocaine problems. The evaluation 
recommended that GPs and public health services should ask people more often about 
whether they use recreational drugs and offer brief interventions or harm reduction advice.  
The data suggested that the previously observed increased people moving into recovery had 
stalled. Services did have written plans for each person on long term methadone setting out 
how they plan to move into recovery and the drug services had carried out segmentation 
exercises to identify people for intensive support. Wirral’s lower performance compared with 
other areas could be due to a particularly ‘sticky’ population, or services not responding to a 
change of emphasis in the drug treatment system, or a combination of both. 
It was reported that quite often people in Wirral who were previously heroin addicts are 
drifting into alcohol dependence, so it is important to address both at the same time. The 
evaluation recommended that if people are coming off methadone they need to be 
supported to drink safely; otherwise they would probably be better off staying on methadone 
than drinking alcohol excessively every day. Some drugs workers said that it can actually be 
more difficult to give up alcohol than other drugs in the long term as alcohol pervades British 
culture so most occasions and celebrations are marked with alcohol, and people like to test 
themselves by having a drink which often leads back into dependence. Service 
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commissioners talked about how, as more flexibility was introduced to the funding system, 
some of Wirral’s drug treatment budget was spent on alcohol treatment. This was trying to 
recognise that recovery was just as relevant for alcohol, and that many people who initially 
have drug problems will also have or go onto develop alcohol problems.  
Services mentioned that there was a limited resource for residential detoxification and 
rehabilitation. Both of these are quite expensive but it may be that a more efficient way of 
providing these services can be found. Many clients benefit from going out of area for their 
rehabilitation as they are further away from the people and the lifestyle that reinforces their 
drug use. Because drug clients are by their nature chaotic (one former client described 
themselves as a "juggernaut of self-destruction") it is hard to know how to target resource to 
get the most benefit; sometimes it is just about creating the right conditions for when "the 
penny drops" and someone is ready to change. Some drug service clients said how they 
learned something every time they relapsed so all of the cycles of relapse and recovery were 
not necessarily wasted; rather they indicated the natural cycles associated with drug use and 
recovery. Several people in drug services said it was very difficult to get drug treatment 
clients recognised as vulnerable adults by social services and this meant that drug treatment 
services were doing the job of social services. 
Drug treatment service users reinforced issues over people being on high doses of 
methadone for a long time without any plan to get them drug-free; the need to sell clients the 
idea of recovery; the need for drug workers to be compassionate but also to push their 
clients to become drug-free; and that people in the recovery community could have a greater 
role in drug services. Some clients reported that they were stable on methadone and able to 
live productive, fulfilling lives and that pushing them into recovery could jeopardise their 
situation.  
Clients discharged from the main drug treatment services provided by CWP showed 
significant improvements on self-reported psychological health and quality of life. Clients and 
other services indicated that the time that CWP drug services were able to spend with clients 
was not optimal and that some clients were on a long-term methadone prescription and most 
often were being followed up over the phone. It may be that services need to do more to 
focus on the interaction as well as the transaction with these clients.  
The CWP Harm Reduction Unit include prescribing for common health problems and flu jabs 
and they argue that they act like a primary care service for some of the most marginalised 
people who may not access other services. The harm reduction service has spent a long 
time building up goodwill and trust with clients. The evaluation stated that these clients 
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needed to be considered when thinking about a future model for drug treatment as they 
might not access services if they were provided in community hubs.  
Wirral has a lower prevalence of blood borne viruses like Hep B, Hep C and HIV than other 
areas (HPA, 2012), which is an indication of the success of needle & syringe exchange 
programmes, as well as prescribing and psychosocial treatment. These services are likely to 
be very cost effective, based on the results from other published evidence (e.g. Health 
Outcomes International, 2002). 
Combating social isolation is really important in preventing drug use, and in helping prevent 
relapse in people who are in recovery who may have left their lifestyle and all of their friends 
behind, and may have moved from a different area. Promoting social inclusion and tackling 
stigma in communities is crucial (Weiss et al., 2014). There were issues highlighted around 
difficulties in finding housing for recovering drug addicts and for people coming out of prison. 
It was recommended that the council could endeavour to work more closely with hostels and 
housing associations to make sure all clients’ needs were met.The data in this research 
found that the drug environment in Wirral was changing, with opiate and crack cocaine use 
decreasing, and other drug use being stable. Test on arrest data suggests that powder 
cocaine use has increased over the last ten years. National data suggests that drugs like 
ketamine, and novel psychoactive substances like mephedrone are increasing in use. The 
average age of first use for cannabis clients in ARCH was 14 which suggests that 
interventions aimed at reducing cannabis use need to be in place from a young age. 
Changing the culture around drugs and teaching young people that drug use is less common 
than they might think is also important. 
Data from needle & syringe exchanges indicates that use of performance and image 
enhancing drugs like anabolic steroids, which are often injected, have also increased, which 
means that these people need access to advice and needle and syringe exchange 
programmes to prevent transmission of blood borne viruses and damage to blood vessels. 
These individuals are mainly young men, who often use other drugs and are at risk of 
spreading blood borne viruses through sharing needles, and having many sexual partners 
and infrequent condom use. These men often get their information and drugs from the 
internet and often use several different chemicals and use cocaine at weekends as well. 
It is likely that prescription drug abuse is increasing, with prescription drugs being easier to 
obtain over the internet. GPs and other prescribers need to be very aware of the risk of 
drugs being diverted, particularly benzodiazepines, opiate analgesics like Tramadol, and 
Ritalin (Luty, 2014). The CWP drug service had one dedicated member of staff for 
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prescription drug dependence but they may only be seeing the tip of the iceberg, and it is 
believed that GPs would like a lot more help particularly for people addicted to 
benzodiazepine drugs like Valium. 
In future if the opiate and crack using population continues to decline, there will be less need 
for the type of drug treatment services that there are now, and drug treatment services will 
have to realign more to provide brief interventions for less addictive drugs, and to treat 
powder cocaine as well as more novel drugs and prescription drug addictions. If the budget 
for drug treatment is reduced it needs to be reduced in a managed way to mitigate the 
chance of a blood borne virus or crime outbreak.  
Drug treatment started on the principle of being accessible, accommodating and non-
punitive, and being pragmatic in dealing with the presenting problem. If in the future, drug 
contacts are provided through council or healthcare hubs, or single points of assessment, 
this way of working needs to be preserved otherwise people may not access the services 
that they need. 
Service providers reported that changes in funding to services for children and young 
people, and changes to benefits like the “bedroom tax”, paying benefits monthly, and 
increasing use of sanctions may have a negative impact on the most deprived communities 
and increase the risk of drug problems and make life harder for people who are already drug 
users. There is a danger that as heroin and crack addicts become less visible and the 
narrative around them disappears from the popular discourse, the stigma and fear 
associated with these drugs will diminish, and young people will be more likely to try them 
again. So reinforcing the message around the dangers of all drugs is important. 
Using a welfarist perspective, it may be argued that drug users put a lower premium on 
health because they take risks with their health through their drug taking behaviour. However 
in our evaluations we have found that the increases in self-reported quality of life, and 
physical and psychological health, are much greater in magnitude than those reported from 
other studies where QALYs were used, which would typically be taking an extra-welfarist 
perspective. This may indicate that actually the differences in health related quality of life are 
more noticeable to drug users. However because the self-reported quality of life and health 
questions are asked to drug users as part of their meetings with case workers which involve 
a frank discussion of their recent drug use, there is some potential that they are primed to 
relate their drug use with health and thus give scores that relate more to their drug use, than 
say if they were asked after they had been to the gym. There is also the chance that they 
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would report bigger improvements to please their key worker because of a perceived risk of 
losing their methadone prescription or of other sanctions.  
The DIP (Drug Interventions Programme) is a programme which deals with drug use relating 
to offending, including prison engagement and ‘test on arrest’ where people arrested for 
trigger crimes are tested for drugs and put into drug treatment. Data from LJMU and 
Merseyside Police was modelled.  In Wirral crime costs were 77% lower in the 12 months 
post DIP than in 12 months before the DIP with an average difference of around £9,000 per 
client. An economic model suggested that the service was likely to be cost effective in Wirral. 
Although violent crimes are not considered ‘trigger crimes’ in the DIP, people can be drug 
tested on an Inspector’s authority, and anecdotally, there has been an increase in people 
arrested for violent crime who test positive for cocaine. 
Wirral is an area that has had a history of drug problems and still has quite a large drug 
using population (Hay et al., 2010). This combined with its long history of drug treatment 
services may mean that services in Wirral are more cost effective and more efficient than 
similar services in other areas which may be smaller and have a greater ratio of fixed costs 
to variable costs. The DIP evaluation should still be useful however in informing national and 
international decision making around drug test on arrest schemes. Because this kind of 
richness of crime data is not available for other drug and alcohol treatment services, the 
present study cannot make a direct comparison with other services in terms of their cost 
effectiveness through preventing crime. 
The DIP evaluation cohort included people tested for opiates, cocaine or both. There are 
other commonly used Class A drugs that are not tested for in the DIP such as LSD, 
psilocybin mushrooms and MDMA (ecstasy). Opiates would include prescription drugs like 
Tramadol and codeine as well as street heroin and methadone.  
The DIP testing process does not differentiate between powder cocaine and crack cocaine. 
It may be that some powder cocaine clients are more likely to be recreational or weekend 
drug users whereas crack cocaine clients are more likely to be addicts and to commit 
acquisitive crime to fund their addiction. Because crack is inhaled it produces a more intense 
high, which means that the dopamine system is typically down regulated more quickly than 
in powder cocaine use, leading to greater addiction (de Wit & Stewart, 1981). In clients who 
tested positive for cocaine, 46% had only one crime in the 12 months pre-test and of these, 
79% of these had no crimes in the 12 months post-test which may indicate people being 
picked up for drugs possession may not have been arrested again in the future regardless of 
DIP contact. However within people spoken to in drug services it was felt that both powder 
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cocaine and crack cocaine clients benefitted from drug treatment, and crime was reduced in 
all groups. People working within drug treatment reported that powder cocaine users that 
they encountered had financial and health problems and that many were in a chemical 
depression from their continued drug use.  This chimes with examples of financial problems 
(Boys et al., 2000), health problems (Murphy et al., 1989) and depression (Griffin et al., 
1989) reported in the published literature. 
In general cost-utility studies use an ‘extra-welfarist’ school of economics where utility is 
valued equally between individuals, rather than a ‘welfarist’ school where an attempt is made 
to value the individual welfare someone gets from an improvement in health-related quality 
of life (Brouwer et al., 2008). The QALY estimates used were from the DTORS, which may 
not accurately reflect the reality of the quality of life benefits for clients who have been 
through the DIP. The QALY estimates used the SF-12 survey instrument rather than the EQ-
5D which is considered by NICE to be the gold standard. The change in TOPS data over 
time suggests that individuals who are identified through the DIP show a significant 
improvement in quality of life. The TOPs quality of life scores showed a 27% improvement 
between treatment start and treatment exit, which if translated into QALYs could make the 
DIP come out as much more cost effective. However unlike other quality of life 
questionnaires like the EQ-5D, Short Form 12 and Health Utility Index there is currently no 
standard method for converting the TOPs scores into QALYs. Because the health and 
quality of life questions on the TOPs follow other questions which relate to drug use and 
crime, there may be an effect of clients wanting to please their key worker by giving them 
positive answers to the questions on the TOPs. This analysis only had a one year time 
horizon so the actual cost savings and benefits may be much greater. Because the DIP is 
essentially a way of funnelling people away from crime into drug treatment there is not a set 
amount of the benefits that can be attributed to the DIP alone, as it is part of an integrated 
system of criminal justice, and drug and alcohol treatment. 
The data used in this study were before and after data so there may be issues around 
regression to the mean. The DTORS cost effectiveness study was also a before and after 
study, which may underestimate the QALY gains from drug treatment, as without drug 
treatment individual quality of life may have declined rather than been stable, and a higher 
proportion of individuals may have died as well. It may not be considered ethical or practical 
to run randomised controlled trials in drug treatment but there may be scope for more robust 
research designs like cluster randomised controlled trials or natural trials in future. It would 
be interesting to compare the change in crime and drug treatment rates between areas that 
retain the DIP and areas that decommission it. However it is likely that the first areas to 
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decommission the DIP will be the areas that have the smallest problems around drugs and 
crime.  
7.4.7 Conclusion 
This evaluation was used as part of the recommissioning process; these services were 
about to be recommissioned when this piece of work was completed. Having a 'future proof' 
service with a focus more on the causes of drug use rather than on specific drugs was 
recognised as important, as this evaluation had stressed how fragmented the drug scene 
had become and that prescription drug use was also a growing problem. So for instance 
Table 56 shows a huge variety of different drugs being used by people in treatment; 
comparable historical data was not available but it is likely that drug use 20 years ago was a 
lot less diverse.  Having more services targeted towards young people and more prevention 
was also recognised as important. Having services that gave people who had been on long 
term methadone an extra push towards recovery also featured in the process. There was 
talk about services being commissioned as generic addiction services, covering gambling 
addictions for instance, but this failed to materialise.  
The results for the Drugs Intervention Programme were positive for Wirral; this was in 
contrast to some other areas in the North West of England which did not show the same 
magnitude of crime reduction in 12 months after being tested (Cuddy et al., 2015). Whether 
these results were due to how the service was implemented in Wirral, or due to differences 
in populations, we were not certain. In terms of the commissioning process this work was 
useful for commissioners and gave some ideas of what was working and what was not 
working. Because the narrative around drug addiction is so strong, and drug users in 
recovery become ‘evangelists’ for whatever method worked for them, it can be difficult to get 
a realist idea of which elements of a service were most successful in supporting to someone 
to become drug-free.  
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Chapter 8. Discussion 
8.1 What this Thesis adds to the Canon of Knowledge 
This chapter will discuss what this thesis adds to the existing body of knowledge, and make 
recommendations for policy and further research. The initial hypothesis was that economic 
evaluation when appropriately used potentially provides a useful tool by which to evaluate 
public health interventions and thereby to inform local decision making. The three case 
studies emphasize how the sensitive combining and application of economic evaluation 
techniques, equity impact analysis and realist evaluation can generate useful evidence to 
target public health resources more effectively. By combining detailed data and qualitative 
analysis with economic evaluation techniques it is possible to undertake a valid and reliable 
battery of techniques for evaluating the success of public health programmes. The case 
studies were undertaken in an action research setting in which they were directly fed into the 
public health decision making process within Wirral at a senior level. The feedback from 
decision makers emphasised the value that they placed on such evidence in terms of 
understanding the cost effectiveness of their services and identifying practical 
recommendations for how services can be improved. The modelling and the realist 
evaluation techniques used meant that the case studies had a lot of internal validity – the 
results were a good description of the local picture, but may have lower external validity – 
the results may be less applicable to other areas. But what is applicable to other areas is the 
techniques used, which means that with a few changes to the data, this type of evaluation 
could be replicated. The evaluation techniques in this thesis could be used in low income 
countries where public health interventions may have more potential to improve health and 
more years of life are lost through disease that is amenable to public health. In terms of 
treatment of addictions, there is definitely a need in low income countries. Tobacco smoking 
is becoming a much bigger cause of death in low income countries as tobacco companies 
have moved their efforts from Western countries where smoking rates are falling, to 
emerging markets which are less regulated in terms of tobacco control (Lee et al., 2012). 
Drug and alcohol use causes a high level of years of life lost in countries such as Namibia, 
Gabon and Mongolia compared to other countries (IMHE, 2015). 
Implementation 
In terms of implementation, measuring fidelity is important; if frontline service providers at 
the make changes to how services are implemented, the reasons and justification for such 
changes should be documented and made explicit. Effective service provision requires 
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providers to understand the processes of service implementation and provision and the links 
between inputs, processes and the outcome of service provision rather than  being more 'ad 
hoc'  in their approaches and judgments. In smoking and drug and alcohol treatment there 
exists considerable variation in success rates between different approaches and even within 
the same basic approach, and between individual case workers or advisors. In such a 
situation the effective dissemination and sharing of best practice and the implementation of 
effective mentoring becomes crucial. A lot of the success of these type of inter personal 
psychosocial interventions is down to using the right language and body language so 
learning this is crucial and for practitioners, having several different ways to explain 
something is essential. 
One example of an intervention which provoked a debate around implementation was the 
ASSIST (A Stop Smoking in Schools Trial) which was implemented in several areas and was 
recommended as an approach by NICE. The ASSIST programme is a peer-based 
intervention which takes students aged 12-13 out of classrooms, starting with a minimum of 
80 students for the first session and identifying approximately 18% as the most influential 
opinion leaders to continue and be trained as peer educators. Young people are more likely 
to smoke if their peers smoke; this is because of peer selection – selecting friends who 
smoke, and peer pressure – taking up similar behaviour to one’s peers to fit in with the 
group. The intervention aims to change the social norms in the school community to be that 
of a non-smoking environment. ASSIST was based on the American ‘Popular Opinion 
Leader (POL)’ initiative for the promotion of sexual health in gay men. ASSIST was piloted in 
Wales and shown to be effective across different settings, although more effective in rural 
locations. ASSIST was shown to reduce uptake significantly by 25% after one year and by 
15% after 2 years (although not statistically significantly after 2 years) (Campbell et al., 
2008). An economic modelling study found that the programme was cost effective 
(Hollingworth et al., 2012).  
After the pilot, ASSIST was developed as a set of products that local authority areas in the 
UK bought into. One such area was Wirral, where this service was implemented with some 
changes, made because of financial, planning and logistical issues, so while the original 
programme was delivered with young people aged 14 outside of school venues, the 
intervention in Wirral was delivered within schools. Now this may be regarded by the team 
who originally developed the interventions would as a case of omitting a crucial element of 
the programme, without which it may not have the same level of success, as a key 
component of the intervention was developing a rapport with young people and seeing the 
intervention as existing outside of discipline and control of the school system (Holliday et al., 
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2009). So with this change in implementation, if the intervention was still successful or was 
more successful than the pilot, then it may be regarded as making a successful change or at 
least trimming out an element that was not crucial in the success of the intervention. 
However if the intervention was not successful it could be claimed that this lack of fidelity to 
the original intervention was the reason for a lack of success. This is what Hogwood & Gunn 
(1984) call the difference between ‘non-implementation’ and ‘unsuccessful implementation’.  
Policy making can be described as ‘top down’, incremental or ‘bottom up’. Incremental policy 
means taking into account the situation as you find it rather than starting from zero and 
relying only on the evidence. Wirral was a pioneer for the harm reduction approach to heroin 
addiction so it was part of a ‘bottom up’ approach to policy. Also in Wirral there has been a 
history of a very small number of drug users being prescribed diamorphine (heroin) which 
may not be the case in other areas. This initially stemmed from patients transferred from one 
GP who was using a ‘bottom up’ or an experimental approach to implementation in terms of 
prescribing heroin and cocaine to drug users, while national policy said otherwise. But this 
was a GP with a special interest in treating drug addicts and perhaps a certain talent in it, or 
was at least welcomed because they were keeping drug addicts out of other GP’s clinics. 
Any new service provider that takes over the service may have a blanket policy of not 
prescribing heroin, but they may be flexible and wish to understand the historical context that 
applies to these clients and may even make an exception. This is an example of a service 
being implemented differently to suit the context. 
One of the aims in developing this thesis was to provide a set of techniques for how health 
economists, or analysts with modelling or research skills, should perform economic analyses 
of public health programmes. At a time of severe resource constraint in the provision of 
public health services the development of a body of cost effectiveness evidence based on 
rigorous and high quality economic evaluations will be essential in targeting interventions to 
areas of greatest health gain to local populations. Making the case for social gains from 
interventions debunks the libertarian argument that people should be left to make their own 
choices and the state should not step in. The external effects of alcohol, drug and tobacco 
use mean that everyone benefits from specialist interventions. The development of such an 
evidence base concerning how public health interventions work in the real world should also 
shed further light on factors underlying the significant variations that exist in outcomes for 
public health interventions. Such variations may result from differences in local population or 
other unavoidable characteristics; however they may also arise as a direct consequence of 
differences in the nature and quality of the implementation process and the quality, training 
and motivation of the staff involved in the implementation process. The methods in this 
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thesis mainly used an uncontrolled, before and after approach but these methods could be 
adapted to a control group approach which may produce more robust results.  
Although many local area public health teams commission and carry out evaluations 
(including economic evaluations) very few of them are shared outside of their organisations. 
Given that the most important issues facing public health tend to be the same throughout the 
UK this 'silo' mentality appears to be inappropriate. Although lessons learnt from one locality 
may not be directly and immediately transferable to other localities the underlying lessons 
are likely to be generalisable to different locations. Such sharing of research results would 
greatly facilitate the development of true structures of evidence based policymaking within 
public health. The reasons for the current situation could partly be because organisations 
feel that their evaluations are commercially sensitive, or they are worried that the methods 
they have used were good enough for making the decision but may be criticised by others. 
There are many public health commissioners across the country with similar questions 
concerning the comparative clinical and cost effectiveness of the services that they support. 
However identifying methods by which the sharing of results becomes standard or even 
developing research partnerships by which public health bodies can develop consortiums to 
jointly identify, commission, fund and share in the results of research of interest to all 
providers or funders of public health initiatives would transform the quality and quantity of the 
evidence base on which to make these crucial prioritization decisions for the weakest 
members of our society. 
8.2 Policy Recommendations 
In order to effectively inform public health decision making evaluations must be of high 
quality, relevant to the decision in question and, above all, timely. Unfortunately evaluation 
and research is often undertaken to a different timeframe which makes it of limited practical 
relevance in informing public health policy and decision making. To be relevant, evaluation 
should become more aligned more with the policy cycle. More needs to be done to align the 
public health research, evidence, policy and commissioning landscape so that policies and 
interventions that have been proven to be clinically and cost effective are promoted. 
However, given that public health often straddles the border between health and social 
policy, these relationships between research, policy and knowledge transfer (turning 
evidence into practice) are complex and may suffer from poorly defined lines of responsibility 
and accountability. 
The case studies in this thesis address areas of great importance to public health and are all 
priority areas for national policymakers. All of the services considered in the case studies in 
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this thesis are driven by national policies. The methods in this thesis may not be rigorous 
enough for the outcomes to influence policy directly, and the case studies may be seen as 
too parochial but there should be an opportunity for some of the deep qualitative insight to 
be used, or for the methods to be replicated. There are few studies that combine elements of 
realist evaluation with economic modelling. If public health interventions come out as very 
cost effective when compared to classical clinical interventions, and given that there is a 
large target population for them, these results could be used as evidence to call for a greater 
investment in public health. At the moment around 4% of the healthcare budget in the UK is 
spent on public health (PHE, 2015), when there is an argument for spending more on 
upstream interventions or changes in policy rather than treatment for diseases. Services for 
clients suffering from drug and alcohol addiction make up approximately 30% of national 
public health expenditure while policies and interventions aimed at enhancing smoking 
cessation make up another 5% (PHE, 2015). The high level of cost effectiveness arising 
from effective public health interventions aimed at smoking cessation implies that nationally 
more should be done to get smokers ‘through the door’ and into treatment. NICE’s move to 
recommend harm reduction for smoking cessation for the first time means that local 
authorities could provide more interventions to help individuals to reduce their smoking 
rather than quit outright (NICE, 2013b). 
Addiction services have all been evaluated to some extent, although the relative paucity of 
robust economic evaluations, particularly of drug and alcohol services, is perhaps surprising. 
The theory of people being robbed of their free will by addiction is one of the reasons the 
state justifies spending so much public money on treating addictions; these services are 
helping people who probably cannot help themselves (Vohs and Baumeister, 2009). But the 
main reason is that the cost of drug, alcohol and tobacco addiction on the health, social care 
and benefits system is huge, and the cost of drug and alcohol dependence on the criminal 
justice system are huge too (although in the case of alcohol, many people who are not 
dependent still use the health & criminal justice systems as a result of alcohol use as well). If 
services are very difficult to evaluate then this has implications for policy as well, as it raises 
the question of whether services should be commissioned if we cannot be certain that they 
work. As the policy space gets more crowded with an increasing number of policies, 
programmes and interventions, the number of interactions and the level of complexity in the 
system increases (Hogwood & Gunn, 1984). Policy can sometimes have unintended 
consequences where outcomes are different to those anticipated. For example the illicit drug 
economy is a complex system where an intervention to control supply of one drug may move 
people onto another more harmful drug. This is one reason why techniques such as realist 
evaluation are so valuable, because they take into account this complexity in systems.  
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This work also has implications for policy in demonstrating the success of these 
interventions that could be compared to other upstream policy interventions. The evidence is 
that, as you work down the chain from universal policy measures to individual level 
interventions, the risk of broadening rather than narrowing inequalities often increases 
(McGill et al., 2015). So even though we will see that the services looked at generally seem 
cost effective, they still have a large failure rate - people who do not recover from their 
addiction. Upstream interventions to reduce demand and access to alcohol, tobacco and 
drugs may be more successful and more cost effective. In the case of tobacco there have 
been several policy measures in recent years in the UK such as banning tobacco 
advertising, banning smoking in indoor public places, raising the minimum age to buy 
tobacco to 18, and plain tobacco packaging. It might be that in future bringing in measures 
like raising the age at which people can buy tobacco first to 21, then 25, then 30 years would 
be a cost effective addition to the current investment in stop smoking services. Or in the 
case of alcohol it might be that bringing in minimum alcohol pricing, displaying the calories 
prominently on alcohol bottles, and having mass education campaigns and making people in 
the alcohol industry pay towards alcohol-related injuries would be an addition to the current 
investment in alcohol treatment. It has been said that all policies can be boiled down to 
carrots, sticks and sermons; maybe the question is to find the most efficient mix of these 
three types of policies. 
Because some of these addiction services have been around for a long time, it may be that 
they have become slightly tired and a shake-up is needed, or that all of the 'low hanging fruit' 
- the people who were ready to change and give up their addictions - have been through 
services, and they are left with inertia, with the 'refuseniks' who find it too hard to give up. 
Certainly with some of these services the trend over time is for the uptake rates or success 
rates to fall; for example in Niblett (2014), smoking cessation uptake had fallen for two years 
in England. The data in the alcohol chapter showed how a lot of alcohol detoxification clients 
represent to treatment within a short time, or in the case of opiate addiction there are many 
people who have been on methadone substitution therapy for many years. Maybe the fact 
that they are still alive, no longer using street heroin and no longer committing crime is a 
success, but maybe the fact that they are still dependent on opiates is a failure. The policy 
around drug treatment has changed to a recovery model, but for clients who have been on 
methadone for a long time, and may have been promised that they could stay on methadone 
forever, it may be difficult for them to react to this policy change. Merely telling someone that 
they need to aim for recovery isn't going to suddenly change their behaviour, and some 
people have moved on to stable lives with jobs and families, so coming off methadone is just 
an issue that they do not want to contemplate. 
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There is a wide variation in practice between local public health teams in terms of how 
services are commissioned which implies that services can be tailored to the individualised 
needs of local populations. However such localised commissioning can also be inefficient in 
terms of the effort required to produce individual service specifications and the size of the 
population for which services are being commissioned. In this regard developing a greater 
culture for sharing information and the templates on which contracts are based would 
significantly reduce unnecessary duplication of effort and enhance the efficiency underlying 
the process. 
Contracts for public health services often specify data requirements without having clarified 
in detail what the data is needed for. Information that is both timely and accurate is the life 
blood of the public health commissioning process and developing a clear and rational view of 
data requirements is essential. In this regard the development of a national information 
system that can be easily accessed by commissioners to evaluate services would provide 
invaluable evidence to support their decision making. A lot of time in this project was 
devoted to requesting, chasing up, checking and cleaning data to ensure its availability, 
consistency and reliability. Further significant effort was required to match up data between 
different information systems with many information systems being largely designed for 
customer relations or contract management rather than analysing activity and outcomes. 
There has been several cost effectiveness models produced that have been mentioned or 
used in this thesis. Most of these demonstrate that investment in public health interventions 
is a good use of resources when compared with a given threshold, for example the NICE 
threshold of £20,000 - £30,000 per QALY gained (Rawlins et al., 2010). Commissioners and 
providers like to know that their services are cost effective; however having more 
benchmarking data would be useful in terms of understanding whether services are efficient 
when compared with each other or with similar services in other parts of the country. Some 
tools around drug treatment like the Cost Effectiveness Tool and the Value for Money tool 
(PHE, 2013) allow comparison with national averages but not with local neighbours. There 
are always caveats around these types of comparison, in terms of comparative service costs 
and the extent to which differences in client characteristics make different services non-
comparable.  
8.3 Limitations of this Research 
The nature of public health research is such that, almost inevitably, any comparisons made 
will be based on before and after data with no control group. Therefore it is not always 
possible to be sure that any change in behaviour or outcomes happened as a result of the 
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intervention and not as the result of external factors that will have altered between the two 
periods being analysed. These case studies have where possible looked at a pattern of 
outcomes rather just one outcome, and many have shown an improvement across several 
outcomes. Because many public health interventions involve moving people from behaving 
like a less healthy population to behaving like a more healthy population, there is usually a 
good quality theory for the mechanism of how an intervention improves health (Fischer et al., 
2013). Using qualitative research and realist evaluation helps to understand and describe 
the mechanisms and give more evidence for how interventions work. With smoking 
cessation people have to exhibit a minimum level of motivation that is captured in their 
desire to access services. Requiring clients to display this level of motivation is crucial in 
effectively targeting services. For services to be most efficient they need to be accessed by 
people who are motivated to change their underlying health behaviours. If services are 
merely being used by either people who are not going to quit, or people who would have quit 
anyway, then they are not changing the health behaviour or improving the health experience 
of clients. It is identifying and assessing the extent of this alteration in knowledge, attitudes 
and behaviour that makes the isolation of effect underlying the provision of public health 
interventions so difficult to determine accurately. 
It is difficult to compare results of studies with different perspectives and methodologies; this 
work has mainly taken a health and social care perspective. Having better data linkage 
between systems - so having access to healthcare usage, crime data, benefits data and use 
of public health funded services - would allow a far more comprehensive analysis to be 
undertaken with regard to comparative cost effectiveness. 
8.4 Recommendations for Future Research & Methods 
The double blind randomised controlled trial is universally perceived as being the 'gold 
standard' method for evaluation the effectiveness of healthcare provision. There is a 
significant body of such evidence in support of the belief that smoking cessation works but 
there have been comparatively few randomised controlled trials of drug and alcohol 
interventions. With drug and alcohol interventions there is still a real tension between the 
'medical' and the 'social' model and identifying the optimum mixture of psychosocial and 
pharmacological interventions required by each client is paramount to achieving a successful 
outcome. In this manner having more practical research to identify which elements of 
psychosocial and pharmacological treatment are most important and how they can combine 
together in a mutually supportive manner would be useful.  
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The ambition with this thesis was to work towards a practical set of techniques and 
recommendations that should underpin the economic evaluation of public health 
programmes. In this regard the following recommendations are proposed for evaluating 
public health programmes; 
1. Specify good quality, raw data from providers (but not data that is not needed).  
Without raw data it is difficult to model the effectiveness of services, and to carry out equity 
impact analysis to understand if the service is taken up by those who need it most, and who 
the service works best for. 
2. Do not reinvent the wheel, there are lots of models & tools out there, use them. 
There has been an increase over the last few years in tools that can be used by local areas 
to estimate the return on investment for different public health interventions such as the 
NSMC Tools (Lister & Merritt, 2013) or the NICE Tobacco Control Return on Investment tool 
(Meads, 2014). It would be useful if more academics who produce models of cost 
effectiveness could in future try to package up their models so that they can be used by 
commissioners, and if more tools could be produced to measure efficiency as well as cost 
effectiveness, such as by collecting data and benchmarking between areas.  
3. Engage with stakeholders; find out what questions they want the work to answer. 
Take time to immerse yourself and understand how services work. 
The ambition with these pieces of work was for them to be useful for commissioners so 
always had in mind what the decisions were that the work was supporting. Engaging with 
stakeholders is really important in understanding mechanisms, particularly any novel 
mechanisms that may be missing from the policy literature.  
4. Look at the international, national and local policy context. 
Knowing what the policy objectives are and the story of why services were commissioned is 
an important element of evaluation. Understanding how policy has changed over time and 
who the main stakeholders are is important, so for instance in tobacco control the tobacco 
industry has traditionally fought against policy measures whereas in the case of illegal drugs 
the industry does not have such a public presence. Most of the services evaluated in this 
thesis have their roots in a rational, often 'top-down' evidence-based medicine or evidence-
based policy approach, albeit that in the case of drug treatment, Wirral was a pioneer of 
harm reduction measures like needle and syringe exchange. Understanding the policy 
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context is important in describing which elements of a service or an evaluation are 
transferable and which may be unique to a particular service in a particular place. 
5. Consider how services are commissioned; could they be commissioned on a bigger 
footprint? Do they need commissioners to take more of a handle or are they being 
micro-managed too much? Are services being commissioned for outcomes? 
How services are commissioned is a key driver in how successful they are; striking the right 
balance in terms of size of service, and how much input the commissioners and providers 
have is important. If services are too small they may not be efficient but if they are too big 
they may be unmanageable. If commissioners and providers do not have a good relationship 
then they might reach a stalemate where providers are waiting to be micromanaged and 
commissioners are waiting for services to bring new ideas to the table. This relates to the 
implementation question, how much should implementation follow a 'top-down' process and 
how much should it be 'bottom-up' process? If services play it safe too much they may not 
be sensitive enough to local needs, but if they change too much they may lose the crucial 
ingredients of a service that really make it work. 
6. Look at any JSNA or other needs assessments for any unmet needs in the 
population; are services hitting the right people? Is the service targeted towards 
vulnerable groups? This is the Equity Impact Assessment element. Think about 
inequalities in terms of equity impact analysis and consider using distributional cost 
effectiveness analysis. 
Public health services have a responsibility to improve the health of the population but also 
to provide what Marmot (2011) called proportionate universalism, that is to tackle health 
inequalities, so understanding whether services are taken up and are achieving outcomes in 
proportion with the level of need in the population is important. Distributional cost 
effectiveness analysis has potential especially in describing services where cost 
effectiveness may be lower in some marginalised groups but this is where needs are 
greatest, and the cost of engaging and maintaining contact with vulnerable groups may be 
higher.  
7. Realist evaluation – think about the context-mechanism-outcome; if you do not know 
which contexts and mechanisms generate the best outcomes then it is hard to 
generalise from the results. 
Public health interventions are more context dependent than other clinical interventions so 
ignoring the influence of context and local implementation would mean that part of the 
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picture was being missed. Realist evaluation is not the only method, and other methods such 
as cause and effect or driver diagrams, ‘theories of change’ or implementation science could 
be used, but carrying out evaluation without considering the complexities of service delivery 
would be falling short of the potential to generate real insight into how a service worked. Any 
evaluation needs to try to account for the context, even if it cannot always control for the 
context. 
8. State your perspective – in terms of economics, politics etc. There is no such thing as 
being impartial in social research. 
It can be argued that being explicit about where you are coming from as an evaluator is 
important, however some people disagree with this position and in this piece of work this 
was not really included. One of the principles of realist evaluation is being clear about your 
own perspective (Pawson, 2013). 
9. Tailor the economic model to the question being answered. 
Any modelling should be driven by the question being posed, not by fitting a model to the 
question. Some services lend themselves better to a long term Markov model while some fit 
a decision tree model better. In the case of addictions, services where people are in contact 
with services for a long time and have a pattern of many cycles of relapse and recovery may 
lend themselves better to Markov models. Of course there are always compromises where 
data is not available.  
10. Think about social return on investment and wider social value. Most public health 
interventions have cross sector effects so should not be measured in terms of health 
outcomes alone. 
Having a broader perspective beyond health is important when looking at public health 
interventions, so for instance cigarettes are associated with litter and fires; alcohol and drugs 
are associated with crime. Considering these outcomes is important in working towards a 
true assessment of the value of these interventions. Including cross sector outcomes is 
difficult but not impossible; and it is better to try to include them even if it is difficult to be very 
precise. 
11. Many services will come out as cost effective when compared to a threshold or a do-
nothing alternative but most will not be maximally efficient. Where possible use 
benchmarking data to compare efficiency with similar areas. 
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Many public health interventions are cost effective when compared to a ‘do nothing’ 
comparator. Understanding which elements are most cost effective is important and involves 
thinking about which mechanisms are most successful in producing outcomes, and using 
benchmarking data to compare with similar areas allows an understanding of whether a 
service is as efficient as it can be. For instance, smoking cessation is very cost effective, but 
if an area has a cost per quit that is twice the national average; there may be scope for it to 
be a lot more efficient.  
 
8.5 Reflections on Research 
8.5.1 Overall Reflections 
Overall commissioners and service managers welcomed these case studies as representing 
a “deep dive” look at the clinical and cost effectiveness of their major services. All service 
providers and commissioners want their services to be as good as possible and welcome 
feedback. In undertaking an evaluation of any public health intervention it is vital to work 
closely with health professionals who understand the context in which services operate. 
However when speaking to service providers and service users it is important to be aware of 
the commitment that they will have in favour of the service being evaluated--they are not 
independent assessors and should not be treated as such. They are inherently biased in 
favour of their own services, and often the knowledge that an evaluation was taking place 
would make them worry about the future of their service and concerned to show the service 
in a good light. However the experience of this thesis is that as long as the evaluator is 
aware that service providers and users are likely to provide a 'rosy' picture from their specific 
perspective, then the information and insights you can get from them can be invaluable 
Without getting this context from services around outcomes and activities it is difficult to get 
towards the 'true' value underlying the provision of each service. 
There exists a scepticism in certain parts of public health with regard to the appropriate role 
that health economics should play in the evaluation of public health interventions (Brouwer et 
al., 2007). There is a perception in some that health economics can only play a limited role in 
terms of assessing the clinical and cost effectiveness of public health interventions. One of 
the major lessons of this thesis concerns the inherent importance of health economics in 
evaluating and targeting public health interventions. Just as in the case of other therapeutic 
interventions public health must make its case to be trusted with our increasingly scarce 
healthcare resources. A major element underlying such a case is the need to prove that the 
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outcomes that they produce are greater than those that can be produced through the use of 
their resources applied in some alternative manner. Public health cannot be spared the 
rigours associated with the justification of resource allocation on the basis of opportunity 
cost. 
One of the principles of health economics is that wherever possible the analyses should be 
undertaken from a societal perspective which includes all relevant costs and outcomes 
(Weatherly et al., 2009). This thesis has emphasised the extent to which public health 
interventions have cross-sector effects which require an assessment of indirect and broader 
outcomes such as crime and productivity. There was resistance from some staff concerning 
collecting more outcomes data; as part of this process of evaluation it became routine for a 
lot more services to collect EQ-5D and WEMWBS data (sadly not for the case studies in this 
thesis) and spent a lot of time meeting with staff to explain how to do this. Both of these 
measures are self-reported so should be relatively simple to collect but it was a case of 
explaining to staff why it was important that such data should be collected and making staff 
feel confident about collecting them. 
Services need to have outcome measures that are useful, practical but are robust and 
reliable. In drug & alcohol services they use TOPs (Treatment Outcomes Profiles) as the 
main outcome measure. These were developed by the UK National Treatment Agency 
(NTA). This includes questions about quality of life. However many economic evaluations 
use cost per QALY as the main outcome measure. It would be very valuable if a study could 
be done either linking TOPs results with EQ-5D data to estimate the health related quality of 
life changes associated with TOPs states, and to produce a lookup or conversion table to 
match up TOPs with EQ-5D and QALYs. This would be contingent on there being a 
consistent relationship observed between TOPs and EQ-5D. Alternatively, substance misuse 
services could use the EQ-5D instead of the health and quality of life questions on the TOPs. 
It could be that the NTA have explored this already and the decision is driven by issues 
around licensing the EQ-5D. It may be reasonable to expect that drug clients may not always 
be honest on questions on the TOPs as they want to maintain any substitution therapy (e.g. 
methadone) they get access to, and feel they need to please their key worker by showing 
that they are making progress. 
8.5.2 QALYs 
Some senior managers said that they knew what QALYs were but in fact it was clear that 
they thought of them as life years without the quality of life element. They did not realise that 
QALYs were often gained through an improvement of quality of life rather than an increase 
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in life expectancy. Although QALYs are the gold standard recognised by NICE, there still 
seems to be some way to go in explaining QALYs to people outside of the research and 
health economics fields, despite them being quite easy to understand once they have been 
explained. 
Some managers were concerned about saying that services were cost effective 'compared 
to a do-nothing alternative'. This is a standard phrase used in health economics where there 
is no comparator, which is often the case when we look at public health interventions. But 
managers were concerned because they thought that this meant that an intervention was 
only slightly better than doing nothing. So health economics as a discipline should think 
about how these phrases can be interpreted. 
8.5.3 Modelling  
The main reason that modelling was used in this work was to account for gaps in the 
outcomes data and to estimate long term outcomes based on short term surrogate 
outcomes. Senior management did not particularly want to get involved in the complexities 
involved in modelling. On reflection, the researcher may not have made enough attempts to 
engage commissioners in the modelling process but tried their best to explain the models 
and their limitations to them. In particular it stressed how better quality outcomes data and 
cost data would make models more accurate and reduce uncertainty.   
There was often disagreement between senior managers on key issues and on interpreting 
the results of the work; this is probably healthy though and indicates that there are not a 
small number of people setting the narrative. Managers bring their own experience into their 
perspective so those with a criminal justice background may have a different perspective to 
those with a nursing background, to those with a medical background or a psychology 
background. 
There was concern that commissioners might not be happy with the estimates of cost 
effectiveness from these evaluations which were generally more conservative than those 
published elsewhere. For instance the incremental cost per QALY in the smoking cost 
effectiveness model was higher than other models which found that services would be cost 
saving. The main driver of this was the long term quit rate - national studies have long term 
quit rates of 20-30% with dual NRT or with Champix (Fidler et al., 2011), but there is not a lot 
of evidence for this, and in Scotland where they record long term quit rates it is more like 6-
8% (NHS Scotland, 2012). 
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Commissioners were interested in the difference between cost effectiveness and efficiency; 
all of the interventions included in this programme of evaluations came out as cost effective 
(although some elements of another set of services looked at around weight management 
did not come out as cost-effective). But being cost effective compared to a do nothing 
alternative is not the same as being maximally efficient. Even if a service is cost saving, 
there may still be an opportunity cost when compared to another service that may produce a 
larger cost saving. Commissioners need to be getting the best value for money, not just 
delivering value at less than the threshold of £20,000 per QALY. For drug treatment services 
there was a broad range of benchmarking tools that allowed cost per client and cost per 
completion to be compared against national. But commissioners are only able to get data for 
their own area, not for their neighbours to compare against. Having more benchmarking data 
for public health services would enable better comparisons of efficiency to be made. For 
smoking cessation services there is a national data collection programme which enables 
cost per quitter to be benchmarked by local authority, although there are some doubts about 
consistency in the data collection.  
Since public health split from mainly being one team to having separate commissioners and 
providers, there are probably expectations from providers who want the economic 
evaluations to demonstrate that services are cost effective, to commissioners who may want 
to demonstrate services are cost effective to show that they have been commissioning them 
well, or may want to demonstrate that they are not as cost effective as they could be and use 
this as reason to decommission or to  put services out to tender, or at least to ask services to 
do more within their budget. From the outset these evaluations attempted to maintain an 
impartial perspective. 
8.5.4 Realist Evaluation  
This thesis has shown signs of how realist evaluation and health economics can 
complement each other well. Most of the researcher’s work has been evaluating and 
prioritising public health interventions and realist evaluation is especially useful for 
accounting for the complexity (as well as cross sector effects, long payback time) and 
differences in implementation observed with public health interventions Other qualitative 
methods like logic modelling or ‘theories of change’ also have a contribution to make, but 
they often assume a linear sequence of events between inputs and outputs and may miss 
some of the latent power relationships that may determine whether programmes really work. 
In realist evaluation, programmes are said to be unique but programme theories are rarely 
unique and are said to often be transferable and crop up over and over again. If this is the 
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case, it would be good for there to be a list/repository/database somewhere for programme 
theories, but this is not the case at the moment. This would mean that evaluators would not 
be starting from scratch so often.  
In terms of understanding CMO configurations, it is difficult to know when elements stop 
being the mechanism and start being the context, so for injecting drug users, the availability 
of methadone and needle exchange services was originally the intervention in the mid-1980s 
but it could be argued that it has become the context, and possibly reinforces some drug 
using behaviour rather than limits it. For example drug users talked about methadone being 
something that was expected, which they then topped up with other street drugs like crack 
and heroin.  
When public health managers were briefed about realist evaluation, they were generally 
quite interested in it. Public health managers are increasingly thinking about an assets-
based approach to health rather than a deficit based approach and realist evaluation fits in 
well with this because like the assets-based approach it values the importance of 
understanding the local context (Morgan & Ziglio, 2007).  
Realist evaluation uses the researcher’s experience and viewpoints; but there is an idea 
that if the researcher is too empowered and enjoying themselves too much then they cannot 
be producing good research. Some commentators think that good research should be 
painful or it is not proper research. Realist evaluation is traditionally a mixed methodology. 
Qualitative and quantitative methods have been associated with different epistemological 
viewpoints and different research paradigms over the years. Traditionally quantitative 
research methods aim to design out the personal influence of the researcher with methods 
such as randomisation or blinding whereas some qualitative researchers believe in 
acknowledging or even celebrating the psychological identity of the researcher and the 
personal history and viewpoints that they bring to a research topic in the form of 
‘positionality’. Some research of sub-cultures would be impossible without first achieving 
insider status. However some commentators have suggested that qualitative research 
should also aim to be impartial (Hammersley, 2000). 
As well as thinking about realist evaluation techniques within the narrative of the evaluations, 
the realist evaluation has been summarised using context-mechanism-outcome 
configurations in the form of a table. In some cases this has listed some contexts 
independent of mechanisms, which may not be the orthodox way of doing it. This has tried to 
disaggregate the CMO configurations by who the agent is, for example, whether it is the 
client using the service, the general population, or the service itself. It may have been useful 
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to add in an estimate of the importance or the proportion of people affected by a CMO 
configuration, so for instance for methadone, estimate what proportion of clients are afraid of 
no longer being prescribed methadone. It may also be useful to have an estimate of certainty 
for each CMO configuration, as they are essentially early theories. Highlighting which CMO 
configurations are based on only a small number of testimonies or a small body of evidence 
would be useful.  
8.6 Conclusions 
Health economics is still in its infancy and hence any 'conclusion' with regard to its role is 
inevitably premature. This is particularly so with regard to the application of health economic 
methodologies and techniques to the complex and inherently 'messy' area of public health. 
This thesis has used three case studies to demonstrate how economic evaluation 
techniques can be combined with elements of realist evaluation and equity impact analysis 
to develop a structure of evaluation that can and has been applied in practice to evaluate a 
series of public health programmes at a local level. Public health programmes typically 
comprise of complex interventions embedded in complex systems in which external 
elements (peer pressure etc.) are likely to be at least as powerful as the public health policy 
being assessed. As such, and in the absence of a randomised controlled trial, caution has to 
be exercised in identifying and isolating the effect of the public health programme alone. 
Economic modelling techniques combined with realist evaluation techniques can mitigate 
this to a certain extent and provide a method by which longer term outcomes can be 
modelled from short term surrogate outcomes enabling the true cost effectiveness of 
interventions to be estimated more robustly. Because most public health interventions 
involve trying to ‘nudge’ less healthy populations towards behaving more like healthier 
populations, theory plays a big role in planning programmes. Given the importance of 
targeting services at clients who are in the greatest need, equity impact analysis provided a 
method by which this crucial element could be incorporated into the evaluation. This was 
undertaken by analysing the distribution of clients accessing public health programmes and 
comparing this to a distribution of need or deprivation in the local population. In this manner 
it proved possible to  assess the extent to which each intervention was achieving their aim of 
not only providing effective health outcomes at an acceptable level of cost effectiveness but 
also of assessing the extent to which each intervention proved effective in impacting on 
health inequalities.  
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Appendix 2. Semi Structured Interview Questions. 
 
Questions for semi structured interview for specialist smoking 
cessation treatment. 
If there are any questions you don’t want to answer or don’t feel confident answering 
then this is fine. Any answers will be reported in a general way, not attributed to you. 
1. How / why did you get into working in smoking cessation services? What are your 
personal motivations now? 
2. What do you think makes for an effective stop smoking advisor?  
3. How do you think the focus of smoking cessation has changed over time? 
4. What do you think smoking cessation services should be delivering, in the way of 
services and outcomes? 
5. How well do you think services work together? 
6. What do you think needs to happen to make services work better? 
7. What do you think about different stop smoking aids like NRT and Champix? 
8. What do you think about electronic cigarettes and their impact on smoking and on 
services? 
9. What factors do you think predict success in smoking cessation clients? 
10. What are the changes you have seen in the smoking population you have seen over 
the last 3-5 years? 
Questions for semi structured interview for alcohol specialist treatment. 
If there are any questions you don’t want to answer or don’t feel confident answering then 
this is fine. Any answers will be reported in a general way, not attributed to you. 
1. How / why did you get into working in alcohol treatment services? What are your 
personal motivations now? 
2. What do you think makes for an effective alcohol worker?  
3. How do you think the focus of alcohol treatment has changed over time? 
4. What do you think alcohol treatment should be delivering, in the way of services and 
outcomes? 
5. How well do you think services work together? 
6. What do you think needs to happen to make services work better? 
7. Do you think alcohol culture has changed over time? 
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8. What do we need to do to tackle the alcohol problems we have? 
9. What proportion of alcohol clients are current or ex drug users? 
10. What do you think about the effectiveness of alcohol detox? 
11. What do you think about the effectiveness of residential rehab for alcohol problems? 
 
Questions for semi structured interview for drug treatment. 
If there are any questions you don’t want to answer or don’t feel confident answering then 
this is fine. Any answers will be reported in a general way, not attributed to you. 
1. How / why did you get into working in drug services? What are your personal 
motivations now? 
2. What do you think makes for an effective drug/substance misuse worker? What is an 
effective substance misuse worker?  
3. I might ask what they understand by the term “Recovery”, what do they think 
“Recovery” means? 
4. Asking about the move to add recovery to the agenda and what they think about the 
shift of focus from “harm Reduction” to Recovery. Is this a good change?  
5. What do you think substance misuse services should be delivering, in the way of 
services and outcomes? 
6. How well do you think services work together? 
7. What do you think needs to happen to make services work better? 
8. Do you think there is more of a role for people in recovery in helping services? 
9. What do you think about the role of methadone? 
10. What do you think about fellowship? 
11. What factors do you think predict success in drug service clients? 
12. What are the changes you have seen in the drug treatment population over the last 
3-5 years? 
13. Do you think there are serious unmet needs in the population for drug treatment? 
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Appendix 3. Brief Report; Using a Survey to Estimate Health 
Expectancy and Quality Adjusted Life Expectancy to Assess 
Inequalities in Health and Quality of Life. 
Keywords: EQ-5D, QALYs, population surveys, health inequalities 
Word count: 2,410 
Table count: 2 
Figure count: 2 
Abstract 
There has been a policy debate in the UK about moving beyond traditional measures of life 
expectancy and economic output to developing more meaningful ways of measuring national 
wellbeing. In this study EQ-5D data from a wellbeing survey was combined with actuarial life 
expectancy (LE) data to estimate healthy life expectancy (HLE) i.e. years of life lived in good health, 
and quality adjusted life expectancy (QALE); i.e. quality adjusted life years lived for Wirral, a borough 
in the North West of England. It was found that the gap between Wirral and the most deprived areas 
was 4.45 years for LE, 5.34 for QALE and 7.55 for HLE. The gap in QALE was 20% greater than the 
gap in LE, while the gap in HLE was 70% greater. The fact that the QALE value lies between the HLE 
value and the LE value suggests that QALE is a more sensitive indicator than HLE, as in this study 
QALE is derived from 243 possible EQ-5D profiles whereas HLE is based only on whether or not an 
individual rates their health as good, a binary variable. This study discusses how QALE could be 
useful indicator for measuring health inequalities in future, especially as cost utility and QALYs are 
seen as the gold standard used by NICE in the UK to measure outcomes for health interventions in 
England, and discusses how a monetary valuation of QALYs could be used to put a societal cost on 
health inequalities. 
1 Introduction 
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In the UK there has been a recent policy debate about regarding wellbeing as an economic good, 
measured alongside established measures of income like GDP, and health, such as life expectancy 
(LE) (1). This change in focus chimes with the OECD’s Istanbul Declaration (2) on improving 
wellbeing and considers the Easterlin paradox first described in 1974 (3) – that increasing income 
does not always increase happiness, and hedonic treadmill theory, that adverse life events do not 
change an individual’s level of happiness as much as expected (4). The UK Office for National 
Statistics (ONS) has formulated wellbeing measures across ten domains; the economy, individual 
well-being, our relationships; where we live, health, natural environment, personal finance, what we 
do, governance, and education and skills (5).  
The UK had increasing levels of income inequalities since the 1970s, with inequalities in health 
outcomes remaining despite targeted investment (6). The gap in health expectancy or healthy life 
expectancy (HLE) between areas is typically wider than the gap in LE, indicating that health 
inequalities are greater when morbidity and mortality are combined. In the EU-27 countries the largest 
LE gap between countries for males is 12.3 years (between Iceland and Lithuania) whereas the 
largest HLE gap is 50% greater at 18.4 years (between Sweden and Slovakia). For females the 
highest LE gap is 7.6 years whereas the highest HLE gap is 18.3 years (data for 2009 (7)). A study 
comparing QALE across countries found some interesting patterns with women in two countries 
(Spain and the Netherlands) having a smaller QALE gap than LE gap, meaning that Spanish women 
live longer with more health problems than Dutch women (8). 
ONS have previously measured disability-free life expectancy (DFLE) as well as HLE at birth and at 
age 65, calculated by combining actuarial cohort LE data with survey data. Although EQ-5D is used in 
population health surveys such as the Health Survey for England, it has not been routinely used to 
assess quality adjusted life years (QALYs) experienced across a population. There is a disparity 
between the UK gold standard in measuring health outcomes (the EQ-5D and QALYs recommended 
by the National Institute for Health and Clinical Excellence (NICE)) and what is seen as the gold 
standard in measuring health status across the population (measures such as HLE recommended by 
ONS). Internationally, DALYs (disability adjusted life years) are used for the World Health 
Organisation (WHO)’s Global Burden of Disease (GBD) project which was recently updated (9).  
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The EQ-5D-3L (Euroqol 5-dimension-3 level) is a self-reported health related quality of life tool which 
consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) 
each of which can take one of three levels of severity (no problems/some or moderate 
problems/extreme problems). EQ-5D profiles are matched to UK utility scores giving the desirability of 
a particular health state, measured  between -0.594 (worst health state) and 1 (perfect health). In a 
randomised controlled trial (RCT), change in utility as a result of a health intervention is measured in 
the same person at baseline and at set time intervals, so that any change can be attributed to the 
intervention. This change in utility is used to calculate QALYs experienced. The EQ-5D being self-
reported has an element of subjectivity where individuals may have similar health status but 
responses indicate different levels of health problems. In a RCT individual improvement in the EQ-5D 
is used to calculate the QALYs gained, so this accounts for some of the subjectivity, an improvement 
is always an improvement. But in a population level study such as this, each individual is completing 
the EQ-5D once; however with a large sample size (1,522 people in this study) some of these 
subjective differences would even out across the population. This element of subjectivity is also true 
for HLE which is widely used as a measure of health status. It has been claimed that the EQ-5D is not 
sensitive in measuring health problems such as fatigue, sensory impairment, or mental health 
problems, and if so then the impact of these conditions would be under-represented in QALE derived 
from EQ-5D survey data. 
The aim of this study was to show that because QALE is based on the EQ-5D profile, which has 243 
possible health states, QALE will be more robust as an indicator of population health than LE or HLE, 
which are both essentially based on binary variables, i.e. whether after a period of time an individual 
is still alive, and if they are, whether they rate their health as good.  
2 Methods  
Life expectancy (LE), healthy life expectancy (HLE), and quality adjusted life expectancy (QALE) were 
calculated for Wirral, a borough in the North West of England, with an estimated ONS population of 
309,000 people in 2009. This area was chosen because Wirral has extremes of affluence and 
poverty, with the East side containing some of the most deprived areas in England and the West side 
being an affluent retirement destination. Data was combined from a wellbeing survey (10) that was 
commissioned for the North West of England (N=1522 for Wirral), and carried out in 2009, and 
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mortality and population data for 2005-07 (3 years pooled), which was the most recent data available 
when the results were analysed. The methods for collecting the survey are described in more detail 
elsewhere (11). Survey data was weighted by age, gender and deprivation so that the scores should 
represent a true average. The weighted EQ-5D index scores and health status scores were combined 
for males and females and grouped into six age bands, 16-17, 18-24, 25-39, 40-54, 55-64 and 65 and 
over. These utility scores used the UK EQ-5D value set produced by Euroqol using a representative 
sample (3,359 people) of the UK population using the time trade-off method (12). Because the 
wellbeing survey was only carried out on individuals aged 16 and over, a maximum utility score of 1 
and a probability of reporting oneself as being healthy of 1 was assumed for ages under 16.  
Cohort life expectancy was calculated using the Chiang II method (13) used by UK ONS. The utility 
and self-reported health data was combined with the life expectancy data using the method outlined 
by Sullivan in 1971 (14). This is where QALE is calculated as 
QALE = 
∑ (𝑈𝑎×𝑃𝑎)𝑧𝑎
∑𝑃
× 𝐿𝐸 
Where U=average utility in age group a, P=Population surviving in age group a, z= maximum age 
group, and LE = total cohort life expectancy (years). 
To understand inequalities in health and quality of life, the analysis was carried out for the whole of 
Wirral, as well as for the areas of Wirral that fell into the 20% most deprived and 20% least deprived 
lower layer super output areas (LSOAs, a small area geography used by ONS, where each contains 
on average 1,500 people) nationally based on the Index of Multiple Deprivation (IMD) 2007, which is a 
widely used UK deprivation measure (15). Of the Wirral population at the time, 32% fell into the most 
deprived quintile, and 10% into the least deprived quintile. 
3 Results 
The differences in utility and LE were analysed for Wirral as a whole and for the most and least 
deprived quintiles. The characteristics of respondents from each group are shown in Table 1. The 
least deprived areas have a greater proportion of males answering the survey, are older on average, 
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and have a greater proportion of people in employment. The groups were similar for average mental 
wellbeing score as measured using the Short Warwick Edinburgh Mental Wellbeing Scale 
(SWEMWBS). The sample size in the most deprived areas is much greater, because people in the 
most deprived quintile make up a greater proportion of the population in Wirral than those in the least 
deprived, and a booster sample in the most deprived areas was commissioned. 
[Table 1. Comparative statistics for the most & least deprived areas and the whole of Wirral.] 
With an independent samples t-test, there was a significant difference in EQ-5D derived utility scores 
between deprivation quintile 5 (most deprived) (mean=0.749, sd= 0.343) and deprivation quintiles 1-4 
(the rest of Wirral) (mean =0.809, sd=0.286); (t(1522)=-3.710, p<0.001). This result means that the 
most deprived areas experienced significantly lower utility on average than the rest of Wirral. 
Weighted utility scores were lower for the most deprived areas than for Wirral and for the least 
deprived areas for all age groups except 18-24. The differences were most pronounced in the 40-54 
and 55-64 age groups, with a 25% gap between most and least deprived (see Figure 1). The utility 
scores were from a population sample, not a cohort, so the smaller difference in older age groups 
could be due to a healthy survivor effect where individuals with the worst health have died at a 
younger age. 
[Figure 1. Average EQ-5D index utility score by age group, whole of Wirral, Wirral most deprived, and 
Wirral least deprived.] 
In terms of LE, the gap between the least and most deprived areas in Wirral was 8.1 years, while the 
QALE gap was greater at 12.7 years, and the gap in HLE was greatest at 14.7 years (see Table 1 and 
Figure 2). Between Wirral and the most deprived areas, the gap was 4.45 years for LE, 5.34 for QALE 
and 7.55 for HLE. The gap in QALE was 20% greater than the gap in LE, while the gap in HLE was 
70% greater. 
[Table 2. Life expectancy, healthy life expectancy and quality adjusted life expectancy in Wirral, most 
and least deprived areas, based on mortality and population data for 2005-07.] 
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[Figure 2. Life expectancy, healthy life expectancy and quality adjusted life expectancy in Wirral, 
based on mortality and population data for 2005-07.] 
4 Discussion 
For Wirral, years lived in good health were 73.7 on average for 2005-07, an increase of 6.1 years 
since the Census in 2001 when HLE was 68.6 years, although it may be that there are methodological 
issues with the survey used, such as it under-representing people who live in nursing homes or 
hospitals who are likely to have poorer health and lower utility scores. The sample size of the survey 
was quite large (1,522 across Wirral), and was weighted for age, gender and deprivation, but there 
were two relatively affluent areas of Wirral, Heswall and Royden, under-represented in the survey 
data. Also the survey was only carried out on individuals aged 16 and over, so we have assumed a 
maximum utility score of 1 for ages under 16, which was the average for 16-17 year olds in the 
survey, however it is likely that very young children suffer from more illnesses than 16-17 year olds 
meaning lower utility.  
This study shows that depending on which measure is used, health inequalities can be shown to be 
much wider than the gap in LE alone. It may not be a surprise that the QALE gap is wider than the LE 
gap, as people who are healthy will generally live longer, but being able to quantify the gap over time 
will give an idea of how the gap has changed, and there are examples (such as comparing women in 
Spain and the Netherlands) where the LE gap is wider than the QALE gap, which is useful for 
stimulating discussion around trade-offs between health and longevity. 
This study has shown how individuals living just a few kilometres away from each other in Wirral are 
experiencing health and illness differently; and Wirral has been said to be almost a microcosm of 
England in terms of having wide health inequalities. The fact that the QALE value lies between the LE 
value and the HLE value can be regarded as good evidence that it may be closer to the true picture of 
health expectancy. Whereas health expectancy is based on a binary variable, the EQ-5D-3L has 243 
different health states. 
Because EQ-5D derived utility scores can be less than zero, this could pose a mathematical problem 
in using QALE as a population health indicator, as people with utility scores less than zero would have 
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negative QALE, and would in effect have their life expectancy deducted from the population life 
expectancy. We used average utility scores in each age group, but scores below zero will have 
contributed to these averages. Some other studies have adjusted utility values so they are floored at 
zero (16). This ability of EQ-5D indices to be less than zero may be one of the reasons it is not 
routinely used to measure health-adjusted life expectancy across a population, as this may be 
ethically or methodologically controversial. 
A study by Burström and colleagues (17) put a monetary value on the QALY gains that occurred over 
a period of time in Sweden, using a value of $100,000 per QALY. Monetary values are not typically 
attributed to health inequalities in this way in UK policy literature. The quoted NICE threshold for 
paying for new technologies is an incremental cost effectiveness ratio (ICER) of £30,000 per QALY 
gained. From the QALE data it can be calculated how many QALYs would be needed to raise the 
QALE in the most deprived areas to that of the whole of Wirral; this is 2053.9 QALYs per year. It can 
therefore be said that at this threshold of £30,000 per QALY, that the QALE gap in Wirral is worth 
£61.6million per year, or £620 per person in the most deprived quintile. This lost potential for quality 
and quantity of life could be considered as a premium that society pays for allowing such social 
inequities that manifest themselves in health behaviours and outcomes from before birth. This is only 
taking into account the threshold for investment to reduce health inequalities alone, as other forms of 
spending, such as on parks, policing or social care, do not have a similar decision rule, but would be 
closely bound to health inequalities and wellbeing.  
Limitations of this analysis are that the wellbeing survey was for a slightly different time period than 
the mortality and population data was for, 2009 against 2005-07. The data we used was for all 
persons combined; the reason for not splitting by gender was because otherwise the numbers for 
individual deprivation quintiles and age groups would be too low to produce significant results. If 
males and females were analysed separately then males would have a lower LE and a wider gap 
between the most and least deprived, as the Slope Index of Inequality data for Wirral indicates (18). 
To calculate QALYs experienced we used the population in each age group and the average utility, 
we did not attempt to turn the utility scores into a continuous curve, so this may affect the QALE 
calculation in particular in the 65+ age group which is open-ended.  
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In conclusion, this article has outlined a method of combining health-related quality of life data (in this 
case using the EQ-5D) with life expectancy data to illuminate the socioeconomic gradient in quality-
adjusted life expectancy. We have shown that in Wirral, average utility in the most deprived areas was 
significantly lower than in the rest of Wirral, and the gap in QALE was greater than the LE gap, and 
less than the HLE gap. This indicator of health inequalities could be used in future for testing the 
impact of health interventions on QALYs experienced across a population. 
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Appendix 4. Smoking Treatment Data Definitions 
Category Data Item Description 
 Basic Data   ID Unique ID for each client 
 Basic Data   Attempt No. Quit attempt number 
 Basic Data   Location Local authority (always Wirral for Wirral data) 
PersonalDetail Gender Gender (male or female) 
PersonalDetail Age Age in years 
PersonalDetail Postcode Partial postcode in format CH43  
PersonalDetail Electoral Ward electoral ward 
PersonalDetail Ethnicity ethnicity (standard ONS groups) 
PersonalDetail 
Socio economic 
classification 
Full Time Student ; Home Carers (unpaid) ; 
Intermediate Occupation ; Managerial and 
Professional Occupations ; Never Worked or 
Unemployed For Over 1 Year ; Retired ; Routine 
and Manual Occupation ; Sick/Disabled and Unable 
To Return To Work ; Unable to code . 
PersonalDetail Fagerstromscore 
Fagerstrom nicotine dependence test score 
(measured between 0 and 10). 
Health Medical Conditions 
List of medical conditions e.g. high blood pressure, 
mental health problems, diabetes etc. 
DetailofQuit Type of Referral 
Person who referred client, e.g. self, midwife, GP 
etc. 
DetailofQuit Attempt/Quit Date Date of quit attempt in format 01/05/2011 
DetailofQuit 4 Week Quit 
Whether client has quit at 4 weeks and whether 
confirmed with carbon monoxide 
DetailofQuit 12 Week Quit 
Whether client has quit at 12 weeks and whether 
confirmed with carbon monoxide 
DetailofQuit 
Type of Intervention 
Delivered 
Type of intervention out of Closed Groups ; Drop In ; 
Family/Couples ; One To One ; 
Open Groups ; Telephone Support. 
DetailofQuit 
Type of Intervention 
Setting 
Setting of smoking intervention out of; 
Community Setting ; General Practice Setting ; 
Hospital ; Other: Please State; Pharmacy ; Primary 
Care ; Stop Smoking Service ; 
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Appendix 5. Drug & Alcohol Treatment Data Definitions 
Note: These data definitions come from the NDTMS (national drug treatment monitoring 
system) dataset that was current when these data were analysed for the evaluation. 
SEX 
ETHNIC  
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NATION – nationality  
REFLD – date of referral  
AGNCY- Agency code 
CLIENT – client reference number  
CLIENTID – client ID 
EPISODID – episode of treatment ID 
CONSENT 
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PREVTR 
 
PC – postcode  
ACCMNEED 
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PRNTSTAT 
 
DAT - Drug Action Team (of residence based on postcode) 
PCT – Primary Care Trust (of residence based on postcode) 
LA – Local Authority (of residence based on postcode) 
DRUG1, DRUG2, DRUG3 
 
309 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
310 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
311 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
312 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
313 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
314 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
 
 
315 Applying Economic Evaluation to Public Health:  
Case Studies in Cost Effectiveness 
 
DRUG1AGE - age when first used drug 1 
ROUTE 
 
RFLS 
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TRIAGED – triage date  
CPLANDT – care plan start date  
INJSTAT 
 
CHILDWTH 
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PREGNANT 
 
ALCDDAYS 
Drinking days - Number of days in the 28 days prior to initial assessment that the client 
consumed alcohol  
 
ALCUNITS 
Typical number of units consumed on a drinking day in the 28 days prior to initial 
assessment  
 
DUALDIAG 
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HEPCSTAT 
 
HEPCTD HEPCTSTD 
 
HEPBVAC 
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HEPBSTAT 
 
HLCASSDT 
 
Drug treatment health care assessment date  
 
TOPCC 
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DISD – discharge date  
DISRSN 
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MODAL 
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REFMODDT – modality referral date  
MODID – modality ID  
FAOMODDT 
Date of First Appointment Offered for Modality  
 
MODST – modality start date  
MODEND – modality end date  
MODEXIT 
 
SUBMODDT – sub modality start date  
TITDATE – time in treatment date  
TITREAT 
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TITID – time in treatment ID  
TOPDATE - TOPS date completed  
TOPID – TOPS ID  
TRSTAGE 
 
 
ALCUSE OPIUSE CONSMP CRAUSE COCAUSE AMPHUSE CANNUSE OTDRGUSE 
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IVDRGUSE SHARING 
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SHOTHEFT DRGSELL OTHTHEFT ASSAULT 
 
PSYHSTAT PHSTAT QUALLIFE PWORK EDUCAT ACUTHPBM HRISK 
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EMPSTAT 
 
 
 
